[
  {
    "model": "accounts.customaccount",
    "pk": 12,
    "fields": {
      "password": "pbkdf2_sha256$600000$cPmzjrONlsziodDHXHNqk2$fvkZYUaYqWa2pfTxFmYjbtgY9n8NiBgQDQ5Wzy49Luw=",
      "last_login": "2025-12-01 22:55:49.242173",
      "is_superuser": 1,
      "username": "Nick",
      "first_name": "",
      "last_name": "",
      "is_staff": 1,
      "is_active": 1,
      "date_joined": "2025-06-05 11:13:53.180298",
      "role": "",
      "email": "Nick@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 13,
    "fields": {
      "password": "pbkdf2_sha256$600000$ENkhm3KlMGWAUrbirgyVhQ$e8W2tHwrgxeyc3nIWQueKHTsIVdlTAW2rAKp14jOMgY=",
      "last_login": "2025-08-14 11:05:12.257977",
      "is_superuser": 0,
      "username": "CVS_pharm",
      "first_name": "CVS",
      "last_name": "Pharm",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-05 11:18:59",
      "role": "pharmacy admin",
      "email": "cvs@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 14,
    "fields": {
      "password": "pbkdf2_sha256$600000$QgY39KRXAnQEPag2P14neJ$UlNbwc0dBYTPPbcGDE+EY3je8ZZWvI3bG1TWugE8XTU=",
      "last_login": "2025-08-14 17:17:33.143124",
      "is_superuser": 0,
      "username": "RightAide_pharm",
      "first_name": "Right Aide",
      "last_name": "Pharm",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-05 11:32:09",
      "role": "pharmacy admin",
      "email": "rightaide@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 15,
    "fields": {
      "password": "pbkdf2_sha256$600000$uaEmEYdTjixs84XSXmnUqU$nyLO4FNglvL707YH6q/7Mv+JckKfcv9pPheAH/o+1UU=",
      "last_login": "2025-08-14 17:17:09.400084",
      "is_superuser": 0,
      "username": "ngeorge",
      "first_name": "Nick",
      "last_name": "George",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-05 11:45:30",
      "role": "pharmacist",
      "email": "ngeorge@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 16,
    "fields": {
      "password": "pbkdf2_sha256$720000$qqJKog2UTCHOKexgbd84zb$JKsTg7nGIGCVB0n1UmhMBvEAoFOYXdgh4KQMWNznnFQ=",
      "last_login": "2025-07-16 11:48:48.471246",
      "is_superuser": 0,
      "username": "rsmith",
      "first_name": "Rod",
      "last_name": "Smith",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-05 12:10:56",
      "role": "pharmacist",
      "email": "rsmith25@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 17,
    "fields": {
      "password": "pbkdf2_sha256$600000$0fWzdohWR2b54beOhbpt9s$74JvMp8bkA8afUbUCM838PAKtGI30JykVlrW5bYQkO4=",
      "last_login": "2026-01-03 13:04:53.236289",
      "is_superuser": 0,
      "username": "jjackson",
      "first_name": "Justin",
      "last_name": "Jackson",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-05 12:28:43",
      "role": "patient",
      "email": "jjackson@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 23,
    "fields": {
      "password": "pbkdf2_sha256$600000$ocBo1fWPqwUs2KX5zkfh8d$/N7hOPKzuW9q1KuYDHHMcNJrPr81UgXix35KGyDrkAs=",
      "last_login": "2026-01-05 20:38:49.702613",
      "is_superuser": 0,
      "username": "woodlands_pharm",
      "first_name": "woodlands",
      "last_name": "pharmacy",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 10:31:32",
      "role": "pharmacy admin",
      "email": "woodlands@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 47,
    "fields": {
      "password": "pbkdf2_sha256$600000$RaQH0gTPl2QaLDd2T6mN1j$6/neAUUP5x/pnJ6ig2VWexA3Ff0mTr/1uLd2nlfhauc=",
      "last_login": "2026-01-02 22:19:05.614658",
      "is_superuser": 0,
      "username": "marshallgroup_pharm",
      "first_name": "marshallgroup",
      "last_name": "pharmacy",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 10:31:48",
      "role": "pharmacy admin",
      "email": "marshallgroup@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 70,
    "fields": {
      "password": "pbkdf2_sha256$720000$ffDp5zYB6hCkOlqbBnNuTw$pSlfdJVnqXO0mhPSFdYDo6u/8o70lYxaLD/gP2iQCek=",
      "last_login": null,
      "is_superuser": 0,
      "username": "wallbrowns_pharm",
      "first_name": "wallbrowns",
      "last_name": "pharmacy",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 10:32:05",
      "role": "pharmacy admin",
      "email": "wallbrowns@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 302,
    "fields": {
      "password": "pbkdf2_sha256$720000$YdUzW1QGzGlHvS8Xf2J7mQ$WU4IoJIQGFVMEN5oRzSSep/OewE2ro9SAG6BbhytZBs=",
      "last_login": null,
      "is_superuser": 0,
      "username": "rnavarro",
      "first_name": "Randall",
      "last_name": "Navarro",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:35.841442",
      "role": "pharmacist",
      "email": "rnavarro@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 303,
    "fields": {
      "password": "pbkdf2_sha256$720000$IFgX6jjv5K9JOOtdjoO9TU$pRfJcouSQta6nRVAuG7iyDqPrXUPPWgkuOwhiRICNlI=",
      "last_login": null,
      "is_superuser": 0,
      "username": "cjones",
      "first_name": "Christina",
      "last_name": "Jones",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:36.468988",
      "role": "pharmacist",
      "email": "cjones@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 304,
    "fields": {
      "password": "pbkdf2_sha256$720000$1bZ1AYx4DHXIdBTsGvjn51$Il9vTk2GI0jq/OvN5I/dkcfBb6mRqjFG4F/oVcNFdH0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "rrichmond",
      "first_name": "Richard",
      "last_name": "Richmond",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:36.896154",
      "role": "pharmacist",
      "email": "rrichmond@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 305,
    "fields": {
      "password": "pbkdf2_sha256$720000$qkRdPMhAiCGZAlUg0Zgehc$fI7ho86Dq6Y9RN0GMMaUlRKXyLaGXut8KQA3Ht50+wo=",
      "last_login": null,
      "is_superuser": 0,
      "username": "acamacho",
      "first_name": "Andrea",
      "last_name": "Camacho",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:37.355272",
      "role": "patient",
      "email": "acamacho@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 306,
    "fields": {
      "password": "pbkdf2_sha256$720000$59cVSNCXnmyVdJD2liAXYq$64unD7RyD83yI8c7aUasbDY4vdg1fuEvQxfubzX/XKg=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jprice",
      "first_name": "Jordan",
      "last_name": "Price",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:37.779164",
      "role": "patient",
      "email": "jprice@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 307,
    "fields": {
      "password": "pbkdf2_sha256$720000$v7wFRpYSd2F8A16qXhqLsG$aLCsTxtb/aeYyQLq/csxFNnWXuE8OIs+18z71WbmsUw=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jmoore",
      "first_name": "Jodi",
      "last_name": "Moore",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:38.204877",
      "role": "patient",
      "email": "jmoore@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 308,
    "fields": {
      "password": "pbkdf2_sha256$720000$qH7hqgvrj2wLCcSo6Qdhcf$OfgwZ+OBK2IUXW9qf/h3fafrc/suZCpv9ljRrkeUWTg=",
      "last_login": null,
      "is_superuser": 0,
      "username": "mperez",
      "first_name": "Mark",
      "last_name": "Perez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:38.656820",
      "role": "patient",
      "email": "mperez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 309,
    "fields": {
      "password": "pbkdf2_sha256$720000$LnomslKPTvVs6gGTcgYhSb$CsvONG2GJNvvSm1GebykmO414ZlfUuLlDU8+wEu7EcQ=",
      "last_login": null,
      "is_superuser": 0,
      "username": "tgay",
      "first_name": "Tammy",
      "last_name": "Gay",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:39.119279",
      "role": "patient",
      "email": "tgay@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 310,
    "fields": {
      "password": "pbkdf2_sha256$720000$84mVtxWhGNQHSf6Jvf7ldj$Pl4k4mvYzGTWYiKFAGilSJ/4rH+PwlGbInceCtPVkI4=",
      "last_login": null,
      "is_superuser": 0,
      "username": "kmiller",
      "first_name": "Kelly",
      "last_name": "Miller",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:39.630921",
      "role": "patient",
      "email": "kmiller@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 311,
    "fields": {
      "password": "pbkdf2_sha256$720000$pKhIsNdBFi9v3XYOEHfJiL$0X8HYH5f40Bk9av5CAfrR9VmIkaBol/AWzFdwWDywF0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "tmcfarland",
      "first_name": "Tanya",
      "last_name": "Mcfarland",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:40.128294",
      "role": "patient",
      "email": "tmcfarland@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 312,
    "fields": {
      "password": "pbkdf2_sha256$720000$bPKrW12qsxmH21XFNffml5$z5eU/MwZyq33vYzk9W22zWCMnYFldpmBZ0ox4sjqdwc=",
      "last_login": null,
      "is_superuser": 0,
      "username": "pwallace",
      "first_name": "Patrick",
      "last_name": "Wallace",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:40.624356",
      "role": "patient",
      "email": "pwallace@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 313,
    "fields": {
      "password": "pbkdf2_sha256$720000$EdXDd0csXliw3nCR7Ez014$8+dLZ+J6etLCEXWGc2EHeCULm+UO8Y1pC/sisMMp9PY=",
      "last_login": null,
      "is_superuser": 0,
      "username": "dhall",
      "first_name": "Donald",
      "last_name": "Hall",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:41.052941",
      "role": "patient",
      "email": "dhall@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 314,
    "fields": {
      "password": "pbkdf2_sha256$720000$H1lYzA1RcsKVXLL0reS6Z6$zNEo/Tyn6azGTkYFukASYMcjUx8oE4Tj6Vh+3Paq79U=",
      "last_login": null,
      "is_superuser": 0,
      "username": "cmelendez",
      "first_name": "Christine",
      "last_name": "Melendez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:41.508258",
      "role": "patient",
      "email": "cmelendez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 315,
    "fields": {
      "password": "pbkdf2_sha256$720000$cj90sBAfyYxq9Xt6aemKjE$T23gKBkFYksLJU8mOjzTy/7EYRgMOsFzlR+q3Kn10AI=",
      "last_login": null,
      "is_superuser": 0,
      "username": "abanks",
      "first_name": "Allen",
      "last_name": "Banks",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:41.947516",
      "role": "patient",
      "email": "abanks@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 316,
    "fields": {
      "password": "pbkdf2_sha256$720000$dy0B8rTL5caxxHBPu3tNC2$gHNu10K12qVzEYLReCKlZfBlFQJiudNj3t4zVhaa04w=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jcampbell",
      "first_name": "James",
      "last_name": "Campbell",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:42.402888",
      "role": "patient",
      "email": "jcampbell@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 317,
    "fields": {
      "password": "pbkdf2_sha256$720000$GURTv9MRjCwwXYALA7xtSu$1vuH1OhCZm9kCnifMQMcLU1cEVZ7kANKwbHhNhvG7Jo=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jknight",
      "first_name": "Justin",
      "last_name": "Knight",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:42.832972",
      "role": "patient",
      "email": "jknight@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 318,
    "fields": {
      "password": "pbkdf2_sha256$720000$gcSUlsiKvMqDeAo1qE6Vf1$hjbT/meyQbxle9HEU4pGS6KXMPrsdgLoOOEjmdGmgvc=",
      "last_login": null,
      "is_superuser": 0,
      "username": "csavage",
      "first_name": "Cassandra",
      "last_name": "Savage",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:43.275247",
      "role": "patient",
      "email": "csavage@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 319,
    "fields": {
      "password": "pbkdf2_sha256$720000$oqnHtr9M7NDU4CdKQfrIC1$pvLolXk2fJZab1u733WwVOE/7131yczYV5sI4MK/+Os=",
      "last_login": null,
      "is_superuser": 0,
      "username": "kcortez",
      "first_name": "Kurt",
      "last_name": "Cortez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:43.737505",
      "role": "patient",
      "email": "kcortez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 320,
    "fields": {
      "password": "pbkdf2_sha256$720000$MramKDmO6XZshWDWjJSusf$UzobuPqCgCbi370zcBpWxHM8DKfS6MIcBEBW3oEFJUE=",
      "last_login": null,
      "is_superuser": 0,
      "username": "rmurillo",
      "first_name": "Richard",
      "last_name": "Murillo",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:44.176888",
      "role": "patient",
      "email": "rmurillo@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 321,
    "fields": {
      "password": "pbkdf2_sha256$720000$wsShBUXZadg8bprGOe1r7q$T+3oUdzus1XonXoTggdPKEb8o/FSXr3qXbqqjPCH6RY=",
      "last_login": null,
      "is_superuser": 0,
      "username": "mmiller",
      "first_name": "Michelle",
      "last_name": "Miller",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:44.634464",
      "role": "patient",
      "email": "mmiller@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 322,
    "fields": {
      "password": "pbkdf2_sha256$720000$j7hKknKfyXcuJRtcVktMaM$0v/7NfnkXA7UnkC610QFZPd0qcp0JF0aWd/1nrpBdYA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "dallen",
      "first_name": "Dana",
      "last_name": "Allen",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:45.075827",
      "role": "patient",
      "email": "dallen@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 323,
    "fields": {
      "password": "pbkdf2_sha256$720000$GrsXpxXWCqumj8OOhSMSge$05XgBtS8Q1oCnuFZds//6DTlIdhpWG0GQMU6j7WcQns=",
      "last_login": "2025-07-07 10:51:23.533510",
      "is_superuser": 0,
      "username": "rweeks",
      "first_name": "Renee",
      "last_name": "Weeks",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:45.538810",
      "role": "patient",
      "email": "rweeks@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 324,
    "fields": {
      "password": "pbkdf2_sha256$720000$vCrBDFIPffltfF016xIikU$HDW0p5xS3h0x/A5WTipeMJUNhuOSFVpAp2Ts+oA34Hs=",
      "last_login": null,
      "is_superuser": 0,
      "username": "mmoore",
      "first_name": "Mark",
      "last_name": "Moore",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:45.990285",
      "role": "patient",
      "email": "mmoore@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 325,
    "fields": {
      "password": "pbkdf2_sha256$600000$xUsjyfTMc5qpZy7Q1OnNW7$pORkNbFe3k4J1KxsUwC6icTiK8nBLH8C8HROesMx5hc=",
      "last_login": "2026-01-03 11:42:38.748477",
      "is_superuser": 0,
      "username": "tmartinez",
      "first_name": "Teresa",
      "last_name": "Martinez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:46.460254",
      "role": "pharmacist",
      "email": "tmartinez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 326,
    "fields": {
      "password": "pbkdf2_sha256$720000$yPfKciyssjTwqGjsV85yNM$8cvMds2QbZEkAJgIrPil1VP4IYtdgnFH1r5rV8vREIo=",
      "last_login": null,
      "is_superuser": 0,
      "username": "lcrane",
      "first_name": "Leroy",
      "last_name": "Crane",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:46.921689",
      "role": "pharmacist",
      "email": "lcrane@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 327,
    "fields": {
      "password": "pbkdf2_sha256$720000$1OxLFXawGYBx7U0sQzGCcU$Sc05Y/lCMnytlU02TFpTcxtt3yukx69e8fcpZSxjHLU=",
      "last_login": null,
      "is_superuser": 0,
      "username": "rleach",
      "first_name": "Rachel",
      "last_name": "Leach",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:47.388156",
      "role": "pharmacist",
      "email": "rleach@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 328,
    "fields": {
      "password": "pbkdf2_sha256$720000$BYZOAUaYPyk1gFL0jZoW8M$9OQjf797Sx453YaTkjaxJWFPzxJWr93VbyC94MVUB7U=",
      "last_login": null,
      "is_superuser": 0,
      "username": "scarroll",
      "first_name": "Scott",
      "last_name": "Carroll",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:47.840147",
      "role": "patient",
      "email": "scarroll@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 329,
    "fields": {
      "password": "pbkdf2_sha256$720000$ALcnT7KgJ3VNL9H6XSCVat$hmjUoumQJ0yY/9flI5pNXu57qb2R0qkER5cMRa4azOI=",
      "last_login": null,
      "is_superuser": 0,
      "username": "cbolton",
      "first_name": "Corey",
      "last_name": "Bolton",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:48.312761",
      "role": "patient",
      "email": "cbolton@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 330,
    "fields": {
      "password": "pbkdf2_sha256$720000$UscbwAtrflkhPV6mDU3dTW$N5alb0FGAo+8PuodhiqZBQysFK6uXjFZnHCFrmveTWk=",
      "last_login": null,
      "is_superuser": 0,
      "username": "kjimenez",
      "first_name": "Kim",
      "last_name": "Jimenez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:48.772201",
      "role": "patient",
      "email": "kjimenez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 331,
    "fields": {
      "password": "pbkdf2_sha256$720000$tvxZf29Qr5rEoRyYXaVmOm$8znegHcgPgfHFc5YEN79AW0P/mcRiZvaX0ZE8MmUVO0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "breed",
      "first_name": "Bonnie",
      "last_name": "Reed",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:49.229828",
      "role": "patient",
      "email": "breed@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 332,
    "fields": {
      "password": "pbkdf2_sha256$720000$kuPLslDH2ICqKI3U2ZxzO7$4huID6wbzz+6NwN97p++KnGKrEr+Oh6+qndVUEKB8mI=",
      "last_login": null,
      "is_superuser": 0,
      "username": "tdoyle",
      "first_name": "Timothy",
      "last_name": "Doyle",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:49.738213",
      "role": "patient",
      "email": "tdoyle@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 333,
    "fields": {
      "password": "pbkdf2_sha256$720000$6JQmHoyujxxCI1rLE2fTWX$Gp0CqfeDXBbESzT5+UWUewFt0VhvHYqJVhDqcNqz08I=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jdecker",
      "first_name": "Jennifer",
      "last_name": "Decker",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:50.219949",
      "role": "patient",
      "email": "jdecker@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 334,
    "fields": {
      "password": "pbkdf2_sha256$720000$MYmjU9JuDqT2j08dRNRz4i$Up587N805C4tIiZAv2VWZZporsBmpXZ8yX7BH7z/jug=",
      "last_login": null,
      "is_superuser": 0,
      "username": "rbrown",
      "first_name": "Ryan",
      "last_name": "Brown",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:50.736088",
      "role": "patient",
      "email": "rbrown@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 335,
    "fields": {
      "password": "pbkdf2_sha256$720000$SVCh4X402G56EFi7m5gKcN$zXWI5LbVY/K0VAxhq/QX/3hnZ4e0JBR8DpFHBPvR+ww=",
      "last_login": null,
      "is_superuser": 0,
      "username": "mkelly",
      "first_name": "Michael",
      "last_name": "Kelly",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:51.222311",
      "role": "patient",
      "email": "mkelly@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 336,
    "fields": {
      "password": "pbkdf2_sha256$720000$bWVAQhqPHLwCtegh6eXkul$KUhXEEi6Jjv06nhxg8ER6iTOcKWg/jvvs3YnZGaHajk=",
      "last_login": null,
      "is_superuser": 0,
      "username": "tstevens",
      "first_name": "Theresa",
      "last_name": "Stevens",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:51.740941",
      "role": "patient",
      "email": "tstevens@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 337,
    "fields": {
      "password": "pbkdf2_sha256$720000$GKP8QIywDWCYGMnXtepRtp$YHtD1YtwRi/3O//0qUVjrkCVS0HSQTAJmHIBzfHrfX0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "mmartin",
      "first_name": "Misty",
      "last_name": "Martin",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:52.225195",
      "role": "patient",
      "email": "mmartin@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 338,
    "fields": {
      "password": "pbkdf2_sha256$720000$KQemjgztMRmECrE1sYAhN9$P4/FX0rK74bPpc1TAi0mdOP0jtu2gIpQyjxjewy1En8=",
      "last_login": null,
      "is_superuser": 0,
      "username": "janthony",
      "first_name": "Justin",
      "last_name": "Anthony",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:52.721378",
      "role": "patient",
      "email": "janthony@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 339,
    "fields": {
      "password": "pbkdf2_sha256$720000$ZsPNyzqEmyq6MfN1mDLJMX$xcWH/L0kT4xlBH8d13rnIfXu3/7AXFqe7rLMpcEFZH0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "nramos",
      "first_name": "Nicole",
      "last_name": "Ramos",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:53.206083",
      "role": "patient",
      "email": "nramos@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 340,
    "fields": {
      "password": "pbkdf2_sha256$720000$2SGJKosswjuhex1QXxFHoT$YWxR36wbghJ+8v3JJZYPpM9MiCDjY4czf+D6LOu0kHg=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jcombs",
      "first_name": "Jesse",
      "last_name": "Combs",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:53.697199",
      "role": "patient",
      "email": "jcombs@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 341,
    "fields": {
      "password": "pbkdf2_sha256$720000$fi6bvUZSrV2Rew6kQ3j20v$DICJ5Qs9pTfagosGsqRLA/z3XhE41dDe1A7/L3/wU3U=",
      "last_login": null,
      "is_superuser": 0,
      "username": "trichards",
      "first_name": "Thomas",
      "last_name": "Richards",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:54.170535",
      "role": "patient",
      "email": "trichards@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 342,
    "fields": {
      "password": "pbkdf2_sha256$720000$5p6Padpk1Ulj2mUjUSjyEP$aqQuCvn/qp4t+AKVbwjT8sm7X//ntn1btlBl2ucWeZw=",
      "last_login": null,
      "is_superuser": 0,
      "username": "vtodd",
      "first_name": "Victor",
      "last_name": "Todd",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:54.661405",
      "role": "patient",
      "email": "vtodd@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 343,
    "fields": {
      "password": "pbkdf2_sha256$720000$niFFtlN2AeA0r6Udjjmwp2$e8c2dctCDsDuUTVxnZexerZDWe8SFtKF4nxxLdscTHU=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jchapman",
      "first_name": "Justin",
      "last_name": "Chapman",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:55.123263",
      "role": "patient",
      "email": "jchapman@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 344,
    "fields": {
      "password": "pbkdf2_sha256$720000$8HY9tB06AOGpQ5Q0Ujvys4$FqeR778PexoDfNluxA+0c3IJ9cIxpg8XF3OHnAheyv0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "rwilson",
      "first_name": "Robert",
      "last_name": "Wilson",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:55.626502",
      "role": "patient",
      "email": "rwilson@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 345,
    "fields": {
      "password": "pbkdf2_sha256$720000$E5P9X1kQwPvvE1cdZNvf5j$qLl3KMz9y/MHgrFKIZbqiUiZXaPMmHXvwLB4xGAKnNA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "whubbard",
      "first_name": "William",
      "last_name": "Hubbard",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:56.115813",
      "role": "patient",
      "email": "whubbard@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 346,
    "fields": {
      "password": "pbkdf2_sha256$720000$ytgg6RL0rmlb4aFYJBiOpY$d/Hzfn/+dGBlbja5zPLtLg8M0It+e+hpSblwPrbuAnQ=",
      "last_login": null,
      "is_superuser": 0,
      "username": "bhenderson",
      "first_name": "Brandon",
      "last_name": "Henderson",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:56.617717",
      "role": "patient",
      "email": "bhenderson@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 347,
    "fields": {
      "password": "pbkdf2_sha256$720000$ostX0C7GR7mP4HnvsO6J11$bySKVINHy/ziqZZL12GIF9MNIomURCojG4x+5pHQPeE=",
      "last_login": null,
      "is_superuser": 0,
      "username": "tfreeman",
      "first_name": "Terry",
      "last_name": "Freeman",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:57.088173",
      "role": "patient",
      "email": "tfreeman@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 348,
    "fields": {
      "password": "pbkdf2_sha256$600000$vIUaMW6ZHWxiS2H2ckInnd$SwAk16iu2Y6KX5IirlNTMI2D0vaH0TlFeymkl6gbObQ=",
      "last_login": "2026-01-05 20:37:39.792174",
      "is_superuser": 0,
      "username": "lmason",
      "first_name": "Logan",
      "last_name": "Mason",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:57.605072",
      "role": "pharmacist",
      "email": "lmason@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 349,
    "fields": {
      "password": "pbkdf2_sha256$600000$Be0frlIdwvxKfaj28pGj20$Jm2G0Aei9Te57O+VlpCR1h7TCgGXzNqMZLiNYAAr4+8=",
      "last_login": "2025-11-06 17:50:45.860365",
      "is_superuser": 0,
      "username": "mfleming",
      "first_name": "Mark",
      "last_name": "Fleming",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:58.083710",
      "role": "pharmacist",
      "email": "mfleming@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 350,
    "fields": {
      "password": "pbkdf2_sha256$720000$XYiCjzWWCUSZAYbZjpYyxA$0UOSoZDHO7YiLSYfe1XZpiBExJT+KZhMZGQibplbfdA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "godonnell",
      "first_name": "Gregory",
      "last_name": "Odonnell",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:58.598470",
      "role": "pharmacist",
      "email": "godonnell@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 351,
    "fields": {
      "password": "pbkdf2_sha256$720000$IKx63PrsekI2YGkH0tmbhN$MeKoNoIG8pzrZ15JsBjW6pA2O7VuOC0GL2j4YpxxPuU=",
      "last_login": null,
      "is_superuser": 0,
      "username": "ksims",
      "first_name": "Kathleen",
      "last_name": "Sims",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:59.085900",
      "role": "patient",
      "email": "ksims@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 352,
    "fields": {
      "password": "pbkdf2_sha256$720000$xfZBEMZOZTG80iiBXDMg0i$V5nqNo1MaK/gDYM3NhIfT3oxHG1MkC6Y02nRRUUVlJA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "cjenkins",
      "first_name": "Crystal",
      "last_name": "Jenkins",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:09:59.591005",
      "role": "patient",
      "email": "cjenkins@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 353,
    "fields": {
      "password": "pbkdf2_sha256$720000$uEVqUalONzyvLzo14dTYmp$O7KCLOYdXFX+712p2CnPIIWRW9eojkuAqcSHIPUc4Ck=",
      "last_login": null,
      "is_superuser": 0,
      "username": "dcolon",
      "first_name": "David",
      "last_name": "Colon",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:00.084021",
      "role": "patient",
      "email": "dcolon@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 354,
    "fields": {
      "password": "pbkdf2_sha256$720000$Ddv0ZGgyxAFtM1DypfoyDk$4OkP1Pr/Mnl7FM5x8oCQWQ2OW8iKXSXBtP2cqv3QtC4=",
      "last_login": null,
      "is_superuser": 0,
      "username": "msutton",
      "first_name": "Mary",
      "last_name": "Sutton",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:00.598588",
      "role": "patient",
      "email": "msutton@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 355,
    "fields": {
      "password": "pbkdf2_sha256$720000$ZQoOULzx3p71r3H0kkGE2O$gWQFT7BjMpaywYY+LfKCQLp2WuHb/ndwpL7wHqBlbc8=",
      "last_login": null,
      "is_superuser": 0,
      "username": "kmullins",
      "first_name": "Karen",
      "last_name": "Mullins",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:01.080133",
      "role": "patient",
      "email": "kmullins@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 356,
    "fields": {
      "password": "pbkdf2_sha256$720000$mEeQcweeVTi966V61WDGn2$bAFkbA+eMLZsT9eeM/t8NwpcWWMS+w7SNbITiYSDf5s=",
      "last_login": null,
      "is_superuser": 0,
      "username": "ahowell",
      "first_name": "Amy",
      "last_name": "Howell",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:01.589893",
      "role": "patient",
      "email": "ahowell@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 357,
    "fields": {
      "password": "pbkdf2_sha256$720000$1a0fbmI3ixIfblh4etBuvm$YqtxCSZlwRsGU3HiqG0ovo7y65TWA2VBFYlho6gE1W8=",
      "last_login": null,
      "is_superuser": 0,
      "username": "kross",
      "first_name": "Kevin",
      "last_name": "Ross",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:02.084194",
      "role": "patient",
      "email": "kross@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 358,
    "fields": {
      "password": "pbkdf2_sha256$720000$VGnshCtwTJGH3BQKZqJB1Q$nUgNarVrvaZID41QTIb1OV2IyJFqsch7sWQ9amZKuEQ=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jcolon",
      "first_name": "Joseph",
      "last_name": "Colon",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:02.822285",
      "role": "patient",
      "email": "jcolon@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 359,
    "fields": {
      "password": "pbkdf2_sha256$720000$9vzhgpDmCo2sJ0QlVixZsi$1EnFfSXgwVG6/6idrFINCbIG8VYvvgsNiBhn2x3RBMQ=",
      "last_login": null,
      "is_superuser": 0,
      "username": "fgreen",
      "first_name": "Frances",
      "last_name": "Green",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:03.458699",
      "role": "patient",
      "email": "fgreen@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 360,
    "fields": {
      "password": "pbkdf2_sha256$720000$xOvPkrH4nkA1zZpztI50RW$j8LHrbVCGpIDdkMalmxJxibT2x4tak3XvLVnnqb/uyQ=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jrussell",
      "first_name": "Joseph",
      "last_name": "Russell",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:03.969644",
      "role": "patient",
      "email": "jrussell@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 361,
    "fields": {
      "password": "pbkdf2_sha256$720000$UGVDOFVEI7MX7oJJhnFtbr$drUk/yHVb+VNy4pXdNAuOuTd7V1XYSpheuHKusnkIM8=",
      "last_login": null,
      "is_superuser": 0,
      "username": "drivas",
      "first_name": "Daryl",
      "last_name": "Rivas",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:04.497322",
      "role": "patient",
      "email": "drivas@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 362,
    "fields": {
      "password": "pbkdf2_sha256$720000$pBMKOxrIohzCKIMiKMxuT4$M75MPbTOVOYXEjkm7z3Q3cMSjtzC0XV7/o+4YmAWzMI=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jmartinez",
      "first_name": "Jose",
      "last_name": "Martinez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:04.988112",
      "role": "patient",
      "email": "jmartinez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 363,
    "fields": {
      "password": "pbkdf2_sha256$600000$FlrjIknhBJRr6SESPGXszW$N2/lG2TqPgPNSYRMfSUCLiRLWAbZqSgI7QFbxzmvH0w=",
      "last_login": "2025-10-22 10:20:29.618478",
      "is_superuser": 0,
      "username": "jalexander",
      "first_name": "Jamie",
      "last_name": "Alexander",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:05.507099",
      "role": "patient",
      "email": "jalexander@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 364,
    "fields": {
      "password": "pbkdf2_sha256$720000$MavAWMovBSTNd47A2N8itL$EWzgcNJQNQf4ZLeSLgsCUM5Uqq2DZyhjTJztpGQfnJw=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jmeyers",
      "first_name": "James",
      "last_name": "Meyers",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:06.000944",
      "role": "patient",
      "email": "jmeyers@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 365,
    "fields": {
      "password": "pbkdf2_sha256$720000$zayqJWumhJa9UDxX3DiwDl$8mXj3xaE0Nn/yIoy8sYlebzNNyjGj/HZruwy2iPTuH0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "adouglas",
      "first_name": "Amanda",
      "last_name": "Douglas",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:06.511342",
      "role": "patient",
      "email": "adouglas@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 366,
    "fields": {
      "password": "pbkdf2_sha256$720000$CZFEEulotNjYrPZnMEyKwS$ZUB0i0Ylk0Qm5Ix+9HdgDA/5Z8mjNEeMw284SOM5Zv8=",
      "last_login": null,
      "is_superuser": 0,
      "username": "tcampos",
      "first_name": "Theresa",
      "last_name": "Campos",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:07.010110",
      "role": "patient",
      "email": "tcampos@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 367,
    "fields": {
      "password": "pbkdf2_sha256$720000$RMhd1RcUwaAA2q2bP67SPF$jALD7QpHLA2KWjSZ//imWEVb/Nn8yMwrBzEKybX0vGU=",
      "last_login": null,
      "is_superuser": 0,
      "username": "bjones",
      "first_name": "Barbara",
      "last_name": "Jones",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:07.548006",
      "role": "patient",
      "email": "bjones@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 368,
    "fields": {
      "password": "pbkdf2_sha256$600000$Wp5etZ7g6r4KC965iSsEKt$8u7JPRnpyZGpx37LklmAU8oR3nhn2mRyUXtOyxLyXLE=",
      "last_login": "2025-10-09 11:58:02.519580",
      "is_superuser": 0,
      "username": "ayork",
      "first_name": "Allen",
      "last_name": "York",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:08.068011",
      "role": "patient",
      "email": "ayork@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 369,
    "fields": {
      "password": "pbkdf2_sha256$720000$dFedUYOu0CNImHtiJHxDF4$yJ6KwHCcGyA+EpkdWRIK0hs6V+PRjBTBI4nlHaBwo3U=",
      "last_login": null,
      "is_superuser": 0,
      "username": "dbates",
      "first_name": "Damon",
      "last_name": "Bates",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:08.581035",
      "role": "patient",
      "email": "dbates@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 370,
    "fields": {
      "password": "pbkdf2_sha256$720000$nlwPiknz6WLPLJaqA2Ldja$iB8oHica90s3AClpM59AdP1ocDf9d0RkYure4C3Zq+E=",
      "last_login": null,
      "is_superuser": 0,
      "username": "abass",
      "first_name": "Amanda",
      "last_name": "Bass",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:09.076574",
      "role": "patient",
      "email": "abass@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 371,
    "fields": {
      "password": "pbkdf2_sha256$720000$egIUI8P9uVBCd5RrbsxyqU$QfWf0RiFKu916bR2nYwX3NHW3a9lMbcLLQn48crze6Q=",
      "last_login": null,
      "is_superuser": 0,
      "username": "bcombs",
      "first_name": "Brian",
      "last_name": "Combs",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:09.592117",
      "role": "pharmacist",
      "email": "bcombs@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 372,
    "fields": {
      "password": "pbkdf2_sha256$720000$2sWoEyAPQFL023rone1hkQ$4nA/j3KgGUHfbxS7zG3sVCwiDjywmKwnr6vb9BmbIxc=",
      "last_login": null,
      "is_superuser": 0,
      "username": "mwelch",
      "first_name": "Mikayla",
      "last_name": "Welch",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:10.102292",
      "role": "pharmacist",
      "email": "mwelch@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 373,
    "fields": {
      "password": "pbkdf2_sha256$720000$i4kuz985hbnypeTDoiM9dp$65qsG1ihD+hbxzBeqJ8QSdKpWYcs7eAo6HXLMTg2vVg=",
      "last_login": null,
      "is_superuser": 0,
      "username": "wcarlson",
      "first_name": "William",
      "last_name": "Carlson",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:10.626103",
      "role": "pharmacist",
      "email": "wcarlson@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 374,
    "fields": {
      "password": "pbkdf2_sha256$720000$6f9I4a2bVGoFWGgy8wO3H9$I4/6caw/XVa0/7FM7xzwYIwg82j0IG3xKUHq0y2qbW0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "mweber",
      "first_name": "Michael",
      "last_name": "Weber",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:11.128463",
      "role": "patient",
      "email": "mweber@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 375,
    "fields": {
      "password": "pbkdf2_sha256$720000$O3ck9CbJhfs6mFuLGtLc2U$ypV9Kea7v8u7pVis5qRg7WO0vaOIIyrEATNyq/ah05c=",
      "last_login": null,
      "is_superuser": 0,
      "username": "amartinez",
      "first_name": "Angela",
      "last_name": "Martinez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:11.766472",
      "role": "patient",
      "email": "amartinez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 376,
    "fields": {
      "password": "pbkdf2_sha256$720000$WkmCK0On32KhRRaD8WnfEd$fhv0GifZKJtC/8Q9cCy7wlPiTScMWAcpxsy+Pt1o5kY=",
      "last_login": null,
      "is_superuser": 0,
      "username": "dperry",
      "first_name": "Douglas",
      "last_name": "Perry",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:12.363981",
      "role": "patient",
      "email": "dperry@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 377,
    "fields": {
      "password": "pbkdf2_sha256$720000$0guvF3I3FiEEt4lZY5ECc7$mZocw9bDmxaBlkvOrT+M849SqZa8WXP9Kr42Choyfno=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jhunt",
      "first_name": "James",
      "last_name": "Hunt",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:12.854337",
      "role": "patient",
      "email": "jhunt@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 378,
    "fields": {
      "password": "pbkdf2_sha256$720000$sen8scwPFDKGNw1Y3NzQof$iis0yVeC66us4V3Ab1UQlpAl1QvX9gT0AxBLjGKcWqA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jcameron",
      "first_name": "Jonathan",
      "last_name": "Cameron",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:13.382129",
      "role": "patient",
      "email": "jcameron@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 379,
    "fields": {
      "password": "pbkdf2_sha256$720000$8aFIuruWc79VhyQWcJOFg4$O09oKam/5IICs1KeYY4t848r9zrk/BHcpFaGQIerS2E=",
      "last_login": null,
      "is_superuser": 0,
      "username": "cstewart",
      "first_name": "Carl",
      "last_name": "Stewart",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:13.886931",
      "role": "patient",
      "email": "cstewart@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 380,
    "fields": {
      "password": "pbkdf2_sha256$720000$aWQDjYlKbJJP3hExtIAIpc$QFQkmY3pRvpqgGk6IzUEmlKMe6KEZQJ7w8HHTcuxVC8=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jdonovan",
      "first_name": "Jerry",
      "last_name": "Donovan",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:14.405643",
      "role": "patient",
      "email": "jdonovan@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 381,
    "fields": {
      "password": "pbkdf2_sha256$720000$errrRIBAGXlmbH5uzu7I40$5nBtZoGU1q9GwNyN30I9T8YKtqHzw9LEWL+xJBhugok=",
      "last_login": null,
      "is_superuser": 0,
      "username": "shamilton",
      "first_name": "Sara",
      "last_name": "Hamilton",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:14.909702",
      "role": "patient",
      "email": "shamilton@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 382,
    "fields": {
      "password": "pbkdf2_sha256$720000$u3PN6Fl7rq0nxdcbgbbc7R$VN+jZlonuq9OSbVTravb96nWGzsQ+C+aDFy3cL2NGso=",
      "last_login": null,
      "is_superuser": 0,
      "username": "atrujillo",
      "first_name": "Adrienne",
      "last_name": "Trujillo",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:15.457101",
      "role": "patient",
      "email": "atrujillo@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 383,
    "fields": {
      "password": "pbkdf2_sha256$720000$v60XW8ffnO5tPvGS139of7$AAktYdrB+XuchhjxqqKeRzh9i+A5hk3gljHpzlu1q0M=",
      "last_login": null,
      "is_superuser": 0,
      "username": "creed",
      "first_name": "Crystal",
      "last_name": "Reed",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:15.952997",
      "role": "patient",
      "email": "creed@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 384,
    "fields": {
      "password": "pbkdf2_sha256$720000$xgw3VjUqjHWiwsKKEaDJYi$8b8rqKQThhZ4jeGtatkpQmwEU1qiEnQxGfF7zGZox0A=",
      "last_login": null,
      "is_superuser": 0,
      "username": "wturner",
      "first_name": "Wayne",
      "last_name": "Turner",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:16.476410",
      "role": "patient",
      "email": "wturner@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 385,
    "fields": {
      "password": "pbkdf2_sha256$720000$ZmiNDX7KcPFRx6SwGPSEQQ$dxJ4/WZDfP9SenyoVTmEIgaecigJdAiQoNoS7YtpiLE=",
      "last_login": null,
      "is_superuser": 0,
      "username": "wphillips",
      "first_name": "William",
      "last_name": "Phillips",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:16.996365",
      "role": "patient",
      "email": "wphillips@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 386,
    "fields": {
      "password": "pbkdf2_sha256$720000$MlxRUjGSUR04wiHZwe7pIH$G2MCVzAqD6H0UX9G0c8zZWaF5prZIoC8ImablV5XXUU=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jmcguire",
      "first_name": "Jason",
      "last_name": "Mcguire",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:17.535494",
      "role": "patient",
      "email": "jmcguire@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 387,
    "fields": {
      "password": "pbkdf2_sha256$720000$GB3trX5BE3VhB2KokjC2xg$q0nWj03LMV3OzqrzLCqRZR68eELpEe5KN7KgdqbTExQ=",
      "last_login": null,
      "is_superuser": 0,
      "username": "ttorres",
      "first_name": "Tina",
      "last_name": "Torres",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:18.050709",
      "role": "patient",
      "email": "ttorres@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 388,
    "fields": {
      "password": "pbkdf2_sha256$720000$w1rc89OQN8pcsp7LthOVQ2$XQI/b+jZcY08wiovcjUktW7L0fQnNUej1uHmifEynx0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "lcook",
      "first_name": "Lawrence",
      "last_name": "Cook",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:18.575119",
      "role": "patient",
      "email": "lcook@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 389,
    "fields": {
      "password": "pbkdf2_sha256$720000$uMIVPeU9R2Pkk4v3Y0F298$WpjjbRV97a2oPkzen2WyvP2yWItMBmSfoN6dQKHzkdQ=",
      "last_login": null,
      "is_superuser": 0,
      "username": "rdiaz",
      "first_name": "Robin",
      "last_name": "Diaz",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:19.093350",
      "role": "patient",
      "email": "rdiaz@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 390,
    "fields": {
      "password": "pbkdf2_sha256$720000$C5wB7e93pQCyd9feZ1uwon$iXphibktZnHpO2raydETQmJq444ZDmgqHnpreQl3qyg=",
      "last_login": null,
      "is_superuser": 0,
      "username": "lmendoza",
      "first_name": "Luis",
      "last_name": "Mendoza",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:19.629365",
      "role": "patient",
      "email": "lmendoza@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 391,
    "fields": {
      "password": "pbkdf2_sha256$720000$xi8WphdTXHBl1YI4XJQKys$yuXqldmB0wUuT/N/+qaFFGAM864DrAtiOSbU+26nzMA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "cphillips",
      "first_name": "Charles",
      "last_name": "Phillips",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:20.139601",
      "role": "patient",
      "email": "cphillips@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 392,
    "fields": {
      "password": "pbkdf2_sha256$720000$PUN7ZEL5m8t0WNRpKWuZOU$4gWNbRZ/0hERvgVPcY7GVCHuJiFPOLKgAqa2i1KkB9Q=",
      "last_login": null,
      "is_superuser": 0,
      "username": "crodriguez",
      "first_name": "Charles",
      "last_name": "Rodriguez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:20.676702",
      "role": "patient",
      "email": "crodriguez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 393,
    "fields": {
      "password": "pbkdf2_sha256$720000$fi8GteOPimW8BlFOTbvnyl$wRIH/b+s5+MEMQ9vAY8b1A1nIpL2t6KGWOY0lyuVrEM=",
      "last_login": null,
      "is_superuser": 0,
      "username": "tmorgan",
      "first_name": "Tanya",
      "last_name": "Morgan",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:21.189783",
      "role": "patient",
      "email": "tmorgan@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 394,
    "fields": {
      "password": "pbkdf2_sha256$720000$3cN0Fk3FVLDt6eM3cVrRC7$Y3CCCSMZ53np2+4ZUtrr+azIRqALGRI5rF/DcxVKwUA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "cwarner",
      "first_name": "Christopher",
      "last_name": "Warner",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:21.738072",
      "role": "pharmacist",
      "email": "cwarner@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 395,
    "fields": {
      "password": "pbkdf2_sha256$720000$WGlNTwXS3ld8sS0Ekh9i4B$Y6Y+cGciEB5eCJyu1WxuH3z//MJVfDJlVxzLReFT+5g=",
      "last_login": null,
      "is_superuser": 0,
      "username": "vwilliams",
      "first_name": "Vincent",
      "last_name": "Williams",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:22.252884",
      "role": "pharmacist",
      "email": "vwilliams@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 396,
    "fields": {
      "password": "pbkdf2_sha256$720000$9reMiRK4Eu00vAajPgdPTR$PlRogrZY/aSU0QSebJfFFDv9wvzMxsQzgoMSUgCmeSg=",
      "last_login": null,
      "is_superuser": 0,
      "username": "ljohnson",
      "first_name": "Leslie",
      "last_name": "Johnson",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:22.795304",
      "role": "pharmacist",
      "email": "ljohnson@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 397,
    "fields": {
      "password": "pbkdf2_sha256$720000$ySicjv8wiYVjq0gXNuCH2X$GBxdKa9IwY0rCDa9hFUVKYT+pzENHhoOgJ8qBssXtNA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "mdavis",
      "first_name": "Megan",
      "last_name": "Davis",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:23.318049",
      "role": "patient",
      "email": "mdavis@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 398,
    "fields": {
      "password": "pbkdf2_sha256$720000$F7Ye1Fw2zlwJoWK4hIiIiG$Qce195pR+ZIF5Med/HWxs3AsyBISRH0WgkUtNl1uzU8=",
      "last_login": null,
      "is_superuser": 0,
      "username": "lnichols",
      "first_name": "Lauren",
      "last_name": "Nichols",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:23.831441",
      "role": "patient",
      "email": "lnichols@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 399,
    "fields": {
      "password": "pbkdf2_sha256$720000$aXhcDa9bbHPCVwDps9KEbT$+mmCim/lMz9iSQIUIAOHETMVUTeIH/LNuDVYoCo//JI=",
      "last_login": null,
      "is_superuser": 0,
      "username": "mberry",
      "first_name": "Miranda",
      "last_name": "Berry",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:24.357898",
      "role": "patient",
      "email": "mberry@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 400,
    "fields": {
      "password": "pbkdf2_sha256$720000$TpIhpJn0lnTCrnruO99MAS$tvywuCr3Fq1rIWYBpv0AyEaUWhWRcw2Zyz9NV9zr28k=",
      "last_login": null,
      "is_superuser": 0,
      "username": "kmccoy",
      "first_name": "Kelsey",
      "last_name": "Mccoy",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:24.867054",
      "role": "patient",
      "email": "kmccoy@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 401,
    "fields": {
      "password": "pbkdf2_sha256$720000$dQgcBQGg8o1E9a4nMsq6ju$a+adMLurkB55QqSAI3L4MP4oeQTKY/ZraMiWVItTg7c=",
      "last_login": null,
      "is_superuser": 0,
      "username": "bvasquez",
      "first_name": "Brittany",
      "last_name": "Vasquez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:25.411020",
      "role": "patient",
      "email": "bvasquez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 402,
    "fields": {
      "password": "pbkdf2_sha256$720000$1iTB4K7B0fq9gP5r4ZxkRw$eM5bt570EgSndHsrJYe3ergYxtEjUC0CLH1sZNI1474=",
      "last_login": null,
      "is_superuser": 0,
      "username": "sclayton",
      "first_name": "Sarah",
      "last_name": "Clayton",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:25.920132",
      "role": "patient",
      "email": "sclayton@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 403,
    "fields": {
      "password": "pbkdf2_sha256$720000$ZtiYzDmC32MOUVMrZJZOyF$ZBSQAva4vTWPwQqOtB6NdCmWYRfxAnacuE60VFSyGt4=",
      "last_login": null,
      "is_superuser": 0,
      "username": "dzamora",
      "first_name": "Dave",
      "last_name": "Zamora",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:26.473921",
      "role": "patient",
      "email": "dzamora@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 404,
    "fields": {
      "password": "pbkdf2_sha256$720000$7XKF9xD4m6dnHHa3fjWnEO$XO5fYpECJSfZlDTZwDCtnmF10/KUnGgXV8Dk/dmtttQ=",
      "last_login": null,
      "is_superuser": 0,
      "username": "award",
      "first_name": "Angel",
      "last_name": "Ward",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:26.980284",
      "role": "patient",
      "email": "award@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 405,
    "fields": {
      "password": "pbkdf2_sha256$720000$5bxBELznua8eELvfbpEwfQ$edVOPQeD0GJkJmff9pUvTRoGUnUCdR76f5YeQ0yV2c0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jlowe",
      "first_name": "Joe",
      "last_name": "Lowe",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:27.522637",
      "role": "patient",
      "email": "jlowe@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 406,
    "fields": {
      "password": "pbkdf2_sha256$720000$wmvyiYDdkn9vdmHSipjdjw$/2LG+F2+yyX9sFpHP6MuWwxeV7S1u7kFrzQMWSSu2PA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "afoster",
      "first_name": "Allison",
      "last_name": "Foster",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:28.032003",
      "role": "patient",
      "email": "afoster@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 407,
    "fields": {
      "password": "pbkdf2_sha256$720000$44Pz7AyzHxgOvzEdFHJcpS$wCJb6KW6xjzOFpWGJD9G13XuoTrhQtu707wvH0N16qM=",
      "last_login": null,
      "is_superuser": 0,
      "username": "bkennedy",
      "first_name": "Brian",
      "last_name": "Kennedy",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:28.590001",
      "role": "patient",
      "email": "bkennedy@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 408,
    "fields": {
      "password": "pbkdf2_sha256$720000$zrWd3lLLEgscgqwaxcoPgW$4gqGvPcQMb5YTZIqZBO5J13WaHgMVC3XY0YliNNrGeA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "wcruz",
      "first_name": "Wanda",
      "last_name": "Cruz",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:29.110926",
      "role": "patient",
      "email": "wcruz@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 409,
    "fields": {
      "password": "pbkdf2_sha256$720000$bqgSTkujJgwXHuKnjIzda7$N33vv7fivQ8ysesaNGE71DMlsRkLMZc5260aAVAgEbo=",
      "last_login": null,
      "is_superuser": 0,
      "username": "kshelton",
      "first_name": "Kevin",
      "last_name": "Shelton",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:29.646319",
      "role": "patient",
      "email": "kshelton@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 410,
    "fields": {
      "password": "pbkdf2_sha256$720000$IVdoPZGvI9fF3Hatgekd35$AWdVc4qVB6K1se+X4B9JYa5yPw4N3CJrin7tNPv8Ars=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jhernandez",
      "first_name": "Joshua",
      "last_name": "Hernandez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:30.169192",
      "role": "patient",
      "email": "jhernandez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 411,
    "fields": {
      "password": "pbkdf2_sha256$720000$cZNxXsnA9KcXnSsQKiBZ04$XdIu95tQnvqQnacQdCbn2tFEumpXKWqGfymVkJwi/PI=",
      "last_login": null,
      "is_superuser": 0,
      "username": "ajordan",
      "first_name": "Ashley",
      "last_name": "Jordan",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:30.710111",
      "role": "patient",
      "email": "ajordan@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 412,
    "fields": {
      "password": "pbkdf2_sha256$720000$uXK7tbLL9lNL11RPuzd93C$x5dYickvUZZPmXsVeN6OfuEU62N+y88xdnUF0iabup8=",
      "last_login": null,
      "is_superuser": 0,
      "username": "agallagher",
      "first_name": "Ashley",
      "last_name": "Gallagher",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:31.238535",
      "role": "patient",
      "email": "agallagher@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 413,
    "fields": {
      "password": "pbkdf2_sha256$720000$voQr7ceZ2FRni5Br8odnqZ$yGO3ovHj4qy/CZ+zS5w4sW5bDvrllVjSO6NHv/HDiL0=",
      "last_login": null,
      "is_superuser": 0,
      "username": "jvincent",
      "first_name": "Jesse",
      "last_name": "Vincent",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:31.848950",
      "role": "patient",
      "email": "jvincent@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 414,
    "fields": {
      "password": "pbkdf2_sha256$720000$yT2X4W7U2kvxe9PMkKJ5FM$5qe6rnSkG0wTA2bMT9TA2FtA73uel4dOh0+n46NffL4=",
      "last_login": null,
      "is_superuser": 0,
      "username": "ktate",
      "first_name": "Kelly",
      "last_name": "Tate",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:32.394564",
      "role": "patient",
      "email": "ktate@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 415,
    "fields": {
      "password": "pbkdf2_sha256$600000$gLTbWsPDdiD6OIkjsoJ80K$wNi40dnLRQOCIBecGCagLushG3Z6P8tyDSiK6ShvYEo=",
      "last_login": "2025-09-19 11:21:02.264068",
      "is_superuser": 0,
      "username": "bgomez",
      "first_name": "Brian",
      "last_name": "Gomez",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:32.917019",
      "role": "patient",
      "email": "bgomez@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 416,
    "fields": {
      "password": "pbkdf2_sha256$720000$4Bj6xlTUwO713aALD1yJfv$cObq4mIezwRbp/b9dxTA7vWjjlN9SRRZAyh8FHARoXs=",
      "last_login": null,
      "is_superuser": 0,
      "username": "kturner",
      "first_name": "Kyle",
      "last_name": "Turner",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-06-12 11:10:33.453207",
      "role": "patient",
      "email": "kturner@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 417,
    "fields": {
      "password": "system123",
      "last_login": "2025-10-02 12:14:11",
      "is_superuser": 1,
      "username": "system",
      "first_name": "Notification",
      "last_name": "System",
      "is_staff": 1,
      "is_active": 1,
      "date_joined": "2025-10-02 12:08:06",
      "role": "system",
      "email": "noreply@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 418,
    "fields": {
      "password": "pbkdf2_sha256$600000$DTqkkFsAzXIFvEYH4UZ08u$2pTHUPfyDp1rA9Ufn0WenDXwYpecKPylzX1nhpKoXGw=",
      "last_login": "2025-12-01 22:43:06.877050",
      "is_superuser": 0,
      "username": "kgeorge",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-01 22:30:25.871554",
      "role": "patient",
      "email": "kgeorge@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 419,
    "fields": {
      "password": "pbkdf2_sha256$600000$T7rMN1Vh35OoP1pSpdWPca$1QvoVVvj2y8btEmsDYEhWSO20sKwNYugWvRQQ2lRPSA=",
      "last_login": null,
      "is_superuser": 0,
      "username": "tshelby",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-01 22:35:47.409395",
      "role": "pharmacist",
      "email": "tshelby@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 420,
    "fields": {
      "password": "pbkdf2_sha256$600000$AYqVJ7UaBlvn9vQ7g7XCLZ$inIyZkKUzyIMOIpn8hzAGXsxjU3wTYfrPQYP5tIC91U=",
      "last_login": "2025-12-01 22:36:42.686402",
      "is_superuser": 0,
      "username": "tshelby21",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-01 22:36:42.172814",
      "role": "pharmacist",
      "email": "tshelby21@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 421,
    "fields": {
      "password": "pbkdf2_sha256$600000$kyvKiwWfJvH4TcpamzykSP$ilLvkCHnxtMeD/BfJEODB9f4ht5HG0n9KhXxnZFf81Y=",
      "last_login": "2025-12-01 23:22:15.562696",
      "is_superuser": 0,
      "username": "sgeorge27",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-01 22:39:34.196950",
      "role": "pharmacy admin",
      "email": "sgeorge27@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 422,
    "fields": {
      "password": "pbkdf2_sha256$600000$ywZdJmgqDvGD8ivKNkz1sI$DkTzlmhoG0/oi/mnZpOjIjvRK06YvAab7uCj8Gjww5o=",
      "last_login": "2025-12-01 23:23:48.463865",
      "is_superuser": 0,
      "username": "jmcain",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-01 23:23:00.474296",
      "role": "pharmacist",
      "email": "jmcain@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 423,
    "fields": {
      "password": "pbkdf2_sha256$600000$Pj9kKuKIDvwLDcT8CP7ugz$NLdB5/z181+LmZ8X3SqnqwiqBel7PRqdNDbGABANouk=",
      "last_login": "2025-12-01 23:23:35.307715",
      "is_superuser": 0,
      "username": "jmcain12",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-01 23:23:34.794544",
      "role": "pharmacist",
      "email": "jmcain12@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 424,
    "fields": {
      "password": "pbkdf2_sha256$600000$gBcYwJLPpo4v5uuXSjrLZX$5PNKuA9Yeh0T4JVoRTfNwfDYA6+uhs5V4AZqJy51hOk=",
      "last_login": "2025-12-10 19:21:44.031746",
      "is_superuser": 0,
      "username": "Josh",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-10 19:21:43.321654",
      "role": "patient",
      "email": "Josh@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 425,
    "fields": {
      "password": "pbkdf2_sha256$600000$sKtb1JrMu5MSfe5pGKTNrJ$Lvmkyj3KMmqb1yK9MnvBi/3VM1Cc17QmN+F7X1cwr6M=",
      "last_login": "2025-12-10 19:26:41.173992",
      "is_superuser": 0,
      "username": "Craig",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-10 19:26:40.520742",
      "role": "patient",
      "email": "Craig@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 426,
    "fields": {
      "password": "pbkdf2_sha256$600000$X2jUTKMd6T7gs0dFOJGURQ$S6yUVFMRSCl2rTFmX1PCBxJvYV3dnnVEG+B9NNa5SRw=",
      "last_login": "2025-12-10 19:30:12.772043",
      "is_superuser": 0,
      "username": "Johnny",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-10 19:30:12.138077",
      "role": "patient",
      "email": "Johnny@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 427,
    "fields": {
      "password": "pbkdf2_sha256$600000$7Z0k66fg2nw8viB0O2ZseT$Sz2DC9PTvUXufw6IUrVCYko2mWeoKIYuBDGVDcOBXkA=",
      "last_login": "2025-12-31 22:40:26.368218",
      "is_superuser": 0,
      "username": "woodlands_phar",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-31 22:40:25.825357",
      "role": "pharmacy admin",
      "email": "woodlandspharm@mail.com"
    }
  },
  {
    "model": "accounts.customaccount",
    "pk": 428,
    "fields": {
      "password": "pbkdf2_sha256$600000$imPxx8DHI4cPmlIuXGvY9w$VWK+yd7lTjT6vS+1Y6GT3AjoAsxok6XkjtlOt80woYQ=",
      "last_login": "2026-01-03 12:38:51.951743",
      "is_superuser": 0,
      "username": "ngeorge1",
      "first_name": "",
      "last_name": "",
      "is_staff": 0,
      "is_active": 1,
      "date_joined": "2025-12-31 22:57:14.284086",
      "role": "patient",
      "email": "ngeorge12@mail.com"
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 1,
    "fields": {
      "dob": "1995-04-23",
      "gender": "M",
      "user_id": 17,
      "first_name": "Justin",
      "last_name": "Jackson",
      "phone_number": "215-987-4567",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 241,
    "fields": {
      "dob": "1944-03-18",
      "gender": "F",
      "user_id": 305,
      "first_name": "Andrea",
      "last_name": "Camacho",
      "phone_number": "574-560-2117",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 242,
    "fields": {
      "dob": "1958-05-21",
      "gender": "F",
      "user_id": 306,
      "first_name": "Jordan",
      "last_name": "Price",
      "phone_number": "333-590-6745",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 243,
    "fields": {
      "dob": "1992-12-28",
      "gender": "F",
      "user_id": 307,
      "first_name": "Jodi",
      "last_name": "Moore",
      "phone_number": "753-552-1322",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 244,
    "fields": {
      "dob": "1953-11-02",
      "gender": "M",
      "user_id": 308,
      "first_name": "Mark",
      "last_name": "Perez",
      "phone_number": "974-777-0916",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 245,
    "fields": {
      "dob": "1951-10-27",
      "gender": "F",
      "user_id": 309,
      "first_name": "Tammy",
      "last_name": "Gay",
      "phone_number": "479-137-3333",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 246,
    "fields": {
      "dob": "1936-11-21",
      "gender": "F",
      "user_id": 310,
      "first_name": "Kelly",
      "last_name": "Miller",
      "phone_number": "297-351-0056",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 247,
    "fields": {
      "dob": "1981-09-21",
      "gender": "F",
      "user_id": 311,
      "first_name": "Tanya",
      "last_name": "Mcfarland",
      "phone_number": "768-630-0008",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 248,
    "fields": {
      "dob": "1972-06-03",
      "gender": "M",
      "user_id": 312,
      "first_name": "Patrick",
      "last_name": "Wallace",
      "phone_number": "572-520-3503",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 249,
    "fields": {
      "dob": "1938-08-20",
      "gender": "M",
      "user_id": 313,
      "first_name": "Donald",
      "last_name": "Hall",
      "phone_number": "813-376-6549",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 250,
    "fields": {
      "dob": "1982-06-27",
      "gender": "F",
      "user_id": 314,
      "first_name": "Christine",
      "last_name": "Melendez",
      "phone_number": "085-061-6387",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 251,
    "fields": {
      "dob": "1959-04-26",
      "gender": "M",
      "user_id": 315,
      "first_name": "Allen",
      "last_name": "Banks",
      "phone_number": "437-674-5826",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 252,
    "fields": {
      "dob": "1981-11-24",
      "gender": "M",
      "user_id": 316,
      "first_name": "James",
      "last_name": "Campbell",
      "phone_number": "879-274-2176",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 253,
    "fields": {
      "dob": "1960-05-03",
      "gender": "M",
      "user_id": 317,
      "first_name": "Justin",
      "last_name": "Knight",
      "phone_number": "823-923-1182",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 254,
    "fields": {
      "dob": "1986-04-16",
      "gender": "F",
      "user_id": 318,
      "first_name": "Cassandra",
      "last_name": "Savage",
      "phone_number": "238-514-1666",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 255,
    "fields": {
      "dob": "1977-10-15",
      "gender": "M",
      "user_id": 319,
      "first_name": "Kurt",
      "last_name": "Cortez",
      "phone_number": "461-204-4662",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 256,
    "fields": {
      "dob": "1969-04-12",
      "gender": "M",
      "user_id": 320,
      "first_name": "Richard",
      "last_name": "Murillo",
      "phone_number": "822-837-3783",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 257,
    "fields": {
      "dob": "1982-11-19",
      "gender": "F",
      "user_id": 321,
      "first_name": "Michelle",
      "last_name": "Miller",
      "phone_number": "096-926-8993",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 258,
    "fields": {
      "dob": "1969-05-07",
      "gender": "F",
      "user_id": 322,
      "first_name": "Dana",
      "last_name": "Allen",
      "phone_number": "986-887-6201",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 259,
    "fields": {
      "dob": "2006-06-25",
      "gender": "F",
      "user_id": 323,
      "first_name": "Renee",
      "last_name": "Weeks",
      "phone_number": "615-290-6174",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 260,
    "fields": {
      "dob": "1974-11-27",
      "gender": "M",
      "user_id": 324,
      "first_name": "Mark",
      "last_name": "Moore",
      "phone_number": "564-076-8890",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 261,
    "fields": {
      "dob": "1953-06-19",
      "gender": "M",
      "user_id": 328,
      "first_name": "Scott",
      "last_name": "Carroll",
      "phone_number": "301-171-4281",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 262,
    "fields": {
      "dob": "1973-03-02",
      "gender": "M",
      "user_id": 329,
      "first_name": "Corey",
      "last_name": "Bolton",
      "phone_number": "588-032-3052",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 263,
    "fields": {
      "dob": "1945-06-11",
      "gender": "F",
      "user_id": 330,
      "first_name": "Kim",
      "last_name": "Jimenez",
      "phone_number": "976-665-5149",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 264,
    "fields": {
      "dob": "1988-07-22",
      "gender": "F",
      "user_id": 331,
      "first_name": "Bonnie",
      "last_name": "Reed",
      "phone_number": "641-820-7904",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 265,
    "fields": {
      "dob": "1973-02-10",
      "gender": "M",
      "user_id": 332,
      "first_name": "Timothy",
      "last_name": "Doyle",
      "phone_number": "361-321-9011",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 266,
    "fields": {
      "dob": "1971-12-21",
      "gender": "F",
      "user_id": 333,
      "first_name": "Jennifer",
      "last_name": "Decker",
      "phone_number": "686-068-1993",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 267,
    "fields": {
      "dob": "1967-08-13",
      "gender": "M",
      "user_id": 334,
      "first_name": "Ryan",
      "last_name": "Brown",
      "phone_number": "571-029-4984",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 268,
    "fields": {
      "dob": "1959-07-22",
      "gender": "M",
      "user_id": 335,
      "first_name": "Michael",
      "last_name": "Kelly",
      "phone_number": "048-234-1359",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 269,
    "fields": {
      "dob": "1960-02-10",
      "gender": "F",
      "user_id": 336,
      "first_name": "Theresa",
      "last_name": "Stevens",
      "phone_number": "839-393-2057",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 270,
    "fields": {
      "dob": "1987-10-04",
      "gender": "F",
      "user_id": 337,
      "first_name": "Misty",
      "last_name": "Martin",
      "phone_number": "807-627-0988",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 271,
    "fields": {
      "dob": "1993-02-28",
      "gender": "M",
      "user_id": 338,
      "first_name": "Justin",
      "last_name": "Anthony",
      "phone_number": "679-166-7338",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 272,
    "fields": {
      "dob": "1984-03-19",
      "gender": "F",
      "user_id": 339,
      "first_name": "Nicole",
      "last_name": "Ramos",
      "phone_number": "949-770-1276",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 273,
    "fields": {
      "dob": "1989-12-03",
      "gender": "M",
      "user_id": 340,
      "first_name": "Jesse",
      "last_name": "Combs",
      "phone_number": "240-258-0995",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 274,
    "fields": {
      "dob": "1976-03-09",
      "gender": "M",
      "user_id": 341,
      "first_name": "Thomas",
      "last_name": "Richards",
      "phone_number": "734-626-2395",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 275,
    "fields": {
      "dob": "1976-04-03",
      "gender": "M",
      "user_id": 342,
      "first_name": "Victor",
      "last_name": "Todd",
      "phone_number": "665-672-7609",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 276,
    "fields": {
      "dob": "1970-01-07",
      "gender": "M",
      "user_id": 343,
      "first_name": "Justin",
      "last_name": "Chapman",
      "phone_number": "658-463-4306",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 277,
    "fields": {
      "dob": "1985-12-25",
      "gender": "M",
      "user_id": 344,
      "first_name": "Robert",
      "last_name": "Wilson",
      "phone_number": "802-804-1043",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 278,
    "fields": {
      "dob": "1976-12-18",
      "gender": "M",
      "user_id": 345,
      "first_name": "William",
      "last_name": "Hubbard",
      "phone_number": "627-350-1472",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 279,
    "fields": {
      "dob": "1982-02-13",
      "gender": "M",
      "user_id": 346,
      "first_name": "Brandon",
      "last_name": "Henderson",
      "phone_number": "068-746-9574",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 280,
    "fields": {
      "dob": "1987-10-08",
      "gender": "M",
      "user_id": 347,
      "first_name": "Terry",
      "last_name": "Freeman",
      "phone_number": "782-053-9816",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 281,
    "fields": {
      "dob": "2000-05-20",
      "gender": "F",
      "user_id": 351,
      "first_name": "Kathleen",
      "last_name": "Sims",
      "phone_number": "901-141-7681",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 282,
    "fields": {
      "dob": "1988-01-07",
      "gender": "F",
      "user_id": 352,
      "first_name": "Crystal",
      "last_name": "Jenkins",
      "phone_number": "708-313-2005",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 283,
    "fields": {
      "dob": "1989-12-28",
      "gender": "M",
      "user_id": 353,
      "first_name": "David",
      "last_name": "Colon",
      "phone_number": "458-353-4011",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 284,
    "fields": {
      "dob": "2007-05-08",
      "gender": "F",
      "user_id": 354,
      "first_name": "Mary",
      "last_name": "Sutton",
      "phone_number": "563-706-9724",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 285,
    "fields": {
      "dob": "1942-08-27",
      "gender": "F",
      "user_id": 355,
      "first_name": "Karen",
      "last_name": "Mullins",
      "phone_number": "311-832-9309",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 286,
    "fields": {
      "dob": "1951-07-01",
      "gender": "F",
      "user_id": 356,
      "first_name": "Amy",
      "last_name": "Howell",
      "phone_number": "439-439-3664",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 287,
    "fields": {
      "dob": "1937-05-13",
      "gender": "M",
      "user_id": 357,
      "first_name": "Kevin",
      "last_name": "Ross",
      "phone_number": "286-470-7706",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 288,
    "fields": {
      "dob": "1975-01-26",
      "gender": "M",
      "user_id": 358,
      "first_name": "Joseph",
      "last_name": "Colon",
      "phone_number": "026-210-6305",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 289,
    "fields": {
      "dob": "1994-05-28",
      "gender": "F",
      "user_id": 359,
      "first_name": "Frances",
      "last_name": "Green",
      "phone_number": "349-359-5433",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 290,
    "fields": {
      "dob": "1965-07-25",
      "gender": "M",
      "user_id": 360,
      "first_name": "Joseph",
      "last_name": "Russell",
      "phone_number": "177-152-0323",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 291,
    "fields": {
      "dob": "2001-06-18",
      "gender": "M",
      "user_id": 361,
      "first_name": "Daryl",
      "last_name": "Rivas",
      "phone_number": "446-527-5711",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 292,
    "fields": {
      "dob": "1979-03-10",
      "gender": "M",
      "user_id": 362,
      "first_name": "Jose",
      "last_name": "Martinez",
      "phone_number": "968-094-4163",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 293,
    "fields": {
      "dob": "1950-03-15",
      "gender": "F",
      "user_id": 363,
      "first_name": "Jamie",
      "last_name": "Alexander",
      "phone_number": "885-592-1018",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 294,
    "fields": {
      "dob": "1986-06-20",
      "gender": "M",
      "user_id": 364,
      "first_name": "James",
      "last_name": "Meyers",
      "phone_number": "029-468-3333",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 295,
    "fields": {
      "dob": "1942-10-22",
      "gender": "F",
      "user_id": 365,
      "first_name": "Amanda",
      "last_name": "Douglas",
      "phone_number": "157-643-5064",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 296,
    "fields": {
      "dob": "2006-09-11",
      "gender": "F",
      "user_id": 366,
      "first_name": "Theresa",
      "last_name": "Campos",
      "phone_number": "190-926-6737",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 297,
    "fields": {
      "dob": "1945-08-20",
      "gender": "F",
      "user_id": 367,
      "first_name": "Barbara",
      "last_name": "Jones",
      "phone_number": "475-675-2250",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 298,
    "fields": {
      "dob": "1974-06-05",
      "gender": "M",
      "user_id": 368,
      "first_name": "Allen",
      "last_name": "York",
      "phone_number": "037-159-3739",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 299,
    "fields": {
      "dob": "1983-09-23",
      "gender": "M",
      "user_id": 369,
      "first_name": "Damon",
      "last_name": "Bates",
      "phone_number": "708-423-0643",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 300,
    "fields": {
      "dob": "1937-06-09",
      "gender": "F",
      "user_id": 370,
      "first_name": "Amanda",
      "last_name": "Bass",
      "phone_number": "397-279-8527",
      "pharmacy_id": 3
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 301,
    "fields": {
      "dob": "1964-01-10",
      "gender": "M",
      "user_id": 374,
      "first_name": "Michael",
      "last_name": "Weber",
      "phone_number": "386-103-3523",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 302,
    "fields": {
      "dob": "1987-03-16",
      "gender": "F",
      "user_id": 375,
      "first_name": "Angela",
      "last_name": "Martinez",
      "phone_number": "687-884-7742",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 303,
    "fields": {
      "dob": "1985-02-07",
      "gender": "M",
      "user_id": 376,
      "first_name": "Douglas",
      "last_name": "Perry",
      "phone_number": "523-082-6664",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 304,
    "fields": {
      "dob": "1972-03-14",
      "gender": "M",
      "user_id": 377,
      "first_name": "James",
      "last_name": "Hunt",
      "phone_number": "273-600-1468",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 305,
    "fields": {
      "dob": "1980-12-16",
      "gender": "M",
      "user_id": 378,
      "first_name": "Jonathan",
      "last_name": "Cameron",
      "phone_number": "402-327-5689",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 306,
    "fields": {
      "dob": "1945-03-20",
      "gender": "M",
      "user_id": 379,
      "first_name": "Carl",
      "last_name": "Stewart",
      "phone_number": "353-972-8445",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 307,
    "fields": {
      "dob": "1987-12-08",
      "gender": "M",
      "user_id": 380,
      "first_name": "Jerry",
      "last_name": "Donovan",
      "phone_number": "815-947-1009",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 308,
    "fields": {
      "dob": "2004-11-28",
      "gender": "F",
      "user_id": 381,
      "first_name": "Sara",
      "last_name": "Hamilton",
      "phone_number": "099-026-3941",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 309,
    "fields": {
      "dob": "1954-08-12",
      "gender": "F",
      "user_id": 382,
      "first_name": "Adrienne",
      "last_name": "Trujillo",
      "phone_number": "046-627-2169",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 310,
    "fields": {
      "dob": "1938-06-24",
      "gender": "F",
      "user_id": 383,
      "first_name": "Crystal",
      "last_name": "Reed",
      "phone_number": "674-237-9741",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 311,
    "fields": {
      "dob": "1986-04-21",
      "gender": "M",
      "user_id": 384,
      "first_name": "Wayne",
      "last_name": "Turner",
      "phone_number": "937-480-5512",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 312,
    "fields": {
      "dob": "2005-11-14",
      "gender": "M",
      "user_id": 385,
      "first_name": "William",
      "last_name": "Phillips",
      "phone_number": "803-667-0923",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 313,
    "fields": {
      "dob": "1983-05-18",
      "gender": "M",
      "user_id": 386,
      "first_name": "Jason",
      "last_name": "Mcguire",
      "phone_number": "346-054-3358",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 314,
    "fields": {
      "dob": "1947-01-31",
      "gender": "F",
      "user_id": 387,
      "first_name": "Tina",
      "last_name": "Torres",
      "phone_number": "560-090-0378",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 315,
    "fields": {
      "dob": "1961-02-28",
      "gender": "M",
      "user_id": 388,
      "first_name": "Lawrence",
      "last_name": "Cook",
      "phone_number": "331-132-9837",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 316,
    "fields": {
      "dob": "1988-11-18",
      "gender": "F",
      "user_id": 389,
      "first_name": "Robin",
      "last_name": "Diaz",
      "phone_number": "596-450-4333",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 317,
    "fields": {
      "dob": "1939-10-11",
      "gender": "M",
      "user_id": 390,
      "first_name": "Luis",
      "last_name": "Mendoza",
      "phone_number": "990-896-0894",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 318,
    "fields": {
      "dob": "2005-02-27",
      "gender": "M",
      "user_id": 391,
      "first_name": "Charles",
      "last_name": "Phillips",
      "phone_number": "607-315-2647",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 319,
    "fields": {
      "dob": "2007-06-01",
      "gender": "M",
      "user_id": 392,
      "first_name": "Charles",
      "last_name": "Rodriguez",
      "phone_number": "784-686-8172",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 320,
    "fields": {
      "dob": "1986-01-04",
      "gender": "F",
      "user_id": 393,
      "first_name": "Tanya",
      "last_name": "Morgan",
      "phone_number": "208-036-6735",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 321,
    "fields": {
      "dob": "2004-08-08",
      "gender": "F",
      "user_id": 397,
      "first_name": "Megan",
      "last_name": "Davis",
      "phone_number": "622-257-9776",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 322,
    "fields": {
      "dob": "1946-10-22",
      "gender": "F",
      "user_id": 398,
      "first_name": "Lauren",
      "last_name": "Nichols",
      "phone_number": "218-973-3060",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 323,
    "fields": {
      "dob": "1978-12-10",
      "gender": "F",
      "user_id": 399,
      "first_name": "Miranda",
      "last_name": "Berry",
      "phone_number": "856-695-8952",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 324,
    "fields": {
      "dob": "1970-01-03",
      "gender": "F",
      "user_id": 400,
      "first_name": "Kelsey",
      "last_name": "Mccoy",
      "phone_number": "495-194-0886",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 325,
    "fields": {
      "dob": "1963-04-22",
      "gender": "F",
      "user_id": 401,
      "first_name": "Brittany",
      "last_name": "Vasquez",
      "phone_number": "083-877-4324",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 326,
    "fields": {
      "dob": "1966-11-30",
      "gender": "F",
      "user_id": 402,
      "first_name": "Sarah",
      "last_name": "Clayton",
      "phone_number": "124-067-4167",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 327,
    "fields": {
      "dob": "1975-08-09",
      "gender": "M",
      "user_id": 403,
      "first_name": "Dave",
      "last_name": "Zamora",
      "phone_number": "554-154-8742",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 328,
    "fields": {
      "dob": "1965-06-04",
      "gender": "F",
      "user_id": 404,
      "first_name": "Angel",
      "last_name": "Ward",
      "phone_number": "833-869-5938",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 329,
    "fields": {
      "dob": "1971-07-06",
      "gender": "M",
      "user_id": 405,
      "first_name": "Joe",
      "last_name": "Lowe",
      "phone_number": "824-235-6386",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 330,
    "fields": {
      "dob": "1975-08-07",
      "gender": "F",
      "user_id": 406,
      "first_name": "Allison",
      "last_name": "Foster",
      "phone_number": "331-129-9489",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 331,
    "fields": {
      "dob": "1963-10-16",
      "gender": "M",
      "user_id": 407,
      "first_name": "Brian",
      "last_name": "Kennedy",
      "phone_number": "260-910-5031",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 332,
    "fields": {
      "dob": "1974-08-23",
      "gender": "F",
      "user_id": 408,
      "first_name": "Wanda",
      "last_name": "Cruz",
      "phone_number": "697-281-1374",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 333,
    "fields": {
      "dob": "1996-05-21",
      "gender": "M",
      "user_id": 409,
      "first_name": "Kevin",
      "last_name": "Shelton",
      "phone_number": "250-586-6401",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 334,
    "fields": {
      "dob": "1986-01-29",
      "gender": "M",
      "user_id": 410,
      "first_name": "Joshua",
      "last_name": "Hernandez",
      "phone_number": "068-487-4246",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 335,
    "fields": {
      "dob": "2003-05-02",
      "gender": "F",
      "user_id": 411,
      "first_name": "Ashley",
      "last_name": "Jordan",
      "phone_number": "825-881-3026",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 336,
    "fields": {
      "dob": "1998-12-20",
      "gender": "F",
      "user_id": 412,
      "first_name": "Ashley",
      "last_name": "Gallagher",
      "phone_number": "437-790-3213",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 337,
    "fields": {
      "dob": "1986-01-02",
      "gender": "M",
      "user_id": 413,
      "first_name": "Jesse",
      "last_name": "Vincent",
      "phone_number": "667-176-8073",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 338,
    "fields": {
      "dob": "1983-01-02",
      "gender": "F",
      "user_id": 414,
      "first_name": "Kelly",
      "last_name": "Tate",
      "phone_number": "514-489-3775",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 339,
    "fields": {
      "dob": "1935-12-10",
      "gender": "M",
      "user_id": 415,
      "first_name": "Brian",
      "last_name": "Gomez",
      "phone_number": "274-354-3514",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 340,
    "fields": {
      "dob": "1953-03-18",
      "gender": "M",
      "user_id": 416,
      "first_name": "Kyle",
      "last_name": "Turner",
      "phone_number": "093-995-8519",
      "pharmacy_id": 5
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 341,
    "fields": {
      "dob": "1988-03-21",
      "gender": "M",
      "user_id": 418,
      "first_name": "Keith",
      "last_name": "George",
      "phone_number": "267-255-1088",
      "pharmacy_id": 2
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 342,
    "fields": {
      "dob": "1999-12-17",
      "gender": "M",
      "user_id": 424,
      "first_name": "Josh",
      "last_name": "George",
      "phone_number": "2674744395",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 343,
    "fields": {
      "dob": "1999-12-10",
      "gender": "M",
      "user_id": 425,
      "first_name": "Craig",
      "last_name": "David",
      "phone_number": "2674744395",
      "pharmacy_id": 1
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 344,
    "fields": {
      "dob": "1998-12-09",
      "gender": "M",
      "user_id": 426,
      "first_name": "Johnny",
      "last_name": "Sack",
      "phone_number": "2674744395",
      "pharmacy_id": 4
    }
  },
  {
    "model": "patients.patientprofile",
    "pk": 345,
    "fields": {
      "dob": "2006-04-09",
      "gender": "O",
      "user_id": 428,
      "first_name": "Nick",
      "last_name": "George",
      "phone_number": "(267) 474-4395",
      "pharmacy_id": 2
    }
  },
  {
    "model": "pharmacy.pharmacyprofile",
    "pk": 1,
    "fields": {
      "pharmacy_name": "CVS",
      "user_id": 13,
      "join_code": "CF1667",
      "city": "Philadelphia",
      "street_address": "123 newark avenue",
      "zip_code": "19929",
      "state": "Pennsylvania"
    }
  },
  {
    "model": "pharmacy.pharmacyprofile",
    "pk": 2,
    "fields": {
      "pharmacy_name": "Right Aide",
      "user_id": 14,
      "join_code": "681593",
      "city": "Trenton",
      "street_address": "456 Welch Street",
      "zip_code": "12342",
      "state": "New Jersey"
    }
  },
  {
    "model": "pharmacy.pharmacyprofile",
    "pk": 3,
    "fields": {
      "pharmacy_name": "Woodlands",
      "user_id": 23,
      "join_code": "2E1546",
      "city": "South Helenbury",
      "street_address": "0317 Sandra Lake Suite 459",
      "zip_code": "43520",
      "state": "Tennessee"
    }
  },
  {
    "model": "pharmacy.pharmacyprofile",
    "pk": 4,
    "fields": {
      "pharmacy_name": "Marshall Group",
      "user_id": 47,
      "join_code": "AABEC9",
      "city": "Kathleenbury",
      "street_address": "42609 Ann Vista Suite 462",
      "zip_code": "09028",
      "state": "Washington"
    }
  },
  {
    "model": "pharmacy.pharmacyprofile",
    "pk": 5,
    "fields": {
      "pharmacy_name": "wallbrowns",
      "user_id": 70,
      "join_code": "493F3D",
      "city": "South Jessicafort",
      "street_address": "14192 Joseph Lock Apt. 633",
      "zip_code": "39607",
      "state": "Kentucky"
    }
  },
  {
    "model": "pharmacy.pharmacyprofile",
    "pk": 6,
    "fields": {
      "pharmacy_name": "Giant Pharmacy",
      "user_id": 421,
      "join_code": "02A02B",
      "city": "Philadelphia",
      "street_address": "134 Bustleton Ave",
      "zip_code": "19115",
      "state": "PA"
    }
  },
  {
    "model": "pharmacy.pharmacyprofile",
    "pk": 7,
    "fields": {
      "pharmacy_name": "cvs",
      "user_id": 427,
      "join_code": "7DE91A",
      "city": "sadsdas",
      "street_address": "sdsdas",
      "zip_code": "ddddd",
      "state": "dsasd"
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 1,
    "fields": {
      "first_name": "Nicholas",
      "last_name": "George",
      "pharmacy_id": 1,
      "user_id": 15
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 2,
    "fields": {
      "first_name": "Rick",
      "last_name": "Smith",
      "pharmacy_id": 2,
      "user_id": 16
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 40,
    "fields": {
      "first_name": "Randall",
      "last_name": "Navarro",
      "pharmacy_id": 1,
      "user_id": 302
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 41,
    "fields": {
      "first_name": "Christina",
      "last_name": "Jones",
      "pharmacy_id": 1,
      "user_id": 303
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 42,
    "fields": {
      "first_name": "Richard",
      "last_name": "Richmond",
      "pharmacy_id": 1,
      "user_id": 304
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 43,
    "fields": {
      "first_name": "Teresa",
      "last_name": "Martinez",
      "pharmacy_id": 2,
      "user_id": 325
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 44,
    "fields": {
      "first_name": "Leroy",
      "last_name": "Crane",
      "pharmacy_id": 2,
      "user_id": 326
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 45,
    "fields": {
      "first_name": "Rachel",
      "last_name": "Leach",
      "pharmacy_id": 2,
      "user_id": 327
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 46,
    "fields": {
      "first_name": "Logan",
      "last_name": "Mason",
      "pharmacy_id": 3,
      "user_id": 348
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 47,
    "fields": {
      "first_name": "Mark",
      "last_name": "Fleming",
      "pharmacy_id": 3,
      "user_id": 349
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 48,
    "fields": {
      "first_name": "Gregory",
      "last_name": "Odonnell",
      "pharmacy_id": 3,
      "user_id": 350
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 49,
    "fields": {
      "first_name": "Brian",
      "last_name": "Combs",
      "pharmacy_id": 4,
      "user_id": 371
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 50,
    "fields": {
      "first_name": "Mikayla",
      "last_name": "Welch",
      "pharmacy_id": 4,
      "user_id": 372
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 51,
    "fields": {
      "first_name": "William",
      "last_name": "Carlson",
      "pharmacy_id": 4,
      "user_id": 373
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 52,
    "fields": {
      "first_name": "Christopher",
      "last_name": "Warner",
      "pharmacy_id": 5,
      "user_id": 394
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 53,
    "fields": {
      "first_name": "Vincent",
      "last_name": "Williams",
      "pharmacy_id": 5,
      "user_id": 395
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 54,
    "fields": {
      "first_name": "Leslie",
      "last_name": "Johnson",
      "pharmacy_id": 5,
      "user_id": 396
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 55,
    "fields": {
      "first_name": "Thomas",
      "last_name": "Shelby",
      "pharmacy_id": 3,
      "user_id": 420
    }
  },
  {
    "model": "pharmacy.pharmacistprofile",
    "pk": 56,
    "fields": {
      "first_name": "Jared",
      "last_name": "Mcain",
      "pharmacy_id": 6,
      "user_id": 423
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 485,
    "fields": {
      "name": "ACETAMINOPHEN",
      "brand": "Pain Reliever Extra Strength",
      "description": "",
      "dosage": "Directions do not take more than directed adults and children 12 years and over take 2 gelcaps every",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 486,
    "fields": {
      "name": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN",
      "brand": "Hydrocodone Bitartrate and Acetaminophen",
      "description": "DESCRIPTION Hydrocodone bitartrate and acetaminophen, USP is available in tablet form for oral administration. It is affected by light. It has the following structural formula: Acetaminophen, 4' -hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "Initial Dosage Initiating Treatment with Hydrocodone Bitartrate and Acetaminophen Tablets 2.5 mg/325",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 487,
    "fields": {
      "name": "ALBUTEROL SULFATE",
      "brand": "Albuterol Sulfate HFA",
      "description": "Albuterol sulfate has the chemical name \u03b1 1 -[( tert -butylamino)methyl]-4-hydroxy- m -xylene-\u03b1, \u03b1\u2032-diol sulfate (2:1)(salt) and the following chemical structure: Albuterol sulfate is a white crystalline powder with a molecular weight of 576.7, and the empirical formula is (C 13 H 21 NO 3 ) 2 \u2022H 2 SO 4 . Each canister contains a microcrystalline suspension of albuterol sulfate in propellant HFA\u2011134a (1,1,1,2\u2011tetrafluoroethane). Prime Albuterol Sulfate HFA before using for the first time, when the inhaler has not been used for more than 2 weeks, or when the inhaler has been dropped.",
      "dosage": "2 DOSAGE AND ADMINISTRATION For oral inhalation only. ( 2 ) Treatment or prevention of bronchospasm ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 488,
    "fields": {
      "name": "ALENDRONATE SODIUM",
      "brand": "Binosto",
      "description": "11 DESCRIPTION BINOSTO (alendronate sodium) is a bisphosphonate that acts as a specific inhibitor of osteoclast-mediated bone resorption. Alendronate sodium is chemically described as (4 amino-1-hydroxybutylidene) bisphosphonic acid, monosodium salt, trihydrate. Once the effervescent tablet is dissolved in water, the alendronate sodium is present in a citrate-buffered solution of pH 4.8 to 5.4.",
      "dosage": "Take BINOSTO upon arising for the day and at least 30 minutes before the first food, beverage, or me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 489,
    "fields": {
      "name": "ALLOPURINOL",
      "brand": "Allopurinol",
      "description": "11 DESCRIPTION Allopurinol, USP is a xanthine oxidase inhibitor. It has the following structural formula: Allopurinol, USP is known chemically as 1, 5-dihydro-4 H -pyrazolo [3, 4- d ]pyrimidin-4-one and it has a molecular weight of 136.1 g/mol. Each scored white round-shaped tablet contains 100 mg allopurinol and the inactive ingredients colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate.",
      "dosage": "2.3 Recommended Dosage for Gout The initial recommended dosage for the management of gout is 100 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 490,
    "fields": {
      "name": "ALPRAZOLAM",
      "brand": "Alprazolam",
      "description": "11 DESCRIPTION Alprazolam tablets, USP contain alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds. The chemical name of alprazolam is 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-\u03b1] [1,4] benzodiazepine. In addition, the 0.5 mg tablet contains FD&C Yellow # 6 aluminum lake and the 1 mg tablet contains FD&C Blue No.",
      "dosage": "Dosage may be increased, at intervals of every 3 to 4 days, to a maximum recommended daily dose of 4",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 491,
    "fields": {
      "name": "AMOXICILLIN",
      "brand": "Amoxicillin",
      "description": "Amoxicillin Tablets, USP: Each film coated tablet contains 500 mg or 875 mg amoxicillin as the trihydrate. Amoxicillin for Oral Suspension, USP: Each 5 mL of reconstituted suspension contains 125 mg, 200 mg, 250 mg or 400 mg amoxicillin as the trihydrate. Each 5 mL of the 125 mg, 200 mg, 250 mg, and 400 mg reconstituted suspension contains 0.30 mEq (6.95 mg) of sodium.",
      "dosage": "Dosing Recommendations for Adult and Pediatric Patients > 3 Months of Age Infection Severity Dosing ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 492,
    "fields": {
      "name": "AMLODIPINE BESYLATE",
      "brand": "Amlodipine Besylate",
      "description": "11 DESCRIPTION Amlodipine besylate is the besylate salt of amlodipine, a long-acting calcium channel blocker. Amlodipine besylate is chemically described as 3-Ethyl-5-methyl (\u00b1)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, monobenzenesulphonate. Amlodipine besylate tablets USP are formulated as tablets equivalent to 2.5 mg, 5 mg and 10 mg of amlodipine for oral administration.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022Adult recommended starting dose: 5 mg once daily with maximum dose 10 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 493,
    "fields": {
      "name": "ARIPIPRAZOLE",
      "brand": "Aripiprazole",
      "description": "11 DESCRIPTION Aripiprazole is an atypical antipsychotic drug that is available as Aripiprazole Tablets, USP. Aripiprazole is 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril. The empirical formula is C 23 H 27 Cl 2 N 3 O 2 and its molecular weight is 448.38.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Initial Dose Recommended Dose Maximum Dose Schizophrenia \u2013 adults (2.1) ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 494,
    "fields": {
      "name": "ATENOLOL",
      "brand": "Atenolol",
      "description": "DESCRIPTION Atenolol, a synthetic, beta 1 -selective (cardioselective) adrenoreceptor blocking agent, may be chemically described as benzeneacetamide, 4-[2\u2019-hydroxy-3\u2019-[(1-methylethyl)amino]propoxy]-. It is a relatively polar hydrophilic compound with a water solubility of 26.5 mg/mL at 37\u00b0C and a log partition coefficient (octanol/water) of 0.23. Atenolol is available as 25, 50 or 100 mg tablets for oral administration.",
      "dosage": "If an optimal response is not achieved, the dosage should be increased to atenolol 100 mg given as o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 495,
    "fields": {
      "name": "ATORVASTATIN CALCIUM",
      "brand": "Atorvastatin calcium",
      "description": "11 DESCRIPTION Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Atorvastatin calcium USP is (\u03b2R, \u03b4R)-2-(p-fluorophenyl)-\u03b2,\u03b4-dihydroxy-5-isopropyl-3-phenyl-4(phenylcarbamoyl)pyrrole-l-heptanaote (1:2), trihydrate. The molecular formula of atorvastatin calcium USP is C 66 H 68 CaF 2 N 4 O 10 .3H 2 O and its molecular weight is 1209.41.",
      "dosage": "2.1 Important Dosage Information Take atorvastatin calcium tablets orally once daily at any time of ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 496,
    "fields": {
      "name": "AZITHROMYCIN",
      "brand": "Azithromycin",
      "description": "11 DESCRIPTION Azithromycin tablets USP contain the active ingredient azithromycin, a macrolide antibacterial drug, for oral administration. Azithromycin has the chemical name (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-\u03b1-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-\u03b2-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Azithromycin is derived from erythromycin; however, it differs chemically from erythromycin in that a methyl-substituted nitrogen atom is incorporated into the lactone ring.",
      "dosage": "Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 500 mg as a single dose on Da",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 497,
    "fields": {
      "name": "BACLOFEN INJECTION",
      "brand": "Gablofen",
      "description": "11 DESCRIPTION GABLOFEN (baclofen injection) is a muscle relaxant and antispastic. Baclofen's pharmacological class is a gamma-aminobutyric acid (GABA) ergic agonist. Baclofen's chemical name is 4-amino-3-(4-chlorophenyl) butanoic acid, and its structural formula is: Baclofen C 10 H 12 ClNO 2 Baclofen is a white to off-white powder, with a molecular weight of 213.66.",
      "dosage": "2.2 Screening Phase Prior to pump implantation and initiation of chronic infusion of GABLOFEN, patie",
      "stock": 100,
      "route": "INTRATHECAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 498,
    "fields": {
      "name": "BENAZEPRIL HYDROCHLORIDE",
      "brand": "Benazepril Hydrochloride",
      "description": "Its chemical name is benazepril 3-[[1-(ethoxy-carbonyl)-3-phenyl-(1S)-propyl]amino]-2,3,4,5-tetrahydro-2-oxo-1 H -1-(3S)-benzazepine-1-acetic acid monohydrochloride; its structural formula is Its empirical formula is C 24 H 28 N 2 O 5 \u2022HCl and its molecular weight is 460.96. Benazepril hydrochloride is supplied as film-coated tablets containing 5 mg, 10 mg, 20 mg, and 40 mg of benazepril hydrochloride for oral administration. Benazepril hydrochloride tablets USP, 5 mg, 10 mg, 20 mg and 40 mg meet USP Dissolution Test 2.",
      "dosage": "\u2022 Renal Impairment: Initiate with 5 mg once daily in patients with GFR <30 mL/min/1.73 m 2 (serum cr",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 499,
    "fields": {
      "name": "BISOPROLOL FUMARATE",
      "brand": "Bisoprolol fumarate",
      "description": "It possesses an asymmetric carbon atom in its structure and is provided as a racemic mixture. Bisoprolol fumarate tablets are available as 5 and 10 mg tablets for oral administration. The 5 mg tablets also contain Red Iron Oxide.",
      "dosage": "DOSAGE AND ADMINISTRATION The dose of bisoprolol fumarate tablets must be individualized to the need",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 500,
    "fields": {
      "name": "BUPROPION HYDROCHLORIDE",
      "brand": "Bupropion Hydrochloride XL",
      "description": "11 DESCRIPTION Bupropion Hydrochloride USP, an antidepressant of the aminoketone class, is chemically unrelated to tricyclic, tetracyclic, selective serotonin reuptake inhibitor, or other known antidepressant agents. Its structure closely resembles that of diethylpropion; it is related to phenylethylamines. The structural formula is: Bupropion Hydrochloride Extended-Release Tablets USP (XL) are supplied for oral administration as 150 mg and 300 mg white to pale yellow extended-release tablets.",
      "dosage": "2.2 Dosage for Major Depressive Disorder (MDD) The recommended starting dose for MDD is 150 mg once ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 501,
    "fields": {
      "name": "BUSPIRONE HYDROCHLORIDE",
      "brand": "Buspirone Hydrochloride",
      "description": "421.96 Each tablet, for oral administration, contains 5 mg, 7.5 mg, 10 mg, 15 mg or 30 mg of buspirone hydrochloride, USP (equivalent to 4.6 mg, 6.9 mg, 9.1 mg, 13.7 mg and 27.4 mg of buspirone free base, respectively). Thus, a single 15 mg tablet can provide the following doses: 15 mg (entire tablet), 10 mg (two-thirds of a tablet), 7.5 mg (one-half of a tablet), or 5 mg (one-third of a tablet). A single 30 mg tablet can provide the following doses: 30 mg (entire tablet), 20 mg (two-thirds of a tablet), 15 mg (one-half of a tablet), or 10 mg (one-third of a tablet).",
      "dosage": "To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 502,
    "fields": {
      "name": "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE",
      "brand": "Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",
      "description": "11 DESCRIPTION Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are supplied in capsule form for oral administration. Each capsule contains: Butalbital, USP 50 mg Acetaminophen, USP 325 mg Caffeine, USP 40 mg Codeine phosphate, USP 30 mg Butalbital (5-allyl-5-isobutylbarbituric acid), is a short-to intermediate-acting barbiturate. It has the following structural formula: C 11 H 16 N 2 O 3 MW 224.26 Acetaminophen (4'hydroxyacetanilide), is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "2.2 Patient Access to Naloxone for the Emergency Treatment of Opioid Overdose Discuss the availabili",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 503,
    "fields": {
      "name": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "brand": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "description": "DESCRIPTION Captopril and hydrochlorothiazide tablets, USP for oral administration combines two antihypertensive agents: captopril and hydrochlorothiazide. Captopril, USP is a white to off-white crystalline powder with characteristic sulfide-like odor; it is freely soluble in water, ethanol, methanol, chloroform, isopropyl alcohol and methylene chloride and soluble in ethyl acetate. Freely soluble in N,N-Dimethylformamide, in n-Butylamine and in diluted solutions of alkali hydroxides.",
      "dosage": "For patients insufficiently responsive to the initial dose, additional captopril or hydrochlorothiaz",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 504,
    "fields": {
      "name": "CARVEDILOL",
      "brand": "Carvedilol",
      "description": "11 DESCRIPTION Carvedilol is a nonselective \u03b2-adrenergic blocking agent with \u03b1 1 -blocking activity. It is (\u00b1)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol. Carvedilol is a racemic mixture with the following structure: Carvedilol, USP is a white to almost white crystalline powder with a molecular weight of 406.5 and a molecular formula of C 24 H 26 N 2 O 4 .",
      "dosage": "Fluid retention (with or without transient worsening heart failure symptoms) should be treated by an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 505,
    "fields": {
      "name": "CEFDINIR",
      "brand": "Cefdinir",
      "description": "DESCRIPTION Cefdinir capsules, USP contain the active ingredient cefdinir, an extended-spectrum, semisynthetic cephalosporin, for oral administration. Chemically, cefdinir is [6R-[6\u03b1,7\u03b2 (Z)]]-7-[[(2-amino-4 thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid. Cefdinir is a white to slightly brownish-yellow solid.",
      "dosage": "DOSAGE & ADMINISTRATION (see INDICATIONS AND USAGE for Indicated Pathogens) The recommended dosage a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 506,
    "fields": {
      "name": "CEFUROXIME AXETIL",
      "brand": "Cefuroxime axetil",
      "description": "Cefuroxime axetil is a semisynthetic, cephalosporin antibacterial drug for oral administration. The chemical name of cefuroxime axetil (1-(acetyloxy) ethyl ester of cefuroxime) is ( RS )-1 hydroxyethyl (6 R ,7 R )-7-[2-(2-furyl)glyoxyl-amido]-3-(hydroxymethyl)-8-oxo-5-thia-1 azabicyclo[4.2.0]-oct-2-ene-2-carboxylate, 72-( Z )-( O -methyl-oxime), 1-acetate 3-carbamate. Cefuroxime axetil is in the amorphous form and has the following structural formula: Cefuroxime axetil tablets, USP are film-coated and contain the equivalent of 250 or 500 mg of cefuroxime as cefuroxime axetil.",
      "dosage": "Pediatric patients (aged 13 years and older) who cannot swallow the cefuroxime axetil tablets whole ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 507,
    "fields": {
      "name": "CELECOXIB",
      "brand": "CELECOXIB",
      "description": "DESCRIPTION Celecoxib capsule is a nonsteroidal anti-inflammatory drug, available as capsules containing 50 mg, 100 mg, 200 mg and 400 mg celecoxib for oral administration. Its molecular formula is C 17 H 14 F 3 N 3 O 2 S, and it has the following chemical structure: Celecoxib USP is a white or almost white crystalline powder with a pKa of 11.1 (sulfonamide moiety). Celecoxib USP is hydrophobic (log P is 3.5) and is soluble in ethanol and in methylene chloride, practically insoluble in water.",
      "dosage": "For patients >25 kg the recommended dose is 100 mg twice daily. For patients who have difficulty swa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 508,
    "fields": {
      "name": "CETIRIZINE HYDROCHLORIDE TABLETS",
      "brand": "cetirizine hydrochloride",
      "description": "",
      "dosage": "Directions adults and children 6 years and over one 10 mg tablet once daily; do not take more than o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 509,
    "fields": {
      "name": "CIPROFLOXACIN",
      "brand": "ciprofloxacin",
      "description": "DESCRIPTION Ciprofloxacin ophthalmic solution is a synthetic, sterile, multiple dose, antimicrobial for topical ophthalmic use. Ciprofloxacin is a fluoroquinolone antibacterial active against a broad spectrum of gram-positive and gram-negative ocular pathogens. It is available as the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid.",
      "dosage": "DOSAGE AND ADMINISTRATION Corneal Ulcers: The recommended dosage regimen for the treatment of cornea",
      "stock": 100,
      "route": "OPHTHALMIC",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 510,
    "fields": {
      "name": "CITALOPRAM",
      "brand": "Citalopram",
      "description": "11 DESCRIPTION Citalopram tablets, USP contain citalopram, a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide is a racemic bicyclic phthalane structure and is designated (\u00b1)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3\u00addihydroisobenzofuran-5-carbonitrile hydrobromide with the following structural formula: The molecular formula is C 20 H 22 BrFN 2 O and its molecular weight is 405.35. Citalopram hydrobromide, USP occurs as a fine, white to off-white powder.",
      "dosage": "2.1 Recommended Dosage Administer citalopram tablets once daily, with or without food, at an initial",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 511,
    "fields": {
      "name": "CLINDAMYCIN PHOSPHATE",
      "brand": "Clindamycin Phosphate",
      "description": "DESCRIPTION Clindamycin phosphate topical lotion, 1% contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. Clindamycin phosphate is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The lotion contains cetostearyl alcohol (2.5%); glycerin; glyceryl stearate SE (with potassium monostearate); isostearyl alcohol (2.5%); methylparaben (0.3%); sodium lauroyl sarcosinate; stearic acid; and purified water.",
      "dosage": "DOSAGE AND ADMINISTRATION Apply a thin film of clindamycin phosphate topical lotion twice daily to a",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 512,
    "fields": {
      "name": "CLONAZEPAM",
      "brand": "Clonazepam",
      "description": "DESCRIPTION Clonazepam Tablets, USP, a benzodiazepine, is available as scored tablet with debossing \u039b containing 0.5 mg of clonazepam and unscored tablets with debossing \u039b and \u039b containing 1 mg or 2 mg of clonazepam respectively. Each 66 67 69 tablet also contains lactose monohydrate, polyethylene glycol, microcrystalline cellulose, croscarmellose sodium and magnesium stearate with the following colourants: 0.5 mg-FD & C Yellow 6 Al Lake, D & C Yellow 10 Al Lake; 1 mg-FD & C Blue 1 Al lake and FD & C Blue 2 Al lake Chemically, clonazepam is 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder.",
      "dosage": "Geriatric Patients: There is no clinical trial experience with clonazepam tablets in seizure disorde",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 513,
    "fields": {
      "name": "CLOPIDOGREL BISULFATE",
      "brand": "Clopidogrel",
      "description": "11 DESCRIPTION Clopidogrel bisulfate is a thienopyridine class inhibitor of P2Y 12 ADP platelet receptors. Chemically it is methyl (+)-( S )-\u03b1-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4 H )-\u00adacetate sulfate (1:1). The structural formula is as follows: Clopidogrel bisulfate USP is a white to off-white powder.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Acute coronary syndrome ( 2.1 ) \u2013 Initiate clopidogrel tablets with a si",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 514,
    "fields": {
      "name": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "brand": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "description": "DESCRIPTION Cyclobenzaprine hydrochloride, USP is a tricyclic amine salt which is white to off white, odourless, crystalline powder with the molecular formula C 20 H 21 N \u2022 HCl and a molecular weight of 311.9. Cyclobenzaprine hydrochloride is designated chemically as 3-(5H -dibenzo[a,d] cyclohepten-5-ylidene)- N,N -dimethyl-1-propanamine hydrochloride, and has the following structural formula: Cyclobenzaprine hydrochloride tablets, USP are available as 5 mg, 7.5 mg and 10 mg tablets for oral administration. In addition, the 5 mg tablets contain FD&C Blue #2/INDIGO Carmine Aluminum Lake.",
      "dosage": "DOSAGE AND ADMINISTRATION For most patients, the recommended dose of cyclobenzaprine hydrochloride t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 515,
    "fields": {
      "name": "DAPAGLIFLOZIN",
      "brand": "FARXIGA",
      "description": "11 DESCRIPTION Dapagliflozin, an inhibitor of SGLT2, is described chemically as D-glucitol, 1,5-anhydro-1- C -[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1 S )-, compounded with (2 S )-1,2-propanediol, hydrate (1:1:1). The empirical formula is C 21 H 25 ClO 6 \u2022C 3 H 8 O 2 \u2022H 2 O and the molecular weight is 502.98. The structural formula is: FARXIGA is available as a film-coated tablet for oral administration containing the equivalent of 5 mg dapagliflozin as dapagliflozin propanediol or the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol, and the following inactive ingredients: microcrystalline cellulose, anhydrous lactose, crospovidone, silicon dioxide, and magnesium stearate.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022 Assess volume status and correct volume depletion before initiating. I",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 516,
    "fields": {
      "name": "DESVENLAFAXINE SUCCINATE",
      "brand": "Pristiq Extended-Release",
      "description": "11 DESCRIPTION PRISTIQ is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. Desvenlafaxine is designated RS -4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol and has the empirical formula of C 16 H 25 NO 2 (free base) and C 16 H 25 NO 2 \u2219C 4 H 6 O 4 \u2219H 2 O (succinate monohydrate). Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C yellow #6.",
      "dosage": "In clinical studies, doses of 50 mg to 400 mg per day were shown to be effective, although no additi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 517,
    "fields": {
      "name": "DIAZEPAM",
      "brand": "Diazepam",
      "description": "The molecular formula is C 16 H 13 ClN 2 O and the molecular weight is 284.7. The structural formula is as follows: Diazepam is available for oral administration as tablets containing 2 mg, 5 mg or 10 mg diazepam, USP. 10 Aluminum Lake and FD&C Blue No.",
      "dosage": "2 mg to 10 mg, 3 or 4 times daily Adjunctively in Convulsive Disorders. 2 mg to 2.5 mg, 1 or 2 times",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 518,
    "fields": {
      "name": "DICLOFENAC SODIUM",
      "brand": "Diclofenac Sodium",
      "description": "",
      "dosage": "Directions Use up to 21 days unless directed by your doctor Not for strains, sprains, bruises or spo",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 519,
    "fields": {
      "name": "DICYCLOMINE HYDROCHLORIDE",
      "brand": "Dicyclomine hydrochloride",
      "description": "11 DESCRIPTION Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent available as: Dicyclomine hydrochloride capsules, USP for oral use containing 10 mg dicyclomine hydrochloride, USP. Dicyclomine hydrochloride 10 mg capsules contain the following inactive ingredients: corn starch, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. Capsule shells contain FD&C Blue No.1, FD&C Red No.40, gelatin, purified water, and sodium lauryl sulfate.",
      "dosage": "Dosage for dicyclomine hydrochloride capsules must be adjusted to individual patient needs (2) . Aft",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 520,
    "fields": {
      "name": "DIGOXIN",
      "brand": "Digoxin",
      "description": "11 DESCRIPTION Digoxin is one of the cardiac (or digitalis) glycosides, a closely related group of drugs having in common specific effects on the myocardium. These drugs are found in a number of plants. The term \u201cdigitalis\u201d is used to designate the whole group of glycosides.",
      "dosage": "2.2 Loading Dosing Regimen in Adults and Pediatric Patients For adults and pediatric patients if a l",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 521,
    "fields": {
      "name": "DILTIAZEM HYDROCHLORIDE",
      "brand": "diltiazem hydrochloride",
      "description": "DESCRIPTION Diltiazem hydrochloride is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1, 5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2, 3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride,(+)-cis-. The chemical structure is: USP Dissolution pending.",
      "dosage": "Individual patients may respond to higher doses of up to 480 mg once daily. Antihypertensives : Dilt",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 522,
    "fields": {
      "name": "DIPHENHYDRAMINE HCL",
      "brand": "Childrens Allergy Relief",
      "description": "",
      "dosage": "Directions \u25a0 if needed, take every 4-6 hours \u25a0 do not take more than 6 doses in 24-hours children un",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 523,
    "fields": {
      "name": "DIVALPROEX SODIUM",
      "brand": "Divalproex Sodium",
      "description": "Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium extended-release tablets, USP contain divalproex sodium in a once-a-day extended-release formulation equivalent to 250 or 500 mg of valproic acid. Inactive Ingredients: ammonium hydroxide, colloidal anhydrous silica, colloidal silicon dioxide, dibutyl sebacate, ethylcellulose, hydroxyethyl cellulose, hypromellose, oleic acid, polydextrose, polyethylene glycol, silicified microcrystalline cellulose, titanium dioxide and triacetin.",
      "dosage": "Although doses other than 1,000 mg once daily of divalproex sodium extended-release tablets have not",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 524,
    "fields": {
      "name": "DOXYCYCLINE",
      "brand": "doxycycline",
      "description": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Doxycycline is an antibacterial drug synthetically derived from oxytetracycline, and is available as capsules of doxycycline hyclate for oral administration. The structural formula of doxycycline monohydrate is with a molecular formula of C 22 H 24 N 2 O 8 \u2219H 2 O and a molecular weight of 462.46.",
      "dosage": "Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 525,
    "fields": {
      "name": "DULAGLUTIDE",
      "brand": "TRULICITY",
      "description": "11 DESCRIPTION Dulaglutide is a human glucagon-like peptide-1 (GLP-1) receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1 analog sequence covalently linked to the Fc portion of a modified human immunoglobulin G4 (IgG4) heavy chain by a small peptide linker and is produced using mammalian cell (Chinese hamster ovary) culture. The GLP-1 analog portion of dulaglutide is 90% homologous to native human GLP-1 (7-37).",
      "dosage": "2 DOSAGE AND ADMINISTRATION Adult Dosage ( 2.1 ) Recommended starting dosage is 0.75 mg injected sub",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 526,
    "fields": {
      "name": "ENALAPRIL MALEATE",
      "brand": "Enalapril Maleate",
      "description": "DESCRIPTION Enalapril maleate is the maleate salt of enalapril, the ethyl ester of a long-acting angiotensin-converting enzyme inhibitor, enalaprilat. Its molecular formula is C 20 H 28 N 2 O 5 \u2219C 4 H 4 O 4, and its structural formula is: Enalapril maleate is a white to off-white, crystalline powder with a molecular weight of 492.53. Enalapril is a pro-drug; following oral administration, it is bioactivated by hydrolysis of the ethyl ester to enalaprilat, which is the active angiotensin-converting enzyme inhibitor.",
      "dosage": "DOSAGE AND ADMINISTRATION Hypertension In patients who are currently being treated with a diuretic, ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 527,
    "fields": {
      "name": "ESCITALOPRAM ORAL",
      "brand": "Escitalopram Oral Solution",
      "description": "11 DESCRIPTION Escitalopram Oral Solution, USP contains escitalopram oxalate, an orally administered selective serotonin reuptake inhibitor (SSRI), present as escitalopram oxalate salt. Escitalopram is the pure S-enantiomer (single isomer) of the racemic bicyclic phthalane derivative citalopram. Escitalopram oxalate is designated S-(+)-1-[3-(dimethyl-amino)propyl]-1-( p -fluorophenyl)-5-phthalancarbonitrile oxalate with the following structural formula: The molecular formula is C 20 H 21 FN 2O \u2022 C 2 H 2 O 4 and the molecular weight is 414.40.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication and Population Recommended Dosage MDD in Adults ( 2.1 ) Initi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 528,
    "fields": {
      "name": "ESOMEPRAZOLE MAGNESIUM",
      "brand": "Acid Reducer",
      "description": "",
      "dosage": "Directions adults 18 years of age and older this product is to be used once a day (every 24 hours), ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 529,
    "fields": {
      "name": "ESZOPICLONE",
      "brand": "Eszopiclone",
      "description": "11 DESCRIPTION Eszopiclone is a hypnotic agent/nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class. The chemical name of eszopiclone is (+)-4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5 H pyrrolo[3,4- b ]pyrazin-5-(S)-yl ester. In addition, both the 1 mg and 3 mg tablets contain FD&C Blue #2/indigo carmine aluminium lake.",
      "dosage": "May increase dose if clinically indicated, to a maximum of 3 mg ( 2.1 ) \u2022 Geriatric or debilitated p",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 530,
    "fields": {
      "name": "FENTANYL CITRATE",
      "brand": "Fentanyl Citrate",
      "description": "Fentanyl citrate is chemically identified as N -(1-Phenethyl-4-piperidyl)propionanilide citrate (1:1) with the following structural formula: C 22 H 28 N 2 O \u2022 C 6 H 8 O 7 Molecular Weight is 528.59 Each mL contains fentanyl citrate equivalent to 50 mcg (0.05 mg) fentanyl base in Water for Injection. Sodium hydroxide and/or hydrochloric acid added, if needed, for pH adjustment. The pH range is 4.0 to 7.5.",
      "dosage": "For use in more major surgical procedures, in addition to adequate analgesia, may abolish some of th",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 531,
    "fields": {
      "name": "FEXOFENADINE HCL",
      "brand": "Fexofenadine HCL",
      "description": "",
      "dosage": "Directions adults and children 12 years of age and over: take one 180 mg tablet with water every onc",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 532,
    "fields": {
      "name": "FINASTERIDE",
      "brand": "Finasteride",
      "description": "11 DESCRIPTION Finasteride tablets USP, 1 mg contains finasteride as the active ingredient. Finasteride is 4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5\u03b1, 17\u03b2)-. Its structural formula is: Finasteride is a white crystalline powder with a melting point near 250\u00b0 C. It is freely soluble in chloroform and in lower alcohol solvents but is practically insoluble in water.",
      "dosage": "The recommended dose of finasteride tablets USP is one tablet (1 mg) taken once daily. In general, d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 533,
    "fields": {
      "name": "FLUCONAZOLE",
      "brand": "Fluconazole",
      "description": "DESCRIPTION Fluconazole, the first of a new subclass of synthetic triazole antifungal agents, is available as tablets for oral administration. Fluconazole is designated chemically as 2,4-difluoro-\u03b1,\u03b1 1 -bis(1H-1,2,4-triazol-1-ylmethyl) benzyl alcohol with a molecular formula of C 13 H 12 F 2 N 6 O and molecular weight of 306.3. The structural formula is: Fluconazole USP is a white crystalline solid which is slightly soluble in water and saline.",
      "dosage": "DOSAGE AND ADMINISTRATION Dosage and Administration in Adults: Single Dose Vaginal candidiasis: The ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 534,
    "fields": {
      "name": "FLUOXETINE HYDROCHLORIDE",
      "brand": "Fluoxetine",
      "description": "11 DESCRIPTION Fluoxetine capsules, USP are a selective serotonin reuptake inhibitor for oral administration. It is also marketed for the treatment of premenstrual dysphoric disorder (Sarafem \u00ae , fluoxetine hydrochloride). In addition, 20 mg capsules also contains D&C Yellow #10 and 10 mg capsules also contains FD&C Yellow #6.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication Adult Pediatric MDD ( 2.1 ) 20 mg/day in am (initial dose) 10",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 535,
    "fields": {
      "name": "FLUTICASONE PROPIONATE",
      "brand": "FLOVENT DISKUS",
      "description": "11 DESCRIPTION FLOVENT DISKUS inhalation powder is a dry powder inhaler for oral inhalation. The active component of FLOVENT DISKUS 50 mcg, FLOVENT DISKUS 100 mcg, and FLOVENT DISKUS 250 mcg is fluticasone propionate, a corticosteroid having the chemical name S- (fluoromethyl) 6\u03b1,9-difluoro-11\u03b2,17-dihydroxy-16\u03b1-methyl-3-oxoandrosta-1,4-diene-17\u03b2-carbothioate, 17-propionate and the following chemical structure: Fluticasone propionate is a white powder with a molecular weight of 500.6, and the empirical formula is C 25 H 31 F 3 O 5 S. It is practically insoluble in water, freely soluble in dimethyl sulfoxide and dimethylformamide, and slightly soluble in methanol and 95% ethanol. Each blister on the strip contains a white powder mix of micronized fluticasone propionate (50, 100, or 250 mcg) in 12.5 mg of formulation containing lactose monohydrate (which contains milk proteins).",
      "dosage": "2.2 Recommended Dosage Adult and Adolescent Patients Aged 12 Years and Older The starting dosage is ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 536,
    "fields": {
      "name": "GABAPENTIN",
      "brand": "Gabapentin",
      "description": "11 DESCRIPTION The active ingredient in Gabapentin Capsules USP is gabapentin, which has the chemical name 1-(aminomethyl)cyclohexaneacetic acid. The molecular formula of gabapentin is C 9 H 17 NO 2 and the molecular weight is 171.24. The structural formula of gabapentin is: Gabapentin is a white to off-white crystalline solid with a pK a1 of 3.7 and a pK a2 of 10.7.",
      "dosage": "2 DOSAGE AND ADMlNlSTRATION Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 537,
    "fields": {
      "name": "GEMFIBROZIL",
      "brand": "Gemfibrozil",
      "description": "DESCRIPTION Gemfibrozil, USP is a lipid regulating agent. It is available as tablets for oral administration. Each tablet contains 600 mg gemfibrozil.",
      "dosage": "DOSAGE AND ADMINISTRATION The recommended dose for adults is 1,200 mg administered in two divided do",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 538,
    "fields": {
      "name": "GLIMEPIRIDE",
      "brand": "Glimepiride",
      "description": "11 DESCRIPTION Glimepiride tablets USP, are an oral sulfonylurea that contains the active ingredient glimepiride USP. Chemically, glimepiride USP is identified as 1-[[p-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea (C 24 H 34 N 4 O 5 S) with a molecular weight of 490.62. Glimepiride USP is a white to almost white powder, soluble in dimethyl formamide, sparingly soluble in methylene chloride, practically insoluble in water.",
      "dosage": "The recommended starting dose of glimepiride tablets are 1 mg or 2 mg once daily. Patients at increa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 539,
    "fields": {
      "name": "GLIPIZIDE",
      "brand": "Glipizide",
      "description": "The Chemical Abstracts name of glipizide is 1-cyclohexyl-3-[[ p -[2-(5-methylpyrazine-carboxamido)ethyl]phenyl]sulfonyl]urea. The molecular formula is C 21 H 27 N 5 O 4 S; the molecular weight is 445.55; the structural formula is shown below: Glipizide is a whitish, odorless powder with a pKa of 5.9. Glipizide Tablets USP for oral use are available in 5 and 10 mg strengths.",
      "dosage": "In addition to the usual monitoring of urinary glucose, the patient\u2019s blood glucose must also be mon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 540,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 541,
    "fields": {
      "name": "HYDROXYCHLOROQUINE SULFATE",
      "brand": "Hydroxychloroquine Sulfate",
      "description": "DESCRIPTION Hydroxychloroquine sulfate is a white or practically white, crystalline powder, freely soluble in water; practically insoluble in alcohol, chloroform, and in ether. The chemical name for hydroxychloroquine sulfate is 2-[[4-[(7-Chloro-4-quinolyl) amino]pentyl] ethylamino]ethanol sulfate (1:1). Its structural formula is: The molecular weight of hydroxychloroquine sulfate is 433.95, and molecular formula is C 18 H 26 ClN 3 O.H 2 SO 4 .",
      "dosage": "Treatment of Uncomplicated Malaria Adults: 800 mg (620 mg base) followed by 400 mg (310 mg base) at ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 542,
    "fields": {
      "name": "IBUPROFEN",
      "brand": "Ibuprofen Dye Free",
      "description": "",
      "dosage": "Directions do not take more than directed the smallest effective dose should be used adults and chil",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 543,
    "fields": {
      "name": "INSULIN ASPART",
      "brand": "NOVOLOG",
      "description": "11 DESCRIPTION Insulin aspart is a rapid-acting human insulin analog homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Saccharomyces cerevisiae (baker's yeast). Insulin aspart has the empirical formula C 256 H 381 N 65 0 79 S 6 and a molecular weight of 5825.8 Da. NOVOLOG has a pH of 7.2-7.6.",
      "dosage": "\u2022 Continuous Subcutaneous Infusion (Insulin Pump) ( 2.2 ): o Refer to the insulin infusion pump user",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 544,
    "fields": {
      "name": "INSULIN DETEMIR",
      "brand": "LEVEMIR",
      "description": "Insulin detemir has a molecular formula of C 267 H 402 O 76 N 64 S 6 and a molecular weight of 5.917 kDa. Hydrochloric acid and/or sodium hydroxide may be added to adjust pH. Levemir Chemical Structure.jpg",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 545,
    "fields": {
      "name": "INSULIN GLARGINE",
      "brand": "BASAGLAR Tempo Pen",
      "description": "Insulin glargine has the following structural formula: BASAGLAR (insulin glargine) injection is a sterile clear and colorless aqueous solution for subcutaneous use. The 3 mL BASAGLAR prefilled pen presentations contain the following inactive ingredients per mL: glycerin (17 mg), metacresol (2.7 mg), zinc oxide (content adjusted to provide 30 mcg zinc ion), and Water for Injection, USP. BASAGLAR has a pH of approximately 4.",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 546,
    "fields": {
      "name": "INSULIN LISPRO",
      "brand": "ADMELOG",
      "description": "11 DESCRIPTION Insulin lispro is a rapid-acting human insulin analog produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli . Insulin lispro has a pH of 7.0 to 7.8. The pH is adjusted by addition of aqueous solutions of hydrochloric acid and/or sodium hydroxide.",
      "dosage": "Use in accordance with the insulin pump instructions for use. Administer ADMELOG by continuous subcu",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 547,
    "fields": {
      "name": "ISOSORBIDE MONONITRATE",
      "brand": "ISOSORBIDE MONONITRATE",
      "description": "Each tablet, for oral administration, contains either 30 mg, 60 mg or 120 mg of isosorbide mononitrate in an extended-release formulation. In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, diethyl phthalate, hydrogenated castor oil, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc and titanium dioxide. The chemical name for ISMN is 1,4:3,6-dianhydro-,D-glucitol 5-nitrate; the compound has the following structural formula: ISMN is a white, crystalline, odorless compound which is stable in air and in solution, has a melting point of about 90\u00b0C, and an optical rotation of +144\u00b0 (2% in water, 20\u00b0C).",
      "dosage": "After several days, the dosage may be increased to 120 mg (given as a single 120 mg tablet or as two",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 548,
    "fields": {
      "name": "LAMOTRIGINE",
      "brand": "Lamotrigine",
      "description": "11 DESCRIPTION Lamotrigine, USP an AED of the phenyltriazine class, is chemically unrelated to existing AEDs. Lamotrigine\u2019s chemical name is 3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine, its molecular formula is C 9 H 7 N 5 Cl 2 , and its molecular weight is 256.09. Lamotrigine orally disintegrating tablets are formulated using in-house technologies designed to mask the bitter taste of lamotrigine and achieve a rapid dissolution profile.",
      "dosage": "Adjustments to the Maintenance Dose of Lamotrigine in Women Taking Estrogen-Containing Oral Contrace",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 549,
    "fields": {
      "name": "LANSOPRAZOLE",
      "brand": "Lansoprazole",
      "description": "Lansoprazole has the following structure: Lansoprazole is a white to brownish-white odorless crystalline powder which melts with decomposition at approximately 166\u00b0C. The degradation half-life of the drug substance in aqueous solution at 25\u00b0C is approximately 0.5 hour at pH 5.0 and approximately 18 hours at pH 7.0. Lansoprazole Delayed-Release Capsules, USP are supplied in delayed-release capsules for oral administration.The delayed-release capsules are available in two dosage strengths: 15 mg and 30 mg of lansoprazole per capsule.",
      "dosage": "For patients who have difficulty swallowing capsules, Lansoprazole delayed-release capsules can be o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 550,
    "fields": {
      "name": "LEVETIRACETAM",
      "brand": "Levetiracetam Extended-release",
      "description": "11 DESCRIPTION Levetiracetam Extended-release Tablets USP is an antiepileptic drug available as 500 mg and 750 mg (white) extended-release tablets for oral administration. It has the following structural formula: Levetiracetam is a white to off-white crystalline powder with a faint odor and a bitter taste. It is freely soluble in chloroform (65.3 g/100 mL) and in methanol (53.6 g/100 mL), soluble in ethanol (16.5 g/100 mL), sparingly soluble in acetonitrile (5.7 g/100 mL) and practically insoluble in n-hexane.",
      "dosage": "2 DOSAGE & ADMINISTRATION Initiate treatment with a dose of 1,000 mg once daily; increase by 1,000 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 551,
    "fields": {
      "name": "LEVOTHYROXINE, LIOTHYRONINE",
      "brand": "NP Thyroid 120",
      "description": "NP Thyroid \u00ae (thyroid tablets, USP) for oral use is a natural preparation derived from porcine thyroid glands. They contain both tetraiodothyronine sodium (T 4 levothyroxine) and triiodothyronine sodium (T 3 liothyronine) providing 38 mcg levothyroxine (T 4 ) and 9 mcg liothyronine (T 3 ) per grain of thyroid. The inactive ingredients are calcium stearate, dextrose (agglomerated) and mineral oil.",
      "dosage": "DOSAGE AND ADMINISTRATION The dosage of thyroid hormones is determined by the indication and must in",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 552,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 553,
    "fields": {
      "name": "LORAZEPAM",
      "brand": "Lorazepam",
      "description": "DESCRIPTION Lorazepam USP, an antianxiety agent, has the chemical formula, 7-chloro-5-( o -chlorophenyl)-1,3\u2011-dihydro-3-hydroxy-2 H -1,4-benzodiazepin-2-one: It is a nearly white powder almost insoluble in water. Each lorazepam tablet, USP to be taken orally, contains 0.5 mg, 1 mg, or 2 mg of lorazepam, USP. The inactive ingredients present are anhydrous lactose, magnesium stearate, microcrystalline cellulose, and polacrilin potassium.",
      "dosage": "DOSAGE AND ADMINISTRATION Lorazepam tablets are administered orally. For insomnia due to anxiety or ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 554,
    "fields": {
      "name": "LOSARTAN POTASSIUM",
      "brand": "Losartan Potassium",
      "description": "11 DESCRIPTION Losartan potassium is an angiotensin II receptor blocker acting on the AT 1 receptor subtype. Its molecular formula is C 22 H 22 ClKN 6 O, and its structural formula is: Losartan potassium, USP is white to off-white powder with a molecular weight of 461.01. It is freely soluble in water; soluble in isopropyl alcohol; slightly soluble in acetonitrile.",
      "dosage": "Pediatric Hypertension The usual recommended starting dose is 0.7 mg per kg once daily (up to 50 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 555,
    "fields": {
      "name": "LOVASTATIN",
      "brand": "Lovastatin",
      "description": "This enzyme catalyzes the conversion of HMG-CoA to mevalonate, which is an early and rate limiting step in the biosynthesis of cholesterol. 404.55 C 24 H 36 O 5 M.W. Lovastatin Tablets USP, 40 mg also contain D&C Yellow #10 Aluminum Lake, FD&C Blue #1 Aluminum Lake, and FD&C Yellow #6 Aluminum Lake.",
      "dosage": "Patients requiring reductions in LDL-C of 20% or more to achieve their goal (see INDICATIONS AND USA",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 556,
    "fields": {
      "name": "LURASIDONE HYDROCHLORIDE",
      "brand": "Lurasidone Hydrochloride",
      "description": "11 DESCRIPTION Lurasidone hydrochloride is an atypical antipsychotic belonging to the chemical class of benzisothiazol derivatives. Its chemical name is (3a R ,4 S ,7 R ,7a S )-2-{(1 R ,2 R )-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-\u00adylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2 H -isoindole-1,3-dione hydrochloride. Its molecular formula is C 28 H 36 N 4 O 2 S\u00b7HCl and its molecular weight is 529.14.",
      "dosage": "Lurasidone hydrochloride tablets have been shown to be effective in a dose range of 40 mg per day to",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 557,
    "fields": {
      "name": "MELOXICAM",
      "brand": "Meloxicam",
      "description": "11 DESCRIPTION Meloxicam, is a nonsteroidal anti-inflammatory drug (NSAID). Its empirical formula is C 14 H 13 N 3 O 4 S 2 and it has the following structural formula: Meloxicam is a pastel yellow solid, practically insoluble in water, with higher solubility observed in strong acids and bases. Meloxicam tablets USP are available as tablets for oral administration containing 7.5 mg or 15 mg meloxicam.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest effective dosage for the shortest duration consistent wit",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 558,
    "fields": {
      "name": "MEMANTINE",
      "brand": "Memantine hydrochloride",
      "description": "11 DESCRIPTION Memantine hydrochloride, USP is an orally active NMDA receptor antagonist. The tablets also contain the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose and talc. In addition the following inactive ingredients are also present as components of the film coat: D&C Yellow #10, FD&C Blue #2, FD&C Yellow #6, macrogol, polyvinyl alcohol, talc, and titanium dioxide (5 mg tablets), and iron oxide black, iron oxide yellow, macrogol, polyvinyl alcohol, talc and titanium dioxide (10 mg tablets).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dose of memantine hydrochloride tablets is 5 mg",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 559,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 560,
    "fields": {
      "name": "METHADONE HYDROCHLORIDE",
      "brand": "Methadone Hydrochloride",
      "description": "DESCRIPTION Methadone Hydrochloride Oral Concentrate, USP, contains methadone, an opiate agonist, and is available as a cherry flavored liquid concentrate for oral administration. It is present in methadone hydrochloride oral concentrate as the racemic mixture. Other ingredients of Methadone Hydrochloride Oral Concentrate, USP (Dye-Free, Sugar-Free, Unflavored): citric acid anhydrous, purified water, and sodium benzoate.",
      "dosage": "Titration and Maintenance Treatment of Opioid Dependence Patients in maintenance treatment should be",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 561,
    "fields": {
      "name": "METHOCARBAMOL",
      "brand": "Methocarbamol",
      "description": "The chemical name of methocarbamol is 3-(2-meth-oxyphenoxy)-1,2-propanediol 1-carbamate and has the empirical formula C 11 H 15 NO 5 . Its molecular weight is 241.24. Methocarbamol tablets, USP are available as 500 mg and 750 mg tablets for oral administration.",
      "dosage": "Maintenance dosage: 2 tablets q.i.d. Methocarbamol tablets, USP: 750 mg \u2013 Adults: Initial dosage: 2 ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 562,
    "fields": {
      "name": "METHYLPHENIDATE HYDROCHLORIDE",
      "brand": "Methylphenidate Hydrochloride (LA)",
      "description": "Each Methylphenidate Hydrochloride Extended-Release Capsule contains pellets, with half the dose as immediate-release and half as delayed-release, thus providing an immediate release of methylphenidate and a second delayed release of methylphenidate. The active substance in Methylphenidate Hydrochloride Extended-Release Capsules is methyl \u03b1-phenyl-2-piperidineacetate hydrochloride. Its structural formula is as follows: M.W.",
      "dosage": "The drug and applesauce mixture should not be stored for future use. 2.3 Patients Currently Using Me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 563,
    "fields": {
      "name": "METOPROLOL TARTRATE",
      "brand": "Metoprolol Tartrate",
      "description": "11 DESCRIPTION Metoprolol tartrate tablets, USP contain metoprolol tartrate, a selective beta 1 -adrenoreceptor blocking agent. It is very soluble in water; freely soluble in methylene chloride, in chloroform, and in alcohol; slightly soluble in acetone; and insoluble in ether. Metoprolol tartrate tablets, USP are available as 25 mg, 50 mg and 100 mg tablets for oral administration containing 25 mg, 50 mg and 100 mg metoprolol tartrate, respectively.",
      "dosage": "The effective dosage range of metoprolol tartrate tablets is 100 mg to 450 mg per day. The effective",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 564,
    "fields": {
      "name": "METRONIDAZOLE",
      "brand": "Metronidazole",
      "description": "DESCRIPTION Metronidazole tablets, USP 250 mg or 500 mg is an oral formulation of the synthetic nitroimidazole antimicrobial, 2-methyl-5-nitro-1H-imidazole-1-ethanol, which has the following structural formula: Metronidazole tablets USP contain 250 mg or 500 mg of metronidazole. Inactive ingredients include powdered cellulose, hydroxypropyl cellulose, low substituted hydroxypropyl cellulose, hypromellose, polyethylene glycol, stearic acid, and titanium dioxide. Molecular Structure",
      "dosage": "There is some indication from controlled comparative studies that cure rates as determined by vagina",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 565,
    "fields": {
      "name": "MIRTAZAPINE",
      "brand": "Mirtazapine",
      "description": "Mirtazapine has a tetracyclic chemical structure and belongs to the piperazino-azepine group of compounds. It is designated 1,2,3,4,10,14b-hexahydro-2-methylpyrazino [2,1-a] pyrido [2,3-c][2] benzazepine and has the molecular formula of C 17 H 19 N 3 . The structural formula is the following and it is the racemic mixture: Mirtazapine is a white to creamy white crystalline powder which is practically insoluble in water.",
      "dosage": "If patients do not have an adequate response to the initial 15 mg dose, increase the dose up to a ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 566,
    "fields": {
      "name": "MONTELUKAST SODIUM",
      "brand": "Montelukast Sodium",
      "description": "DESCRIPTION Montelukast sodium, the active ingredient in montelukast sodium tablets, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT 1 receptor. Montelukast sodium is described chemically as [ R-(E) ]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl] cyclopropaneacetic acid, monosodium salt. Each 10-mg film-coated montelukast sodium tablet contains 10.4 mg montelukast sodium, which is equivalent to 10 mg of montelukast, and the following inactive ingredients: croscarmellose sodium, ferric oxide red, ferric oxide yellow, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose and titanium dioxide.",
      "dosage": "Patients with both asthma and allergic rhinitis should take only one dose daily in the evening (2.4)",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 567,
    "fields": {
      "name": "NAPROXEN",
      "brand": "Naproxen",
      "description": "11 DESCRIPTION Naproxen Tablets, USP and Naproxen Sodium Tablets, USP are nonsteroidal anti-inflammatory drugs available as follows: Naproxen Tablets, USP are available as follows for oral administration: 250 mg: circular, light orange colored, flat, uncoated tablets, engraved with \u2018G\u2019 and \u201832\u2019 on either side of a break line on one side and \u2018250\u2019 on the other side. The inactive ingredients are croscarmellose sodium, iron oxide red, iron oxide yellow, magnesium stearate, microcrystalline cellulose and povidone. Naproxen, USP and naproxen sodium, USP have the following structures, respectively: Naproxen Naproxen Sodium Naproxen, USP is a white to off-white crystalline powder.",
      "dosage": "Management of Pain, Primary Dysmenorrhea, and Acute Tendonitis and Bursitis Recommended starting dos",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 568,
    "fields": {
      "name": "NITROGLYCERIN",
      "brand": "NITROGLYCERIN",
      "description": "11 DESCRIPTION Nitroglycerin sublingual tablets are stabilized sublingual compressed tablets that contain 0.3 mg, 0.4 mg, or 0.6 mg nitroglycerin; as well as lactose monohydrate, NF; glyceryl monostearate, NF; pregelatinized starch, NF; calcium stearate, NF powder; and silicon dioxide, colloidal, NF. Nitroglycerin, an organic nitrate, is a vasodilating agent. The chemical name for nitroglycerin is 1, 2, 3 propanetriol trinitrate and the chemical structure is: Molecular weight: 227.09 Nitroglycerin Structural Formula",
      "dosage": "2 DOSAGE AND ADMINISTRATION Administer one tablet under the tongue or in the buccal pouch at the fir",
      "stock": 100,
      "route": "SUBLINGUAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 569,
    "fields": {
      "name": "NORTRIPTYLINE HYDROCHLORIDE",
      "brand": "Nortriptyline Hydrochloride",
      "description": "DESCRIPTION Nortriptyline Hydrochloride, USP is 1-propanamine, 3-(10,11-dihydro-5 H -dibenzo[ a,d ]cyclohepten-5-ylidene)- N -methyl, hydrochloride. The structural formula is as follows: C19H21N\u2219HCl MW = 299.84 Each capsule, for oral administration, contains nortriptyline hydrochloride equivalent to 10 mg, 25 mg, 50 mg, and 75 mg of nortriptyline hydrochloride USP. In addition, each capsule contains the following inactive ingredients: black iron oxide, colloidal silicon dioxide, D&C Yellow #10 (aluminum lake), D&C Yellow #10, FD&C Blue #1 (aluminum lake), FD&C Blue #2 (aluminum lake), FD&C Green #3 (10, 50 and 75 mg only), FD&C Red #40 (aluminum lake), gelatin, I.M.S. 74 OP, magnesium stearate, pregelatinized corn starch, shellac, sodium lauryl sulfate and titanium dioxide.",
      "dosage": "Usual Adult Dose 25 mg three or four times daily; dosage should begin at a low level and be increase",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 570,
    "fields": {
      "name": "OMEPRAZOLE",
      "brand": "Omeprazole",
      "description": "",
      "dosage": "Directions for adults 18 years of age and older this product is to be used once a day (every 24 hour",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 571,
    "fields": {
      "name": "ONDANSETRON HYDROCHLORIDE",
      "brand": "ondansetron hydrochloride",
      "description": "11 DESCRIPTION The active ingredient in ondansetron tablets is ondansetron hydrochloride as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT 3 receptor type. Chemically it is (\u00b1) 1, 2, 3, 9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, monohydrochloride, dihydrate. Each tablet also contains the inactive ingredients colloidal silicon dioxide, hypromellose 2910(5cP) (for the 4 mg and 16 mg tablets only) and hypromellose 2910 (6cP) (for the 8 mg and 24 mg tablets only), iron oxide red and iron oxide black (for the 24 mg tablet only), iron oxide yellow (for the 8 mg and 24 mg tablets only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium starch glycolate, and titanium dioxide.",
      "dosage": "2 DOSAGE AND ADMINISTRATION See full prescribing information for the recommended dosage in adults an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 572,
    "fields": {
      "name": "OXYCODONE HYDROCHLORIDE",
      "brand": "Oxycodone Hydrochloride",
      "description": "Each tablet for oral administration contains 15 mg, or 30 mg, of oxycodone hydrochloride USP. Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. The 15 mg and 30 mg tablets contain the equivalent of 13.5 mg and 27.0 mg, respectively, of oxycodone free base.",
      "dosage": "If a decision is made to discontinue the use of non-opioid analgesic, it may be necessary to titrate",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 573,
    "fields": {
      "name": "PANTOPRAZOLE SODIUM INJECTION",
      "brand": "PANTOPRAZOLE SODIUM",
      "description": "11 DESCRIPTION The active ingredient in pantoprazole sodium for injection (pantoprazole sodium), a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S, with a molecular weight of 405.4. The reconstituted solution of pantoprazole sodium for injection is in the pH range of 9.0 to 10.5.",
      "dosage": "( 2.3 , 2.4 ) 2.1 Recommended Dosage for GERD Associated with a History of EE Adult Patients The rec",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 574,
    "fields": {
      "name": "PAROXETINE HYDROCHLORIDE HEMIHYDRATE",
      "brand": "Paroxetine",
      "description": "11 DESCRIPTION Paroxetine tablets contain paroxetine hydrochloride, an SSRI. It is the hydrochloride salt of a phenylpiperidine compound identified chemically as (-)- trans -4 R -(4'-fluorophenyl)-3 S -[(3',4'- methylenedioxyphenoxy) methyl] piperidine hydrochloride hemihydrate and has the empirical formula of C 19 H 20 FNO 3 \u2022HCl\u20221/2H 2 O. The structural formula of paroxetine hydrochloride is: Paroxetine hydrochloride, USP is an odorless, off-white powder, having a melting point range of 120 o to 138 o C and a solubility of 5.4 mg/mL in water.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting and maximum daily dosage for MDD, OCD, PD, and PTSD",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 575,
    "fields": {
      "name": "PENICILLIN G BENZATHINE",
      "brand": "BICILLIN L-A",
      "description": "Description Bicillin L-A (penicillin G benzathine injectable suspension) is available for deep intramuscular injection. Its chemical structure is as follows: Bicillin L-A contains penicillin G benzathine in aqueous suspension with sodium citrate buffer and, as w/v, approximately 0.65% sodium citrate, 0.59% povidone, 0.54% carboxymethylcellulose sodium, 0.53% lecithin, 0.12% methylparaben, and 0.013% propylparaben. Bicillin L-A contains approximately 0.11 mEq of sodium per 600,000 units of penicillin G (approximately 2.59 mg of sodium per 600,000 units of penicillin G).",
      "dosage": "DOSAGE AND ADMINISTRATION Streptococcal (Group A) Upper Respiratory Infections (for example, pharyng",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 576,
    "fields": {
      "name": "PHENYTOIN SODIUM",
      "brand": "Phenytoin Sodium",
      "description": "11 DESCRIPTION Phenytoin Sodium Injection, USP is a sterile solution containing in each mL phenytoin sodium 50 mg, propylene glycol 0.4 mL and alcohol 0.1 mL in Water for Injection. pH 10.0-12.3; sodium hydroxide added, if needed, for pH adjustment. Phenytoin sodium is related to the barbiturates in chemical structure, but has a five-membered ring.",
      "dosage": "( 2.2 , 2.3 ) 2.1 General Dosing Information Because of the increased risk of adverse cardiovascular",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 577,
    "fields": {
      "name": "PIOGLITAZONE HYDROCHLORIDE",
      "brand": "PIOGLITAZONE HYDROCHLORIDE",
      "description": "11 DESCRIPTION Pioglitazone tablets are a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (PPAR) gamma that contains an oral antidiabetic medication: pioglitazone. Pioglitazone [(\u00b1)-5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2,4-] thiazolidinedione monohydrochloride contains one asymmetric carbon, and the compound is synthesized and used as the racemic mixture. The two enantiomers of pioglitazone interconvert in vivo .",
      "dosage": "(2.1) If there is inadequate glycemic control, the dose can be increased in 15 mg increments up to a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 578,
    "fields": {
      "name": "PREDNISONE",
      "brand": "PredniSONE",
      "description": "DESCRIPTION Prednisone is a glucocorticoid. Glucocorticoids are adrenocortical steroids, both naturally occurring and synthetic, which are readily absorbed from the gastrointestinal tract. Prednisone, USP is a white to partially white, crystalline powder.",
      "dosage": "Included in the situations which may make dosage adjustments necessary are changes in clinical statu",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 579,
    "fields": {
      "name": "PREGABALIN",
      "brand": "PREGABALIN",
      "description": "The molecular formula is C 8 H 17 NO 2 and the molecular weight is 159.23. Pregabalin capsules are administered orally and are supplied as imprinted hard-shell capsules containing 25, 50, 75, 100, 150, 200, 225, and 300 mg of pregabalin, along with pregelatinized starch and talc as inactive ingredients. In addition, the orange & red capsule shells contain red iron oxide.",
      "dosage": "( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) Dosing recommendations: INDICATION Dosing Regimen Maximum Dose DPN P",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 580,
    "fields": {
      "name": "PROMETHAZINE HYDROCHLORIDE",
      "brand": "PROMETHAZINE HYDROCHLORIDE",
      "description": "DESCRIPTION Each 12.5 mg promethazine hydrochloride tablet for oral administration contains 12.5 mg promethazine hydrochloride. In addition, 50 mg tablet contains FD&C Red #40 and 12.5 mg tablet contains FD&C Yellow #6. Promethazine hydrochloride is a racemic compound; the empirical formula is C 17 H 20 N 2 S\u2022HCl and its molecular weight is 320.88.",
      "dosage": "The average effective dose of promethazine hydrochloride tablets, USP for the active therapy of naus",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 581,
    "fields": {
      "name": "PROPRANOLOL HYDROCHLORIDE",
      "brand": "Propranolol Hydrochloride",
      "description": "Propranolol Hydrochloride Tablets, USP are available as tablets for oral administration containing either 10 mg, 20 mg, 40 mg, 60 mg, or 80 mg of propranolol hydrochloride, USP. 6 aluminum lake (10 mg and 80 mg), D&C Yellow no. 10 aluminum lake (10 mg, 40 mg, and 80 mg), FD&C Blue no.",
      "dosage": "Hypertension The usual initial dosage is 40 mg propranolol hydrochloride twice daily, whether used a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 582,
    "fields": {
      "name": "QUETIAPINE FUMARATE",
      "brand": "Quetiapine Fumarate",
      "description": "It is present in tablets as the fumarate salt. Quetiapine tablets, USP is supplied for oral administration as 25 mg (round peach), 50 mg (round, white), 100 mg (round yellow), 150 mg (round, off white to light yellow), 200 mg (round, white), 300 mg (capsule-shaped, white), and 400 mg (capsule-shaped, yellow) tablets. The 25 mg tablets contain red iron oxide and yellow iron oxide and the 100 mg, 150 mg and 400 mg tablets contain only yellow iron oxide.",
      "dosage": "Further adjustments can be made in increments of 25 to 50 mg twice a day, in intervals of not less t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 583,
    "fields": {
      "name": "RABEPRAZOLE SODIUM",
      "brand": "Rabeprazole sodium",
      "description": "11 DESCRIPTION The active ingredient in rabeprazole sodium delayed-release tablets is rabeprazole sodium hydrate, USP, which is a proton pump inhibitor. The stability of rabeprazole sodium hydrate, USP is a function of pH; it is rapidly degraded in acid media, and is more stable under alkaline conditions. The structural figure is: Rabeprazole sodium hydrate, USP is available for oral administration as delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium hydrate, USP.",
      "dosage": "The use of rabeprazole sodium delayed-release tablets is not recommended for use in pediatric patien",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 584,
    "fields": {
      "name": "RANITIDINE",
      "brand": "Ranitidine",
      "description": "",
      "dosage": "Directions adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 585,
    "fields": {
      "name": "RISPERIDONE",
      "brand": "RISPERIDONE",
      "description": "11 DESCRIPTION Risperidone tablets, USP contain risperidone USP, an atypical antipsychotic belonging to the chemical class of benzisoxazole derivatives. The structural formula is: Risperidone USP is a white to slightly beige powder. Tablets of 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg also contain talc and titanium dioxide.",
      "dosage": "Maintenance Therapy While it is unknown how long a patient with schizophrenia should remain on rispe",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 586,
    "fields": {
      "name": "ROSUVASTATIN CALCIUM",
      "brand": "Rosuvastatin Calcium",
      "description": "11 DESCRIPTION Rosuvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA)-reductase inhibitor. The chemical name for rosuvastatin calcium is bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt with the following structural formula: The empirical formula for rosuvastatin calcium is (C 22 H 27 FN 3 O 6 S) 2 Ca and the molecular weight is 1001.14. Rosuvastatin calcium is a white or almost white, hygroscopic powder that is slightly soluble in water, freely soluble in methylene chloride, practically insoluble in ethanol.",
      "dosage": "( 2.1 ) Pediatric Patients with HeFH : Recommended dosage range is 5 to 10 mg once daily for patient",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 587,
    "fields": {
      "name": "SERTRALINE HYDROCHLORIDE",
      "brand": "Sertraline Hydrochloride",
      "description": "DESCRIPTION Sertraline hydrochloride is a selective serotonin reuptake inhibitor (SSRI) for oral administration. It has a molecular weight of 342.7. Sertraline hydrochloride, USP has the following chemical name: (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride.",
      "dosage": "While a relationship between dose and effect has not been established for OCD, patients were dosed i",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 588,
    "fields": {
      "name": "SILDENAFIL CITRATE",
      "brand": "SILDENAFIL CITRATE",
      "description": "11 DESCRIPTION Sildenafil tablets, USP, an oral therapy for erectile dysfunction, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Sildenafil citrate, is designated chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1 H -pyrazolo[4,3- d ]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate and has the following structural formula: Sildenafil citrate, USP is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Sildenafil tablets USP are formulated as pale blue to blue film-coated tablets equivalent to 25 mg, 50 mg and 100 mg of sildenafil for oral administration.",
      "dosage": "However, sildenafil tablets may be taken anywhere from 30 minutes to 4 hours before sexual activity ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 589,
    "fields": {
      "name": "EZETIMIBE AND SIMVASTATIN",
      "brand": "Ezetimibe and Simvastatin",
      "description": "11 DESCRIPTION Ezetimibe and simvastatin tablets contain ezetimibe USP, a selective inhibitor of intestinal cholesterol and related phytosterol absorption, and simvastatin USP, an HMG-CoA reductase inhibitor. The chemical name of ezetimibe, USP is 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone. formula 1 formula 2",
      "dosage": "The maximum recommended dosage is ezetimibe and simvastatin tablets 10 mg/40 mg once daily. The ezet",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 590,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 591,
    "fields": {
      "name": "SPIRONOLACTONE",
      "brand": "Spironolactone",
      "description": "11 DESCRIPTION Spironolactone oral tablets contain 25 mg, 50 mg, or 100 mg of the aldosterone antagonist spironolactone, USP 17hydroxy-7\u03b1-mercapto-3-oxo-17\u03b1-pregn-4-ene-21-carboxylic acid \u03b3-lactone acetate, which has the following structural formula: Spironolactone, USP is practically insoluble in water, soluble in alcohol, and freely soluble in benzene and in chloroform. Inactive ingredients include calcium sulfate, corn starch, croscarmellose sodium, peppermint flavor, hypromellose, iron oxide, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, polyvinyl alcohol, povidone, talc, titanium dioxide, and triacetin. The 50 mg tablet also contains D&C yellow # 10 and FD&C yellow #6.",
      "dosage": "2.2 Treatment of Heart Failure In patients with serum potassium \u2264 5.0 mEq/L and eGFR > 50 mL/min/1.7",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 592,
    "fields": {
      "name": "TAMSULOSIN HYDROCHLORIDE",
      "brand": "Tamsulosin Hydrochloride",
      "description": "11 DESCRIPTION Tamsulosin hydrochloride is an antagonist of alpha 1A adrenoceptors in the prostate. It is sparingly soluble in water and methanol, slightly soluble in glacial acetic acid and ethanol, and practically insoluble in ether. The molecular formula of tamsulosin hydrochloride is C 20 H 28 N 2 O 5 S \u2022 HCl.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as th",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 593,
    "fields": {
      "name": "TEMAZEPAM",
      "brand": "Temazepam",
      "description": "DESCRIPTION Temazepam, USP is a benzodiazepine hypnotic agent. The chemical name is 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, and the structural formula is: C 16 H 13 ClN 2 O 2 MW = 300.74 Temazepam, USP is a white, crystalline substance, very slightly soluble in water and sparingly soluble in alcohol USP. Temazepam capsules USP, 7.5 mg, 15 mg, 22.5 mg, and 30 mg, are for oral administration.",
      "dosage": "DOSAGE AND ADMINISTRATION While the recommended usual adult dose is 15 mg before retiring, 7.5 mg ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 594,
    "fields": {
      "name": "TERAZOSIN HYDROCHLORIDE",
      "brand": "Terazosin",
      "description": "DESCRIPTION Terazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name,molecular formula and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride.C 19 H 26 ClN 5 O 4 Terazosin hydrochloride is a white, crystalline substance, freely soluble in water and isotonic saline and has a molecular weight of 423.93. Each capsule, for oral administration, contains 1 mg, 2 mg, 5 mg or 10 mg of terazosin as terazosin hydrochlolde. In addition, each capsule contains the following inactive ingredients: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, and pregelatinized starch.",
      "dosage": "DOSAGE AND ADMINISTRATION If terazosin capsules administration is discontinued for several days, the",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 595,
    "fields": {
      "name": "TIZANIDINE",
      "brand": "tizanidine",
      "description": "11 DESCRIPTION Tizanidine Tablets, USP contains tizanidine hydrochloride as the active ingredient, which is a central alpha 2 -adrenergic agonist. Its chemical name is 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiodiazole monohydrochloride. It has a molecular formula of C 9 H 8 CIN 5 S\u00b7HCl and a molecular weight of 290.17.",
      "dosage": "( 2.1 ) Recommended starting dose: 2 mg by mouth every 6 to 8 hours, as needed, up to a maximum of 3",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 596,
    "fields": {
      "name": "TOPIRAMATE",
      "brand": "topiramate",
      "description": "11 DESCRIPTION Topiramate, USP is a sulfamate-substituted monosaccharide. Topiramate tablets, USP are available as 25 mg, 50 mg, 100 mg, and 200 mg round shaped tablets for oral administration. Its saturated solution has a pH of 6.3.",
      "dosage": "Table 2: Monotherapy Target Total Daily Maintenance Dosing for Patients 2 to 9 Years of Age Weight (",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 597,
    "fields": {
      "name": "TRAMADOL HYDROCHLORIDE",
      "brand": "TRAMADOL HYDROCHLORIDE",
      "description": "The chemical name is (\u00b1) cis -2-[(dimethylamino) methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochloride. It is a white, crystalline powder that is freely soluble in water and methanol, very slightly soluble in acetone and has a pKa of 9.41. Tramadol hydrochloride extended-release tablets, USP contain 100 mg, 200 mg or 300 mg of tramadol hydrochloride, USP in an extended-release formulation.",
      "dosage": "2.5 Safe Reduction or Discontinuation of Tramadol Hydrochloride Extended-Release Tablets Do not abru",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 598,
    "fields": {
      "name": "TRAZODONE HYDROCHLORIDE",
      "brand": "Trazodone Hydrochloride",
      "description": "11 DESCRIPTION Trazodone hydrochloride is a selective serotonin reuptake inhibitor and 5HT2 receptor antagonist. Trazodone hydrochloride, USP is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]- 1,2,4-triazolo[4, 3-a]pyridin-3(2H)-one hydrochloride. It is a white to off-white, crystalline powder which is sparingly soluble in chloroform and in water.",
      "dosage": "The dosage should be initiated at a low-dose and increased gradually, noting the clinical response a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 599,
    "fields": {
      "name": "SACUBITRIL AND VALSARTAN",
      "brand": "ENTRESTO",
      "description": "Its molecular mass is 957.99 g/mol and its schematic structural formula is: ENTRESTO is available as film-coated tablets for oral administration, containing 24 mg of sacubitril and 26 mg of valsartan; 49 mg of sacubitril and 51 mg of valsartan; and 97 mg of sacubitril and 103 mg of valsartan. The film-coat inactive ingredients are hypromellose, iron oxide red (E172), polyethylene glycol 4000, talc, and titanium dioxide (E171). The film-coat for the 49 mg of sacubitril and 51 mg of valsartan tablet contains iron oxide yellow (E172).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dosage for adults is 49 mg/51 mg orally twice d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 600,
    "fields": {
      "name": "VENLAFAXINE",
      "brand": "Venlafaxine",
      "description": "DESCRIPTION Venlafaxine hydrochloride is a structurally novel antidepressant for oral administration. Each venlafaxine tablet, USP intended for oral administration contains venlafaxine hydrochloride equivalent to 25 mg or 37.5 mg or 50 mg or 75 mg or 100 mg of venlafaxine. Structured formula for venlafaxine",
      "dosage": "When treating pregnant women with venlafaxine tablets during the third trimester, the physician shou",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 601,
    "fields": {
      "name": "VERAPAMIL HYDROCHLORIDE",
      "brand": "Verapamil Hydrochloride",
      "description": "DESCRIPTION Verapamil hydrochloride is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets containing 40 mg, 80 mg, or 120 mg of verapamil hydrochloride. The structural formula of verapamil hydrochloride is: Benzeneacetonitrile, \u03b1-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-\u03b1-(1-methylethyl) hydrochloride. Verapamil hydrochloride is an almost white, crystalline powder, practically free of odor, with a bitter taste.",
      "dosage": "Angina: Clinical trials show that the usual dose is 80 mg to 120 mg three times a day. However, 40 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 602,
    "fields": {
      "name": "WARFARIN SODIUM",
      "brand": "Warfarin Sodium",
      "description": "11 DESCRIPTION Warfarin sodium tablets, USP contain warfarin sodium, an anticoagulant that acts by inhibiting vitamin K-dependent coagulation factors. 40 aluminum lake, and D&C yellow no. 10 aluminum lake and FD&C yellow no.",
      "dosage": "The duration of treatment is based on the indication as follows: For patients with a DVT or PE secon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 603,
    "fields": {
      "name": "ZALEPLON",
      "brand": "zaleplon",
      "description": "Its molecular formula is C 17 H 15 N 5 O, and its molecular weight is 305.34. Zaleplon capsules USP contain zaleplon as the active ingredient. The 5 mg capsules also contain FD&C yellow #5.",
      "dosage": "Although the risk of certain adverse events associated with the use of zaleplon capsules appears to ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 604,
    "fields": {
      "name": "ZOLPIDEM TARTRATE",
      "brand": "Zolpidem",
      "description": "11 DESCRIPTION Zolpidem Tartrate Tablets, USP contains Zolpidem tartrate, a gamma-aminobutyric acid (GABA) A receptor positive modulator of the imidazopyridine class. It has the following structure: Zolpidem Tartrate is a white to off-white crystalline powder that is sparingly soluble in water, alcohol, and propylene glycol. Opadry II (pink) contains hypromellose, FD&C Red no.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest dose effective for the patient and must not exceed a tota",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 605,
    "fields": {
      "name": "ZOLMITRIPTAN",
      "brand": "Zolmitriptan",
      "description": "11 DESCRIPTION ZOLMITRIPTAN NASAL SPRAY contains zolmitriptan, which is a selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist. Zolmitriptan is chemically designated as (S)-4-[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone and has the following chemical structure: The empirical formula is C 16 H 21 N 3 O 2 , representing a molecular weight of 287.36. The osmolarity of ZOLMITRIPTAN NASAL SPRAY for 2.5 mg is 360 to 420 mOsmol, and for 5 mg is 420 to 470 mOsmol.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting dose: 2.5 mg (2.1) Maximum single dose: 5 mg (2.1) ",
      "stock": 100,
      "route": "NASAL",
      "resupply_pending": 0,
      "pharmacy_id": 1,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 606,
    "fields": {
      "name": "ACETAMINOPHEN",
      "brand": "Pain Reliever Extra Strength",
      "description": "",
      "dosage": "Directions do not take more than directed adults and children 12 years and over take 2 gelcaps every",
      "stock": 50,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 607,
    "fields": {
      "name": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN",
      "brand": "Hydrocodone Bitartrate and Acetaminophen",
      "description": "DESCRIPTION Hydrocodone bitartrate and acetaminophen, USP is available in tablet form for oral administration. It is affected by light. It has the following structural formula: Acetaminophen, 4' -hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "Initial Dosage Initiating Treatment with Hydrocodone Bitartrate and Acetaminophen Tablets 2.5 mg/325",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 608,
    "fields": {
      "name": "ALBUTEROL SULFATE",
      "brand": "Albuterol Sulfate HFA",
      "description": "Albuterol sulfate has the chemical name \u03b1 1 -[( tert -butylamino)methyl]-4-hydroxy- m -xylene-\u03b1, \u03b1\u2032-diol sulfate (2:1)(salt) and the following chemical structure: Albuterol sulfate is a white crystalline powder with a molecular weight of 576.7, and the empirical formula is (C 13 H 21 NO 3 ) 2 \u2022H 2 SO 4 . Each canister contains a microcrystalline suspension of albuterol sulfate in propellant HFA\u2011134a (1,1,1,2\u2011tetrafluoroethane). Prime Albuterol Sulfate HFA before using for the first time, when the inhaler has not been used for more than 2 weeks, or when the inhaler has been dropped.",
      "dosage": "2 DOSAGE AND ADMINISTRATION For oral inhalation only. ( 2 ) Treatment or prevention of bronchospasm ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 609,
    "fields": {
      "name": "ALENDRONATE SODIUM",
      "brand": "Binosto",
      "description": "11 DESCRIPTION BINOSTO (alendronate sodium) is a bisphosphonate that acts as a specific inhibitor of osteoclast-mediated bone resorption. Alendronate sodium is chemically described as (4 amino-1-hydroxybutylidene) bisphosphonic acid, monosodium salt, trihydrate. Once the effervescent tablet is dissolved in water, the alendronate sodium is present in a citrate-buffered solution of pH 4.8 to 5.4.",
      "dosage": "Take BINOSTO upon arising for the day and at least 30 minutes before the first food, beverage, or me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 610,
    "fields": {
      "name": "ALLOPURINOL",
      "brand": "Allopurinol",
      "description": "11 DESCRIPTION Allopurinol, USP is a xanthine oxidase inhibitor. It has the following structural formula: Allopurinol, USP is known chemically as 1, 5-dihydro-4 H -pyrazolo [3, 4- d ]pyrimidin-4-one and it has a molecular weight of 136.1 g/mol. Each scored white round-shaped tablet contains 100 mg allopurinol and the inactive ingredients colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate.",
      "dosage": "2.3 Recommended Dosage for Gout The initial recommended dosage for the management of gout is 100 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 611,
    "fields": {
      "name": "ALPRAZOLAM",
      "brand": "Alprazolam",
      "description": "11 DESCRIPTION Alprazolam tablets, USP contain alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds. The chemical name of alprazolam is 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-\u03b1] [1,4] benzodiazepine. In addition, the 0.5 mg tablet contains FD&C Yellow # 6 aluminum lake and the 1 mg tablet contains FD&C Blue No.",
      "dosage": "Dosage may be increased, at intervals of every 3 to 4 days, to a maximum recommended daily dose of 4",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 612,
    "fields": {
      "name": "AMOXICILLIN",
      "brand": "Amoxicillin",
      "description": "Amoxicillin Tablets, USP: Each film coated tablet contains 500 mg or 875 mg amoxicillin as the trihydrate. Amoxicillin for Oral Suspension, USP: Each 5 mL of reconstituted suspension contains 125 mg, 200 mg, 250 mg or 400 mg amoxicillin as the trihydrate. Each 5 mL of the 125 mg, 200 mg, 250 mg, and 400 mg reconstituted suspension contains 0.30 mEq (6.95 mg) of sodium.",
      "dosage": "Dosing Recommendations for Adult and Pediatric Patients > 3 Months of Age Infection Severity Dosing ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 613,
    "fields": {
      "name": "AMLODIPINE BESYLATE",
      "brand": "Amlodipine Besylate",
      "description": "11 DESCRIPTION Amlodipine besylate is the besylate salt of amlodipine, a long-acting calcium channel blocker. Amlodipine besylate is chemically described as 3-Ethyl-5-methyl (\u00b1)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, monobenzenesulphonate. Amlodipine besylate tablets USP are formulated as tablets equivalent to 2.5 mg, 5 mg and 10 mg of amlodipine for oral administration.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022Adult recommended starting dose: 5 mg once daily with maximum dose 10 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 614,
    "fields": {
      "name": "ARIPIPRAZOLE",
      "brand": "Aripiprazole",
      "description": "11 DESCRIPTION Aripiprazole is an atypical antipsychotic drug that is available as Aripiprazole Tablets, USP. Aripiprazole is 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril. The empirical formula is C 23 H 27 Cl 2 N 3 O 2 and its molecular weight is 448.38.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Initial Dose Recommended Dose Maximum Dose Schizophrenia \u2013 adults (2.1) ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 615,
    "fields": {
      "name": "ATENOLOL",
      "brand": "Atenolol",
      "description": "DESCRIPTION Atenolol, a synthetic, beta 1 -selective (cardioselective) adrenoreceptor blocking agent, may be chemically described as benzeneacetamide, 4-[2\u2019-hydroxy-3\u2019-[(1-methylethyl)amino]propoxy]-. It is a relatively polar hydrophilic compound with a water solubility of 26.5 mg/mL at 37\u00b0C and a log partition coefficient (octanol/water) of 0.23. Atenolol is available as 25, 50 or 100 mg tablets for oral administration.",
      "dosage": "If an optimal response is not achieved, the dosage should be increased to atenolol 100 mg given as o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 616,
    "fields": {
      "name": "ATORVASTATIN CALCIUM",
      "brand": "Atorvastatin calcium",
      "description": "11 DESCRIPTION Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Atorvastatin calcium USP is (\u03b2R, \u03b4R)-2-(p-fluorophenyl)-\u03b2,\u03b4-dihydroxy-5-isopropyl-3-phenyl-4(phenylcarbamoyl)pyrrole-l-heptanaote (1:2), trihydrate. The molecular formula of atorvastatin calcium USP is C 66 H 68 CaF 2 N 4 O 10 .3H 2 O and its molecular weight is 1209.41.",
      "dosage": "2.1 Important Dosage Information Take atorvastatin calcium tablets orally once daily at any time of ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 617,
    "fields": {
      "name": "AZITHROMYCIN",
      "brand": "Azithromycin",
      "description": "11 DESCRIPTION Azithromycin tablets USP contain the active ingredient azithromycin, a macrolide antibacterial drug, for oral administration. Azithromycin has the chemical name (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-\u03b1-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-\u03b2-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Azithromycin is derived from erythromycin; however, it differs chemically from erythromycin in that a methyl-substituted nitrogen atom is incorporated into the lactone ring.",
      "dosage": "Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 500 mg as a single dose on Da",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 618,
    "fields": {
      "name": "BACLOFEN INJECTION",
      "brand": "Gablofen",
      "description": "11 DESCRIPTION GABLOFEN (baclofen injection) is a muscle relaxant and antispastic. Baclofen's pharmacological class is a gamma-aminobutyric acid (GABA) ergic agonist. Baclofen's chemical name is 4-amino-3-(4-chlorophenyl) butanoic acid, and its structural formula is: Baclofen C 10 H 12 ClNO 2 Baclofen is a white to off-white powder, with a molecular weight of 213.66.",
      "dosage": "2.2 Screening Phase Prior to pump implantation and initiation of chronic infusion of GABLOFEN, patie",
      "stock": 100,
      "route": "INTRATHECAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 619,
    "fields": {
      "name": "BENAZEPRIL HYDROCHLORIDE",
      "brand": "Benazepril Hydrochloride",
      "description": "Its chemical name is benazepril 3-[[1-(ethoxy-carbonyl)-3-phenyl-(1S)-propyl]amino]-2,3,4,5-tetrahydro-2-oxo-1 H -1-(3S)-benzazepine-1-acetic acid monohydrochloride; its structural formula is Its empirical formula is C 24 H 28 N 2 O 5 \u2022HCl and its molecular weight is 460.96. Benazepril hydrochloride is supplied as film-coated tablets containing 5 mg, 10 mg, 20 mg, and 40 mg of benazepril hydrochloride for oral administration. Benazepril hydrochloride tablets USP, 5 mg, 10 mg, 20 mg and 40 mg meet USP Dissolution Test 2.",
      "dosage": "\u2022 Renal Impairment: Initiate with 5 mg once daily in patients with GFR <30 mL/min/1.73 m 2 (serum cr",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 620,
    "fields": {
      "name": "BISOPROLOL FUMARATE",
      "brand": "Bisoprolol fumarate",
      "description": "It possesses an asymmetric carbon atom in its structure and is provided as a racemic mixture. Bisoprolol fumarate tablets are available as 5 and 10 mg tablets for oral administration. The 5 mg tablets also contain Red Iron Oxide.",
      "dosage": "DOSAGE AND ADMINISTRATION The dose of bisoprolol fumarate tablets must be individualized to the need",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 621,
    "fields": {
      "name": "BUPROPION HYDROCHLORIDE",
      "brand": "Bupropion Hydrochloride XL",
      "description": "11 DESCRIPTION Bupropion Hydrochloride USP, an antidepressant of the aminoketone class, is chemically unrelated to tricyclic, tetracyclic, selective serotonin reuptake inhibitor, or other known antidepressant agents. Its structure closely resembles that of diethylpropion; it is related to phenylethylamines. The structural formula is: Bupropion Hydrochloride Extended-Release Tablets USP (XL) are supplied for oral administration as 150 mg and 300 mg white to pale yellow extended-release tablets.",
      "dosage": "2.2 Dosage for Major Depressive Disorder (MDD) The recommended starting dose for MDD is 150 mg once ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 622,
    "fields": {
      "name": "BUSPIRONE HYDROCHLORIDE",
      "brand": "Buspirone Hydrochloride",
      "description": "421.96 Each tablet, for oral administration, contains 5 mg, 7.5 mg, 10 mg, 15 mg or 30 mg of buspirone hydrochloride, USP (equivalent to 4.6 mg, 6.9 mg, 9.1 mg, 13.7 mg and 27.4 mg of buspirone free base, respectively). Thus, a single 15 mg tablet can provide the following doses: 15 mg (entire tablet), 10 mg (two-thirds of a tablet), 7.5 mg (one-half of a tablet), or 5 mg (one-third of a tablet). A single 30 mg tablet can provide the following doses: 30 mg (entire tablet), 20 mg (two-thirds of a tablet), 15 mg (one-half of a tablet), or 10 mg (one-third of a tablet).",
      "dosage": "To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 623,
    "fields": {
      "name": "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE",
      "brand": "Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",
      "description": "11 DESCRIPTION Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are supplied in capsule form for oral administration. Each capsule contains: Butalbital, USP 50 mg Acetaminophen, USP 325 mg Caffeine, USP 40 mg Codeine phosphate, USP 30 mg Butalbital (5-allyl-5-isobutylbarbituric acid), is a short-to intermediate-acting barbiturate. It has the following structural formula: C 11 H 16 N 2 O 3 MW 224.26 Acetaminophen (4'hydroxyacetanilide), is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "2.2 Patient Access to Naloxone for the Emergency Treatment of Opioid Overdose Discuss the availabili",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 624,
    "fields": {
      "name": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "brand": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "description": "DESCRIPTION Captopril and hydrochlorothiazide tablets, USP for oral administration combines two antihypertensive agents: captopril and hydrochlorothiazide. Captopril, USP is a white to off-white crystalline powder with characteristic sulfide-like odor; it is freely soluble in water, ethanol, methanol, chloroform, isopropyl alcohol and methylene chloride and soluble in ethyl acetate. Freely soluble in N,N-Dimethylformamide, in n-Butylamine and in diluted solutions of alkali hydroxides.",
      "dosage": "For patients insufficiently responsive to the initial dose, additional captopril or hydrochlorothiaz",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 625,
    "fields": {
      "name": "CARVEDILOL",
      "brand": "Carvedilol",
      "description": "11 DESCRIPTION Carvedilol is a nonselective \u03b2-adrenergic blocking agent with \u03b1 1 -blocking activity. It is (\u00b1)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol. Carvedilol is a racemic mixture with the following structure: Carvedilol, USP is a white to almost white crystalline powder with a molecular weight of 406.5 and a molecular formula of C 24 H 26 N 2 O 4 .",
      "dosage": "Fluid retention (with or without transient worsening heart failure symptoms) should be treated by an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 626,
    "fields": {
      "name": "CEFDINIR",
      "brand": "Cefdinir",
      "description": "DESCRIPTION Cefdinir capsules, USP contain the active ingredient cefdinir, an extended-spectrum, semisynthetic cephalosporin, for oral administration. Chemically, cefdinir is [6R-[6\u03b1,7\u03b2 (Z)]]-7-[[(2-amino-4 thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid. Cefdinir is a white to slightly brownish-yellow solid.",
      "dosage": "DOSAGE & ADMINISTRATION (see INDICATIONS AND USAGE for Indicated Pathogens) The recommended dosage a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 627,
    "fields": {
      "name": "CEFUROXIME AXETIL",
      "brand": "Cefuroxime axetil",
      "description": "Cefuroxime axetil is a semisynthetic, cephalosporin antibacterial drug for oral administration. The chemical name of cefuroxime axetil (1-(acetyloxy) ethyl ester of cefuroxime) is ( RS )-1 hydroxyethyl (6 R ,7 R )-7-[2-(2-furyl)glyoxyl-amido]-3-(hydroxymethyl)-8-oxo-5-thia-1 azabicyclo[4.2.0]-oct-2-ene-2-carboxylate, 72-( Z )-( O -methyl-oxime), 1-acetate 3-carbamate. Cefuroxime axetil is in the amorphous form and has the following structural formula: Cefuroxime axetil tablets, USP are film-coated and contain the equivalent of 250 or 500 mg of cefuroxime as cefuroxime axetil.",
      "dosage": "Pediatric patients (aged 13 years and older) who cannot swallow the cefuroxime axetil tablets whole ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 628,
    "fields": {
      "name": "CELECOXIB",
      "brand": "CELECOXIB",
      "description": "DESCRIPTION Celecoxib capsule is a nonsteroidal anti-inflammatory drug, available as capsules containing 50 mg, 100 mg, 200 mg and 400 mg celecoxib for oral administration. Its molecular formula is C 17 H 14 F 3 N 3 O 2 S, and it has the following chemical structure: Celecoxib USP is a white or almost white crystalline powder with a pKa of 11.1 (sulfonamide moiety). Celecoxib USP is hydrophobic (log P is 3.5) and is soluble in ethanol and in methylene chloride, practically insoluble in water.",
      "dosage": "For patients >25 kg the recommended dose is 100 mg twice daily. For patients who have difficulty swa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 629,
    "fields": {
      "name": "CETIRIZINE HYDROCHLORIDE TABLETS",
      "brand": "cetirizine hydrochloride",
      "description": "",
      "dosage": "Directions adults and children 6 years and over one 10 mg tablet once daily; do not take more than o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 630,
    "fields": {
      "name": "CIPROFLOXACIN",
      "brand": "ciprofloxacin",
      "description": "DESCRIPTION Ciprofloxacin ophthalmic solution is a synthetic, sterile, multiple dose, antimicrobial for topical ophthalmic use. Ciprofloxacin is a fluoroquinolone antibacterial active against a broad spectrum of gram-positive and gram-negative ocular pathogens. It is available as the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid.",
      "dosage": "DOSAGE AND ADMINISTRATION Corneal Ulcers: The recommended dosage regimen for the treatment of cornea",
      "stock": 100,
      "route": "OPHTHALMIC",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 631,
    "fields": {
      "name": "CITALOPRAM",
      "brand": "Citalopram",
      "description": "11 DESCRIPTION Citalopram tablets, USP contain citalopram, a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide is a racemic bicyclic phthalane structure and is designated (\u00b1)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3\u00addihydroisobenzofuran-5-carbonitrile hydrobromide with the following structural formula: The molecular formula is C 20 H 22 BrFN 2 O and its molecular weight is 405.35. Citalopram hydrobromide, USP occurs as a fine, white to off-white powder.",
      "dosage": "2.1 Recommended Dosage Administer citalopram tablets once daily, with or without food, at an initial",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 632,
    "fields": {
      "name": "CLINDAMYCIN PHOSPHATE",
      "brand": "Clindamycin Phosphate",
      "description": "DESCRIPTION Clindamycin phosphate topical lotion, 1% contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. Clindamycin phosphate is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The lotion contains cetostearyl alcohol (2.5%); glycerin; glyceryl stearate SE (with potassium monostearate); isostearyl alcohol (2.5%); methylparaben (0.3%); sodium lauroyl sarcosinate; stearic acid; and purified water.",
      "dosage": "DOSAGE AND ADMINISTRATION Apply a thin film of clindamycin phosphate topical lotion twice daily to a",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 633,
    "fields": {
      "name": "CLONAZEPAM",
      "brand": "Clonazepam",
      "description": "DESCRIPTION Clonazepam Tablets, USP, a benzodiazepine, is available as scored tablet with debossing \u039b containing 0.5 mg of clonazepam and unscored tablets with debossing \u039b and \u039b containing 1 mg or 2 mg of clonazepam respectively. Each 66 67 69 tablet also contains lactose monohydrate, polyethylene glycol, microcrystalline cellulose, croscarmellose sodium and magnesium stearate with the following colourants: 0.5 mg-FD & C Yellow 6 Al Lake, D & C Yellow 10 Al Lake; 1 mg-FD & C Blue 1 Al lake and FD & C Blue 2 Al lake Chemically, clonazepam is 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder.",
      "dosage": "Geriatric Patients: There is no clinical trial experience with clonazepam tablets in seizure disorde",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 634,
    "fields": {
      "name": "CLOPIDOGREL BISULFATE",
      "brand": "Clopidogrel",
      "description": "11 DESCRIPTION Clopidogrel bisulfate is a thienopyridine class inhibitor of P2Y 12 ADP platelet receptors. Chemically it is methyl (+)-( S )-\u03b1-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4 H )-\u00adacetate sulfate (1:1). The structural formula is as follows: Clopidogrel bisulfate USP is a white to off-white powder.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Acute coronary syndrome ( 2.1 ) \u2013 Initiate clopidogrel tablets with a si",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 635,
    "fields": {
      "name": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "brand": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "description": "DESCRIPTION Cyclobenzaprine hydrochloride, USP is a tricyclic amine salt which is white to off white, odourless, crystalline powder with the molecular formula C 20 H 21 N \u2022 HCl and a molecular weight of 311.9. Cyclobenzaprine hydrochloride is designated chemically as 3-(5H -dibenzo[a,d] cyclohepten-5-ylidene)- N,N -dimethyl-1-propanamine hydrochloride, and has the following structural formula: Cyclobenzaprine hydrochloride tablets, USP are available as 5 mg, 7.5 mg and 10 mg tablets for oral administration. In addition, the 5 mg tablets contain FD&C Blue #2/INDIGO Carmine Aluminum Lake.",
      "dosage": "DOSAGE AND ADMINISTRATION For most patients, the recommended dose of cyclobenzaprine hydrochloride t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 636,
    "fields": {
      "name": "DAPAGLIFLOZIN",
      "brand": "FARXIGA",
      "description": "11 DESCRIPTION Dapagliflozin, an inhibitor of SGLT2, is described chemically as D-glucitol, 1,5-anhydro-1- C -[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1 S )-, compounded with (2 S )-1,2-propanediol, hydrate (1:1:1). The empirical formula is C 21 H 25 ClO 6 \u2022C 3 H 8 O 2 \u2022H 2 O and the molecular weight is 502.98. The structural formula is: FARXIGA is available as a film-coated tablet for oral administration containing the equivalent of 5 mg dapagliflozin as dapagliflozin propanediol or the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol, and the following inactive ingredients: microcrystalline cellulose, anhydrous lactose, crospovidone, silicon dioxide, and magnesium stearate.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022 Assess volume status and correct volume depletion before initiating. I",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 637,
    "fields": {
      "name": "DESVENLAFAXINE SUCCINATE",
      "brand": "Pristiq Extended-Release",
      "description": "11 DESCRIPTION PRISTIQ is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. Desvenlafaxine is designated RS -4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol and has the empirical formula of C 16 H 25 NO 2 (free base) and C 16 H 25 NO 2 \u2219C 4 H 6 O 4 \u2219H 2 O (succinate monohydrate). Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C yellow #6.",
      "dosage": "In clinical studies, doses of 50 mg to 400 mg per day were shown to be effective, although no additi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 638,
    "fields": {
      "name": "DIAZEPAM",
      "brand": "Diazepam",
      "description": "The molecular formula is C 16 H 13 ClN 2 O and the molecular weight is 284.7. The structural formula is as follows: Diazepam is available for oral administration as tablets containing 2 mg, 5 mg or 10 mg diazepam, USP. 10 Aluminum Lake and FD&C Blue No.",
      "dosage": "2 mg to 10 mg, 3 or 4 times daily Adjunctively in Convulsive Disorders. 2 mg to 2.5 mg, 1 or 2 times",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 639,
    "fields": {
      "name": "DICLOFENAC SODIUM",
      "brand": "Diclofenac Sodium",
      "description": "",
      "dosage": "Directions Use up to 21 days unless directed by your doctor Not for strains, sprains, bruises or spo",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 640,
    "fields": {
      "name": "DICYCLOMINE HYDROCHLORIDE",
      "brand": "Dicyclomine hydrochloride",
      "description": "11 DESCRIPTION Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent available as: Dicyclomine hydrochloride capsules, USP for oral use containing 10 mg dicyclomine hydrochloride, USP. Dicyclomine hydrochloride 10 mg capsules contain the following inactive ingredients: corn starch, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. Capsule shells contain FD&C Blue No.1, FD&C Red No.40, gelatin, purified water, and sodium lauryl sulfate.",
      "dosage": "Dosage for dicyclomine hydrochloride capsules must be adjusted to individual patient needs (2) . Aft",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 641,
    "fields": {
      "name": "DIGOXIN",
      "brand": "Digoxin",
      "description": "11 DESCRIPTION Digoxin is one of the cardiac (or digitalis) glycosides, a closely related group of drugs having in common specific effects on the myocardium. These drugs are found in a number of plants. The term \u201cdigitalis\u201d is used to designate the whole group of glycosides.",
      "dosage": "2.2 Loading Dosing Regimen in Adults and Pediatric Patients For adults and pediatric patients if a l",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 642,
    "fields": {
      "name": "DILTIAZEM HYDROCHLORIDE",
      "brand": "diltiazem hydrochloride",
      "description": "DESCRIPTION Diltiazem hydrochloride is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1, 5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2, 3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride,(+)-cis-. The chemical structure is: USP Dissolution pending.",
      "dosage": "Individual patients may respond to higher doses of up to 480 mg once daily. Antihypertensives : Dilt",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 643,
    "fields": {
      "name": "DIPHENHYDRAMINE HCL",
      "brand": "Childrens Allergy Relief",
      "description": "",
      "dosage": "Directions \u25a0 if needed, take every 4-6 hours \u25a0 do not take more than 6 doses in 24-hours children un",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 644,
    "fields": {
      "name": "DIVALPROEX SODIUM",
      "brand": "Divalproex Sodium",
      "description": "Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium extended-release tablets, USP contain divalproex sodium in a once-a-day extended-release formulation equivalent to 250 or 500 mg of valproic acid. Inactive Ingredients: ammonium hydroxide, colloidal anhydrous silica, colloidal silicon dioxide, dibutyl sebacate, ethylcellulose, hydroxyethyl cellulose, hypromellose, oleic acid, polydextrose, polyethylene glycol, silicified microcrystalline cellulose, titanium dioxide and triacetin.",
      "dosage": "Although doses other than 1,000 mg once daily of divalproex sodium extended-release tablets have not",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 645,
    "fields": {
      "name": "DOXYCYCLINE",
      "brand": "doxycycline",
      "description": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Doxycycline is an antibacterial drug synthetically derived from oxytetracycline, and is available as capsules of doxycycline hyclate for oral administration. The structural formula of doxycycline monohydrate is with a molecular formula of C 22 H 24 N 2 O 8 \u2219H 2 O and a molecular weight of 462.46.",
      "dosage": "Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 646,
    "fields": {
      "name": "DULAGLUTIDE",
      "brand": "TRULICITY",
      "description": "11 DESCRIPTION Dulaglutide is a human glucagon-like peptide-1 (GLP-1) receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1 analog sequence covalently linked to the Fc portion of a modified human immunoglobulin G4 (IgG4) heavy chain by a small peptide linker and is produced using mammalian cell (Chinese hamster ovary) culture. The GLP-1 analog portion of dulaglutide is 90% homologous to native human GLP-1 (7-37).",
      "dosage": "2 DOSAGE AND ADMINISTRATION Adult Dosage ( 2.1 ) Recommended starting dosage is 0.75 mg injected sub",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 647,
    "fields": {
      "name": "ENALAPRIL MALEATE",
      "brand": "Enalapril Maleate",
      "description": "DESCRIPTION Enalapril maleate is the maleate salt of enalapril, the ethyl ester of a long-acting angiotensin-converting enzyme inhibitor, enalaprilat. Its molecular formula is C 20 H 28 N 2 O 5 \u2219C 4 H 4 O 4, and its structural formula is: Enalapril maleate is a white to off-white, crystalline powder with a molecular weight of 492.53. Enalapril is a pro-drug; following oral administration, it is bioactivated by hydrolysis of the ethyl ester to enalaprilat, which is the active angiotensin-converting enzyme inhibitor.",
      "dosage": "DOSAGE AND ADMINISTRATION Hypertension In patients who are currently being treated with a diuretic, ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 648,
    "fields": {
      "name": "ESCITALOPRAM ORAL",
      "brand": "Escitalopram Oral Solution",
      "description": "11 DESCRIPTION Escitalopram Oral Solution, USP contains escitalopram oxalate, an orally administered selective serotonin reuptake inhibitor (SSRI), present as escitalopram oxalate salt. Escitalopram is the pure S-enantiomer (single isomer) of the racemic bicyclic phthalane derivative citalopram. Escitalopram oxalate is designated S-(+)-1-[3-(dimethyl-amino)propyl]-1-( p -fluorophenyl)-5-phthalancarbonitrile oxalate with the following structural formula: The molecular formula is C 20 H 21 FN 2O \u2022 C 2 H 2 O 4 and the molecular weight is 414.40.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication and Population Recommended Dosage MDD in Adults ( 2.1 ) Initi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 649,
    "fields": {
      "name": "ESOMEPRAZOLE MAGNESIUM",
      "brand": "Acid Reducer",
      "description": "",
      "dosage": "Directions adults 18 years of age and older this product is to be used once a day (every 24 hours), ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 650,
    "fields": {
      "name": "ESZOPICLONE",
      "brand": "Eszopiclone",
      "description": "11 DESCRIPTION Eszopiclone is a hypnotic agent/nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class. The chemical name of eszopiclone is (+)-4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5 H pyrrolo[3,4- b ]pyrazin-5-(S)-yl ester. In addition, both the 1 mg and 3 mg tablets contain FD&C Blue #2/indigo carmine aluminium lake.",
      "dosage": "May increase dose if clinically indicated, to a maximum of 3 mg ( 2.1 ) \u2022 Geriatric or debilitated p",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 651,
    "fields": {
      "name": "FENTANYL CITRATE",
      "brand": "Fentanyl Citrate",
      "description": "Fentanyl citrate is chemically identified as N -(1-Phenethyl-4-piperidyl)propionanilide citrate (1:1) with the following structural formula: C 22 H 28 N 2 O \u2022 C 6 H 8 O 7 Molecular Weight is 528.59 Each mL contains fentanyl citrate equivalent to 50 mcg (0.05 mg) fentanyl base in Water for Injection. Sodium hydroxide and/or hydrochloric acid added, if needed, for pH adjustment. The pH range is 4.0 to 7.5.",
      "dosage": "For use in more major surgical procedures, in addition to adequate analgesia, may abolish some of th",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 652,
    "fields": {
      "name": "FEXOFENADINE HCL",
      "brand": "Fexofenadine HCL",
      "description": "",
      "dosage": "Directions adults and children 12 years of age and over: take one 180 mg tablet with water every onc",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 653,
    "fields": {
      "name": "FINASTERIDE",
      "brand": "Finasteride",
      "description": "11 DESCRIPTION Finasteride tablets USP, 1 mg contains finasteride as the active ingredient. Finasteride is 4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5\u03b1, 17\u03b2)-. Its structural formula is: Finasteride is a white crystalline powder with a melting point near 250\u00b0 C. It is freely soluble in chloroform and in lower alcohol solvents but is practically insoluble in water.",
      "dosage": "The recommended dose of finasteride tablets USP is one tablet (1 mg) taken once daily. In general, d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 654,
    "fields": {
      "name": "FLUCONAZOLE",
      "brand": "Fluconazole",
      "description": "DESCRIPTION Fluconazole, the first of a new subclass of synthetic triazole antifungal agents, is available as tablets for oral administration. Fluconazole is designated chemically as 2,4-difluoro-\u03b1,\u03b1 1 -bis(1H-1,2,4-triazol-1-ylmethyl) benzyl alcohol with a molecular formula of C 13 H 12 F 2 N 6 O and molecular weight of 306.3. The structural formula is: Fluconazole USP is a white crystalline solid which is slightly soluble in water and saline.",
      "dosage": "DOSAGE AND ADMINISTRATION Dosage and Administration in Adults: Single Dose Vaginal candidiasis: The ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 655,
    "fields": {
      "name": "FLUOXETINE HYDROCHLORIDE",
      "brand": "Fluoxetine",
      "description": "11 DESCRIPTION Fluoxetine capsules, USP are a selective serotonin reuptake inhibitor for oral administration. It is also marketed for the treatment of premenstrual dysphoric disorder (Sarafem \u00ae , fluoxetine hydrochloride). In addition, 20 mg capsules also contains D&C Yellow #10 and 10 mg capsules also contains FD&C Yellow #6.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication Adult Pediatric MDD ( 2.1 ) 20 mg/day in am (initial dose) 10",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 656,
    "fields": {
      "name": "FLUTICASONE PROPIONATE",
      "brand": "FLOVENT DISKUS",
      "description": "11 DESCRIPTION FLOVENT DISKUS inhalation powder is a dry powder inhaler for oral inhalation. The active component of FLOVENT DISKUS 50 mcg, FLOVENT DISKUS 100 mcg, and FLOVENT DISKUS 250 mcg is fluticasone propionate, a corticosteroid having the chemical name S- (fluoromethyl) 6\u03b1,9-difluoro-11\u03b2,17-dihydroxy-16\u03b1-methyl-3-oxoandrosta-1,4-diene-17\u03b2-carbothioate, 17-propionate and the following chemical structure: Fluticasone propionate is a white powder with a molecular weight of 500.6, and the empirical formula is C 25 H 31 F 3 O 5 S. It is practically insoluble in water, freely soluble in dimethyl sulfoxide and dimethylformamide, and slightly soluble in methanol and 95% ethanol. Each blister on the strip contains a white powder mix of micronized fluticasone propionate (50, 100, or 250 mcg) in 12.5 mg of formulation containing lactose monohydrate (which contains milk proteins).",
      "dosage": "2.2 Recommended Dosage Adult and Adolescent Patients Aged 12 Years and Older The starting dosage is ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 657,
    "fields": {
      "name": "GABAPENTIN",
      "brand": "Gabapentin",
      "description": "11 DESCRIPTION The active ingredient in Gabapentin Capsules USP is gabapentin, which has the chemical name 1-(aminomethyl)cyclohexaneacetic acid. The molecular formula of gabapentin is C 9 H 17 NO 2 and the molecular weight is 171.24. The structural formula of gabapentin is: Gabapentin is a white to off-white crystalline solid with a pK a1 of 3.7 and a pK a2 of 10.7.",
      "dosage": "2 DOSAGE AND ADMlNlSTRATION Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 658,
    "fields": {
      "name": "GEMFIBROZIL",
      "brand": "Gemfibrozil",
      "description": "DESCRIPTION Gemfibrozil, USP is a lipid regulating agent. It is available as tablets for oral administration. Each tablet contains 600 mg gemfibrozil.",
      "dosage": "DOSAGE AND ADMINISTRATION The recommended dose for adults is 1,200 mg administered in two divided do",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 659,
    "fields": {
      "name": "GLIMEPIRIDE",
      "brand": "Glimepiride",
      "description": "11 DESCRIPTION Glimepiride tablets USP, are an oral sulfonylurea that contains the active ingredient glimepiride USP. Chemically, glimepiride USP is identified as 1-[[p-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea (C 24 H 34 N 4 O 5 S) with a molecular weight of 490.62. Glimepiride USP is a white to almost white powder, soluble in dimethyl formamide, sparingly soluble in methylene chloride, practically insoluble in water.",
      "dosage": "The recommended starting dose of glimepiride tablets are 1 mg or 2 mg once daily. Patients at increa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 660,
    "fields": {
      "name": "GLIPIZIDE",
      "brand": "Glipizide",
      "description": "The Chemical Abstracts name of glipizide is 1-cyclohexyl-3-[[ p -[2-(5-methylpyrazine-carboxamido)ethyl]phenyl]sulfonyl]urea. The molecular formula is C 21 H 27 N 5 O 4 S; the molecular weight is 445.55; the structural formula is shown below: Glipizide is a whitish, odorless powder with a pKa of 5.9. Glipizide Tablets USP for oral use are available in 5 and 10 mg strengths.",
      "dosage": "In addition to the usual monitoring of urinary glucose, the patient\u2019s blood glucose must also be mon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 661,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 662,
    "fields": {
      "name": "HYDROXYCHLOROQUINE SULFATE",
      "brand": "Hydroxychloroquine Sulfate",
      "description": "DESCRIPTION Hydroxychloroquine sulfate is a white or practically white, crystalline powder, freely soluble in water; practically insoluble in alcohol, chloroform, and in ether. The chemical name for hydroxychloroquine sulfate is 2-[[4-[(7-Chloro-4-quinolyl) amino]pentyl] ethylamino]ethanol sulfate (1:1). Its structural formula is: The molecular weight of hydroxychloroquine sulfate is 433.95, and molecular formula is C 18 H 26 ClN 3 O.H 2 SO 4 .",
      "dosage": "Treatment of Uncomplicated Malaria Adults: 800 mg (620 mg base) followed by 400 mg (310 mg base) at ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 663,
    "fields": {
      "name": "IBUPROFEN",
      "brand": "Ibuprofen Dye Free",
      "description": "",
      "dosage": "Directions do not take more than directed the smallest effective dose should be used adults and chil",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 664,
    "fields": {
      "name": "INSULIN ASPART",
      "brand": "NOVOLOG",
      "description": "11 DESCRIPTION Insulin aspart is a rapid-acting human insulin analog homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Saccharomyces cerevisiae (baker's yeast). Insulin aspart has the empirical formula C 256 H 381 N 65 0 79 S 6 and a molecular weight of 5825.8 Da. NOVOLOG has a pH of 7.2-7.6.",
      "dosage": "\u2022 Continuous Subcutaneous Infusion (Insulin Pump) ( 2.2 ): o Refer to the insulin infusion pump user",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 665,
    "fields": {
      "name": "INSULIN DETEMIR",
      "brand": "LEVEMIR",
      "description": "Insulin detemir has a molecular formula of C 267 H 402 O 76 N 64 S 6 and a molecular weight of 5.917 kDa. Hydrochloric acid and/or sodium hydroxide may be added to adjust pH. Levemir Chemical Structure.jpg",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 666,
    "fields": {
      "name": "INSULIN GLARGINE",
      "brand": "BASAGLAR Tempo Pen",
      "description": "Insulin glargine has the following structural formula: BASAGLAR (insulin glargine) injection is a sterile clear and colorless aqueous solution for subcutaneous use. The 3 mL BASAGLAR prefilled pen presentations contain the following inactive ingredients per mL: glycerin (17 mg), metacresol (2.7 mg), zinc oxide (content adjusted to provide 30 mcg zinc ion), and Water for Injection, USP. BASAGLAR has a pH of approximately 4.",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 667,
    "fields": {
      "name": "INSULIN LISPRO",
      "brand": "ADMELOG",
      "description": "11 DESCRIPTION Insulin lispro is a rapid-acting human insulin analog produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli . Insulin lispro has a pH of 7.0 to 7.8. The pH is adjusted by addition of aqueous solutions of hydrochloric acid and/or sodium hydroxide.",
      "dosage": "Use in accordance with the insulin pump instructions for use. Administer ADMELOG by continuous subcu",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 668,
    "fields": {
      "name": "ISOSORBIDE MONONITRATE",
      "brand": "ISOSORBIDE MONONITRATE",
      "description": "Each tablet, for oral administration, contains either 30 mg, 60 mg or 120 mg of isosorbide mononitrate in an extended-release formulation. In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, diethyl phthalate, hydrogenated castor oil, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc and titanium dioxide. The chemical name for ISMN is 1,4:3,6-dianhydro-,D-glucitol 5-nitrate; the compound has the following structural formula: ISMN is a white, crystalline, odorless compound which is stable in air and in solution, has a melting point of about 90\u00b0C, and an optical rotation of +144\u00b0 (2% in water, 20\u00b0C).",
      "dosage": "After several days, the dosage may be increased to 120 mg (given as a single 120 mg tablet or as two",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 669,
    "fields": {
      "name": "LAMOTRIGINE",
      "brand": "Lamotrigine",
      "description": "11 DESCRIPTION Lamotrigine, USP an AED of the phenyltriazine class, is chemically unrelated to existing AEDs. Lamotrigine\u2019s chemical name is 3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine, its molecular formula is C 9 H 7 N 5 Cl 2 , and its molecular weight is 256.09. Lamotrigine orally disintegrating tablets are formulated using in-house technologies designed to mask the bitter taste of lamotrigine and achieve a rapid dissolution profile.",
      "dosage": "Adjustments to the Maintenance Dose of Lamotrigine in Women Taking Estrogen-Containing Oral Contrace",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 670,
    "fields": {
      "name": "LANSOPRAZOLE",
      "brand": "Lansoprazole",
      "description": "Lansoprazole has the following structure: Lansoprazole is a white to brownish-white odorless crystalline powder which melts with decomposition at approximately 166\u00b0C. The degradation half-life of the drug substance in aqueous solution at 25\u00b0C is approximately 0.5 hour at pH 5.0 and approximately 18 hours at pH 7.0. Lansoprazole Delayed-Release Capsules, USP are supplied in delayed-release capsules for oral administration.The delayed-release capsules are available in two dosage strengths: 15 mg and 30 mg of lansoprazole per capsule.",
      "dosage": "For patients who have difficulty swallowing capsules, Lansoprazole delayed-release capsules can be o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 671,
    "fields": {
      "name": "LEVETIRACETAM",
      "brand": "Levetiracetam Extended-release",
      "description": "11 DESCRIPTION Levetiracetam Extended-release Tablets USP is an antiepileptic drug available as 500 mg and 750 mg (white) extended-release tablets for oral administration. It has the following structural formula: Levetiracetam is a white to off-white crystalline powder with a faint odor and a bitter taste. It is freely soluble in chloroform (65.3 g/100 mL) and in methanol (53.6 g/100 mL), soluble in ethanol (16.5 g/100 mL), sparingly soluble in acetonitrile (5.7 g/100 mL) and practically insoluble in n-hexane.",
      "dosage": "2 DOSAGE & ADMINISTRATION Initiate treatment with a dose of 1,000 mg once daily; increase by 1,000 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 672,
    "fields": {
      "name": "LEVOTHYROXINE, LIOTHYRONINE",
      "brand": "NP Thyroid 120",
      "description": "NP Thyroid \u00ae (thyroid tablets, USP) for oral use is a natural preparation derived from porcine thyroid glands. They contain both tetraiodothyronine sodium (T 4 levothyroxine) and triiodothyronine sodium (T 3 liothyronine) providing 38 mcg levothyroxine (T 4 ) and 9 mcg liothyronine (T 3 ) per grain of thyroid. The inactive ingredients are calcium stearate, dextrose (agglomerated) and mineral oil.",
      "dosage": "DOSAGE AND ADMINISTRATION The dosage of thyroid hormones is determined by the indication and must in",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 673,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 674,
    "fields": {
      "name": "LORAZEPAM",
      "brand": "Lorazepam",
      "description": "DESCRIPTION Lorazepam USP, an antianxiety agent, has the chemical formula, 7-chloro-5-( o -chlorophenyl)-1,3\u2011-dihydro-3-hydroxy-2 H -1,4-benzodiazepin-2-one: It is a nearly white powder almost insoluble in water. Each lorazepam tablet, USP to be taken orally, contains 0.5 mg, 1 mg, or 2 mg of lorazepam, USP. The inactive ingredients present are anhydrous lactose, magnesium stearate, microcrystalline cellulose, and polacrilin potassium.",
      "dosage": "DOSAGE AND ADMINISTRATION Lorazepam tablets are administered orally. For insomnia due to anxiety or ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 675,
    "fields": {
      "name": "LOSARTAN POTASSIUM",
      "brand": "Losartan Potassium",
      "description": "11 DESCRIPTION Losartan potassium is an angiotensin II receptor blocker acting on the AT 1 receptor subtype. Its molecular formula is C 22 H 22 ClKN 6 O, and its structural formula is: Losartan potassium, USP is white to off-white powder with a molecular weight of 461.01. It is freely soluble in water; soluble in isopropyl alcohol; slightly soluble in acetonitrile.",
      "dosage": "Pediatric Hypertension The usual recommended starting dose is 0.7 mg per kg once daily (up to 50 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 676,
    "fields": {
      "name": "LOVASTATIN",
      "brand": "Lovastatin",
      "description": "This enzyme catalyzes the conversion of HMG-CoA to mevalonate, which is an early and rate limiting step in the biosynthesis of cholesterol. 404.55 C 24 H 36 O 5 M.W. Lovastatin Tablets USP, 40 mg also contain D&C Yellow #10 Aluminum Lake, FD&C Blue #1 Aluminum Lake, and FD&C Yellow #6 Aluminum Lake.",
      "dosage": "Patients requiring reductions in LDL-C of 20% or more to achieve their goal (see INDICATIONS AND USA",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 677,
    "fields": {
      "name": "LURASIDONE HYDROCHLORIDE",
      "brand": "Lurasidone Hydrochloride",
      "description": "11 DESCRIPTION Lurasidone hydrochloride is an atypical antipsychotic belonging to the chemical class of benzisothiazol derivatives. Its chemical name is (3a R ,4 S ,7 R ,7a S )-2-{(1 R ,2 R )-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-\u00adylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2 H -isoindole-1,3-dione hydrochloride. Its molecular formula is C 28 H 36 N 4 O 2 S\u00b7HCl and its molecular weight is 529.14.",
      "dosage": "Lurasidone hydrochloride tablets have been shown to be effective in a dose range of 40 mg per day to",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 678,
    "fields": {
      "name": "MELOXICAM",
      "brand": "Meloxicam",
      "description": "11 DESCRIPTION Meloxicam, is a nonsteroidal anti-inflammatory drug (NSAID). Its empirical formula is C 14 H 13 N 3 O 4 S 2 and it has the following structural formula: Meloxicam is a pastel yellow solid, practically insoluble in water, with higher solubility observed in strong acids and bases. Meloxicam tablets USP are available as tablets for oral administration containing 7.5 mg or 15 mg meloxicam.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest effective dosage for the shortest duration consistent wit",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 679,
    "fields": {
      "name": "MEMANTINE",
      "brand": "Memantine hydrochloride",
      "description": "11 DESCRIPTION Memantine hydrochloride, USP is an orally active NMDA receptor antagonist. The tablets also contain the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose and talc. In addition the following inactive ingredients are also present as components of the film coat: D&C Yellow #10, FD&C Blue #2, FD&C Yellow #6, macrogol, polyvinyl alcohol, talc, and titanium dioxide (5 mg tablets), and iron oxide black, iron oxide yellow, macrogol, polyvinyl alcohol, talc and titanium dioxide (10 mg tablets).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dose of memantine hydrochloride tablets is 5 mg",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 680,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 681,
    "fields": {
      "name": "METHADONE HYDROCHLORIDE",
      "brand": "Methadone Hydrochloride",
      "description": "DESCRIPTION Methadone Hydrochloride Oral Concentrate, USP, contains methadone, an opiate agonist, and is available as a cherry flavored liquid concentrate for oral administration. It is present in methadone hydrochloride oral concentrate as the racemic mixture. Other ingredients of Methadone Hydrochloride Oral Concentrate, USP (Dye-Free, Sugar-Free, Unflavored): citric acid anhydrous, purified water, and sodium benzoate.",
      "dosage": "Titration and Maintenance Treatment of Opioid Dependence Patients in maintenance treatment should be",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 682,
    "fields": {
      "name": "METHOCARBAMOL",
      "brand": "Methocarbamol",
      "description": "The chemical name of methocarbamol is 3-(2-meth-oxyphenoxy)-1,2-propanediol 1-carbamate and has the empirical formula C 11 H 15 NO 5 . Its molecular weight is 241.24. Methocarbamol tablets, USP are available as 500 mg and 750 mg tablets for oral administration.",
      "dosage": "Maintenance dosage: 2 tablets q.i.d. Methocarbamol tablets, USP: 750 mg \u2013 Adults: Initial dosage: 2 ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 683,
    "fields": {
      "name": "METHYLPHENIDATE HYDROCHLORIDE",
      "brand": "Methylphenidate Hydrochloride (LA)",
      "description": "Each Methylphenidate Hydrochloride Extended-Release Capsule contains pellets, with half the dose as immediate-release and half as delayed-release, thus providing an immediate release of methylphenidate and a second delayed release of methylphenidate. The active substance in Methylphenidate Hydrochloride Extended-Release Capsules is methyl \u03b1-phenyl-2-piperidineacetate hydrochloride. Its structural formula is as follows: M.W.",
      "dosage": "The drug and applesauce mixture should not be stored for future use. 2.3 Patients Currently Using Me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 684,
    "fields": {
      "name": "METOPROLOL TARTRATE",
      "brand": "Metoprolol Tartrate",
      "description": "11 DESCRIPTION Metoprolol tartrate tablets, USP contain metoprolol tartrate, a selective beta 1 -adrenoreceptor blocking agent. It is very soluble in water; freely soluble in methylene chloride, in chloroform, and in alcohol; slightly soluble in acetone; and insoluble in ether. Metoprolol tartrate tablets, USP are available as 25 mg, 50 mg and 100 mg tablets for oral administration containing 25 mg, 50 mg and 100 mg metoprolol tartrate, respectively.",
      "dosage": "The effective dosage range of metoprolol tartrate tablets is 100 mg to 450 mg per day. The effective",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 685,
    "fields": {
      "name": "METRONIDAZOLE",
      "brand": "Metronidazole",
      "description": "DESCRIPTION Metronidazole tablets, USP 250 mg or 500 mg is an oral formulation of the synthetic nitroimidazole antimicrobial, 2-methyl-5-nitro-1H-imidazole-1-ethanol, which has the following structural formula: Metronidazole tablets USP contain 250 mg or 500 mg of metronidazole. Inactive ingredients include powdered cellulose, hydroxypropyl cellulose, low substituted hydroxypropyl cellulose, hypromellose, polyethylene glycol, stearic acid, and titanium dioxide. Molecular Structure",
      "dosage": "There is some indication from controlled comparative studies that cure rates as determined by vagina",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 686,
    "fields": {
      "name": "MIRTAZAPINE",
      "brand": "Mirtazapine",
      "description": "Mirtazapine has a tetracyclic chemical structure and belongs to the piperazino-azepine group of compounds. It is designated 1,2,3,4,10,14b-hexahydro-2-methylpyrazino [2,1-a] pyrido [2,3-c][2] benzazepine and has the molecular formula of C 17 H 19 N 3 . The structural formula is the following and it is the racemic mixture: Mirtazapine is a white to creamy white crystalline powder which is practically insoluble in water.",
      "dosage": "If patients do not have an adequate response to the initial 15 mg dose, increase the dose up to a ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 687,
    "fields": {
      "name": "MONTELUKAST SODIUM",
      "brand": "Montelukast Sodium",
      "description": "DESCRIPTION Montelukast sodium, the active ingredient in montelukast sodium tablets, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT 1 receptor. Montelukast sodium is described chemically as [ R-(E) ]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl] cyclopropaneacetic acid, monosodium salt. Each 10-mg film-coated montelukast sodium tablet contains 10.4 mg montelukast sodium, which is equivalent to 10 mg of montelukast, and the following inactive ingredients: croscarmellose sodium, ferric oxide red, ferric oxide yellow, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose and titanium dioxide.",
      "dosage": "Patients with both asthma and allergic rhinitis should take only one dose daily in the evening (2.4)",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 688,
    "fields": {
      "name": "NAPROXEN",
      "brand": "Naproxen",
      "description": "11 DESCRIPTION Naproxen Tablets, USP and Naproxen Sodium Tablets, USP are nonsteroidal anti-inflammatory drugs available as follows: Naproxen Tablets, USP are available as follows for oral administration: 250 mg: circular, light orange colored, flat, uncoated tablets, engraved with \u2018G\u2019 and \u201832\u2019 on either side of a break line on one side and \u2018250\u2019 on the other side. The inactive ingredients are croscarmellose sodium, iron oxide red, iron oxide yellow, magnesium stearate, microcrystalline cellulose and povidone. Naproxen, USP and naproxen sodium, USP have the following structures, respectively: Naproxen Naproxen Sodium Naproxen, USP is a white to off-white crystalline powder.",
      "dosage": "Management of Pain, Primary Dysmenorrhea, and Acute Tendonitis and Bursitis Recommended starting dos",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 689,
    "fields": {
      "name": "NITROGLYCERIN",
      "brand": "NITROGLYCERIN",
      "description": "11 DESCRIPTION Nitroglycerin sublingual tablets are stabilized sublingual compressed tablets that contain 0.3 mg, 0.4 mg, or 0.6 mg nitroglycerin; as well as lactose monohydrate, NF; glyceryl monostearate, NF; pregelatinized starch, NF; calcium stearate, NF powder; and silicon dioxide, colloidal, NF. Nitroglycerin, an organic nitrate, is a vasodilating agent. The chemical name for nitroglycerin is 1, 2, 3 propanetriol trinitrate and the chemical structure is: Molecular weight: 227.09 Nitroglycerin Structural Formula",
      "dosage": "2 DOSAGE AND ADMINISTRATION Administer one tablet under the tongue or in the buccal pouch at the fir",
      "stock": 100,
      "route": "SUBLINGUAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 690,
    "fields": {
      "name": "NORTRIPTYLINE HYDROCHLORIDE",
      "brand": "Nortriptyline Hydrochloride",
      "description": "DESCRIPTION Nortriptyline Hydrochloride, USP is 1-propanamine, 3-(10,11-dihydro-5 H -dibenzo[ a,d ]cyclohepten-5-ylidene)- N -methyl, hydrochloride. The structural formula is as follows: C19H21N\u2219HCl MW = 299.84 Each capsule, for oral administration, contains nortriptyline hydrochloride equivalent to 10 mg, 25 mg, 50 mg, and 75 mg of nortriptyline hydrochloride USP. In addition, each capsule contains the following inactive ingredients: black iron oxide, colloidal silicon dioxide, D&C Yellow #10 (aluminum lake), D&C Yellow #10, FD&C Blue #1 (aluminum lake), FD&C Blue #2 (aluminum lake), FD&C Green #3 (10, 50 and 75 mg only), FD&C Red #40 (aluminum lake), gelatin, I.M.S. 74 OP, magnesium stearate, pregelatinized corn starch, shellac, sodium lauryl sulfate and titanium dioxide.",
      "dosage": "Usual Adult Dose 25 mg three or four times daily; dosage should begin at a low level and be increase",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 691,
    "fields": {
      "name": "OMEPRAZOLE",
      "brand": "Omeprazole",
      "description": "",
      "dosage": "Directions for adults 18 years of age and older this product is to be used once a day (every 24 hour",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 692,
    "fields": {
      "name": "ONDANSETRON HYDROCHLORIDE",
      "brand": "ondansetron hydrochloride",
      "description": "11 DESCRIPTION The active ingredient in ondansetron tablets is ondansetron hydrochloride as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT 3 receptor type. Chemically it is (\u00b1) 1, 2, 3, 9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, monohydrochloride, dihydrate. Each tablet also contains the inactive ingredients colloidal silicon dioxide, hypromellose 2910(5cP) (for the 4 mg and 16 mg tablets only) and hypromellose 2910 (6cP) (for the 8 mg and 24 mg tablets only), iron oxide red and iron oxide black (for the 24 mg tablet only), iron oxide yellow (for the 8 mg and 24 mg tablets only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium starch glycolate, and titanium dioxide.",
      "dosage": "2 DOSAGE AND ADMINISTRATION See full prescribing information for the recommended dosage in adults an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 693,
    "fields": {
      "name": "OXYCODONE HYDROCHLORIDE",
      "brand": "Oxycodone Hydrochloride",
      "description": "Each tablet for oral administration contains 15 mg, or 30 mg, of oxycodone hydrochloride USP. Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. The 15 mg and 30 mg tablets contain the equivalent of 13.5 mg and 27.0 mg, respectively, of oxycodone free base.",
      "dosage": "If a decision is made to discontinue the use of non-opioid analgesic, it may be necessary to titrate",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 694,
    "fields": {
      "name": "PANTOPRAZOLE SODIUM INJECTION",
      "brand": "PANTOPRAZOLE SODIUM",
      "description": "11 DESCRIPTION The active ingredient in pantoprazole sodium for injection (pantoprazole sodium), a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S, with a molecular weight of 405.4. The reconstituted solution of pantoprazole sodium for injection is in the pH range of 9.0 to 10.5.",
      "dosage": "( 2.3 , 2.4 ) 2.1 Recommended Dosage for GERD Associated with a History of EE Adult Patients The rec",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 695,
    "fields": {
      "name": "PAROXETINE HYDROCHLORIDE HEMIHYDRATE",
      "brand": "Paroxetine",
      "description": "11 DESCRIPTION Paroxetine tablets contain paroxetine hydrochloride, an SSRI. It is the hydrochloride salt of a phenylpiperidine compound identified chemically as (-)- trans -4 R -(4'-fluorophenyl)-3 S -[(3',4'- methylenedioxyphenoxy) methyl] piperidine hydrochloride hemihydrate and has the empirical formula of C 19 H 20 FNO 3 \u2022HCl\u20221/2H 2 O. The structural formula of paroxetine hydrochloride is: Paroxetine hydrochloride, USP is an odorless, off-white powder, having a melting point range of 120 o to 138 o C and a solubility of 5.4 mg/mL in water.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting and maximum daily dosage for MDD, OCD, PD, and PTSD",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 696,
    "fields": {
      "name": "PENICILLIN G BENZATHINE",
      "brand": "BICILLIN L-A",
      "description": "Description Bicillin L-A (penicillin G benzathine injectable suspension) is available for deep intramuscular injection. Its chemical structure is as follows: Bicillin L-A contains penicillin G benzathine in aqueous suspension with sodium citrate buffer and, as w/v, approximately 0.65% sodium citrate, 0.59% povidone, 0.54% carboxymethylcellulose sodium, 0.53% lecithin, 0.12% methylparaben, and 0.013% propylparaben. Bicillin L-A contains approximately 0.11 mEq of sodium per 600,000 units of penicillin G (approximately 2.59 mg of sodium per 600,000 units of penicillin G).",
      "dosage": "DOSAGE AND ADMINISTRATION Streptococcal (Group A) Upper Respiratory Infections (for example, pharyng",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 697,
    "fields": {
      "name": "PHENYTOIN SODIUM",
      "brand": "Phenytoin Sodium",
      "description": "11 DESCRIPTION Phenytoin Sodium Injection, USP is a sterile solution containing in each mL phenytoin sodium 50 mg, propylene glycol 0.4 mL and alcohol 0.1 mL in Water for Injection. pH 10.0-12.3; sodium hydroxide added, if needed, for pH adjustment. Phenytoin sodium is related to the barbiturates in chemical structure, but has a five-membered ring.",
      "dosage": "( 2.2 , 2.3 ) 2.1 General Dosing Information Because of the increased risk of adverse cardiovascular",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 698,
    "fields": {
      "name": "PIOGLITAZONE HYDROCHLORIDE",
      "brand": "PIOGLITAZONE HYDROCHLORIDE",
      "description": "11 DESCRIPTION Pioglitazone tablets are a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (PPAR) gamma that contains an oral antidiabetic medication: pioglitazone. Pioglitazone [(\u00b1)-5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2,4-] thiazolidinedione monohydrochloride contains one asymmetric carbon, and the compound is synthesized and used as the racemic mixture. The two enantiomers of pioglitazone interconvert in vivo .",
      "dosage": "(2.1) If there is inadequate glycemic control, the dose can be increased in 15 mg increments up to a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 699,
    "fields": {
      "name": "PREDNISONE",
      "brand": "PredniSONE",
      "description": "DESCRIPTION Prednisone is a glucocorticoid. Glucocorticoids are adrenocortical steroids, both naturally occurring and synthetic, which are readily absorbed from the gastrointestinal tract. Prednisone, USP is a white to partially white, crystalline powder.",
      "dosage": "Included in the situations which may make dosage adjustments necessary are changes in clinical statu",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 700,
    "fields": {
      "name": "PREGABALIN",
      "brand": "PREGABALIN",
      "description": "The molecular formula is C 8 H 17 NO 2 and the molecular weight is 159.23. Pregabalin capsules are administered orally and are supplied as imprinted hard-shell capsules containing 25, 50, 75, 100, 150, 200, 225, and 300 mg of pregabalin, along with pregelatinized starch and talc as inactive ingredients. In addition, the orange & red capsule shells contain red iron oxide.",
      "dosage": "( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) Dosing recommendations: INDICATION Dosing Regimen Maximum Dose DPN P",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 701,
    "fields": {
      "name": "PROMETHAZINE HYDROCHLORIDE",
      "brand": "PROMETHAZINE HYDROCHLORIDE",
      "description": "DESCRIPTION Each 12.5 mg promethazine hydrochloride tablet for oral administration contains 12.5 mg promethazine hydrochloride. In addition, 50 mg tablet contains FD&C Red #40 and 12.5 mg tablet contains FD&C Yellow #6. Promethazine hydrochloride is a racemic compound; the empirical formula is C 17 H 20 N 2 S\u2022HCl and its molecular weight is 320.88.",
      "dosage": "The average effective dose of promethazine hydrochloride tablets, USP for the active therapy of naus",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 702,
    "fields": {
      "name": "PROPRANOLOL HYDROCHLORIDE",
      "brand": "Propranolol Hydrochloride",
      "description": "Propranolol Hydrochloride Tablets, USP are available as tablets for oral administration containing either 10 mg, 20 mg, 40 mg, 60 mg, or 80 mg of propranolol hydrochloride, USP. 6 aluminum lake (10 mg and 80 mg), D&C Yellow no. 10 aluminum lake (10 mg, 40 mg, and 80 mg), FD&C Blue no.",
      "dosage": "Hypertension The usual initial dosage is 40 mg propranolol hydrochloride twice daily, whether used a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 703,
    "fields": {
      "name": "QUETIAPINE FUMARATE",
      "brand": "Quetiapine Fumarate",
      "description": "It is present in tablets as the fumarate salt. Quetiapine tablets, USP is supplied for oral administration as 25 mg (round peach), 50 mg (round, white), 100 mg (round yellow), 150 mg (round, off white to light yellow), 200 mg (round, white), 300 mg (capsule-shaped, white), and 400 mg (capsule-shaped, yellow) tablets. The 25 mg tablets contain red iron oxide and yellow iron oxide and the 100 mg, 150 mg and 400 mg tablets contain only yellow iron oxide.",
      "dosage": "Further adjustments can be made in increments of 25 to 50 mg twice a day, in intervals of not less t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 704,
    "fields": {
      "name": "RABEPRAZOLE SODIUM",
      "brand": "Rabeprazole sodium",
      "description": "11 DESCRIPTION The active ingredient in rabeprazole sodium delayed-release tablets is rabeprazole sodium hydrate, USP, which is a proton pump inhibitor. The stability of rabeprazole sodium hydrate, USP is a function of pH; it is rapidly degraded in acid media, and is more stable under alkaline conditions. The structural figure is: Rabeprazole sodium hydrate, USP is available for oral administration as delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium hydrate, USP.",
      "dosage": "The use of rabeprazole sodium delayed-release tablets is not recommended for use in pediatric patien",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 705,
    "fields": {
      "name": "RANITIDINE",
      "brand": "Ranitidine",
      "description": "",
      "dosage": "Directions adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 706,
    "fields": {
      "name": "RISPERIDONE",
      "brand": "RISPERIDONE",
      "description": "11 DESCRIPTION Risperidone tablets, USP contain risperidone USP, an atypical antipsychotic belonging to the chemical class of benzisoxazole derivatives. The structural formula is: Risperidone USP is a white to slightly beige powder. Tablets of 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg also contain talc and titanium dioxide.",
      "dosage": "Maintenance Therapy While it is unknown how long a patient with schizophrenia should remain on rispe",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 707,
    "fields": {
      "name": "ROSUVASTATIN CALCIUM",
      "brand": "Rosuvastatin Calcium",
      "description": "11 DESCRIPTION Rosuvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA)-reductase inhibitor. The chemical name for rosuvastatin calcium is bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt with the following structural formula: The empirical formula for rosuvastatin calcium is (C 22 H 27 FN 3 O 6 S) 2 Ca and the molecular weight is 1001.14. Rosuvastatin calcium is a white or almost white, hygroscopic powder that is slightly soluble in water, freely soluble in methylene chloride, practically insoluble in ethanol.",
      "dosage": "( 2.1 ) Pediatric Patients with HeFH : Recommended dosage range is 5 to 10 mg once daily for patient",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 708,
    "fields": {
      "name": "SERTRALINE HYDROCHLORIDE",
      "brand": "Sertraline Hydrochloride",
      "description": "DESCRIPTION Sertraline hydrochloride is a selective serotonin reuptake inhibitor (SSRI) for oral administration. It has a molecular weight of 342.7. Sertraline hydrochloride, USP has the following chemical name: (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride.",
      "dosage": "While a relationship between dose and effect has not been established for OCD, patients were dosed i",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 709,
    "fields": {
      "name": "SILDENAFIL CITRATE",
      "brand": "SILDENAFIL CITRATE",
      "description": "11 DESCRIPTION Sildenafil tablets, USP, an oral therapy for erectile dysfunction, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Sildenafil citrate, is designated chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1 H -pyrazolo[4,3- d ]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate and has the following structural formula: Sildenafil citrate, USP is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Sildenafil tablets USP are formulated as pale blue to blue film-coated tablets equivalent to 25 mg, 50 mg and 100 mg of sildenafil for oral administration.",
      "dosage": "However, sildenafil tablets may be taken anywhere from 30 minutes to 4 hours before sexual activity ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 710,
    "fields": {
      "name": "EZETIMIBE AND SIMVASTATIN",
      "brand": "Ezetimibe and Simvastatin",
      "description": "11 DESCRIPTION Ezetimibe and simvastatin tablets contain ezetimibe USP, a selective inhibitor of intestinal cholesterol and related phytosterol absorption, and simvastatin USP, an HMG-CoA reductase inhibitor. The chemical name of ezetimibe, USP is 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone. formula 1 formula 2",
      "dosage": "The maximum recommended dosage is ezetimibe and simvastatin tablets 10 mg/40 mg once daily. The ezet",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 711,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 712,
    "fields": {
      "name": "SPIRONOLACTONE",
      "brand": "Spironolactone",
      "description": "11 DESCRIPTION Spironolactone oral tablets contain 25 mg, 50 mg, or 100 mg of the aldosterone antagonist spironolactone, USP 17hydroxy-7\u03b1-mercapto-3-oxo-17\u03b1-pregn-4-ene-21-carboxylic acid \u03b3-lactone acetate, which has the following structural formula: Spironolactone, USP is practically insoluble in water, soluble in alcohol, and freely soluble in benzene and in chloroform. Inactive ingredients include calcium sulfate, corn starch, croscarmellose sodium, peppermint flavor, hypromellose, iron oxide, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, polyvinyl alcohol, povidone, talc, titanium dioxide, and triacetin. The 50 mg tablet also contains D&C yellow # 10 and FD&C yellow #6.",
      "dosage": "2.2 Treatment of Heart Failure In patients with serum potassium \u2264 5.0 mEq/L and eGFR > 50 mL/min/1.7",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 713,
    "fields": {
      "name": "TAMSULOSIN HYDROCHLORIDE",
      "brand": "Tamsulosin Hydrochloride",
      "description": "11 DESCRIPTION Tamsulosin hydrochloride is an antagonist of alpha 1A adrenoceptors in the prostate. It is sparingly soluble in water and methanol, slightly soluble in glacial acetic acid and ethanol, and practically insoluble in ether. The molecular formula of tamsulosin hydrochloride is C 20 H 28 N 2 O 5 S \u2022 HCl.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as th",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 714,
    "fields": {
      "name": "TEMAZEPAM",
      "brand": "Temazepam",
      "description": "DESCRIPTION Temazepam, USP is a benzodiazepine hypnotic agent. The chemical name is 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, and the structural formula is: C 16 H 13 ClN 2 O 2 MW = 300.74 Temazepam, USP is a white, crystalline substance, very slightly soluble in water and sparingly soluble in alcohol USP. Temazepam capsules USP, 7.5 mg, 15 mg, 22.5 mg, and 30 mg, are for oral administration.",
      "dosage": "DOSAGE AND ADMINISTRATION While the recommended usual adult dose is 15 mg before retiring, 7.5 mg ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 715,
    "fields": {
      "name": "TERAZOSIN HYDROCHLORIDE",
      "brand": "Terazosin",
      "description": "DESCRIPTION Terazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name,molecular formula and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride.C 19 H 26 ClN 5 O 4 Terazosin hydrochloride is a white, crystalline substance, freely soluble in water and isotonic saline and has a molecular weight of 423.93. Each capsule, for oral administration, contains 1 mg, 2 mg, 5 mg or 10 mg of terazosin as terazosin hydrochlolde. In addition, each capsule contains the following inactive ingredients: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, and pregelatinized starch.",
      "dosage": "DOSAGE AND ADMINISTRATION If terazosin capsules administration is discontinued for several days, the",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 716,
    "fields": {
      "name": "TIZANIDINE",
      "brand": "tizanidine",
      "description": "11 DESCRIPTION Tizanidine Tablets, USP contains tizanidine hydrochloride as the active ingredient, which is a central alpha 2 -adrenergic agonist. Its chemical name is 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiodiazole monohydrochloride. It has a molecular formula of C 9 H 8 CIN 5 S\u00b7HCl and a molecular weight of 290.17.",
      "dosage": "( 2.1 ) Recommended starting dose: 2 mg by mouth every 6 to 8 hours, as needed, up to a maximum of 3",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 717,
    "fields": {
      "name": "TOPIRAMATE",
      "brand": "topiramate",
      "description": "11 DESCRIPTION Topiramate, USP is a sulfamate-substituted monosaccharide. Topiramate tablets, USP are available as 25 mg, 50 mg, 100 mg, and 200 mg round shaped tablets for oral administration. Its saturated solution has a pH of 6.3.",
      "dosage": "Table 2: Monotherapy Target Total Daily Maintenance Dosing for Patients 2 to 9 Years of Age Weight (",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 718,
    "fields": {
      "name": "TRAMADOL HYDROCHLORIDE",
      "brand": "TRAMADOL HYDROCHLORIDE",
      "description": "The chemical name is (\u00b1) cis -2-[(dimethylamino) methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochloride. It is a white, crystalline powder that is freely soluble in water and methanol, very slightly soluble in acetone and has a pKa of 9.41. Tramadol hydrochloride extended-release tablets, USP contain 100 mg, 200 mg or 300 mg of tramadol hydrochloride, USP in an extended-release formulation.",
      "dosage": "2.5 Safe Reduction or Discontinuation of Tramadol Hydrochloride Extended-Release Tablets Do not abru",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 719,
    "fields": {
      "name": "TRAZODONE HYDROCHLORIDE",
      "brand": "Trazodone Hydrochloride",
      "description": "11 DESCRIPTION Trazodone hydrochloride is a selective serotonin reuptake inhibitor and 5HT2 receptor antagonist. Trazodone hydrochloride, USP is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]- 1,2,4-triazolo[4, 3-a]pyridin-3(2H)-one hydrochloride. It is a white to off-white, crystalline powder which is sparingly soluble in chloroform and in water.",
      "dosage": "The dosage should be initiated at a low-dose and increased gradually, noting the clinical response a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 720,
    "fields": {
      "name": "SACUBITRIL AND VALSARTAN",
      "brand": "ENTRESTO",
      "description": "Its molecular mass is 957.99 g/mol and its schematic structural formula is: ENTRESTO is available as film-coated tablets for oral administration, containing 24 mg of sacubitril and 26 mg of valsartan; 49 mg of sacubitril and 51 mg of valsartan; and 97 mg of sacubitril and 103 mg of valsartan. The film-coat inactive ingredients are hypromellose, iron oxide red (E172), polyethylene glycol 4000, talc, and titanium dioxide (E171). The film-coat for the 49 mg of sacubitril and 51 mg of valsartan tablet contains iron oxide yellow (E172).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dosage for adults is 49 mg/51 mg orally twice d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 721,
    "fields": {
      "name": "VENLAFAXINE",
      "brand": "Venlafaxine",
      "description": "DESCRIPTION Venlafaxine hydrochloride is a structurally novel antidepressant for oral administration. Each venlafaxine tablet, USP intended for oral administration contains venlafaxine hydrochloride equivalent to 25 mg or 37.5 mg or 50 mg or 75 mg or 100 mg of venlafaxine. Structured formula for venlafaxine",
      "dosage": "When treating pregnant women with venlafaxine tablets during the third trimester, the physician shou",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 722,
    "fields": {
      "name": "VERAPAMIL HYDROCHLORIDE",
      "brand": "Verapamil Hydrochloride",
      "description": "DESCRIPTION Verapamil hydrochloride is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets containing 40 mg, 80 mg, or 120 mg of verapamil hydrochloride. The structural formula of verapamil hydrochloride is: Benzeneacetonitrile, \u03b1-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-\u03b1-(1-methylethyl) hydrochloride. Verapamil hydrochloride is an almost white, crystalline powder, practically free of odor, with a bitter taste.",
      "dosage": "Angina: Clinical trials show that the usual dose is 80 mg to 120 mg three times a day. However, 40 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 723,
    "fields": {
      "name": "WARFARIN SODIUM",
      "brand": "Warfarin Sodium",
      "description": "11 DESCRIPTION Warfarin sodium tablets, USP contain warfarin sodium, an anticoagulant that acts by inhibiting vitamin K-dependent coagulation factors. 40 aluminum lake, and D&C yellow no. 10 aluminum lake and FD&C yellow no.",
      "dosage": "The duration of treatment is based on the indication as follows: For patients with a DVT or PE secon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 724,
    "fields": {
      "name": "ZALEPLON",
      "brand": "zaleplon",
      "description": "Its molecular formula is C 17 H 15 N 5 O, and its molecular weight is 305.34. Zaleplon capsules USP contain zaleplon as the active ingredient. The 5 mg capsules also contain FD&C yellow #5.",
      "dosage": "Although the risk of certain adverse events associated with the use of zaleplon capsules appears to ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 725,
    "fields": {
      "name": "ZOLPIDEM TARTRATE",
      "brand": "Zolpidem",
      "description": "11 DESCRIPTION Zolpidem Tartrate Tablets, USP contains Zolpidem tartrate, a gamma-aminobutyric acid (GABA) A receptor positive modulator of the imidazopyridine class. It has the following structure: Zolpidem Tartrate is a white to off-white crystalline powder that is sparingly soluble in water, alcohol, and propylene glycol. Opadry II (pink) contains hypromellose, FD&C Red no.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest dose effective for the patient and must not exceed a tota",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 726,
    "fields": {
      "name": "ZOLMITRIPTAN",
      "brand": "Zolmitriptan",
      "description": "11 DESCRIPTION ZOLMITRIPTAN NASAL SPRAY contains zolmitriptan, which is a selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist. Zolmitriptan is chemically designated as (S)-4-[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone and has the following chemical structure: The empirical formula is C 16 H 21 N 3 O 2 , representing a molecular weight of 287.36. The osmolarity of ZOLMITRIPTAN NASAL SPRAY for 2.5 mg is 360 to 420 mOsmol, and for 5 mg is 420 to 470 mOsmol.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting dose: 2.5 mg (2.1) Maximum single dose: 5 mg (2.1) ",
      "stock": 100,
      "route": "NASAL",
      "resupply_pending": 0,
      "pharmacy_id": 2,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 727,
    "fields": {
      "name": "ACETAMINOPHEN",
      "brand": "Pain Reliever Extra Strength",
      "description": "",
      "dosage": "Directions do not take more than directed adults and children 12 years and over take 2 gelcaps every",
      "stock": 75,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 728,
    "fields": {
      "name": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN",
      "brand": "Hydrocodone Bitartrate and Acetaminophen",
      "description": "DESCRIPTION Hydrocodone bitartrate and acetaminophen, USP is available in tablet form for oral administration. It is affected by light. It has the following structural formula: Acetaminophen, 4' -hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "Initial Dosage Initiating Treatment with Hydrocodone Bitartrate and Acetaminophen Tablets 2.5 mg/325",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 729,
    "fields": {
      "name": "ALBUTEROL SULFATE",
      "brand": "Albuterol Sulfate HFA",
      "description": "Albuterol sulfate has the chemical name \u03b1 1 -[( tert -butylamino)methyl]-4-hydroxy- m -xylene-\u03b1, \u03b1\u2032-diol sulfate (2:1)(salt) and the following chemical structure: Albuterol sulfate is a white crystalline powder with a molecular weight of 576.7, and the empirical formula is (C 13 H 21 NO 3 ) 2 \u2022H 2 SO 4 . Each canister contains a microcrystalline suspension of albuterol sulfate in propellant HFA\u2011134a (1,1,1,2\u2011tetrafluoroethane). Prime Albuterol Sulfate HFA before using for the first time, when the inhaler has not been used for more than 2 weeks, or when the inhaler has been dropped.",
      "dosage": "2 DOSAGE AND ADMINISTRATION For oral inhalation only. ( 2 ) Treatment or prevention of bronchospasm ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 730,
    "fields": {
      "name": "ALENDRONATE SODIUM",
      "brand": "Binosto",
      "description": "11 DESCRIPTION BINOSTO (alendronate sodium) is a bisphosphonate that acts as a specific inhibitor of osteoclast-mediated bone resorption. Alendronate sodium is chemically described as (4 amino-1-hydroxybutylidene) bisphosphonic acid, monosodium salt, trihydrate. Once the effervescent tablet is dissolved in water, the alendronate sodium is present in a citrate-buffered solution of pH 4.8 to 5.4.",
      "dosage": "Take BINOSTO upon arising for the day and at least 30 minutes before the first food, beverage, or me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 731,
    "fields": {
      "name": "ALLOPURINOL",
      "brand": "Allopurinol",
      "description": "11 DESCRIPTION Allopurinol, USP is a xanthine oxidase inhibitor. It has the following structural formula: Allopurinol, USP is known chemically as 1, 5-dihydro-4 H -pyrazolo [3, 4- d ]pyrimidin-4-one and it has a molecular weight of 136.1 g/mol. Each scored white round-shaped tablet contains 100 mg allopurinol and the inactive ingredients colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate.",
      "dosage": "2.3 Recommended Dosage for Gout The initial recommended dosage for the management of gout is 100 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 732,
    "fields": {
      "name": "ALPRAZOLAM",
      "brand": "Alprazolam",
      "description": "11 DESCRIPTION Alprazolam tablets, USP contain alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds. The chemical name of alprazolam is 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-\u03b1] [1,4] benzodiazepine. In addition, the 0.5 mg tablet contains FD&C Yellow # 6 aluminum lake and the 1 mg tablet contains FD&C Blue No.",
      "dosage": "Dosage may be increased, at intervals of every 3 to 4 days, to a maximum recommended daily dose of 4",
      "stock": 80,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 733,
    "fields": {
      "name": "AMOXICILLIN",
      "brand": "Amoxicillin",
      "description": "Amoxicillin Tablets, USP: Each film coated tablet contains 500 mg or 875 mg amoxicillin as the trihydrate. Amoxicillin for Oral Suspension, USP: Each 5 mL of reconstituted suspension contains 125 mg, 200 mg, 250 mg or 400 mg amoxicillin as the trihydrate. Each 5 mL of the 125 mg, 200 mg, 250 mg, and 400 mg reconstituted suspension contains 0.30 mEq (6.95 mg) of sodium.",
      "dosage": "Dosing Recommendations for Adult and Pediatric Patients > 3 Months of Age Infection Severity Dosing ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 734,
    "fields": {
      "name": "AMLODIPINE BESYLATE",
      "brand": "Amlodipine Besylate",
      "description": "11 DESCRIPTION Amlodipine besylate is the besylate salt of amlodipine, a long-acting calcium channel blocker. Amlodipine besylate is chemically described as 3-Ethyl-5-methyl (\u00b1)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, monobenzenesulphonate. Amlodipine besylate tablets USP are formulated as tablets equivalent to 2.5 mg, 5 mg and 10 mg of amlodipine for oral administration.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022Adult recommended starting dose: 5 mg once daily with maximum dose 10 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 735,
    "fields": {
      "name": "ARIPIPRAZOLE",
      "brand": "Aripiprazole",
      "description": "11 DESCRIPTION Aripiprazole is an atypical antipsychotic drug that is available as Aripiprazole Tablets, USP. Aripiprazole is 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril. The empirical formula is C 23 H 27 Cl 2 N 3 O 2 and its molecular weight is 448.38.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Initial Dose Recommended Dose Maximum Dose Schizophrenia \u2013 adults (2.1) ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 736,
    "fields": {
      "name": "ATENOLOL",
      "brand": "Atenolol",
      "description": "DESCRIPTION Atenolol, a synthetic, beta 1 -selective (cardioselective) adrenoreceptor blocking agent, may be chemically described as benzeneacetamide, 4-[2\u2019-hydroxy-3\u2019-[(1-methylethyl)amino]propoxy]-. It is a relatively polar hydrophilic compound with a water solubility of 26.5 mg/mL at 37\u00b0C and a log partition coefficient (octanol/water) of 0.23. Atenolol is available as 25, 50 or 100 mg tablets for oral administration.",
      "dosage": "If an optimal response is not achieved, the dosage should be increased to atenolol 100 mg given as o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 737,
    "fields": {
      "name": "ATORVASTATIN CALCIUM",
      "brand": "Atorvastatin calcium",
      "description": "11 DESCRIPTION Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Atorvastatin calcium USP is (\u03b2R, \u03b4R)-2-(p-fluorophenyl)-\u03b2,\u03b4-dihydroxy-5-isopropyl-3-phenyl-4(phenylcarbamoyl)pyrrole-l-heptanaote (1:2), trihydrate. The molecular formula of atorvastatin calcium USP is C 66 H 68 CaF 2 N 4 O 10 .3H 2 O and its molecular weight is 1209.41.",
      "dosage": "2.1 Important Dosage Information Take atorvastatin calcium tablets orally once daily at any time of ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 738,
    "fields": {
      "name": "AZITHROMYCIN",
      "brand": "Azithromycin",
      "description": "11 DESCRIPTION Azithromycin tablets USP contain the active ingredient azithromycin, a macrolide antibacterial drug, for oral administration. Azithromycin has the chemical name (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-\u03b1-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-\u03b2-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Azithromycin is derived from erythromycin; however, it differs chemically from erythromycin in that a methyl-substituted nitrogen atom is incorporated into the lactone ring.",
      "dosage": "Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 500 mg as a single dose on Da",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 739,
    "fields": {
      "name": "BACLOFEN INJECTION",
      "brand": "Gablofen",
      "description": "11 DESCRIPTION GABLOFEN (baclofen injection) is a muscle relaxant and antispastic. Baclofen's pharmacological class is a gamma-aminobutyric acid (GABA) ergic agonist. Baclofen's chemical name is 4-amino-3-(4-chlorophenyl) butanoic acid, and its structural formula is: Baclofen C 10 H 12 ClNO 2 Baclofen is a white to off-white powder, with a molecular weight of 213.66.",
      "dosage": "2.2 Screening Phase Prior to pump implantation and initiation of chronic infusion of GABLOFEN, patie",
      "stock": 100,
      "route": "INTRATHECAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 740,
    "fields": {
      "name": "BENAZEPRIL HYDROCHLORIDE",
      "brand": "Benazepril Hydrochloride",
      "description": "Its chemical name is benazepril 3-[[1-(ethoxy-carbonyl)-3-phenyl-(1S)-propyl]amino]-2,3,4,5-tetrahydro-2-oxo-1 H -1-(3S)-benzazepine-1-acetic acid monohydrochloride; its structural formula is Its empirical formula is C 24 H 28 N 2 O 5 \u2022HCl and its molecular weight is 460.96. Benazepril hydrochloride is supplied as film-coated tablets containing 5 mg, 10 mg, 20 mg, and 40 mg of benazepril hydrochloride for oral administration. Benazepril hydrochloride tablets USP, 5 mg, 10 mg, 20 mg and 40 mg meet USP Dissolution Test 2.",
      "dosage": "\u2022 Renal Impairment: Initiate with 5 mg once daily in patients with GFR <30 mL/min/1.73 m 2 (serum cr",
      "stock": 99,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 741,
    "fields": {
      "name": "BISOPROLOL FUMARATE",
      "brand": "Bisoprolol fumarate",
      "description": "It possesses an asymmetric carbon atom in its structure and is provided as a racemic mixture. Bisoprolol fumarate tablets are available as 5 and 10 mg tablets for oral administration. The 5 mg tablets also contain Red Iron Oxide.",
      "dosage": "DOSAGE AND ADMINISTRATION The dose of bisoprolol fumarate tablets must be individualized to the need",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 742,
    "fields": {
      "name": "BUPROPION HYDROCHLORIDE",
      "brand": "Bupropion Hydrochloride XL",
      "description": "11 DESCRIPTION Bupropion Hydrochloride USP, an antidepressant of the aminoketone class, is chemically unrelated to tricyclic, tetracyclic, selective serotonin reuptake inhibitor, or other known antidepressant agents. Its structure closely resembles that of diethylpropion; it is related to phenylethylamines. The structural formula is: Bupropion Hydrochloride Extended-Release Tablets USP (XL) are supplied for oral administration as 150 mg and 300 mg white to pale yellow extended-release tablets.",
      "dosage": "2.2 Dosage for Major Depressive Disorder (MDD) The recommended starting dose for MDD is 150 mg once ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 743,
    "fields": {
      "name": "BUSPIRONE HYDROCHLORIDE",
      "brand": "Buspirone Hydrochloride",
      "description": "421.96 Each tablet, for oral administration, contains 5 mg, 7.5 mg, 10 mg, 15 mg or 30 mg of buspirone hydrochloride, USP (equivalent to 4.6 mg, 6.9 mg, 9.1 mg, 13.7 mg and 27.4 mg of buspirone free base, respectively). Thus, a single 15 mg tablet can provide the following doses: 15 mg (entire tablet), 10 mg (two-thirds of a tablet), 7.5 mg (one-half of a tablet), or 5 mg (one-third of a tablet). A single 30 mg tablet can provide the following doses: 30 mg (entire tablet), 20 mg (two-thirds of a tablet), 15 mg (one-half of a tablet), or 10 mg (one-third of a tablet).",
      "dosage": "To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 744,
    "fields": {
      "name": "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE",
      "brand": "Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",
      "description": "11 DESCRIPTION Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are supplied in capsule form for oral administration. Each capsule contains: Butalbital, USP 50 mg Acetaminophen, USP 325 mg Caffeine, USP 40 mg Codeine phosphate, USP 30 mg Butalbital (5-allyl-5-isobutylbarbituric acid), is a short-to intermediate-acting barbiturate. It has the following structural formula: C 11 H 16 N 2 O 3 MW 224.26 Acetaminophen (4'hydroxyacetanilide), is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "2.2 Patient Access to Naloxone for the Emergency Treatment of Opioid Overdose Discuss the availabili",
      "stock": 60,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 745,
    "fields": {
      "name": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "brand": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "description": "DESCRIPTION Captopril and hydrochlorothiazide tablets, USP for oral administration combines two antihypertensive agents: captopril and hydrochlorothiazide. Captopril, USP is a white to off-white crystalline powder with characteristic sulfide-like odor; it is freely soluble in water, ethanol, methanol, chloroform, isopropyl alcohol and methylene chloride and soluble in ethyl acetate. Freely soluble in N,N-Dimethylformamide, in n-Butylamine and in diluted solutions of alkali hydroxides.",
      "dosage": "For patients insufficiently responsive to the initial dose, additional captopril or hydrochlorothiaz",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 746,
    "fields": {
      "name": "CARVEDILOL",
      "brand": "Carvedilol",
      "description": "11 DESCRIPTION Carvedilol is a nonselective \u03b2-adrenergic blocking agent with \u03b1 1 -blocking activity. It is (\u00b1)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol. Carvedilol is a racemic mixture with the following structure: Carvedilol, USP is a white to almost white crystalline powder with a molecular weight of 406.5 and a molecular formula of C 24 H 26 N 2 O 4 .",
      "dosage": "Fluid retention (with or without transient worsening heart failure symptoms) should be treated by an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 747,
    "fields": {
      "name": "CEFDINIR",
      "brand": "Cefdinir",
      "description": "DESCRIPTION Cefdinir capsules, USP contain the active ingredient cefdinir, an extended-spectrum, semisynthetic cephalosporin, for oral administration. Chemically, cefdinir is [6R-[6\u03b1,7\u03b2 (Z)]]-7-[[(2-amino-4 thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid. Cefdinir is a white to slightly brownish-yellow solid.",
      "dosage": "DOSAGE & ADMINISTRATION (see INDICATIONS AND USAGE for Indicated Pathogens) The recommended dosage a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 748,
    "fields": {
      "name": "CEFUROXIME AXETIL",
      "brand": "Cefuroxime axetil",
      "description": "Cefuroxime axetil is a semisynthetic, cephalosporin antibacterial drug for oral administration. The chemical name of cefuroxime axetil (1-(acetyloxy) ethyl ester of cefuroxime) is ( RS )-1 hydroxyethyl (6 R ,7 R )-7-[2-(2-furyl)glyoxyl-amido]-3-(hydroxymethyl)-8-oxo-5-thia-1 azabicyclo[4.2.0]-oct-2-ene-2-carboxylate, 72-( Z )-( O -methyl-oxime), 1-acetate 3-carbamate. Cefuroxime axetil is in the amorphous form and has the following structural formula: Cefuroxime axetil tablets, USP are film-coated and contain the equivalent of 250 or 500 mg of cefuroxime as cefuroxime axetil.",
      "dosage": "Pediatric patients (aged 13 years and older) who cannot swallow the cefuroxime axetil tablets whole ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 749,
    "fields": {
      "name": "CELECOXIB",
      "brand": "CELECOXIB",
      "description": "DESCRIPTION Celecoxib capsule is a nonsteroidal anti-inflammatory drug, available as capsules containing 50 mg, 100 mg, 200 mg and 400 mg celecoxib for oral administration. Its molecular formula is C 17 H 14 F 3 N 3 O 2 S, and it has the following chemical structure: Celecoxib USP is a white or almost white crystalline powder with a pKa of 11.1 (sulfonamide moiety). Celecoxib USP is hydrophobic (log P is 3.5) and is soluble in ethanol and in methylene chloride, practically insoluble in water.",
      "dosage": "For patients >25 kg the recommended dose is 100 mg twice daily. For patients who have difficulty swa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 750,
    "fields": {
      "name": "CETIRIZINE HYDROCHLORIDE TABLETS",
      "brand": "cetirizine hydrochloride",
      "description": "",
      "dosage": "Directions adults and children 6 years and over one 10 mg tablet once daily; do not take more than o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 751,
    "fields": {
      "name": "CIPROFLOXACIN",
      "brand": "ciprofloxacin",
      "description": "DESCRIPTION Ciprofloxacin ophthalmic solution is a synthetic, sterile, multiple dose, antimicrobial for topical ophthalmic use. Ciprofloxacin is a fluoroquinolone antibacterial active against a broad spectrum of gram-positive and gram-negative ocular pathogens. It is available as the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid.",
      "dosage": "DOSAGE AND ADMINISTRATION Corneal Ulcers: The recommended dosage regimen for the treatment of cornea",
      "stock": 100,
      "route": "OPHTHALMIC",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 752,
    "fields": {
      "name": "CITALOPRAM",
      "brand": "Citalopram",
      "description": "11 DESCRIPTION Citalopram tablets, USP contain citalopram, a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide is a racemic bicyclic phthalane structure and is designated (\u00b1)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3\u00addihydroisobenzofuran-5-carbonitrile hydrobromide with the following structural formula: The molecular formula is C 20 H 22 BrFN 2 O and its molecular weight is 405.35. Citalopram hydrobromide, USP occurs as a fine, white to off-white powder.",
      "dosage": "2.1 Recommended Dosage Administer citalopram tablets once daily, with or without food, at an initial",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 753,
    "fields": {
      "name": "CLINDAMYCIN PHOSPHATE",
      "brand": "Clindamycin Phosphate",
      "description": "DESCRIPTION Clindamycin phosphate topical lotion, 1% contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. Clindamycin phosphate is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The lotion contains cetostearyl alcohol (2.5%); glycerin; glyceryl stearate SE (with potassium monostearate); isostearyl alcohol (2.5%); methylparaben (0.3%); sodium lauroyl sarcosinate; stearic acid; and purified water.",
      "dosage": "DOSAGE AND ADMINISTRATION Apply a thin film of clindamycin phosphate topical lotion twice daily to a",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 754,
    "fields": {
      "name": "CLONAZEPAM",
      "brand": "Clonazepam",
      "description": "DESCRIPTION Clonazepam Tablets, USP, a benzodiazepine, is available as scored tablet with debossing \u039b containing 0.5 mg of clonazepam and unscored tablets with debossing \u039b and \u039b containing 1 mg or 2 mg of clonazepam respectively. Each 66 67 69 tablet also contains lactose monohydrate, polyethylene glycol, microcrystalline cellulose, croscarmellose sodium and magnesium stearate with the following colourants: 0.5 mg-FD & C Yellow 6 Al Lake, D & C Yellow 10 Al Lake; 1 mg-FD & C Blue 1 Al lake and FD & C Blue 2 Al lake Chemically, clonazepam is 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder.",
      "dosage": "Geriatric Patients: There is no clinical trial experience with clonazepam tablets in seizure disorde",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 755,
    "fields": {
      "name": "CLOPIDOGREL BISULFATE",
      "brand": "Clopidogrel",
      "description": "11 DESCRIPTION Clopidogrel bisulfate is a thienopyridine class inhibitor of P2Y 12 ADP platelet receptors. Chemically it is methyl (+)-( S )-\u03b1-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4 H )-\u00adacetate sulfate (1:1). The structural formula is as follows: Clopidogrel bisulfate USP is a white to off-white powder.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Acute coronary syndrome ( 2.1 ) \u2013 Initiate clopidogrel tablets with a si",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 756,
    "fields": {
      "name": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "brand": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "description": "DESCRIPTION Cyclobenzaprine hydrochloride, USP is a tricyclic amine salt which is white to off white, odourless, crystalline powder with the molecular formula C 20 H 21 N \u2022 HCl and a molecular weight of 311.9. Cyclobenzaprine hydrochloride is designated chemically as 3-(5H -dibenzo[a,d] cyclohepten-5-ylidene)- N,N -dimethyl-1-propanamine hydrochloride, and has the following structural formula: Cyclobenzaprine hydrochloride tablets, USP are available as 5 mg, 7.5 mg and 10 mg tablets for oral administration. In addition, the 5 mg tablets contain FD&C Blue #2/INDIGO Carmine Aluminum Lake.",
      "dosage": "DOSAGE AND ADMINISTRATION For most patients, the recommended dose of cyclobenzaprine hydrochloride t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 757,
    "fields": {
      "name": "DAPAGLIFLOZIN",
      "brand": "FARXIGA",
      "description": "11 DESCRIPTION Dapagliflozin, an inhibitor of SGLT2, is described chemically as D-glucitol, 1,5-anhydro-1- C -[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1 S )-, compounded with (2 S )-1,2-propanediol, hydrate (1:1:1). The empirical formula is C 21 H 25 ClO 6 \u2022C 3 H 8 O 2 \u2022H 2 O and the molecular weight is 502.98. The structural formula is: FARXIGA is available as a film-coated tablet for oral administration containing the equivalent of 5 mg dapagliflozin as dapagliflozin propanediol or the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol, and the following inactive ingredients: microcrystalline cellulose, anhydrous lactose, crospovidone, silicon dioxide, and magnesium stearate.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022 Assess volume status and correct volume depletion before initiating. I",
      "stock": 10,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "low_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 758,
    "fields": {
      "name": "DESVENLAFAXINE SUCCINATE",
      "brand": "Pristiq Extended-Release",
      "description": "11 DESCRIPTION PRISTIQ is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. Desvenlafaxine is designated RS -4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol and has the empirical formula of C 16 H 25 NO 2 (free base) and C 16 H 25 NO 2 \u2219C 4 H 6 O 4 \u2219H 2 O (succinate monohydrate). Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C yellow #6.",
      "dosage": "In clinical studies, doses of 50 mg to 400 mg per day were shown to be effective, although no additi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 759,
    "fields": {
      "name": "DIAZEPAM",
      "brand": "Diazepam",
      "description": "The molecular formula is C 16 H 13 ClN 2 O and the molecular weight is 284.7. The structural formula is as follows: Diazepam is available for oral administration as tablets containing 2 mg, 5 mg or 10 mg diazepam, USP. 10 Aluminum Lake and FD&C Blue No.",
      "dosage": "2 mg to 10 mg, 3 or 4 times daily Adjunctively in Convulsive Disorders. 2 mg to 2.5 mg, 1 or 2 times",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 760,
    "fields": {
      "name": "DICLOFENAC SODIUM",
      "brand": "Diclofenac Sodium",
      "description": "",
      "dosage": "Directions Use up to 21 days unless directed by your doctor Not for strains, sprains, bruises or spo",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 761,
    "fields": {
      "name": "DICYCLOMINE HYDROCHLORIDE",
      "brand": "Dicyclomine hydrochloride",
      "description": "11 DESCRIPTION Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent available as: Dicyclomine hydrochloride capsules, USP for oral use containing 10 mg dicyclomine hydrochloride, USP. Dicyclomine hydrochloride 10 mg capsules contain the following inactive ingredients: corn starch, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. Capsule shells contain FD&C Blue No.1, FD&C Red No.40, gelatin, purified water, and sodium lauryl sulfate.",
      "dosage": "Dosage for dicyclomine hydrochloride capsules must be adjusted to individual patient needs (2) . Aft",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 762,
    "fields": {
      "name": "DIGOXIN",
      "brand": "Digoxin",
      "description": "11 DESCRIPTION Digoxin is one of the cardiac (or digitalis) glycosides, a closely related group of drugs having in common specific effects on the myocardium. These drugs are found in a number of plants. The term \u201cdigitalis\u201d is used to designate the whole group of glycosides.",
      "dosage": "2.2 Loading Dosing Regimen in Adults and Pediatric Patients For adults and pediatric patients if a l",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 763,
    "fields": {
      "name": "DILTIAZEM HYDROCHLORIDE",
      "brand": "diltiazem hydrochloride",
      "description": "DESCRIPTION Diltiazem hydrochloride is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1, 5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2, 3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride,(+)-cis-. The chemical structure is: USP Dissolution pending.",
      "dosage": "Individual patients may respond to higher doses of up to 480 mg once daily. Antihypertensives : Dilt",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 764,
    "fields": {
      "name": "DIPHENHYDRAMINE HCL",
      "brand": "Childrens Allergy Relief",
      "description": "",
      "dosage": "Directions \u25a0 if needed, take every 4-6 hours \u25a0 do not take more than 6 doses in 24-hours children un",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 765,
    "fields": {
      "name": "DIVALPROEX SODIUM",
      "brand": "Divalproex Sodium",
      "description": "Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium extended-release tablets, USP contain divalproex sodium in a once-a-day extended-release formulation equivalent to 250 or 500 mg of valproic acid. Inactive Ingredients: ammonium hydroxide, colloidal anhydrous silica, colloidal silicon dioxide, dibutyl sebacate, ethylcellulose, hydroxyethyl cellulose, hypromellose, oleic acid, polydextrose, polyethylene glycol, silicified microcrystalline cellulose, titanium dioxide and triacetin.",
      "dosage": "Although doses other than 1,000 mg once daily of divalproex sodium extended-release tablets have not",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 766,
    "fields": {
      "name": "DOXYCYCLINE",
      "brand": "doxycycline",
      "description": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Doxycycline is an antibacterial drug synthetically derived from oxytetracycline, and is available as capsules of doxycycline hyclate for oral administration. The structural formula of doxycycline monohydrate is with a molecular formula of C 22 H 24 N 2 O 8 \u2219H 2 O and a molecular weight of 462.46.",
      "dosage": "Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 767,
    "fields": {
      "name": "DULAGLUTIDE",
      "brand": "TRULICITY",
      "description": "11 DESCRIPTION Dulaglutide is a human glucagon-like peptide-1 (GLP-1) receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1 analog sequence covalently linked to the Fc portion of a modified human immunoglobulin G4 (IgG4) heavy chain by a small peptide linker and is produced using mammalian cell (Chinese hamster ovary) culture. The GLP-1 analog portion of dulaglutide is 90% homologous to native human GLP-1 (7-37).",
      "dosage": "2 DOSAGE AND ADMINISTRATION Adult Dosage ( 2.1 ) Recommended starting dosage is 0.75 mg injected sub",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 768,
    "fields": {
      "name": "ENALAPRIL MALEATE",
      "brand": "Enalapril Maleate",
      "description": "DESCRIPTION Enalapril maleate is the maleate salt of enalapril, the ethyl ester of a long-acting angiotensin-converting enzyme inhibitor, enalaprilat. Its molecular formula is C 20 H 28 N 2 O 5 \u2219C 4 H 4 O 4, and its structural formula is: Enalapril maleate is a white to off-white, crystalline powder with a molecular weight of 492.53. Enalapril is a pro-drug; following oral administration, it is bioactivated by hydrolysis of the ethyl ester to enalaprilat, which is the active angiotensin-converting enzyme inhibitor.",
      "dosage": "DOSAGE AND ADMINISTRATION Hypertension In patients who are currently being treated with a diuretic, ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 769,
    "fields": {
      "name": "ESCITALOPRAM ORAL",
      "brand": "Escitalopram Oral Solution",
      "description": "11 DESCRIPTION Escitalopram Oral Solution, USP contains escitalopram oxalate, an orally administered selective serotonin reuptake inhibitor (SSRI), present as escitalopram oxalate salt. Escitalopram is the pure S-enantiomer (single isomer) of the racemic bicyclic phthalane derivative citalopram. Escitalopram oxalate is designated S-(+)-1-[3-(dimethyl-amino)propyl]-1-( p -fluorophenyl)-5-phthalancarbonitrile oxalate with the following structural formula: The molecular formula is C 20 H 21 FN 2O \u2022 C 2 H 2 O 4 and the molecular weight is 414.40.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication and Population Recommended Dosage MDD in Adults ( 2.1 ) Initi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 770,
    "fields": {
      "name": "ESOMEPRAZOLE MAGNESIUM",
      "brand": "Acid Reducer",
      "description": "",
      "dosage": "Directions adults 18 years of age and older this product is to be used once a day (every 24 hours), ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 771,
    "fields": {
      "name": "ESZOPICLONE",
      "brand": "Eszopiclone",
      "description": "11 DESCRIPTION Eszopiclone is a hypnotic agent/nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class. The chemical name of eszopiclone is (+)-4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5 H pyrrolo[3,4- b ]pyrazin-5-(S)-yl ester. In addition, both the 1 mg and 3 mg tablets contain FD&C Blue #2/indigo carmine aluminium lake.",
      "dosage": "May increase dose if clinically indicated, to a maximum of 3 mg ( 2.1 ) \u2022 Geriatric or debilitated p",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 772,
    "fields": {
      "name": "FENTANYL CITRATE",
      "brand": "Fentanyl Citrate",
      "description": "Fentanyl citrate is chemically identified as N -(1-Phenethyl-4-piperidyl)propionanilide citrate (1:1) with the following structural formula: C 22 H 28 N 2 O \u2022 C 6 H 8 O 7 Molecular Weight is 528.59 Each mL contains fentanyl citrate equivalent to 50 mcg (0.05 mg) fentanyl base in Water for Injection. Sodium hydroxide and/or hydrochloric acid added, if needed, for pH adjustment. The pH range is 4.0 to 7.5.",
      "dosage": "For use in more major surgical procedures, in addition to adequate analgesia, may abolish some of th",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 773,
    "fields": {
      "name": "FEXOFENADINE HCL",
      "brand": "Fexofenadine HCL",
      "description": "",
      "dosage": "Directions adults and children 12 years of age and over: take one 180 mg tablet with water every onc",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 774,
    "fields": {
      "name": "FINASTERIDE",
      "brand": "Finasteride",
      "description": "11 DESCRIPTION Finasteride tablets USP, 1 mg contains finasteride as the active ingredient. Finasteride is 4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5\u03b1, 17\u03b2)-. Its structural formula is: Finasteride is a white crystalline powder with a melting point near 250\u00b0 C. It is freely soluble in chloroform and in lower alcohol solvents but is practically insoluble in water.",
      "dosage": "The recommended dose of finasteride tablets USP is one tablet (1 mg) taken once daily. In general, d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 775,
    "fields": {
      "name": "FLUCONAZOLE",
      "brand": "Fluconazole",
      "description": "DESCRIPTION Fluconazole, the first of a new subclass of synthetic triazole antifungal agents, is available as tablets for oral administration. Fluconazole is designated chemically as 2,4-difluoro-\u03b1,\u03b1 1 -bis(1H-1,2,4-triazol-1-ylmethyl) benzyl alcohol with a molecular formula of C 13 H 12 F 2 N 6 O and molecular weight of 306.3. The structural formula is: Fluconazole USP is a white crystalline solid which is slightly soluble in water and saline.",
      "dosage": "DOSAGE AND ADMINISTRATION Dosage and Administration in Adults: Single Dose Vaginal candidiasis: The ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 776,
    "fields": {
      "name": "FLUOXETINE HYDROCHLORIDE",
      "brand": "Fluoxetine",
      "description": "11 DESCRIPTION Fluoxetine capsules, USP are a selective serotonin reuptake inhibitor for oral administration. It is also marketed for the treatment of premenstrual dysphoric disorder (Sarafem \u00ae , fluoxetine hydrochloride). In addition, 20 mg capsules also contains D&C Yellow #10 and 10 mg capsules also contains FD&C Yellow #6.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication Adult Pediatric MDD ( 2.1 ) 20 mg/day in am (initial dose) 10",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 777,
    "fields": {
      "name": "FLUTICASONE PROPIONATE",
      "brand": "FLOVENT DISKUS",
      "description": "11 DESCRIPTION FLOVENT DISKUS inhalation powder is a dry powder inhaler for oral inhalation. The active component of FLOVENT DISKUS 50 mcg, FLOVENT DISKUS 100 mcg, and FLOVENT DISKUS 250 mcg is fluticasone propionate, a corticosteroid having the chemical name S- (fluoromethyl) 6\u03b1,9-difluoro-11\u03b2,17-dihydroxy-16\u03b1-methyl-3-oxoandrosta-1,4-diene-17\u03b2-carbothioate, 17-propionate and the following chemical structure: Fluticasone propionate is a white powder with a molecular weight of 500.6, and the empirical formula is C 25 H 31 F 3 O 5 S. It is practically insoluble in water, freely soluble in dimethyl sulfoxide and dimethylformamide, and slightly soluble in methanol and 95% ethanol. Each blister on the strip contains a white powder mix of micronized fluticasone propionate (50, 100, or 250 mcg) in 12.5 mg of formulation containing lactose monohydrate (which contains milk proteins).",
      "dosage": "2.2 Recommended Dosage Adult and Adolescent Patients Aged 12 Years and Older The starting dosage is ",
      "stock": 80,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 778,
    "fields": {
      "name": "GABAPENTIN",
      "brand": "Gabapentin",
      "description": "11 DESCRIPTION The active ingredient in Gabapentin Capsules USP is gabapentin, which has the chemical name 1-(aminomethyl)cyclohexaneacetic acid. The molecular formula of gabapentin is C 9 H 17 NO 2 and the molecular weight is 171.24. The structural formula of gabapentin is: Gabapentin is a white to off-white crystalline solid with a pK a1 of 3.7 and a pK a2 of 10.7.",
      "dosage": "2 DOSAGE AND ADMlNlSTRATION Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 779,
    "fields": {
      "name": "GEMFIBROZIL",
      "brand": "Gemfibrozil",
      "description": "DESCRIPTION Gemfibrozil, USP is a lipid regulating agent. It is available as tablets for oral administration. Each tablet contains 600 mg gemfibrozil.",
      "dosage": "DOSAGE AND ADMINISTRATION The recommended dose for adults is 1,200 mg administered in two divided do",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 780,
    "fields": {
      "name": "GLIMEPIRIDE",
      "brand": "Glimepiride",
      "description": "11 DESCRIPTION Glimepiride tablets USP, are an oral sulfonylurea that contains the active ingredient glimepiride USP. Chemically, glimepiride USP is identified as 1-[[p-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea (C 24 H 34 N 4 O 5 S) with a molecular weight of 490.62. Glimepiride USP is a white to almost white powder, soluble in dimethyl formamide, sparingly soluble in methylene chloride, practically insoluble in water.",
      "dosage": "The recommended starting dose of glimepiride tablets are 1 mg or 2 mg once daily. Patients at increa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 781,
    "fields": {
      "name": "GLIPIZIDE",
      "brand": "Glipizide",
      "description": "The Chemical Abstracts name of glipizide is 1-cyclohexyl-3-[[ p -[2-(5-methylpyrazine-carboxamido)ethyl]phenyl]sulfonyl]urea. The molecular formula is C 21 H 27 N 5 O 4 S; the molecular weight is 445.55; the structural formula is shown below: Glipizide is a whitish, odorless powder with a pKa of 5.9. Glipizide Tablets USP for oral use are available in 5 and 10 mg strengths.",
      "dosage": "In addition to the usual monitoring of urinary glucose, the patient\u2019s blood glucose must also be mon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 782,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 783,
    "fields": {
      "name": "HYDROXYCHLOROQUINE SULFATE",
      "brand": "Hydroxychloroquine Sulfate",
      "description": "DESCRIPTION Hydroxychloroquine sulfate is a white or practically white, crystalline powder, freely soluble in water; practically insoluble in alcohol, chloroform, and in ether. The chemical name for hydroxychloroquine sulfate is 2-[[4-[(7-Chloro-4-quinolyl) amino]pentyl] ethylamino]ethanol sulfate (1:1). Its structural formula is: The molecular weight of hydroxychloroquine sulfate is 433.95, and molecular formula is C 18 H 26 ClN 3 O.H 2 SO 4 .",
      "dosage": "Treatment of Uncomplicated Malaria Adults: 800 mg (620 mg base) followed by 400 mg (310 mg base) at ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 784,
    "fields": {
      "name": "IBUPROFEN",
      "brand": "Ibuprofen Dye Free",
      "description": "",
      "dosage": "Directions do not take more than directed the smallest effective dose should be used adults and chil",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 785,
    "fields": {
      "name": "INSULIN ASPART",
      "brand": "NOVOLOG",
      "description": "11 DESCRIPTION Insulin aspart is a rapid-acting human insulin analog homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Saccharomyces cerevisiae (baker's yeast). Insulin aspart has the empirical formula C 256 H 381 N 65 0 79 S 6 and a molecular weight of 5825.8 Da. NOVOLOG has a pH of 7.2-7.6.",
      "dosage": "\u2022 Continuous Subcutaneous Infusion (Insulin Pump) ( 2.2 ): o Refer to the insulin infusion pump user",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 786,
    "fields": {
      "name": "INSULIN DETEMIR",
      "brand": "LEVEMIR",
      "description": "Insulin detemir has a molecular formula of C 267 H 402 O 76 N 64 S 6 and a molecular weight of 5.917 kDa. Hydrochloric acid and/or sodium hydroxide may be added to adjust pH. Levemir Chemical Structure.jpg",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 787,
    "fields": {
      "name": "INSULIN GLARGINE",
      "brand": "BASAGLAR Tempo Pen",
      "description": "Insulin glargine has the following structural formula: BASAGLAR (insulin glargine) injection is a sterile clear and colorless aqueous solution for subcutaneous use. The 3 mL BASAGLAR prefilled pen presentations contain the following inactive ingredients per mL: glycerin (17 mg), metacresol (2.7 mg), zinc oxide (content adjusted to provide 30 mcg zinc ion), and Water for Injection, USP. BASAGLAR has a pH of approximately 4.",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 788,
    "fields": {
      "name": "INSULIN LISPRO",
      "brand": "ADMELOG",
      "description": "11 DESCRIPTION Insulin lispro is a rapid-acting human insulin analog produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli . Insulin lispro has a pH of 7.0 to 7.8. The pH is adjusted by addition of aqueous solutions of hydrochloric acid and/or sodium hydroxide.",
      "dosage": "Use in accordance with the insulin pump instructions for use. Administer ADMELOG by continuous subcu",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 789,
    "fields": {
      "name": "ISOSORBIDE MONONITRATE",
      "brand": "ISOSORBIDE MONONITRATE",
      "description": "Each tablet, for oral administration, contains either 30 mg, 60 mg or 120 mg of isosorbide mononitrate in an extended-release formulation. In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, diethyl phthalate, hydrogenated castor oil, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc and titanium dioxide. The chemical name for ISMN is 1,4:3,6-dianhydro-,D-glucitol 5-nitrate; the compound has the following structural formula: ISMN is a white, crystalline, odorless compound which is stable in air and in solution, has a melting point of about 90\u00b0C, and an optical rotation of +144\u00b0 (2% in water, 20\u00b0C).",
      "dosage": "After several days, the dosage may be increased to 120 mg (given as a single 120 mg tablet or as two",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 790,
    "fields": {
      "name": "LAMOTRIGINE",
      "brand": "Lamotrigine",
      "description": "11 DESCRIPTION Lamotrigine, USP an AED of the phenyltriazine class, is chemically unrelated to existing AEDs. Lamotrigine\u2019s chemical name is 3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine, its molecular formula is C 9 H 7 N 5 Cl 2 , and its molecular weight is 256.09. Lamotrigine orally disintegrating tablets are formulated using in-house technologies designed to mask the bitter taste of lamotrigine and achieve a rapid dissolution profile.",
      "dosage": "Adjustments to the Maintenance Dose of Lamotrigine in Women Taking Estrogen-Containing Oral Contrace",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 791,
    "fields": {
      "name": "LANSOPRAZOLE",
      "brand": "Lansoprazole",
      "description": "Lansoprazole has the following structure: Lansoprazole is a white to brownish-white odorless crystalline powder which melts with decomposition at approximately 166\u00b0C. The degradation half-life of the drug substance in aqueous solution at 25\u00b0C is approximately 0.5 hour at pH 5.0 and approximately 18 hours at pH 7.0. Lansoprazole Delayed-Release Capsules, USP are supplied in delayed-release capsules for oral administration.The delayed-release capsules are available in two dosage strengths: 15 mg and 30 mg of lansoprazole per capsule.",
      "dosage": "For patients who have difficulty swallowing capsules, Lansoprazole delayed-release capsules can be o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 792,
    "fields": {
      "name": "LEVETIRACETAM",
      "brand": "Levetiracetam Extended-release",
      "description": "11 DESCRIPTION Levetiracetam Extended-release Tablets USP is an antiepileptic drug available as 500 mg and 750 mg (white) extended-release tablets for oral administration. It has the following structural formula: Levetiracetam is a white to off-white crystalline powder with a faint odor and a bitter taste. It is freely soluble in chloroform (65.3 g/100 mL) and in methanol (53.6 g/100 mL), soluble in ethanol (16.5 g/100 mL), sparingly soluble in acetonitrile (5.7 g/100 mL) and practically insoluble in n-hexane.",
      "dosage": "2 DOSAGE & ADMINISTRATION Initiate treatment with a dose of 1,000 mg once daily; increase by 1,000 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 793,
    "fields": {
      "name": "LEVOTHYROXINE, LIOTHYRONINE",
      "brand": "NP Thyroid 120",
      "description": "NP Thyroid \u00ae (thyroid tablets, USP) for oral use is a natural preparation derived from porcine thyroid glands. They contain both tetraiodothyronine sodium (T 4 levothyroxine) and triiodothyronine sodium (T 3 liothyronine) providing 38 mcg levothyroxine (T 4 ) and 9 mcg liothyronine (T 3 ) per grain of thyroid. The inactive ingredients are calcium stearate, dextrose (agglomerated) and mineral oil.",
      "dosage": "DOSAGE AND ADMINISTRATION The dosage of thyroid hormones is determined by the indication and must in",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 794,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 795,
    "fields": {
      "name": "LORAZEPAM",
      "brand": "Lorazepam",
      "description": "DESCRIPTION Lorazepam USP, an antianxiety agent, has the chemical formula, 7-chloro-5-( o -chlorophenyl)-1,3\u2011-dihydro-3-hydroxy-2 H -1,4-benzodiazepin-2-one: It is a nearly white powder almost insoluble in water. Each lorazepam tablet, USP to be taken orally, contains 0.5 mg, 1 mg, or 2 mg of lorazepam, USP. The inactive ingredients present are anhydrous lactose, magnesium stearate, microcrystalline cellulose, and polacrilin potassium.",
      "dosage": "DOSAGE AND ADMINISTRATION Lorazepam tablets are administered orally. For insomnia due to anxiety or ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 796,
    "fields": {
      "name": "LOSARTAN POTASSIUM",
      "brand": "Losartan Potassium",
      "description": "11 DESCRIPTION Losartan potassium is an angiotensin II receptor blocker acting on the AT 1 receptor subtype. Its molecular formula is C 22 H 22 ClKN 6 O, and its structural formula is: Losartan potassium, USP is white to off-white powder with a molecular weight of 461.01. It is freely soluble in water; soluble in isopropyl alcohol; slightly soluble in acetonitrile.",
      "dosage": "Pediatric Hypertension The usual recommended starting dose is 0.7 mg per kg once daily (up to 50 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 797,
    "fields": {
      "name": "LOVASTATIN",
      "brand": "Lovastatin",
      "description": "This enzyme catalyzes the conversion of HMG-CoA to mevalonate, which is an early and rate limiting step in the biosynthesis of cholesterol. 404.55 C 24 H 36 O 5 M.W. Lovastatin Tablets USP, 40 mg also contain D&C Yellow #10 Aluminum Lake, FD&C Blue #1 Aluminum Lake, and FD&C Yellow #6 Aluminum Lake.",
      "dosage": "Patients requiring reductions in LDL-C of 20% or more to achieve their goal (see INDICATIONS AND USA",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 798,
    "fields": {
      "name": "LURASIDONE HYDROCHLORIDE",
      "brand": "Lurasidone Hydrochloride",
      "description": "11 DESCRIPTION Lurasidone hydrochloride is an atypical antipsychotic belonging to the chemical class of benzisothiazol derivatives. Its chemical name is (3a R ,4 S ,7 R ,7a S )-2-{(1 R ,2 R )-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-\u00adylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2 H -isoindole-1,3-dione hydrochloride. Its molecular formula is C 28 H 36 N 4 O 2 S\u00b7HCl and its molecular weight is 529.14.",
      "dosage": "Lurasidone hydrochloride tablets have been shown to be effective in a dose range of 40 mg per day to",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 799,
    "fields": {
      "name": "MELOXICAM",
      "brand": "Meloxicam",
      "description": "11 DESCRIPTION Meloxicam, is a nonsteroidal anti-inflammatory drug (NSAID). Its empirical formula is C 14 H 13 N 3 O 4 S 2 and it has the following structural formula: Meloxicam is a pastel yellow solid, practically insoluble in water, with higher solubility observed in strong acids and bases. Meloxicam tablets USP are available as tablets for oral administration containing 7.5 mg or 15 mg meloxicam.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest effective dosage for the shortest duration consistent wit",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 800,
    "fields": {
      "name": "MEMANTINE",
      "brand": "Memantine hydrochloride",
      "description": "11 DESCRIPTION Memantine hydrochloride, USP is an orally active NMDA receptor antagonist. The tablets also contain the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose and talc. In addition the following inactive ingredients are also present as components of the film coat: D&C Yellow #10, FD&C Blue #2, FD&C Yellow #6, macrogol, polyvinyl alcohol, talc, and titanium dioxide (5 mg tablets), and iron oxide black, iron oxide yellow, macrogol, polyvinyl alcohol, talc and titanium dioxide (10 mg tablets).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dose of memantine hydrochloride tablets is 5 mg",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 801,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 802,
    "fields": {
      "name": "METHADONE HYDROCHLORIDE",
      "brand": "Methadone Hydrochloride",
      "description": "DESCRIPTION Methadone Hydrochloride Oral Concentrate, USP, contains methadone, an opiate agonist, and is available as a cherry flavored liquid concentrate for oral administration. It is present in methadone hydrochloride oral concentrate as the racemic mixture. Other ingredients of Methadone Hydrochloride Oral Concentrate, USP (Dye-Free, Sugar-Free, Unflavored): citric acid anhydrous, purified water, and sodium benzoate.",
      "dosage": "Titration and Maintenance Treatment of Opioid Dependence Patients in maintenance treatment should be",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 803,
    "fields": {
      "name": "METHOCARBAMOL",
      "brand": "Methocarbamol",
      "description": "The chemical name of methocarbamol is 3-(2-meth-oxyphenoxy)-1,2-propanediol 1-carbamate and has the empirical formula C 11 H 15 NO 5 . Its molecular weight is 241.24. Methocarbamol tablets, USP are available as 500 mg and 750 mg tablets for oral administration.",
      "dosage": "Maintenance dosage: 2 tablets q.i.d. Methocarbamol tablets, USP: 750 mg \u2013 Adults: Initial dosage: 2 ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 804,
    "fields": {
      "name": "METHYLPHENIDATE HYDROCHLORIDE",
      "brand": "Methylphenidate Hydrochloride (LA)",
      "description": "Each Methylphenidate Hydrochloride Extended-Release Capsule contains pellets, with half the dose as immediate-release and half as delayed-release, thus providing an immediate release of methylphenidate and a second delayed release of methylphenidate. The active substance in Methylphenidate Hydrochloride Extended-Release Capsules is methyl \u03b1-phenyl-2-piperidineacetate hydrochloride. Its structural formula is as follows: M.W.",
      "dosage": "The drug and applesauce mixture should not be stored for future use. 2.3 Patients Currently Using Me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 805,
    "fields": {
      "name": "METOPROLOL TARTRATE",
      "brand": "Metoprolol Tartrate",
      "description": "11 DESCRIPTION Metoprolol tartrate tablets, USP contain metoprolol tartrate, a selective beta 1 -adrenoreceptor blocking agent. It is very soluble in water; freely soluble in methylene chloride, in chloroform, and in alcohol; slightly soluble in acetone; and insoluble in ether. Metoprolol tartrate tablets, USP are available as 25 mg, 50 mg and 100 mg tablets for oral administration containing 25 mg, 50 mg and 100 mg metoprolol tartrate, respectively.",
      "dosage": "The effective dosage range of metoprolol tartrate tablets is 100 mg to 450 mg per day. The effective",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 806,
    "fields": {
      "name": "METRONIDAZOLE",
      "brand": "Metronidazole",
      "description": "DESCRIPTION Metronidazole tablets, USP 250 mg or 500 mg is an oral formulation of the synthetic nitroimidazole antimicrobial, 2-methyl-5-nitro-1H-imidazole-1-ethanol, which has the following structural formula: Metronidazole tablets USP contain 250 mg or 500 mg of metronidazole. Inactive ingredients include powdered cellulose, hydroxypropyl cellulose, low substituted hydroxypropyl cellulose, hypromellose, polyethylene glycol, stearic acid, and titanium dioxide. Molecular Structure",
      "dosage": "There is some indication from controlled comparative studies that cure rates as determined by vagina",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 807,
    "fields": {
      "name": "MIRTAZAPINE",
      "brand": "Mirtazapine",
      "description": "Mirtazapine has a tetracyclic chemical structure and belongs to the piperazino-azepine group of compounds. It is designated 1,2,3,4,10,14b-hexahydro-2-methylpyrazino [2,1-a] pyrido [2,3-c][2] benzazepine and has the molecular formula of C 17 H 19 N 3 . The structural formula is the following and it is the racemic mixture: Mirtazapine is a white to creamy white crystalline powder which is practically insoluble in water.",
      "dosage": "If patients do not have an adequate response to the initial 15 mg dose, increase the dose up to a ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 808,
    "fields": {
      "name": "MONTELUKAST SODIUM",
      "brand": "Montelukast Sodium",
      "description": "DESCRIPTION Montelukast sodium, the active ingredient in montelukast sodium tablets, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT 1 receptor. Montelukast sodium is described chemically as [ R-(E) ]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl] cyclopropaneacetic acid, monosodium salt. Each 10-mg film-coated montelukast sodium tablet contains 10.4 mg montelukast sodium, which is equivalent to 10 mg of montelukast, and the following inactive ingredients: croscarmellose sodium, ferric oxide red, ferric oxide yellow, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose and titanium dioxide.",
      "dosage": "Patients with both asthma and allergic rhinitis should take only one dose daily in the evening (2.4)",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 809,
    "fields": {
      "name": "NAPROXEN",
      "brand": "Naproxen",
      "description": "11 DESCRIPTION Naproxen Tablets, USP and Naproxen Sodium Tablets, USP are nonsteroidal anti-inflammatory drugs available as follows: Naproxen Tablets, USP are available as follows for oral administration: 250 mg: circular, light orange colored, flat, uncoated tablets, engraved with \u2018G\u2019 and \u201832\u2019 on either side of a break line on one side and \u2018250\u2019 on the other side. The inactive ingredients are croscarmellose sodium, iron oxide red, iron oxide yellow, magnesium stearate, microcrystalline cellulose and povidone. Naproxen, USP and naproxen sodium, USP have the following structures, respectively: Naproxen Naproxen Sodium Naproxen, USP is a white to off-white crystalline powder.",
      "dosage": "Management of Pain, Primary Dysmenorrhea, and Acute Tendonitis and Bursitis Recommended starting dos",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 810,
    "fields": {
      "name": "NITROGLYCERIN",
      "brand": "NITROGLYCERIN",
      "description": "11 DESCRIPTION Nitroglycerin sublingual tablets are stabilized sublingual compressed tablets that contain 0.3 mg, 0.4 mg, or 0.6 mg nitroglycerin; as well as lactose monohydrate, NF; glyceryl monostearate, NF; pregelatinized starch, NF; calcium stearate, NF powder; and silicon dioxide, colloidal, NF. Nitroglycerin, an organic nitrate, is a vasodilating agent. The chemical name for nitroglycerin is 1, 2, 3 propanetriol trinitrate and the chemical structure is: Molecular weight: 227.09 Nitroglycerin Structural Formula",
      "dosage": "2 DOSAGE AND ADMINISTRATION Administer one tablet under the tongue or in the buccal pouch at the fir",
      "stock": 100,
      "route": "SUBLINGUAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 811,
    "fields": {
      "name": "NORTRIPTYLINE HYDROCHLORIDE",
      "brand": "Nortriptyline Hydrochloride",
      "description": "DESCRIPTION Nortriptyline Hydrochloride, USP is 1-propanamine, 3-(10,11-dihydro-5 H -dibenzo[ a,d ]cyclohepten-5-ylidene)- N -methyl, hydrochloride. The structural formula is as follows: C19H21N\u2219HCl MW = 299.84 Each capsule, for oral administration, contains nortriptyline hydrochloride equivalent to 10 mg, 25 mg, 50 mg, and 75 mg of nortriptyline hydrochloride USP. In addition, each capsule contains the following inactive ingredients: black iron oxide, colloidal silicon dioxide, D&C Yellow #10 (aluminum lake), D&C Yellow #10, FD&C Blue #1 (aluminum lake), FD&C Blue #2 (aluminum lake), FD&C Green #3 (10, 50 and 75 mg only), FD&C Red #40 (aluminum lake), gelatin, I.M.S. 74 OP, magnesium stearate, pregelatinized corn starch, shellac, sodium lauryl sulfate and titanium dioxide.",
      "dosage": "Usual Adult Dose 25 mg three or four times daily; dosage should begin at a low level and be increase",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 812,
    "fields": {
      "name": "OMEPRAZOLE",
      "brand": "Omeprazole",
      "description": "",
      "dosage": "Directions for adults 18 years of age and older this product is to be used once a day (every 24 hour",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 813,
    "fields": {
      "name": "ONDANSETRON HYDROCHLORIDE",
      "brand": "ondansetron hydrochloride",
      "description": "11 DESCRIPTION The active ingredient in ondansetron tablets is ondansetron hydrochloride as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT 3 receptor type. Chemically it is (\u00b1) 1, 2, 3, 9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, monohydrochloride, dihydrate. Each tablet also contains the inactive ingredients colloidal silicon dioxide, hypromellose 2910(5cP) (for the 4 mg and 16 mg tablets only) and hypromellose 2910 (6cP) (for the 8 mg and 24 mg tablets only), iron oxide red and iron oxide black (for the 24 mg tablet only), iron oxide yellow (for the 8 mg and 24 mg tablets only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium starch glycolate, and titanium dioxide.",
      "dosage": "2 DOSAGE AND ADMINISTRATION See full prescribing information for the recommended dosage in adults an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 814,
    "fields": {
      "name": "OXYCODONE HYDROCHLORIDE",
      "brand": "Oxycodone Hydrochloride",
      "description": "Each tablet for oral administration contains 15 mg, or 30 mg, of oxycodone hydrochloride USP. Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. The 15 mg and 30 mg tablets contain the equivalent of 13.5 mg and 27.0 mg, respectively, of oxycodone free base.",
      "dosage": "If a decision is made to discontinue the use of non-opioid analgesic, it may be necessary to titrate",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 815,
    "fields": {
      "name": "PANTOPRAZOLE SODIUM INJECTION",
      "brand": "PANTOPRAZOLE SODIUM",
      "description": "11 DESCRIPTION The active ingredient in pantoprazole sodium for injection (pantoprazole sodium), a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S, with a molecular weight of 405.4. The reconstituted solution of pantoprazole sodium for injection is in the pH range of 9.0 to 10.5.",
      "dosage": "( 2.3 , 2.4 ) 2.1 Recommended Dosage for GERD Associated with a History of EE Adult Patients The rec",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 816,
    "fields": {
      "name": "PAROXETINE HYDROCHLORIDE HEMIHYDRATE",
      "brand": "Paroxetine",
      "description": "11 DESCRIPTION Paroxetine tablets contain paroxetine hydrochloride, an SSRI. It is the hydrochloride salt of a phenylpiperidine compound identified chemically as (-)- trans -4 R -(4'-fluorophenyl)-3 S -[(3',4'- methylenedioxyphenoxy) methyl] piperidine hydrochloride hemihydrate and has the empirical formula of C 19 H 20 FNO 3 \u2022HCl\u20221/2H 2 O. The structural formula of paroxetine hydrochloride is: Paroxetine hydrochloride, USP is an odorless, off-white powder, having a melting point range of 120 o to 138 o C and a solubility of 5.4 mg/mL in water.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting and maximum daily dosage for MDD, OCD, PD, and PTSD",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 817,
    "fields": {
      "name": "PENICILLIN G BENZATHINE",
      "brand": "BICILLIN L-A",
      "description": "Description Bicillin L-A (penicillin G benzathine injectable suspension) is available for deep intramuscular injection. Its chemical structure is as follows: Bicillin L-A contains penicillin G benzathine in aqueous suspension with sodium citrate buffer and, as w/v, approximately 0.65% sodium citrate, 0.59% povidone, 0.54% carboxymethylcellulose sodium, 0.53% lecithin, 0.12% methylparaben, and 0.013% propylparaben. Bicillin L-A contains approximately 0.11 mEq of sodium per 600,000 units of penicillin G (approximately 2.59 mg of sodium per 600,000 units of penicillin G).",
      "dosage": "DOSAGE AND ADMINISTRATION Streptococcal (Group A) Upper Respiratory Infections (for example, pharyng",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 818,
    "fields": {
      "name": "PHENYTOIN SODIUM",
      "brand": "Phenytoin Sodium",
      "description": "11 DESCRIPTION Phenytoin Sodium Injection, USP is a sterile solution containing in each mL phenytoin sodium 50 mg, propylene glycol 0.4 mL and alcohol 0.1 mL in Water for Injection. pH 10.0-12.3; sodium hydroxide added, if needed, for pH adjustment. Phenytoin sodium is related to the barbiturates in chemical structure, but has a five-membered ring.",
      "dosage": "( 2.2 , 2.3 ) 2.1 General Dosing Information Because of the increased risk of adverse cardiovascular",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 819,
    "fields": {
      "name": "PIOGLITAZONE HYDROCHLORIDE",
      "brand": "PIOGLITAZONE HYDROCHLORIDE",
      "description": "11 DESCRIPTION Pioglitazone tablets are a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (PPAR) gamma that contains an oral antidiabetic medication: pioglitazone. Pioglitazone [(\u00b1)-5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2,4-] thiazolidinedione monohydrochloride contains one asymmetric carbon, and the compound is synthesized and used as the racemic mixture. The two enantiomers of pioglitazone interconvert in vivo .",
      "dosage": "(2.1) If there is inadequate glycemic control, the dose can be increased in 15 mg increments up to a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 820,
    "fields": {
      "name": "PREDNISONE",
      "brand": "PredniSONE",
      "description": "DESCRIPTION Prednisone is a glucocorticoid. Glucocorticoids are adrenocortical steroids, both naturally occurring and synthetic, which are readily absorbed from the gastrointestinal tract. Prednisone, USP is a white to partially white, crystalline powder.",
      "dosage": "Included in the situations which may make dosage adjustments necessary are changes in clinical statu",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 821,
    "fields": {
      "name": "PREGABALIN",
      "brand": "PREGABALIN",
      "description": "The molecular formula is C 8 H 17 NO 2 and the molecular weight is 159.23. Pregabalin capsules are administered orally and are supplied as imprinted hard-shell capsules containing 25, 50, 75, 100, 150, 200, 225, and 300 mg of pregabalin, along with pregelatinized starch and talc as inactive ingredients. In addition, the orange & red capsule shells contain red iron oxide.",
      "dosage": "( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) Dosing recommendations: INDICATION Dosing Regimen Maximum Dose DPN P",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 822,
    "fields": {
      "name": "PROMETHAZINE HYDROCHLORIDE",
      "brand": "PROMETHAZINE HYDROCHLORIDE",
      "description": "DESCRIPTION Each 12.5 mg promethazine hydrochloride tablet for oral administration contains 12.5 mg promethazine hydrochloride. In addition, 50 mg tablet contains FD&C Red #40 and 12.5 mg tablet contains FD&C Yellow #6. Promethazine hydrochloride is a racemic compound; the empirical formula is C 17 H 20 N 2 S\u2022HCl and its molecular weight is 320.88.",
      "dosage": "The average effective dose of promethazine hydrochloride tablets, USP for the active therapy of naus",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 823,
    "fields": {
      "name": "PROPRANOLOL HYDROCHLORIDE",
      "brand": "Propranolol Hydrochloride",
      "description": "Propranolol Hydrochloride Tablets, USP are available as tablets for oral administration containing either 10 mg, 20 mg, 40 mg, 60 mg, or 80 mg of propranolol hydrochloride, USP. 6 aluminum lake (10 mg and 80 mg), D&C Yellow no. 10 aluminum lake (10 mg, 40 mg, and 80 mg), FD&C Blue no.",
      "dosage": "Hypertension The usual initial dosage is 40 mg propranolol hydrochloride twice daily, whether used a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 824,
    "fields": {
      "name": "QUETIAPINE FUMARATE",
      "brand": "Quetiapine Fumarate",
      "description": "It is present in tablets as the fumarate salt. Quetiapine tablets, USP is supplied for oral administration as 25 mg (round peach), 50 mg (round, white), 100 mg (round yellow), 150 mg (round, off white to light yellow), 200 mg (round, white), 300 mg (capsule-shaped, white), and 400 mg (capsule-shaped, yellow) tablets. The 25 mg tablets contain red iron oxide and yellow iron oxide and the 100 mg, 150 mg and 400 mg tablets contain only yellow iron oxide.",
      "dosage": "Further adjustments can be made in increments of 25 to 50 mg twice a day, in intervals of not less t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 825,
    "fields": {
      "name": "RABEPRAZOLE SODIUM",
      "brand": "Rabeprazole sodium",
      "description": "11 DESCRIPTION The active ingredient in rabeprazole sodium delayed-release tablets is rabeprazole sodium hydrate, USP, which is a proton pump inhibitor. The stability of rabeprazole sodium hydrate, USP is a function of pH; it is rapidly degraded in acid media, and is more stable under alkaline conditions. The structural figure is: Rabeprazole sodium hydrate, USP is available for oral administration as delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium hydrate, USP.",
      "dosage": "The use of rabeprazole sodium delayed-release tablets is not recommended for use in pediatric patien",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 826,
    "fields": {
      "name": "RANITIDINE",
      "brand": "Ranitidine",
      "description": "",
      "dosage": "Directions adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 827,
    "fields": {
      "name": "RISPERIDONE",
      "brand": "RISPERIDONE",
      "description": "11 DESCRIPTION Risperidone tablets, USP contain risperidone USP, an atypical antipsychotic belonging to the chemical class of benzisoxazole derivatives. The structural formula is: Risperidone USP is a white to slightly beige powder. Tablets of 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg also contain talc and titanium dioxide.",
      "dosage": "Maintenance Therapy While it is unknown how long a patient with schizophrenia should remain on rispe",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 828,
    "fields": {
      "name": "ROSUVASTATIN CALCIUM",
      "brand": "Rosuvastatin Calcium",
      "description": "11 DESCRIPTION Rosuvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA)-reductase inhibitor. The chemical name for rosuvastatin calcium is bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt with the following structural formula: The empirical formula for rosuvastatin calcium is (C 22 H 27 FN 3 O 6 S) 2 Ca and the molecular weight is 1001.14. Rosuvastatin calcium is a white or almost white, hygroscopic powder that is slightly soluble in water, freely soluble in methylene chloride, practically insoluble in ethanol.",
      "dosage": "( 2.1 ) Pediatric Patients with HeFH : Recommended dosage range is 5 to 10 mg once daily for patient",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 829,
    "fields": {
      "name": "SERTRALINE HYDROCHLORIDE",
      "brand": "Sertraline Hydrochloride",
      "description": "DESCRIPTION Sertraline hydrochloride is a selective serotonin reuptake inhibitor (SSRI) for oral administration. It has a molecular weight of 342.7. Sertraline hydrochloride, USP has the following chemical name: (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride.",
      "dosage": "While a relationship between dose and effect has not been established for OCD, patients were dosed i",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 830,
    "fields": {
      "name": "SILDENAFIL CITRATE",
      "brand": "SILDENAFIL CITRATE",
      "description": "11 DESCRIPTION Sildenafil tablets, USP, an oral therapy for erectile dysfunction, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Sildenafil citrate, is designated chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1 H -pyrazolo[4,3- d ]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate and has the following structural formula: Sildenafil citrate, USP is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Sildenafil tablets USP are formulated as pale blue to blue film-coated tablets equivalent to 25 mg, 50 mg and 100 mg of sildenafil for oral administration.",
      "dosage": "However, sildenafil tablets may be taken anywhere from 30 minutes to 4 hours before sexual activity ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 831,
    "fields": {
      "name": "EZETIMIBE AND SIMVASTATIN",
      "brand": "Ezetimibe and Simvastatin",
      "description": "11 DESCRIPTION Ezetimibe and simvastatin tablets contain ezetimibe USP, a selective inhibitor of intestinal cholesterol and related phytosterol absorption, and simvastatin USP, an HMG-CoA reductase inhibitor. The chemical name of ezetimibe, USP is 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone. formula 1 formula 2",
      "dosage": "The maximum recommended dosage is ezetimibe and simvastatin tablets 10 mg/40 mg once daily. The ezet",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 832,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 833,
    "fields": {
      "name": "SPIRONOLACTONE",
      "brand": "Spironolactone",
      "description": "11 DESCRIPTION Spironolactone oral tablets contain 25 mg, 50 mg, or 100 mg of the aldosterone antagonist spironolactone, USP 17hydroxy-7\u03b1-mercapto-3-oxo-17\u03b1-pregn-4-ene-21-carboxylic acid \u03b3-lactone acetate, which has the following structural formula: Spironolactone, USP is practically insoluble in water, soluble in alcohol, and freely soluble in benzene and in chloroform. Inactive ingredients include calcium sulfate, corn starch, croscarmellose sodium, peppermint flavor, hypromellose, iron oxide, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, polyvinyl alcohol, povidone, talc, titanium dioxide, and triacetin. The 50 mg tablet also contains D&C yellow # 10 and FD&C yellow #6.",
      "dosage": "2.2 Treatment of Heart Failure In patients with serum potassium \u2264 5.0 mEq/L and eGFR > 50 mL/min/1.7",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 834,
    "fields": {
      "name": "TAMSULOSIN HYDROCHLORIDE",
      "brand": "Tamsulosin Hydrochloride",
      "description": "11 DESCRIPTION Tamsulosin hydrochloride is an antagonist of alpha 1A adrenoceptors in the prostate. It is sparingly soluble in water and methanol, slightly soluble in glacial acetic acid and ethanol, and practically insoluble in ether. The molecular formula of tamsulosin hydrochloride is C 20 H 28 N 2 O 5 S \u2022 HCl.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as th",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 835,
    "fields": {
      "name": "TEMAZEPAM",
      "brand": "Temazepam",
      "description": "DESCRIPTION Temazepam, USP is a benzodiazepine hypnotic agent. The chemical name is 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, and the structural formula is: C 16 H 13 ClN 2 O 2 MW = 300.74 Temazepam, USP is a white, crystalline substance, very slightly soluble in water and sparingly soluble in alcohol USP. Temazepam capsules USP, 7.5 mg, 15 mg, 22.5 mg, and 30 mg, are for oral administration.",
      "dosage": "DOSAGE AND ADMINISTRATION While the recommended usual adult dose is 15 mg before retiring, 7.5 mg ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 836,
    "fields": {
      "name": "TERAZOSIN HYDROCHLORIDE",
      "brand": "Terazosin",
      "description": "DESCRIPTION Terazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name,molecular formula and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride.C 19 H 26 ClN 5 O 4 Terazosin hydrochloride is a white, crystalline substance, freely soluble in water and isotonic saline and has a molecular weight of 423.93. Each capsule, for oral administration, contains 1 mg, 2 mg, 5 mg or 10 mg of terazosin as terazosin hydrochlolde. In addition, each capsule contains the following inactive ingredients: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, and pregelatinized starch.",
      "dosage": "DOSAGE AND ADMINISTRATION If terazosin capsules administration is discontinued for several days, the",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 837,
    "fields": {
      "name": "TIZANIDINE",
      "brand": "tizanidine",
      "description": "11 DESCRIPTION Tizanidine Tablets, USP contains tizanidine hydrochloride as the active ingredient, which is a central alpha 2 -adrenergic agonist. Its chemical name is 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiodiazole monohydrochloride. It has a molecular formula of C 9 H 8 CIN 5 S\u00b7HCl and a molecular weight of 290.17.",
      "dosage": "( 2.1 ) Recommended starting dose: 2 mg by mouth every 6 to 8 hours, as needed, up to a maximum of 3",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 838,
    "fields": {
      "name": "TOPIRAMATE",
      "brand": "topiramate",
      "description": "11 DESCRIPTION Topiramate, USP is a sulfamate-substituted monosaccharide. Topiramate tablets, USP are available as 25 mg, 50 mg, 100 mg, and 200 mg round shaped tablets for oral administration. Its saturated solution has a pH of 6.3.",
      "dosage": "Table 2: Monotherapy Target Total Daily Maintenance Dosing for Patients 2 to 9 Years of Age Weight (",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 839,
    "fields": {
      "name": "TRAMADOL HYDROCHLORIDE",
      "brand": "TRAMADOL HYDROCHLORIDE",
      "description": "The chemical name is (\u00b1) cis -2-[(dimethylamino) methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochloride. It is a white, crystalline powder that is freely soluble in water and methanol, very slightly soluble in acetone and has a pKa of 9.41. Tramadol hydrochloride extended-release tablets, USP contain 100 mg, 200 mg or 300 mg of tramadol hydrochloride, USP in an extended-release formulation.",
      "dosage": "2.5 Safe Reduction or Discontinuation of Tramadol Hydrochloride Extended-Release Tablets Do not abru",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 840,
    "fields": {
      "name": "TRAZODONE HYDROCHLORIDE",
      "brand": "Trazodone Hydrochloride",
      "description": "11 DESCRIPTION Trazodone hydrochloride is a selective serotonin reuptake inhibitor and 5HT2 receptor antagonist. Trazodone hydrochloride, USP is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]- 1,2,4-triazolo[4, 3-a]pyridin-3(2H)-one hydrochloride. It is a white to off-white, crystalline powder which is sparingly soluble in chloroform and in water.",
      "dosage": "The dosage should be initiated at a low-dose and increased gradually, noting the clinical response a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 841,
    "fields": {
      "name": "SACUBITRIL AND VALSARTAN",
      "brand": "ENTRESTO",
      "description": "Its molecular mass is 957.99 g/mol and its schematic structural formula is: ENTRESTO is available as film-coated tablets for oral administration, containing 24 mg of sacubitril and 26 mg of valsartan; 49 mg of sacubitril and 51 mg of valsartan; and 97 mg of sacubitril and 103 mg of valsartan. The film-coat inactive ingredients are hypromellose, iron oxide red (E172), polyethylene glycol 4000, talc, and titanium dioxide (E171). The film-coat for the 49 mg of sacubitril and 51 mg of valsartan tablet contains iron oxide yellow (E172).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dosage for adults is 49 mg/51 mg orally twice d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 842,
    "fields": {
      "name": "VENLAFAXINE",
      "brand": "Venlafaxine",
      "description": "DESCRIPTION Venlafaxine hydrochloride is a structurally novel antidepressant for oral administration. Each venlafaxine tablet, USP intended for oral administration contains venlafaxine hydrochloride equivalent to 25 mg or 37.5 mg or 50 mg or 75 mg or 100 mg of venlafaxine. Structured formula for venlafaxine",
      "dosage": "When treating pregnant women with venlafaxine tablets during the third trimester, the physician shou",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 843,
    "fields": {
      "name": "VERAPAMIL HYDROCHLORIDE",
      "brand": "Verapamil Hydrochloride",
      "description": "DESCRIPTION Verapamil hydrochloride is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets containing 40 mg, 80 mg, or 120 mg of verapamil hydrochloride. The structural formula of verapamil hydrochloride is: Benzeneacetonitrile, \u03b1-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-\u03b1-(1-methylethyl) hydrochloride. Verapamil hydrochloride is an almost white, crystalline powder, practically free of odor, with a bitter taste.",
      "dosage": "Angina: Clinical trials show that the usual dose is 80 mg to 120 mg three times a day. However, 40 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 844,
    "fields": {
      "name": "WARFARIN SODIUM",
      "brand": "Warfarin Sodium",
      "description": "11 DESCRIPTION Warfarin sodium tablets, USP contain warfarin sodium, an anticoagulant that acts by inhibiting vitamin K-dependent coagulation factors. 40 aluminum lake, and D&C yellow no. 10 aluminum lake and FD&C yellow no.",
      "dosage": "The duration of treatment is based on the indication as follows: For patients with a DVT or PE secon",
      "stock": 90,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 845,
    "fields": {
      "name": "ZALEPLON",
      "brand": "zaleplon",
      "description": "Its molecular formula is C 17 H 15 N 5 O, and its molecular weight is 305.34. Zaleplon capsules USP contain zaleplon as the active ingredient. The 5 mg capsules also contain FD&C yellow #5.",
      "dosage": "Although the risk of certain adverse events associated with the use of zaleplon capsules appears to ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 846,
    "fields": {
      "name": "ZOLPIDEM TARTRATE",
      "brand": "Zolpidem",
      "description": "11 DESCRIPTION Zolpidem Tartrate Tablets, USP contains Zolpidem tartrate, a gamma-aminobutyric acid (GABA) A receptor positive modulator of the imidazopyridine class. It has the following structure: Zolpidem Tartrate is a white to off-white crystalline powder that is sparingly soluble in water, alcohol, and propylene glycol. Opadry II (pink) contains hypromellose, FD&C Red no.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest dose effective for the patient and must not exceed a tota",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 847,
    "fields": {
      "name": "ZOLMITRIPTAN",
      "brand": "Zolmitriptan",
      "description": "11 DESCRIPTION ZOLMITRIPTAN NASAL SPRAY contains zolmitriptan, which is a selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist. Zolmitriptan is chemically designated as (S)-4-[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone and has the following chemical structure: The empirical formula is C 16 H 21 N 3 O 2 , representing a molecular weight of 287.36. The osmolarity of ZOLMITRIPTAN NASAL SPRAY for 2.5 mg is 360 to 420 mOsmol, and for 5 mg is 420 to 470 mOsmol.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting dose: 2.5 mg (2.1) Maximum single dose: 5 mg (2.1) ",
      "stock": 100,
      "route": "NASAL",
      "resupply_pending": 0,
      "pharmacy_id": 3,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 848,
    "fields": {
      "name": "ACETAMINOPHEN",
      "brand": "Pain Reliever Extra Strength",
      "description": "",
      "dosage": "Directions do not take more than directed adults and children 12 years and over take 2 gelcaps every",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 849,
    "fields": {
      "name": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN",
      "brand": "Hydrocodone Bitartrate and Acetaminophen",
      "description": "DESCRIPTION Hydrocodone bitartrate and acetaminophen, USP is available in tablet form for oral administration. It is affected by light. It has the following structural formula: Acetaminophen, 4' -hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "Initial Dosage Initiating Treatment with Hydrocodone Bitartrate and Acetaminophen Tablets 2.5 mg/325",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 850,
    "fields": {
      "name": "ALBUTEROL SULFATE",
      "brand": "Albuterol Sulfate HFA",
      "description": "Albuterol sulfate has the chemical name \u03b1 1 -[( tert -butylamino)methyl]-4-hydroxy- m -xylene-\u03b1, \u03b1\u2032-diol sulfate (2:1)(salt) and the following chemical structure: Albuterol sulfate is a white crystalline powder with a molecular weight of 576.7, and the empirical formula is (C 13 H 21 NO 3 ) 2 \u2022H 2 SO 4 . Each canister contains a microcrystalline suspension of albuterol sulfate in propellant HFA\u2011134a (1,1,1,2\u2011tetrafluoroethane). Prime Albuterol Sulfate HFA before using for the first time, when the inhaler has not been used for more than 2 weeks, or when the inhaler has been dropped.",
      "dosage": "2 DOSAGE AND ADMINISTRATION For oral inhalation only. ( 2 ) Treatment or prevention of bronchospasm ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 851,
    "fields": {
      "name": "ALENDRONATE SODIUM",
      "brand": "Binosto",
      "description": "11 DESCRIPTION BINOSTO (alendronate sodium) is a bisphosphonate that acts as a specific inhibitor of osteoclast-mediated bone resorption. Alendronate sodium is chemically described as (4 amino-1-hydroxybutylidene) bisphosphonic acid, monosodium salt, trihydrate. Once the effervescent tablet is dissolved in water, the alendronate sodium is present in a citrate-buffered solution of pH 4.8 to 5.4.",
      "dosage": "Take BINOSTO upon arising for the day and at least 30 minutes before the first food, beverage, or me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 852,
    "fields": {
      "name": "ALLOPURINOL",
      "brand": "Allopurinol",
      "description": "11 DESCRIPTION Allopurinol, USP is a xanthine oxidase inhibitor. It has the following structural formula: Allopurinol, USP is known chemically as 1, 5-dihydro-4 H -pyrazolo [3, 4- d ]pyrimidin-4-one and it has a molecular weight of 136.1 g/mol. Each scored white round-shaped tablet contains 100 mg allopurinol and the inactive ingredients colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate.",
      "dosage": "2.3 Recommended Dosage for Gout The initial recommended dosage for the management of gout is 100 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 853,
    "fields": {
      "name": "ALPRAZOLAM",
      "brand": "Alprazolam",
      "description": "11 DESCRIPTION Alprazolam tablets, USP contain alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds. The chemical name of alprazolam is 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-\u03b1] [1,4] benzodiazepine. In addition, the 0.5 mg tablet contains FD&C Yellow # 6 aluminum lake and the 1 mg tablet contains FD&C Blue No.",
      "dosage": "Dosage may be increased, at intervals of every 3 to 4 days, to a maximum recommended daily dose of 4",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 854,
    "fields": {
      "name": "AMOXICILLIN",
      "brand": "Amoxicillin",
      "description": "Amoxicillin Tablets, USP: Each film coated tablet contains 500 mg or 875 mg amoxicillin as the trihydrate. Amoxicillin for Oral Suspension, USP: Each 5 mL of reconstituted suspension contains 125 mg, 200 mg, 250 mg or 400 mg amoxicillin as the trihydrate. Each 5 mL of the 125 mg, 200 mg, 250 mg, and 400 mg reconstituted suspension contains 0.30 mEq (6.95 mg) of sodium.",
      "dosage": "Dosing Recommendations for Adult and Pediatric Patients > 3 Months of Age Infection Severity Dosing ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 855,
    "fields": {
      "name": "AMLODIPINE BESYLATE",
      "brand": "Amlodipine Besylate",
      "description": "11 DESCRIPTION Amlodipine besylate is the besylate salt of amlodipine, a long-acting calcium channel blocker. Amlodipine besylate is chemically described as 3-Ethyl-5-methyl (\u00b1)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, monobenzenesulphonate. Amlodipine besylate tablets USP are formulated as tablets equivalent to 2.5 mg, 5 mg and 10 mg of amlodipine for oral administration.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022Adult recommended starting dose: 5 mg once daily with maximum dose 10 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 856,
    "fields": {
      "name": "ARIPIPRAZOLE",
      "brand": "Aripiprazole",
      "description": "11 DESCRIPTION Aripiprazole is an atypical antipsychotic drug that is available as Aripiprazole Tablets, USP. Aripiprazole is 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril. The empirical formula is C 23 H 27 Cl 2 N 3 O 2 and its molecular weight is 448.38.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Initial Dose Recommended Dose Maximum Dose Schizophrenia \u2013 adults (2.1) ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 857,
    "fields": {
      "name": "ATENOLOL",
      "brand": "Atenolol",
      "description": "DESCRIPTION Atenolol, a synthetic, beta 1 -selective (cardioselective) adrenoreceptor blocking agent, may be chemically described as benzeneacetamide, 4-[2\u2019-hydroxy-3\u2019-[(1-methylethyl)amino]propoxy]-. It is a relatively polar hydrophilic compound with a water solubility of 26.5 mg/mL at 37\u00b0C and a log partition coefficient (octanol/water) of 0.23. Atenolol is available as 25, 50 or 100 mg tablets for oral administration.",
      "dosage": "If an optimal response is not achieved, the dosage should be increased to atenolol 100 mg given as o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 858,
    "fields": {
      "name": "ATORVASTATIN CALCIUM",
      "brand": "Atorvastatin calcium",
      "description": "11 DESCRIPTION Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Atorvastatin calcium USP is (\u03b2R, \u03b4R)-2-(p-fluorophenyl)-\u03b2,\u03b4-dihydroxy-5-isopropyl-3-phenyl-4(phenylcarbamoyl)pyrrole-l-heptanaote (1:2), trihydrate. The molecular formula of atorvastatin calcium USP is C 66 H 68 CaF 2 N 4 O 10 .3H 2 O and its molecular weight is 1209.41.",
      "dosage": "2.1 Important Dosage Information Take atorvastatin calcium tablets orally once daily at any time of ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 859,
    "fields": {
      "name": "AZITHROMYCIN",
      "brand": "Azithromycin",
      "description": "11 DESCRIPTION Azithromycin tablets USP contain the active ingredient azithromycin, a macrolide antibacterial drug, for oral administration. Azithromycin has the chemical name (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-\u03b1-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-\u03b2-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Azithromycin is derived from erythromycin; however, it differs chemically from erythromycin in that a methyl-substituted nitrogen atom is incorporated into the lactone ring.",
      "dosage": "Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 500 mg as a single dose on Da",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 860,
    "fields": {
      "name": "BACLOFEN INJECTION",
      "brand": "Gablofen",
      "description": "11 DESCRIPTION GABLOFEN (baclofen injection) is a muscle relaxant and antispastic. Baclofen's pharmacological class is a gamma-aminobutyric acid (GABA) ergic agonist. Baclofen's chemical name is 4-amino-3-(4-chlorophenyl) butanoic acid, and its structural formula is: Baclofen C 10 H 12 ClNO 2 Baclofen is a white to off-white powder, with a molecular weight of 213.66.",
      "dosage": "2.2 Screening Phase Prior to pump implantation and initiation of chronic infusion of GABLOFEN, patie",
      "stock": 100,
      "route": "INTRATHECAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 861,
    "fields": {
      "name": "BENAZEPRIL HYDROCHLORIDE",
      "brand": "Benazepril Hydrochloride",
      "description": "Its chemical name is benazepril 3-[[1-(ethoxy-carbonyl)-3-phenyl-(1S)-propyl]amino]-2,3,4,5-tetrahydro-2-oxo-1 H -1-(3S)-benzazepine-1-acetic acid monohydrochloride; its structural formula is Its empirical formula is C 24 H 28 N 2 O 5 \u2022HCl and its molecular weight is 460.96. Benazepril hydrochloride is supplied as film-coated tablets containing 5 mg, 10 mg, 20 mg, and 40 mg of benazepril hydrochloride for oral administration. Benazepril hydrochloride tablets USP, 5 mg, 10 mg, 20 mg and 40 mg meet USP Dissolution Test 2.",
      "dosage": "\u2022 Renal Impairment: Initiate with 5 mg once daily in patients with GFR <30 mL/min/1.73 m 2 (serum cr",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 862,
    "fields": {
      "name": "BISOPROLOL FUMARATE",
      "brand": "Bisoprolol fumarate",
      "description": "It possesses an asymmetric carbon atom in its structure and is provided as a racemic mixture. Bisoprolol fumarate tablets are available as 5 and 10 mg tablets for oral administration. The 5 mg tablets also contain Red Iron Oxide.",
      "dosage": "DOSAGE AND ADMINISTRATION The dose of bisoprolol fumarate tablets must be individualized to the need",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 863,
    "fields": {
      "name": "BUPROPION HYDROCHLORIDE",
      "brand": "Bupropion Hydrochloride XL",
      "description": "11 DESCRIPTION Bupropion Hydrochloride USP, an antidepressant of the aminoketone class, is chemically unrelated to tricyclic, tetracyclic, selective serotonin reuptake inhibitor, or other known antidepressant agents. Its structure closely resembles that of diethylpropion; it is related to phenylethylamines. The structural formula is: Bupropion Hydrochloride Extended-Release Tablets USP (XL) are supplied for oral administration as 150 mg and 300 mg white to pale yellow extended-release tablets.",
      "dosage": "2.2 Dosage for Major Depressive Disorder (MDD) The recommended starting dose for MDD is 150 mg once ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 864,
    "fields": {
      "name": "BUSPIRONE HYDROCHLORIDE",
      "brand": "Buspirone Hydrochloride",
      "description": "421.96 Each tablet, for oral administration, contains 5 mg, 7.5 mg, 10 mg, 15 mg or 30 mg of buspirone hydrochloride, USP (equivalent to 4.6 mg, 6.9 mg, 9.1 mg, 13.7 mg and 27.4 mg of buspirone free base, respectively). Thus, a single 15 mg tablet can provide the following doses: 15 mg (entire tablet), 10 mg (two-thirds of a tablet), 7.5 mg (one-half of a tablet), or 5 mg (one-third of a tablet). A single 30 mg tablet can provide the following doses: 30 mg (entire tablet), 20 mg (two-thirds of a tablet), 15 mg (one-half of a tablet), or 10 mg (one-third of a tablet).",
      "dosage": "To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 865,
    "fields": {
      "name": "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE",
      "brand": "Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",
      "description": "11 DESCRIPTION Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are supplied in capsule form for oral administration. Each capsule contains: Butalbital, USP 50 mg Acetaminophen, USP 325 mg Caffeine, USP 40 mg Codeine phosphate, USP 30 mg Butalbital (5-allyl-5-isobutylbarbituric acid), is a short-to intermediate-acting barbiturate. It has the following structural formula: C 11 H 16 N 2 O 3 MW 224.26 Acetaminophen (4'hydroxyacetanilide), is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "2.2 Patient Access to Naloxone for the Emergency Treatment of Opioid Overdose Discuss the availabili",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 866,
    "fields": {
      "name": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "brand": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "description": "DESCRIPTION Captopril and hydrochlorothiazide tablets, USP for oral administration combines two antihypertensive agents: captopril and hydrochlorothiazide. Captopril, USP is a white to off-white crystalline powder with characteristic sulfide-like odor; it is freely soluble in water, ethanol, methanol, chloroform, isopropyl alcohol and methylene chloride and soluble in ethyl acetate. Freely soluble in N,N-Dimethylformamide, in n-Butylamine and in diluted solutions of alkali hydroxides.",
      "dosage": "For patients insufficiently responsive to the initial dose, additional captopril or hydrochlorothiaz",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 867,
    "fields": {
      "name": "CARVEDILOL",
      "brand": "Carvedilol",
      "description": "11 DESCRIPTION Carvedilol is a nonselective \u03b2-adrenergic blocking agent with \u03b1 1 -blocking activity. It is (\u00b1)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol. Carvedilol is a racemic mixture with the following structure: Carvedilol, USP is a white to almost white crystalline powder with a molecular weight of 406.5 and a molecular formula of C 24 H 26 N 2 O 4 .",
      "dosage": "Fluid retention (with or without transient worsening heart failure symptoms) should be treated by an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 868,
    "fields": {
      "name": "CEFDINIR",
      "brand": "Cefdinir",
      "description": "DESCRIPTION Cefdinir capsules, USP contain the active ingredient cefdinir, an extended-spectrum, semisynthetic cephalosporin, for oral administration. Chemically, cefdinir is [6R-[6\u03b1,7\u03b2 (Z)]]-7-[[(2-amino-4 thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid. Cefdinir is a white to slightly brownish-yellow solid.",
      "dosage": "DOSAGE & ADMINISTRATION (see INDICATIONS AND USAGE for Indicated Pathogens) The recommended dosage a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 869,
    "fields": {
      "name": "CEFUROXIME AXETIL",
      "brand": "Cefuroxime axetil",
      "description": "Cefuroxime axetil is a semisynthetic, cephalosporin antibacterial drug for oral administration. The chemical name of cefuroxime axetil (1-(acetyloxy) ethyl ester of cefuroxime) is ( RS )-1 hydroxyethyl (6 R ,7 R )-7-[2-(2-furyl)glyoxyl-amido]-3-(hydroxymethyl)-8-oxo-5-thia-1 azabicyclo[4.2.0]-oct-2-ene-2-carboxylate, 72-( Z )-( O -methyl-oxime), 1-acetate 3-carbamate. Cefuroxime axetil is in the amorphous form and has the following structural formula: Cefuroxime axetil tablets, USP are film-coated and contain the equivalent of 250 or 500 mg of cefuroxime as cefuroxime axetil.",
      "dosage": "Pediatric patients (aged 13 years and older) who cannot swallow the cefuroxime axetil tablets whole ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 870,
    "fields": {
      "name": "CELECOXIB",
      "brand": "CELECOXIB",
      "description": "DESCRIPTION Celecoxib capsule is a nonsteroidal anti-inflammatory drug, available as capsules containing 50 mg, 100 mg, 200 mg and 400 mg celecoxib for oral administration. Its molecular formula is C 17 H 14 F 3 N 3 O 2 S, and it has the following chemical structure: Celecoxib USP is a white or almost white crystalline powder with a pKa of 11.1 (sulfonamide moiety). Celecoxib USP is hydrophobic (log P is 3.5) and is soluble in ethanol and in methylene chloride, practically insoluble in water.",
      "dosage": "For patients >25 kg the recommended dose is 100 mg twice daily. For patients who have difficulty swa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 871,
    "fields": {
      "name": "CETIRIZINE HYDROCHLORIDE TABLETS",
      "brand": "cetirizine hydrochloride",
      "description": "",
      "dosage": "Directions adults and children 6 years and over one 10 mg tablet once daily; do not take more than o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 872,
    "fields": {
      "name": "CIPROFLOXACIN",
      "brand": "ciprofloxacin",
      "description": "DESCRIPTION Ciprofloxacin ophthalmic solution is a synthetic, sterile, multiple dose, antimicrobial for topical ophthalmic use. Ciprofloxacin is a fluoroquinolone antibacterial active against a broad spectrum of gram-positive and gram-negative ocular pathogens. It is available as the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid.",
      "dosage": "DOSAGE AND ADMINISTRATION Corneal Ulcers: The recommended dosage regimen for the treatment of cornea",
      "stock": 100,
      "route": "OPHTHALMIC",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 873,
    "fields": {
      "name": "CITALOPRAM",
      "brand": "Citalopram",
      "description": "11 DESCRIPTION Citalopram tablets, USP contain citalopram, a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide is a racemic bicyclic phthalane structure and is designated (\u00b1)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3\u00addihydroisobenzofuran-5-carbonitrile hydrobromide with the following structural formula: The molecular formula is C 20 H 22 BrFN 2 O and its molecular weight is 405.35. Citalopram hydrobromide, USP occurs as a fine, white to off-white powder.",
      "dosage": "2.1 Recommended Dosage Administer citalopram tablets once daily, with or without food, at an initial",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 874,
    "fields": {
      "name": "CLINDAMYCIN PHOSPHATE",
      "brand": "Clindamycin Phosphate",
      "description": "DESCRIPTION Clindamycin phosphate topical lotion, 1% contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. Clindamycin phosphate is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The lotion contains cetostearyl alcohol (2.5%); glycerin; glyceryl stearate SE (with potassium monostearate); isostearyl alcohol (2.5%); methylparaben (0.3%); sodium lauroyl sarcosinate; stearic acid; and purified water.",
      "dosage": "DOSAGE AND ADMINISTRATION Apply a thin film of clindamycin phosphate topical lotion twice daily to a",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 875,
    "fields": {
      "name": "CLONAZEPAM",
      "brand": "Clonazepam",
      "description": "DESCRIPTION Clonazepam Tablets, USP, a benzodiazepine, is available as scored tablet with debossing \u039b containing 0.5 mg of clonazepam and unscored tablets with debossing \u039b and \u039b containing 1 mg or 2 mg of clonazepam respectively. Each 66 67 69 tablet also contains lactose monohydrate, polyethylene glycol, microcrystalline cellulose, croscarmellose sodium and magnesium stearate with the following colourants: 0.5 mg-FD & C Yellow 6 Al Lake, D & C Yellow 10 Al Lake; 1 mg-FD & C Blue 1 Al lake and FD & C Blue 2 Al lake Chemically, clonazepam is 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder.",
      "dosage": "Geriatric Patients: There is no clinical trial experience with clonazepam tablets in seizure disorde",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 876,
    "fields": {
      "name": "CLOPIDOGREL BISULFATE",
      "brand": "Clopidogrel",
      "description": "11 DESCRIPTION Clopidogrel bisulfate is a thienopyridine class inhibitor of P2Y 12 ADP platelet receptors. Chemically it is methyl (+)-( S )-\u03b1-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4 H )-\u00adacetate sulfate (1:1). The structural formula is as follows: Clopidogrel bisulfate USP is a white to off-white powder.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Acute coronary syndrome ( 2.1 ) \u2013 Initiate clopidogrel tablets with a si",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 877,
    "fields": {
      "name": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "brand": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "description": "DESCRIPTION Cyclobenzaprine hydrochloride, USP is a tricyclic amine salt which is white to off white, odourless, crystalline powder with the molecular formula C 20 H 21 N \u2022 HCl and a molecular weight of 311.9. Cyclobenzaprine hydrochloride is designated chemically as 3-(5H -dibenzo[a,d] cyclohepten-5-ylidene)- N,N -dimethyl-1-propanamine hydrochloride, and has the following structural formula: Cyclobenzaprine hydrochloride tablets, USP are available as 5 mg, 7.5 mg and 10 mg tablets for oral administration. In addition, the 5 mg tablets contain FD&C Blue #2/INDIGO Carmine Aluminum Lake.",
      "dosage": "DOSAGE AND ADMINISTRATION For most patients, the recommended dose of cyclobenzaprine hydrochloride t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 878,
    "fields": {
      "name": "DAPAGLIFLOZIN",
      "brand": "FARXIGA",
      "description": "11 DESCRIPTION Dapagliflozin, an inhibitor of SGLT2, is described chemically as D-glucitol, 1,5-anhydro-1- C -[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1 S )-, compounded with (2 S )-1,2-propanediol, hydrate (1:1:1). The empirical formula is C 21 H 25 ClO 6 \u2022C 3 H 8 O 2 \u2022H 2 O and the molecular weight is 502.98. The structural formula is: FARXIGA is available as a film-coated tablet for oral administration containing the equivalent of 5 mg dapagliflozin as dapagliflozin propanediol or the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol, and the following inactive ingredients: microcrystalline cellulose, anhydrous lactose, crospovidone, silicon dioxide, and magnesium stearate.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022 Assess volume status and correct volume depletion before initiating. I",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 879,
    "fields": {
      "name": "DESVENLAFAXINE SUCCINATE",
      "brand": "Pristiq Extended-Release",
      "description": "11 DESCRIPTION PRISTIQ is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. Desvenlafaxine is designated RS -4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol and has the empirical formula of C 16 H 25 NO 2 (free base) and C 16 H 25 NO 2 \u2219C 4 H 6 O 4 \u2219H 2 O (succinate monohydrate). Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C yellow #6.",
      "dosage": "In clinical studies, doses of 50 mg to 400 mg per day were shown to be effective, although no additi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 880,
    "fields": {
      "name": "DIAZEPAM",
      "brand": "Diazepam",
      "description": "The molecular formula is C 16 H 13 ClN 2 O and the molecular weight is 284.7. The structural formula is as follows: Diazepam is available for oral administration as tablets containing 2 mg, 5 mg or 10 mg diazepam, USP. 10 Aluminum Lake and FD&C Blue No.",
      "dosage": "2 mg to 10 mg, 3 or 4 times daily Adjunctively in Convulsive Disorders. 2 mg to 2.5 mg, 1 or 2 times",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 881,
    "fields": {
      "name": "DICLOFENAC SODIUM",
      "brand": "Diclofenac Sodium",
      "description": "",
      "dosage": "Directions Use up to 21 days unless directed by your doctor Not for strains, sprains, bruises or spo",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 882,
    "fields": {
      "name": "DICYCLOMINE HYDROCHLORIDE",
      "brand": "Dicyclomine hydrochloride",
      "description": "11 DESCRIPTION Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent available as: Dicyclomine hydrochloride capsules, USP for oral use containing 10 mg dicyclomine hydrochloride, USP. Dicyclomine hydrochloride 10 mg capsules contain the following inactive ingredients: corn starch, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. Capsule shells contain FD&C Blue No.1, FD&C Red No.40, gelatin, purified water, and sodium lauryl sulfate.",
      "dosage": "Dosage for dicyclomine hydrochloride capsules must be adjusted to individual patient needs (2) . Aft",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 883,
    "fields": {
      "name": "DIGOXIN",
      "brand": "Digoxin",
      "description": "11 DESCRIPTION Digoxin is one of the cardiac (or digitalis) glycosides, a closely related group of drugs having in common specific effects on the myocardium. These drugs are found in a number of plants. The term \u201cdigitalis\u201d is used to designate the whole group of glycosides.",
      "dosage": "2.2 Loading Dosing Regimen in Adults and Pediatric Patients For adults and pediatric patients if a l",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 884,
    "fields": {
      "name": "DILTIAZEM HYDROCHLORIDE",
      "brand": "diltiazem hydrochloride",
      "description": "DESCRIPTION Diltiazem hydrochloride is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1, 5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2, 3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride,(+)-cis-. The chemical structure is: USP Dissolution pending.",
      "dosage": "Individual patients may respond to higher doses of up to 480 mg once daily. Antihypertensives : Dilt",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 885,
    "fields": {
      "name": "DIPHENHYDRAMINE HCL",
      "brand": "Childrens Allergy Relief",
      "description": "",
      "dosage": "Directions \u25a0 if needed, take every 4-6 hours \u25a0 do not take more than 6 doses in 24-hours children un",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 886,
    "fields": {
      "name": "DIVALPROEX SODIUM",
      "brand": "Divalproex Sodium",
      "description": "Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium extended-release tablets, USP contain divalproex sodium in a once-a-day extended-release formulation equivalent to 250 or 500 mg of valproic acid. Inactive Ingredients: ammonium hydroxide, colloidal anhydrous silica, colloidal silicon dioxide, dibutyl sebacate, ethylcellulose, hydroxyethyl cellulose, hypromellose, oleic acid, polydextrose, polyethylene glycol, silicified microcrystalline cellulose, titanium dioxide and triacetin.",
      "dosage": "Although doses other than 1,000 mg once daily of divalproex sodium extended-release tablets have not",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 887,
    "fields": {
      "name": "DOXYCYCLINE",
      "brand": "doxycycline",
      "description": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Doxycycline is an antibacterial drug synthetically derived from oxytetracycline, and is available as capsules of doxycycline hyclate for oral administration. The structural formula of doxycycline monohydrate is with a molecular formula of C 22 H 24 N 2 O 8 \u2219H 2 O and a molecular weight of 462.46.",
      "dosage": "Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 888,
    "fields": {
      "name": "DULAGLUTIDE",
      "brand": "TRULICITY",
      "description": "11 DESCRIPTION Dulaglutide is a human glucagon-like peptide-1 (GLP-1) receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1 analog sequence covalently linked to the Fc portion of a modified human immunoglobulin G4 (IgG4) heavy chain by a small peptide linker and is produced using mammalian cell (Chinese hamster ovary) culture. The GLP-1 analog portion of dulaglutide is 90% homologous to native human GLP-1 (7-37).",
      "dosage": "2 DOSAGE AND ADMINISTRATION Adult Dosage ( 2.1 ) Recommended starting dosage is 0.75 mg injected sub",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 889,
    "fields": {
      "name": "ENALAPRIL MALEATE",
      "brand": "Enalapril Maleate",
      "description": "DESCRIPTION Enalapril maleate is the maleate salt of enalapril, the ethyl ester of a long-acting angiotensin-converting enzyme inhibitor, enalaprilat. Its molecular formula is C 20 H 28 N 2 O 5 \u2219C 4 H 4 O 4, and its structural formula is: Enalapril maleate is a white to off-white, crystalline powder with a molecular weight of 492.53. Enalapril is a pro-drug; following oral administration, it is bioactivated by hydrolysis of the ethyl ester to enalaprilat, which is the active angiotensin-converting enzyme inhibitor.",
      "dosage": "DOSAGE AND ADMINISTRATION Hypertension In patients who are currently being treated with a diuretic, ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 890,
    "fields": {
      "name": "ESCITALOPRAM ORAL",
      "brand": "Escitalopram Oral Solution",
      "description": "11 DESCRIPTION Escitalopram Oral Solution, USP contains escitalopram oxalate, an orally administered selective serotonin reuptake inhibitor (SSRI), present as escitalopram oxalate salt. Escitalopram is the pure S-enantiomer (single isomer) of the racemic bicyclic phthalane derivative citalopram. Escitalopram oxalate is designated S-(+)-1-[3-(dimethyl-amino)propyl]-1-( p -fluorophenyl)-5-phthalancarbonitrile oxalate with the following structural formula: The molecular formula is C 20 H 21 FN 2O \u2022 C 2 H 2 O 4 and the molecular weight is 414.40.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication and Population Recommended Dosage MDD in Adults ( 2.1 ) Initi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 891,
    "fields": {
      "name": "ESOMEPRAZOLE MAGNESIUM",
      "brand": "Acid Reducer",
      "description": "",
      "dosage": "Directions adults 18 years of age and older this product is to be used once a day (every 24 hours), ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 892,
    "fields": {
      "name": "ESZOPICLONE",
      "brand": "Eszopiclone",
      "description": "11 DESCRIPTION Eszopiclone is a hypnotic agent/nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class. The chemical name of eszopiclone is (+)-4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5 H pyrrolo[3,4- b ]pyrazin-5-(S)-yl ester. In addition, both the 1 mg and 3 mg tablets contain FD&C Blue #2/indigo carmine aluminium lake.",
      "dosage": "May increase dose if clinically indicated, to a maximum of 3 mg ( 2.1 ) \u2022 Geriatric or debilitated p",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 893,
    "fields": {
      "name": "FENTANYL CITRATE",
      "brand": "Fentanyl Citrate",
      "description": "Fentanyl citrate is chemically identified as N -(1-Phenethyl-4-piperidyl)propionanilide citrate (1:1) with the following structural formula: C 22 H 28 N 2 O \u2022 C 6 H 8 O 7 Molecular Weight is 528.59 Each mL contains fentanyl citrate equivalent to 50 mcg (0.05 mg) fentanyl base in Water for Injection. Sodium hydroxide and/or hydrochloric acid added, if needed, for pH adjustment. The pH range is 4.0 to 7.5.",
      "dosage": "For use in more major surgical procedures, in addition to adequate analgesia, may abolish some of th",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 894,
    "fields": {
      "name": "FEXOFENADINE HCL",
      "brand": "Fexofenadine HCL",
      "description": "",
      "dosage": "Directions adults and children 12 years of age and over: take one 180 mg tablet with water every onc",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 895,
    "fields": {
      "name": "FINASTERIDE",
      "brand": "Finasteride",
      "description": "11 DESCRIPTION Finasteride tablets USP, 1 mg contains finasteride as the active ingredient. Finasteride is 4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5\u03b1, 17\u03b2)-. Its structural formula is: Finasteride is a white crystalline powder with a melting point near 250\u00b0 C. It is freely soluble in chloroform and in lower alcohol solvents but is practically insoluble in water.",
      "dosage": "The recommended dose of finasteride tablets USP is one tablet (1 mg) taken once daily. In general, d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 896,
    "fields": {
      "name": "FLUCONAZOLE",
      "brand": "Fluconazole",
      "description": "DESCRIPTION Fluconazole, the first of a new subclass of synthetic triazole antifungal agents, is available as tablets for oral administration. Fluconazole is designated chemically as 2,4-difluoro-\u03b1,\u03b1 1 -bis(1H-1,2,4-triazol-1-ylmethyl) benzyl alcohol with a molecular formula of C 13 H 12 F 2 N 6 O and molecular weight of 306.3. The structural formula is: Fluconazole USP is a white crystalline solid which is slightly soluble in water and saline.",
      "dosage": "DOSAGE AND ADMINISTRATION Dosage and Administration in Adults: Single Dose Vaginal candidiasis: The ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 897,
    "fields": {
      "name": "FLUOXETINE HYDROCHLORIDE",
      "brand": "Fluoxetine",
      "description": "11 DESCRIPTION Fluoxetine capsules, USP are a selective serotonin reuptake inhibitor for oral administration. It is also marketed for the treatment of premenstrual dysphoric disorder (Sarafem \u00ae , fluoxetine hydrochloride). In addition, 20 mg capsules also contains D&C Yellow #10 and 10 mg capsules also contains FD&C Yellow #6.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication Adult Pediatric MDD ( 2.1 ) 20 mg/day in am (initial dose) 10",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 898,
    "fields": {
      "name": "FLUTICASONE PROPIONATE",
      "brand": "FLOVENT DISKUS",
      "description": "11 DESCRIPTION FLOVENT DISKUS inhalation powder is a dry powder inhaler for oral inhalation. The active component of FLOVENT DISKUS 50 mcg, FLOVENT DISKUS 100 mcg, and FLOVENT DISKUS 250 mcg is fluticasone propionate, a corticosteroid having the chemical name S- (fluoromethyl) 6\u03b1,9-difluoro-11\u03b2,17-dihydroxy-16\u03b1-methyl-3-oxoandrosta-1,4-diene-17\u03b2-carbothioate, 17-propionate and the following chemical structure: Fluticasone propionate is a white powder with a molecular weight of 500.6, and the empirical formula is C 25 H 31 F 3 O 5 S. It is practically insoluble in water, freely soluble in dimethyl sulfoxide and dimethylformamide, and slightly soluble in methanol and 95% ethanol. Each blister on the strip contains a white powder mix of micronized fluticasone propionate (50, 100, or 250 mcg) in 12.5 mg of formulation containing lactose monohydrate (which contains milk proteins).",
      "dosage": "2.2 Recommended Dosage Adult and Adolescent Patients Aged 12 Years and Older The starting dosage is ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 899,
    "fields": {
      "name": "GABAPENTIN",
      "brand": "Gabapentin",
      "description": "11 DESCRIPTION The active ingredient in Gabapentin Capsules USP is gabapentin, which has the chemical name 1-(aminomethyl)cyclohexaneacetic acid. The molecular formula of gabapentin is C 9 H 17 NO 2 and the molecular weight is 171.24. The structural formula of gabapentin is: Gabapentin is a white to off-white crystalline solid with a pK a1 of 3.7 and a pK a2 of 10.7.",
      "dosage": "2 DOSAGE AND ADMlNlSTRATION Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 900,
    "fields": {
      "name": "GEMFIBROZIL",
      "brand": "Gemfibrozil",
      "description": "DESCRIPTION Gemfibrozil, USP is a lipid regulating agent. It is available as tablets for oral administration. Each tablet contains 600 mg gemfibrozil.",
      "dosage": "DOSAGE AND ADMINISTRATION The recommended dose for adults is 1,200 mg administered in two divided do",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 901,
    "fields": {
      "name": "GLIMEPIRIDE",
      "brand": "Glimepiride",
      "description": "11 DESCRIPTION Glimepiride tablets USP, are an oral sulfonylurea that contains the active ingredient glimepiride USP. Chemically, glimepiride USP is identified as 1-[[p-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea (C 24 H 34 N 4 O 5 S) with a molecular weight of 490.62. Glimepiride USP is a white to almost white powder, soluble in dimethyl formamide, sparingly soluble in methylene chloride, practically insoluble in water.",
      "dosage": "The recommended starting dose of glimepiride tablets are 1 mg or 2 mg once daily. Patients at increa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 902,
    "fields": {
      "name": "GLIPIZIDE",
      "brand": "Glipizide",
      "description": "The Chemical Abstracts name of glipizide is 1-cyclohexyl-3-[[ p -[2-(5-methylpyrazine-carboxamido)ethyl]phenyl]sulfonyl]urea. The molecular formula is C 21 H 27 N 5 O 4 S; the molecular weight is 445.55; the structural formula is shown below: Glipizide is a whitish, odorless powder with a pKa of 5.9. Glipizide Tablets USP for oral use are available in 5 and 10 mg strengths.",
      "dosage": "In addition to the usual monitoring of urinary glucose, the patient\u2019s blood glucose must also be mon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 903,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 904,
    "fields": {
      "name": "HYDROXYCHLOROQUINE SULFATE",
      "brand": "Hydroxychloroquine Sulfate",
      "description": "DESCRIPTION Hydroxychloroquine sulfate is a white or practically white, crystalline powder, freely soluble in water; practically insoluble in alcohol, chloroform, and in ether. The chemical name for hydroxychloroquine sulfate is 2-[[4-[(7-Chloro-4-quinolyl) amino]pentyl] ethylamino]ethanol sulfate (1:1). Its structural formula is: The molecular weight of hydroxychloroquine sulfate is 433.95, and molecular formula is C 18 H 26 ClN 3 O.H 2 SO 4 .",
      "dosage": "Treatment of Uncomplicated Malaria Adults: 800 mg (620 mg base) followed by 400 mg (310 mg base) at ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 905,
    "fields": {
      "name": "IBUPROFEN",
      "brand": "Ibuprofen Dye Free",
      "description": "",
      "dosage": "Directions do not take more than directed the smallest effective dose should be used adults and chil",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 906,
    "fields": {
      "name": "INSULIN ASPART",
      "brand": "NOVOLOG",
      "description": "11 DESCRIPTION Insulin aspart is a rapid-acting human insulin analog homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Saccharomyces cerevisiae (baker's yeast). Insulin aspart has the empirical formula C 256 H 381 N 65 0 79 S 6 and a molecular weight of 5825.8 Da. NOVOLOG has a pH of 7.2-7.6.",
      "dosage": "\u2022 Continuous Subcutaneous Infusion (Insulin Pump) ( 2.2 ): o Refer to the insulin infusion pump user",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 907,
    "fields": {
      "name": "INSULIN DETEMIR",
      "brand": "LEVEMIR",
      "description": "Insulin detemir has a molecular formula of C 267 H 402 O 76 N 64 S 6 and a molecular weight of 5.917 kDa. Hydrochloric acid and/or sodium hydroxide may be added to adjust pH. Levemir Chemical Structure.jpg",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 908,
    "fields": {
      "name": "INSULIN GLARGINE",
      "brand": "BASAGLAR Tempo Pen",
      "description": "Insulin glargine has the following structural formula: BASAGLAR (insulin glargine) injection is a sterile clear and colorless aqueous solution for subcutaneous use. The 3 mL BASAGLAR prefilled pen presentations contain the following inactive ingredients per mL: glycerin (17 mg), metacresol (2.7 mg), zinc oxide (content adjusted to provide 30 mcg zinc ion), and Water for Injection, USP. BASAGLAR has a pH of approximately 4.",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 909,
    "fields": {
      "name": "INSULIN LISPRO",
      "brand": "ADMELOG",
      "description": "11 DESCRIPTION Insulin lispro is a rapid-acting human insulin analog produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli . Insulin lispro has a pH of 7.0 to 7.8. The pH is adjusted by addition of aqueous solutions of hydrochloric acid and/or sodium hydroxide.",
      "dosage": "Use in accordance with the insulin pump instructions for use. Administer ADMELOG by continuous subcu",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 910,
    "fields": {
      "name": "ISOSORBIDE MONONITRATE",
      "brand": "ISOSORBIDE MONONITRATE",
      "description": "Each tablet, for oral administration, contains either 30 mg, 60 mg or 120 mg of isosorbide mononitrate in an extended-release formulation. In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, diethyl phthalate, hydrogenated castor oil, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc and titanium dioxide. The chemical name for ISMN is 1,4:3,6-dianhydro-,D-glucitol 5-nitrate; the compound has the following structural formula: ISMN is a white, crystalline, odorless compound which is stable in air and in solution, has a melting point of about 90\u00b0C, and an optical rotation of +144\u00b0 (2% in water, 20\u00b0C).",
      "dosage": "After several days, the dosage may be increased to 120 mg (given as a single 120 mg tablet or as two",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 911,
    "fields": {
      "name": "LAMOTRIGINE",
      "brand": "Lamotrigine",
      "description": "11 DESCRIPTION Lamotrigine, USP an AED of the phenyltriazine class, is chemically unrelated to existing AEDs. Lamotrigine\u2019s chemical name is 3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine, its molecular formula is C 9 H 7 N 5 Cl 2 , and its molecular weight is 256.09. Lamotrigine orally disintegrating tablets are formulated using in-house technologies designed to mask the bitter taste of lamotrigine and achieve a rapid dissolution profile.",
      "dosage": "Adjustments to the Maintenance Dose of Lamotrigine in Women Taking Estrogen-Containing Oral Contrace",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 912,
    "fields": {
      "name": "LANSOPRAZOLE",
      "brand": "Lansoprazole",
      "description": "Lansoprazole has the following structure: Lansoprazole is a white to brownish-white odorless crystalline powder which melts with decomposition at approximately 166\u00b0C. The degradation half-life of the drug substance in aqueous solution at 25\u00b0C is approximately 0.5 hour at pH 5.0 and approximately 18 hours at pH 7.0. Lansoprazole Delayed-Release Capsules, USP are supplied in delayed-release capsules for oral administration.The delayed-release capsules are available in two dosage strengths: 15 mg and 30 mg of lansoprazole per capsule.",
      "dosage": "For patients who have difficulty swallowing capsules, Lansoprazole delayed-release capsules can be o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 913,
    "fields": {
      "name": "LEVETIRACETAM",
      "brand": "Levetiracetam Extended-release",
      "description": "11 DESCRIPTION Levetiracetam Extended-release Tablets USP is an antiepileptic drug available as 500 mg and 750 mg (white) extended-release tablets for oral administration. It has the following structural formula: Levetiracetam is a white to off-white crystalline powder with a faint odor and a bitter taste. It is freely soluble in chloroform (65.3 g/100 mL) and in methanol (53.6 g/100 mL), soluble in ethanol (16.5 g/100 mL), sparingly soluble in acetonitrile (5.7 g/100 mL) and practically insoluble in n-hexane.",
      "dosage": "2 DOSAGE & ADMINISTRATION Initiate treatment with a dose of 1,000 mg once daily; increase by 1,000 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 914,
    "fields": {
      "name": "LEVOTHYROXINE, LIOTHYRONINE",
      "brand": "NP Thyroid 120",
      "description": "NP Thyroid \u00ae (thyroid tablets, USP) for oral use is a natural preparation derived from porcine thyroid glands. They contain both tetraiodothyronine sodium (T 4 levothyroxine) and triiodothyronine sodium (T 3 liothyronine) providing 38 mcg levothyroxine (T 4 ) and 9 mcg liothyronine (T 3 ) per grain of thyroid. The inactive ingredients are calcium stearate, dextrose (agglomerated) and mineral oil.",
      "dosage": "DOSAGE AND ADMINISTRATION The dosage of thyroid hormones is determined by the indication and must in",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 915,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 916,
    "fields": {
      "name": "LORAZEPAM",
      "brand": "Lorazepam",
      "description": "DESCRIPTION Lorazepam USP, an antianxiety agent, has the chemical formula, 7-chloro-5-( o -chlorophenyl)-1,3\u2011-dihydro-3-hydroxy-2 H -1,4-benzodiazepin-2-one: It is a nearly white powder almost insoluble in water. Each lorazepam tablet, USP to be taken orally, contains 0.5 mg, 1 mg, or 2 mg of lorazepam, USP. The inactive ingredients present are anhydrous lactose, magnesium stearate, microcrystalline cellulose, and polacrilin potassium.",
      "dosage": "DOSAGE AND ADMINISTRATION Lorazepam tablets are administered orally. For insomnia due to anxiety or ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 917,
    "fields": {
      "name": "LOSARTAN POTASSIUM",
      "brand": "Losartan Potassium",
      "description": "11 DESCRIPTION Losartan potassium is an angiotensin II receptor blocker acting on the AT 1 receptor subtype. Its molecular formula is C 22 H 22 ClKN 6 O, and its structural formula is: Losartan potassium, USP is white to off-white powder with a molecular weight of 461.01. It is freely soluble in water; soluble in isopropyl alcohol; slightly soluble in acetonitrile.",
      "dosage": "Pediatric Hypertension The usual recommended starting dose is 0.7 mg per kg once daily (up to 50 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 918,
    "fields": {
      "name": "LOVASTATIN",
      "brand": "Lovastatin",
      "description": "This enzyme catalyzes the conversion of HMG-CoA to mevalonate, which is an early and rate limiting step in the biosynthesis of cholesterol. 404.55 C 24 H 36 O 5 M.W. Lovastatin Tablets USP, 40 mg also contain D&C Yellow #10 Aluminum Lake, FD&C Blue #1 Aluminum Lake, and FD&C Yellow #6 Aluminum Lake.",
      "dosage": "Patients requiring reductions in LDL-C of 20% or more to achieve their goal (see INDICATIONS AND USA",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 919,
    "fields": {
      "name": "LURASIDONE HYDROCHLORIDE",
      "brand": "Lurasidone Hydrochloride",
      "description": "11 DESCRIPTION Lurasidone hydrochloride is an atypical antipsychotic belonging to the chemical class of benzisothiazol derivatives. Its chemical name is (3a R ,4 S ,7 R ,7a S )-2-{(1 R ,2 R )-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-\u00adylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2 H -isoindole-1,3-dione hydrochloride. Its molecular formula is C 28 H 36 N 4 O 2 S\u00b7HCl and its molecular weight is 529.14.",
      "dosage": "Lurasidone hydrochloride tablets have been shown to be effective in a dose range of 40 mg per day to",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 920,
    "fields": {
      "name": "MELOXICAM",
      "brand": "Meloxicam",
      "description": "11 DESCRIPTION Meloxicam, is a nonsteroidal anti-inflammatory drug (NSAID). Its empirical formula is C 14 H 13 N 3 O 4 S 2 and it has the following structural formula: Meloxicam is a pastel yellow solid, practically insoluble in water, with higher solubility observed in strong acids and bases. Meloxicam tablets USP are available as tablets for oral administration containing 7.5 mg or 15 mg meloxicam.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest effective dosage for the shortest duration consistent wit",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 921,
    "fields": {
      "name": "MEMANTINE",
      "brand": "Memantine hydrochloride",
      "description": "11 DESCRIPTION Memantine hydrochloride, USP is an orally active NMDA receptor antagonist. The tablets also contain the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose and talc. In addition the following inactive ingredients are also present as components of the film coat: D&C Yellow #10, FD&C Blue #2, FD&C Yellow #6, macrogol, polyvinyl alcohol, talc, and titanium dioxide (5 mg tablets), and iron oxide black, iron oxide yellow, macrogol, polyvinyl alcohol, talc and titanium dioxide (10 mg tablets).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dose of memantine hydrochloride tablets is 5 mg",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 922,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 923,
    "fields": {
      "name": "METHADONE HYDROCHLORIDE",
      "brand": "Methadone Hydrochloride",
      "description": "DESCRIPTION Methadone Hydrochloride Oral Concentrate, USP, contains methadone, an opiate agonist, and is available as a cherry flavored liquid concentrate for oral administration. It is present in methadone hydrochloride oral concentrate as the racemic mixture. Other ingredients of Methadone Hydrochloride Oral Concentrate, USP (Dye-Free, Sugar-Free, Unflavored): citric acid anhydrous, purified water, and sodium benzoate.",
      "dosage": "Titration and Maintenance Treatment of Opioid Dependence Patients in maintenance treatment should be",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 924,
    "fields": {
      "name": "METHOCARBAMOL",
      "brand": "Methocarbamol",
      "description": "The chemical name of methocarbamol is 3-(2-meth-oxyphenoxy)-1,2-propanediol 1-carbamate and has the empirical formula C 11 H 15 NO 5 . Its molecular weight is 241.24. Methocarbamol tablets, USP are available as 500 mg and 750 mg tablets for oral administration.",
      "dosage": "Maintenance dosage: 2 tablets q.i.d. Methocarbamol tablets, USP: 750 mg \u2013 Adults: Initial dosage: 2 ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 925,
    "fields": {
      "name": "METHYLPHENIDATE HYDROCHLORIDE",
      "brand": "Methylphenidate Hydrochloride (LA)",
      "description": "Each Methylphenidate Hydrochloride Extended-Release Capsule contains pellets, with half the dose as immediate-release and half as delayed-release, thus providing an immediate release of methylphenidate and a second delayed release of methylphenidate. The active substance in Methylphenidate Hydrochloride Extended-Release Capsules is methyl \u03b1-phenyl-2-piperidineacetate hydrochloride. Its structural formula is as follows: M.W.",
      "dosage": "The drug and applesauce mixture should not be stored for future use. 2.3 Patients Currently Using Me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 926,
    "fields": {
      "name": "METOPROLOL TARTRATE",
      "brand": "Metoprolol Tartrate",
      "description": "11 DESCRIPTION Metoprolol tartrate tablets, USP contain metoprolol tartrate, a selective beta 1 -adrenoreceptor blocking agent. It is very soluble in water; freely soluble in methylene chloride, in chloroform, and in alcohol; slightly soluble in acetone; and insoluble in ether. Metoprolol tartrate tablets, USP are available as 25 mg, 50 mg and 100 mg tablets for oral administration containing 25 mg, 50 mg and 100 mg metoprolol tartrate, respectively.",
      "dosage": "The effective dosage range of metoprolol tartrate tablets is 100 mg to 450 mg per day. The effective",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 927,
    "fields": {
      "name": "METRONIDAZOLE",
      "brand": "Metronidazole",
      "description": "DESCRIPTION Metronidazole tablets, USP 250 mg or 500 mg is an oral formulation of the synthetic nitroimidazole antimicrobial, 2-methyl-5-nitro-1H-imidazole-1-ethanol, which has the following structural formula: Metronidazole tablets USP contain 250 mg or 500 mg of metronidazole. Inactive ingredients include powdered cellulose, hydroxypropyl cellulose, low substituted hydroxypropyl cellulose, hypromellose, polyethylene glycol, stearic acid, and titanium dioxide. Molecular Structure",
      "dosage": "There is some indication from controlled comparative studies that cure rates as determined by vagina",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 928,
    "fields": {
      "name": "MIRTAZAPINE",
      "brand": "Mirtazapine",
      "description": "Mirtazapine has a tetracyclic chemical structure and belongs to the piperazino-azepine group of compounds. It is designated 1,2,3,4,10,14b-hexahydro-2-methylpyrazino [2,1-a] pyrido [2,3-c][2] benzazepine and has the molecular formula of C 17 H 19 N 3 . The structural formula is the following and it is the racemic mixture: Mirtazapine is a white to creamy white crystalline powder which is practically insoluble in water.",
      "dosage": "If patients do not have an adequate response to the initial 15 mg dose, increase the dose up to a ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 929,
    "fields": {
      "name": "MONTELUKAST SODIUM",
      "brand": "Montelukast Sodium",
      "description": "DESCRIPTION Montelukast sodium, the active ingredient in montelukast sodium tablets, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT 1 receptor. Montelukast sodium is described chemically as [ R-(E) ]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl] cyclopropaneacetic acid, monosodium salt. Each 10-mg film-coated montelukast sodium tablet contains 10.4 mg montelukast sodium, which is equivalent to 10 mg of montelukast, and the following inactive ingredients: croscarmellose sodium, ferric oxide red, ferric oxide yellow, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose and titanium dioxide.",
      "dosage": "Patients with both asthma and allergic rhinitis should take only one dose daily in the evening (2.4)",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 930,
    "fields": {
      "name": "NAPROXEN",
      "brand": "Naproxen",
      "description": "11 DESCRIPTION Naproxen Tablets, USP and Naproxen Sodium Tablets, USP are nonsteroidal anti-inflammatory drugs available as follows: Naproxen Tablets, USP are available as follows for oral administration: 250 mg: circular, light orange colored, flat, uncoated tablets, engraved with \u2018G\u2019 and \u201832\u2019 on either side of a break line on one side and \u2018250\u2019 on the other side. The inactive ingredients are croscarmellose sodium, iron oxide red, iron oxide yellow, magnesium stearate, microcrystalline cellulose and povidone. Naproxen, USP and naproxen sodium, USP have the following structures, respectively: Naproxen Naproxen Sodium Naproxen, USP is a white to off-white crystalline powder.",
      "dosage": "Management of Pain, Primary Dysmenorrhea, and Acute Tendonitis and Bursitis Recommended starting dos",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 931,
    "fields": {
      "name": "NITROGLYCERIN",
      "brand": "NITROGLYCERIN",
      "description": "11 DESCRIPTION Nitroglycerin sublingual tablets are stabilized sublingual compressed tablets that contain 0.3 mg, 0.4 mg, or 0.6 mg nitroglycerin; as well as lactose monohydrate, NF; glyceryl monostearate, NF; pregelatinized starch, NF; calcium stearate, NF powder; and silicon dioxide, colloidal, NF. Nitroglycerin, an organic nitrate, is a vasodilating agent. The chemical name for nitroglycerin is 1, 2, 3 propanetriol trinitrate and the chemical structure is: Molecular weight: 227.09 Nitroglycerin Structural Formula",
      "dosage": "2 DOSAGE AND ADMINISTRATION Administer one tablet under the tongue or in the buccal pouch at the fir",
      "stock": 100,
      "route": "SUBLINGUAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 932,
    "fields": {
      "name": "NORTRIPTYLINE HYDROCHLORIDE",
      "brand": "Nortriptyline Hydrochloride",
      "description": "DESCRIPTION Nortriptyline Hydrochloride, USP is 1-propanamine, 3-(10,11-dihydro-5 H -dibenzo[ a,d ]cyclohepten-5-ylidene)- N -methyl, hydrochloride. The structural formula is as follows: C19H21N\u2219HCl MW = 299.84 Each capsule, for oral administration, contains nortriptyline hydrochloride equivalent to 10 mg, 25 mg, 50 mg, and 75 mg of nortriptyline hydrochloride USP. In addition, each capsule contains the following inactive ingredients: black iron oxide, colloidal silicon dioxide, D&C Yellow #10 (aluminum lake), D&C Yellow #10, FD&C Blue #1 (aluminum lake), FD&C Blue #2 (aluminum lake), FD&C Green #3 (10, 50 and 75 mg only), FD&C Red #40 (aluminum lake), gelatin, I.M.S. 74 OP, magnesium stearate, pregelatinized corn starch, shellac, sodium lauryl sulfate and titanium dioxide.",
      "dosage": "Usual Adult Dose 25 mg three or four times daily; dosage should begin at a low level and be increase",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 933,
    "fields": {
      "name": "OMEPRAZOLE",
      "brand": "Omeprazole",
      "description": "",
      "dosage": "Directions for adults 18 years of age and older this product is to be used once a day (every 24 hour",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 934,
    "fields": {
      "name": "ONDANSETRON HYDROCHLORIDE",
      "brand": "ondansetron hydrochloride",
      "description": "11 DESCRIPTION The active ingredient in ondansetron tablets is ondansetron hydrochloride as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT 3 receptor type. Chemically it is (\u00b1) 1, 2, 3, 9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, monohydrochloride, dihydrate. Each tablet also contains the inactive ingredients colloidal silicon dioxide, hypromellose 2910(5cP) (for the 4 mg and 16 mg tablets only) and hypromellose 2910 (6cP) (for the 8 mg and 24 mg tablets only), iron oxide red and iron oxide black (for the 24 mg tablet only), iron oxide yellow (for the 8 mg and 24 mg tablets only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium starch glycolate, and titanium dioxide.",
      "dosage": "2 DOSAGE AND ADMINISTRATION See full prescribing information for the recommended dosage in adults an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 935,
    "fields": {
      "name": "OXYCODONE HYDROCHLORIDE",
      "brand": "Oxycodone Hydrochloride",
      "description": "Each tablet for oral administration contains 15 mg, or 30 mg, of oxycodone hydrochloride USP. Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. The 15 mg and 30 mg tablets contain the equivalent of 13.5 mg and 27.0 mg, respectively, of oxycodone free base.",
      "dosage": "If a decision is made to discontinue the use of non-opioid analgesic, it may be necessary to titrate",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 936,
    "fields": {
      "name": "PANTOPRAZOLE SODIUM INJECTION",
      "brand": "PANTOPRAZOLE SODIUM",
      "description": "11 DESCRIPTION The active ingredient in pantoprazole sodium for injection (pantoprazole sodium), a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S, with a molecular weight of 405.4. The reconstituted solution of pantoprazole sodium for injection is in the pH range of 9.0 to 10.5.",
      "dosage": "( 2.3 , 2.4 ) 2.1 Recommended Dosage for GERD Associated with a History of EE Adult Patients The rec",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 937,
    "fields": {
      "name": "PAROXETINE HYDROCHLORIDE HEMIHYDRATE",
      "brand": "Paroxetine",
      "description": "11 DESCRIPTION Paroxetine tablets contain paroxetine hydrochloride, an SSRI. It is the hydrochloride salt of a phenylpiperidine compound identified chemically as (-)- trans -4 R -(4'-fluorophenyl)-3 S -[(3',4'- methylenedioxyphenoxy) methyl] piperidine hydrochloride hemihydrate and has the empirical formula of C 19 H 20 FNO 3 \u2022HCl\u20221/2H 2 O. The structural formula of paroxetine hydrochloride is: Paroxetine hydrochloride, USP is an odorless, off-white powder, having a melting point range of 120 o to 138 o C and a solubility of 5.4 mg/mL in water.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting and maximum daily dosage for MDD, OCD, PD, and PTSD",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 938,
    "fields": {
      "name": "PENICILLIN G BENZATHINE",
      "brand": "BICILLIN L-A",
      "description": "Description Bicillin L-A (penicillin G benzathine injectable suspension) is available for deep intramuscular injection. Its chemical structure is as follows: Bicillin L-A contains penicillin G benzathine in aqueous suspension with sodium citrate buffer and, as w/v, approximately 0.65% sodium citrate, 0.59% povidone, 0.54% carboxymethylcellulose sodium, 0.53% lecithin, 0.12% methylparaben, and 0.013% propylparaben. Bicillin L-A contains approximately 0.11 mEq of sodium per 600,000 units of penicillin G (approximately 2.59 mg of sodium per 600,000 units of penicillin G).",
      "dosage": "DOSAGE AND ADMINISTRATION Streptococcal (Group A) Upper Respiratory Infections (for example, pharyng",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 939,
    "fields": {
      "name": "PHENYTOIN SODIUM",
      "brand": "Phenytoin Sodium",
      "description": "11 DESCRIPTION Phenytoin Sodium Injection, USP is a sterile solution containing in each mL phenytoin sodium 50 mg, propylene glycol 0.4 mL and alcohol 0.1 mL in Water for Injection. pH 10.0-12.3; sodium hydroxide added, if needed, for pH adjustment. Phenytoin sodium is related to the barbiturates in chemical structure, but has a five-membered ring.",
      "dosage": "( 2.2 , 2.3 ) 2.1 General Dosing Information Because of the increased risk of adverse cardiovascular",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 940,
    "fields": {
      "name": "PIOGLITAZONE HYDROCHLORIDE",
      "brand": "PIOGLITAZONE HYDROCHLORIDE",
      "description": "11 DESCRIPTION Pioglitazone tablets are a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (PPAR) gamma that contains an oral antidiabetic medication: pioglitazone. Pioglitazone [(\u00b1)-5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2,4-] thiazolidinedione monohydrochloride contains one asymmetric carbon, and the compound is synthesized and used as the racemic mixture. The two enantiomers of pioglitazone interconvert in vivo .",
      "dosage": "(2.1) If there is inadequate glycemic control, the dose can be increased in 15 mg increments up to a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 941,
    "fields": {
      "name": "PREDNISONE",
      "brand": "PredniSONE",
      "description": "DESCRIPTION Prednisone is a glucocorticoid. Glucocorticoids are adrenocortical steroids, both naturally occurring and synthetic, which are readily absorbed from the gastrointestinal tract. Prednisone, USP is a white to partially white, crystalline powder.",
      "dosage": "Included in the situations which may make dosage adjustments necessary are changes in clinical statu",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 942,
    "fields": {
      "name": "PREGABALIN",
      "brand": "PREGABALIN",
      "description": "The molecular formula is C 8 H 17 NO 2 and the molecular weight is 159.23. Pregabalin capsules are administered orally and are supplied as imprinted hard-shell capsules containing 25, 50, 75, 100, 150, 200, 225, and 300 mg of pregabalin, along with pregelatinized starch and talc as inactive ingredients. In addition, the orange & red capsule shells contain red iron oxide.",
      "dosage": "( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) Dosing recommendations: INDICATION Dosing Regimen Maximum Dose DPN P",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 943,
    "fields": {
      "name": "PROMETHAZINE HYDROCHLORIDE",
      "brand": "PROMETHAZINE HYDROCHLORIDE",
      "description": "DESCRIPTION Each 12.5 mg promethazine hydrochloride tablet for oral administration contains 12.5 mg promethazine hydrochloride. In addition, 50 mg tablet contains FD&C Red #40 and 12.5 mg tablet contains FD&C Yellow #6. Promethazine hydrochloride is a racemic compound; the empirical formula is C 17 H 20 N 2 S\u2022HCl and its molecular weight is 320.88.",
      "dosage": "The average effective dose of promethazine hydrochloride tablets, USP for the active therapy of naus",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 944,
    "fields": {
      "name": "PROPRANOLOL HYDROCHLORIDE",
      "brand": "Propranolol Hydrochloride",
      "description": "Propranolol Hydrochloride Tablets, USP are available as tablets for oral administration containing either 10 mg, 20 mg, 40 mg, 60 mg, or 80 mg of propranolol hydrochloride, USP. 6 aluminum lake (10 mg and 80 mg), D&C Yellow no. 10 aluminum lake (10 mg, 40 mg, and 80 mg), FD&C Blue no.",
      "dosage": "Hypertension The usual initial dosage is 40 mg propranolol hydrochloride twice daily, whether used a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 945,
    "fields": {
      "name": "QUETIAPINE FUMARATE",
      "brand": "Quetiapine Fumarate",
      "description": "It is present in tablets as the fumarate salt. Quetiapine tablets, USP is supplied for oral administration as 25 mg (round peach), 50 mg (round, white), 100 mg (round yellow), 150 mg (round, off white to light yellow), 200 mg (round, white), 300 mg (capsule-shaped, white), and 400 mg (capsule-shaped, yellow) tablets. The 25 mg tablets contain red iron oxide and yellow iron oxide and the 100 mg, 150 mg and 400 mg tablets contain only yellow iron oxide.",
      "dosage": "Further adjustments can be made in increments of 25 to 50 mg twice a day, in intervals of not less t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 946,
    "fields": {
      "name": "RABEPRAZOLE SODIUM",
      "brand": "Rabeprazole sodium",
      "description": "11 DESCRIPTION The active ingredient in rabeprazole sodium delayed-release tablets is rabeprazole sodium hydrate, USP, which is a proton pump inhibitor. The stability of rabeprazole sodium hydrate, USP is a function of pH; it is rapidly degraded in acid media, and is more stable under alkaline conditions. The structural figure is: Rabeprazole sodium hydrate, USP is available for oral administration as delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium hydrate, USP.",
      "dosage": "The use of rabeprazole sodium delayed-release tablets is not recommended for use in pediatric patien",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 947,
    "fields": {
      "name": "RANITIDINE",
      "brand": "Ranitidine",
      "description": "",
      "dosage": "Directions adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 948,
    "fields": {
      "name": "RISPERIDONE",
      "brand": "RISPERIDONE",
      "description": "11 DESCRIPTION Risperidone tablets, USP contain risperidone USP, an atypical antipsychotic belonging to the chemical class of benzisoxazole derivatives. The structural formula is: Risperidone USP is a white to slightly beige powder. Tablets of 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg also contain talc and titanium dioxide.",
      "dosage": "Maintenance Therapy While it is unknown how long a patient with schizophrenia should remain on rispe",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 949,
    "fields": {
      "name": "ROSUVASTATIN CALCIUM",
      "brand": "Rosuvastatin Calcium",
      "description": "11 DESCRIPTION Rosuvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA)-reductase inhibitor. The chemical name for rosuvastatin calcium is bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt with the following structural formula: The empirical formula for rosuvastatin calcium is (C 22 H 27 FN 3 O 6 S) 2 Ca and the molecular weight is 1001.14. Rosuvastatin calcium is a white or almost white, hygroscopic powder that is slightly soluble in water, freely soluble in methylene chloride, practically insoluble in ethanol.",
      "dosage": "( 2.1 ) Pediatric Patients with HeFH : Recommended dosage range is 5 to 10 mg once daily for patient",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 950,
    "fields": {
      "name": "SERTRALINE HYDROCHLORIDE",
      "brand": "Sertraline Hydrochloride",
      "description": "DESCRIPTION Sertraline hydrochloride is a selective serotonin reuptake inhibitor (SSRI) for oral administration. It has a molecular weight of 342.7. Sertraline hydrochloride, USP has the following chemical name: (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride.",
      "dosage": "While a relationship between dose and effect has not been established for OCD, patients were dosed i",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 951,
    "fields": {
      "name": "SILDENAFIL CITRATE",
      "brand": "SILDENAFIL CITRATE",
      "description": "11 DESCRIPTION Sildenafil tablets, USP, an oral therapy for erectile dysfunction, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Sildenafil citrate, is designated chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1 H -pyrazolo[4,3- d ]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate and has the following structural formula: Sildenafil citrate, USP is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Sildenafil tablets USP are formulated as pale blue to blue film-coated tablets equivalent to 25 mg, 50 mg and 100 mg of sildenafil for oral administration.",
      "dosage": "However, sildenafil tablets may be taken anywhere from 30 minutes to 4 hours before sexual activity ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 952,
    "fields": {
      "name": "EZETIMIBE AND SIMVASTATIN",
      "brand": "Ezetimibe and Simvastatin",
      "description": "11 DESCRIPTION Ezetimibe and simvastatin tablets contain ezetimibe USP, a selective inhibitor of intestinal cholesterol and related phytosterol absorption, and simvastatin USP, an HMG-CoA reductase inhibitor. The chemical name of ezetimibe, USP is 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone. formula 1 formula 2",
      "dosage": "The maximum recommended dosage is ezetimibe and simvastatin tablets 10 mg/40 mg once daily. The ezet",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 953,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 954,
    "fields": {
      "name": "SPIRONOLACTONE",
      "brand": "Spironolactone",
      "description": "11 DESCRIPTION Spironolactone oral tablets contain 25 mg, 50 mg, or 100 mg of the aldosterone antagonist spironolactone, USP 17hydroxy-7\u03b1-mercapto-3-oxo-17\u03b1-pregn-4-ene-21-carboxylic acid \u03b3-lactone acetate, which has the following structural formula: Spironolactone, USP is practically insoluble in water, soluble in alcohol, and freely soluble in benzene and in chloroform. Inactive ingredients include calcium sulfate, corn starch, croscarmellose sodium, peppermint flavor, hypromellose, iron oxide, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, polyvinyl alcohol, povidone, talc, titanium dioxide, and triacetin. The 50 mg tablet also contains D&C yellow # 10 and FD&C yellow #6.",
      "dosage": "2.2 Treatment of Heart Failure In patients with serum potassium \u2264 5.0 mEq/L and eGFR > 50 mL/min/1.7",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 955,
    "fields": {
      "name": "TAMSULOSIN HYDROCHLORIDE",
      "brand": "Tamsulosin Hydrochloride",
      "description": "11 DESCRIPTION Tamsulosin hydrochloride is an antagonist of alpha 1A adrenoceptors in the prostate. It is sparingly soluble in water and methanol, slightly soluble in glacial acetic acid and ethanol, and practically insoluble in ether. The molecular formula of tamsulosin hydrochloride is C 20 H 28 N 2 O 5 S \u2022 HCl.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as th",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 956,
    "fields": {
      "name": "TEMAZEPAM",
      "brand": "Temazepam",
      "description": "DESCRIPTION Temazepam, USP is a benzodiazepine hypnotic agent. The chemical name is 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, and the structural formula is: C 16 H 13 ClN 2 O 2 MW = 300.74 Temazepam, USP is a white, crystalline substance, very slightly soluble in water and sparingly soluble in alcohol USP. Temazepam capsules USP, 7.5 mg, 15 mg, 22.5 mg, and 30 mg, are for oral administration.",
      "dosage": "DOSAGE AND ADMINISTRATION While the recommended usual adult dose is 15 mg before retiring, 7.5 mg ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 957,
    "fields": {
      "name": "TERAZOSIN HYDROCHLORIDE",
      "brand": "Terazosin",
      "description": "DESCRIPTION Terazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name,molecular formula and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride.C 19 H 26 ClN 5 O 4 Terazosin hydrochloride is a white, crystalline substance, freely soluble in water and isotonic saline and has a molecular weight of 423.93. Each capsule, for oral administration, contains 1 mg, 2 mg, 5 mg or 10 mg of terazosin as terazosin hydrochlolde. In addition, each capsule contains the following inactive ingredients: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, and pregelatinized starch.",
      "dosage": "DOSAGE AND ADMINISTRATION If terazosin capsules administration is discontinued for several days, the",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 958,
    "fields": {
      "name": "TIZANIDINE",
      "brand": "tizanidine",
      "description": "11 DESCRIPTION Tizanidine Tablets, USP contains tizanidine hydrochloride as the active ingredient, which is a central alpha 2 -adrenergic agonist. Its chemical name is 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiodiazole monohydrochloride. It has a molecular formula of C 9 H 8 CIN 5 S\u00b7HCl and a molecular weight of 290.17.",
      "dosage": "( 2.1 ) Recommended starting dose: 2 mg by mouth every 6 to 8 hours, as needed, up to a maximum of 3",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 959,
    "fields": {
      "name": "TOPIRAMATE",
      "brand": "topiramate",
      "description": "11 DESCRIPTION Topiramate, USP is a sulfamate-substituted monosaccharide. Topiramate tablets, USP are available as 25 mg, 50 mg, 100 mg, and 200 mg round shaped tablets for oral administration. Its saturated solution has a pH of 6.3.",
      "dosage": "Table 2: Monotherapy Target Total Daily Maintenance Dosing for Patients 2 to 9 Years of Age Weight (",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 960,
    "fields": {
      "name": "TRAMADOL HYDROCHLORIDE",
      "brand": "TRAMADOL HYDROCHLORIDE",
      "description": "The chemical name is (\u00b1) cis -2-[(dimethylamino) methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochloride. It is a white, crystalline powder that is freely soluble in water and methanol, very slightly soluble in acetone and has a pKa of 9.41. Tramadol hydrochloride extended-release tablets, USP contain 100 mg, 200 mg or 300 mg of tramadol hydrochloride, USP in an extended-release formulation.",
      "dosage": "2.5 Safe Reduction or Discontinuation of Tramadol Hydrochloride Extended-Release Tablets Do not abru",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 961,
    "fields": {
      "name": "TRAZODONE HYDROCHLORIDE",
      "brand": "Trazodone Hydrochloride",
      "description": "11 DESCRIPTION Trazodone hydrochloride is a selective serotonin reuptake inhibitor and 5HT2 receptor antagonist. Trazodone hydrochloride, USP is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]- 1,2,4-triazolo[4, 3-a]pyridin-3(2H)-one hydrochloride. It is a white to off-white, crystalline powder which is sparingly soluble in chloroform and in water.",
      "dosage": "The dosage should be initiated at a low-dose and increased gradually, noting the clinical response a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 962,
    "fields": {
      "name": "SACUBITRIL AND VALSARTAN",
      "brand": "ENTRESTO",
      "description": "Its molecular mass is 957.99 g/mol and its schematic structural formula is: ENTRESTO is available as film-coated tablets for oral administration, containing 24 mg of sacubitril and 26 mg of valsartan; 49 mg of sacubitril and 51 mg of valsartan; and 97 mg of sacubitril and 103 mg of valsartan. The film-coat inactive ingredients are hypromellose, iron oxide red (E172), polyethylene glycol 4000, talc, and titanium dioxide (E171). The film-coat for the 49 mg of sacubitril and 51 mg of valsartan tablet contains iron oxide yellow (E172).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dosage for adults is 49 mg/51 mg orally twice d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 963,
    "fields": {
      "name": "VENLAFAXINE",
      "brand": "Venlafaxine",
      "description": "DESCRIPTION Venlafaxine hydrochloride is a structurally novel antidepressant for oral administration. Each venlafaxine tablet, USP intended for oral administration contains venlafaxine hydrochloride equivalent to 25 mg or 37.5 mg or 50 mg or 75 mg or 100 mg of venlafaxine. Structured formula for venlafaxine",
      "dosage": "When treating pregnant women with venlafaxine tablets during the third trimester, the physician shou",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 964,
    "fields": {
      "name": "VERAPAMIL HYDROCHLORIDE",
      "brand": "Verapamil Hydrochloride",
      "description": "DESCRIPTION Verapamil hydrochloride is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets containing 40 mg, 80 mg, or 120 mg of verapamil hydrochloride. The structural formula of verapamil hydrochloride is: Benzeneacetonitrile, \u03b1-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-\u03b1-(1-methylethyl) hydrochloride. Verapamil hydrochloride is an almost white, crystalline powder, practically free of odor, with a bitter taste.",
      "dosage": "Angina: Clinical trials show that the usual dose is 80 mg to 120 mg three times a day. However, 40 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 965,
    "fields": {
      "name": "WARFARIN SODIUM",
      "brand": "Warfarin Sodium",
      "description": "11 DESCRIPTION Warfarin sodium tablets, USP contain warfarin sodium, an anticoagulant that acts by inhibiting vitamin K-dependent coagulation factors. 40 aluminum lake, and D&C yellow no. 10 aluminum lake and FD&C yellow no.",
      "dosage": "The duration of treatment is based on the indication as follows: For patients with a DVT or PE secon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 966,
    "fields": {
      "name": "ZALEPLON",
      "brand": "zaleplon",
      "description": "Its molecular formula is C 17 H 15 N 5 O, and its molecular weight is 305.34. Zaleplon capsules USP contain zaleplon as the active ingredient. The 5 mg capsules also contain FD&C yellow #5.",
      "dosage": "Although the risk of certain adverse events associated with the use of zaleplon capsules appears to ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 967,
    "fields": {
      "name": "ZOLPIDEM TARTRATE",
      "brand": "Zolpidem",
      "description": "11 DESCRIPTION Zolpidem Tartrate Tablets, USP contains Zolpidem tartrate, a gamma-aminobutyric acid (GABA) A receptor positive modulator of the imidazopyridine class. It has the following structure: Zolpidem Tartrate is a white to off-white crystalline powder that is sparingly soluble in water, alcohol, and propylene glycol. Opadry II (pink) contains hypromellose, FD&C Red no.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest dose effective for the patient and must not exceed a tota",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 968,
    "fields": {
      "name": "ZOLMITRIPTAN",
      "brand": "Zolmitriptan",
      "description": "11 DESCRIPTION ZOLMITRIPTAN NASAL SPRAY contains zolmitriptan, which is a selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist. Zolmitriptan is chemically designated as (S)-4-[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone and has the following chemical structure: The empirical formula is C 16 H 21 N 3 O 2 , representing a molecular weight of 287.36. The osmolarity of ZOLMITRIPTAN NASAL SPRAY for 2.5 mg is 360 to 420 mOsmol, and for 5 mg is 420 to 470 mOsmol.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting dose: 2.5 mg (2.1) Maximum single dose: 5 mg (2.1) ",
      "stock": 100,
      "route": "NASAL",
      "resupply_pending": 0,
      "pharmacy_id": 4,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 969,
    "fields": {
      "name": "ACETAMINOPHEN",
      "brand": "Pain Reliever Extra Strength",
      "description": "",
      "dosage": "Directions do not take more than directed adults and children 12 years and over take 2 gelcaps every",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 970,
    "fields": {
      "name": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN",
      "brand": "Hydrocodone Bitartrate and Acetaminophen",
      "description": "DESCRIPTION Hydrocodone bitartrate and acetaminophen, USP is available in tablet form for oral administration. It is affected by light. It has the following structural formula: Acetaminophen, 4' -hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "Initial Dosage Initiating Treatment with Hydrocodone Bitartrate and Acetaminophen Tablets 2.5 mg/325",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 971,
    "fields": {
      "name": "ALBUTEROL SULFATE",
      "brand": "Albuterol Sulfate HFA",
      "description": "Albuterol sulfate has the chemical name \u03b1 1 -[( tert -butylamino)methyl]-4-hydroxy- m -xylene-\u03b1, \u03b1\u2032-diol sulfate (2:1)(salt) and the following chemical structure: Albuterol sulfate is a white crystalline powder with a molecular weight of 576.7, and the empirical formula is (C 13 H 21 NO 3 ) 2 \u2022H 2 SO 4 . Each canister contains a microcrystalline suspension of albuterol sulfate in propellant HFA\u2011134a (1,1,1,2\u2011tetrafluoroethane). Prime Albuterol Sulfate HFA before using for the first time, when the inhaler has not been used for more than 2 weeks, or when the inhaler has been dropped.",
      "dosage": "2 DOSAGE AND ADMINISTRATION For oral inhalation only. ( 2 ) Treatment or prevention of bronchospasm ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 972,
    "fields": {
      "name": "ALENDRONATE SODIUM",
      "brand": "Binosto",
      "description": "11 DESCRIPTION BINOSTO (alendronate sodium) is a bisphosphonate that acts as a specific inhibitor of osteoclast-mediated bone resorption. Alendronate sodium is chemically described as (4 amino-1-hydroxybutylidene) bisphosphonic acid, monosodium salt, trihydrate. Once the effervescent tablet is dissolved in water, the alendronate sodium is present in a citrate-buffered solution of pH 4.8 to 5.4.",
      "dosage": "Take BINOSTO upon arising for the day and at least 30 minutes before the first food, beverage, or me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 973,
    "fields": {
      "name": "ALLOPURINOL",
      "brand": "Allopurinol",
      "description": "11 DESCRIPTION Allopurinol, USP is a xanthine oxidase inhibitor. It has the following structural formula: Allopurinol, USP is known chemically as 1, 5-dihydro-4 H -pyrazolo [3, 4- d ]pyrimidin-4-one and it has a molecular weight of 136.1 g/mol. Each scored white round-shaped tablet contains 100 mg allopurinol and the inactive ingredients colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate.",
      "dosage": "2.3 Recommended Dosage for Gout The initial recommended dosage for the management of gout is 100 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 974,
    "fields": {
      "name": "ALPRAZOLAM",
      "brand": "Alprazolam",
      "description": "11 DESCRIPTION Alprazolam tablets, USP contain alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds. The chemical name of alprazolam is 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-\u03b1] [1,4] benzodiazepine. In addition, the 0.5 mg tablet contains FD&C Yellow # 6 aluminum lake and the 1 mg tablet contains FD&C Blue No.",
      "dosage": "Dosage may be increased, at intervals of every 3 to 4 days, to a maximum recommended daily dose of 4",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 975,
    "fields": {
      "name": "AMOXICILLIN",
      "brand": "Amoxicillin",
      "description": "Amoxicillin Tablets, USP: Each film coated tablet contains 500 mg or 875 mg amoxicillin as the trihydrate. Amoxicillin for Oral Suspension, USP: Each 5 mL of reconstituted suspension contains 125 mg, 200 mg, 250 mg or 400 mg amoxicillin as the trihydrate. Each 5 mL of the 125 mg, 200 mg, 250 mg, and 400 mg reconstituted suspension contains 0.30 mEq (6.95 mg) of sodium.",
      "dosage": "Dosing Recommendations for Adult and Pediatric Patients > 3 Months of Age Infection Severity Dosing ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 976,
    "fields": {
      "name": "AMLODIPINE BESYLATE",
      "brand": "Amlodipine Besylate",
      "description": "11 DESCRIPTION Amlodipine besylate is the besylate salt of amlodipine, a long-acting calcium channel blocker. Amlodipine besylate is chemically described as 3-Ethyl-5-methyl (\u00b1)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, monobenzenesulphonate. Amlodipine besylate tablets USP are formulated as tablets equivalent to 2.5 mg, 5 mg and 10 mg of amlodipine for oral administration.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022Adult recommended starting dose: 5 mg once daily with maximum dose 10 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 977,
    "fields": {
      "name": "ARIPIPRAZOLE",
      "brand": "Aripiprazole",
      "description": "11 DESCRIPTION Aripiprazole is an atypical antipsychotic drug that is available as Aripiprazole Tablets, USP. Aripiprazole is 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril. The empirical formula is C 23 H 27 Cl 2 N 3 O 2 and its molecular weight is 448.38.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Initial Dose Recommended Dose Maximum Dose Schizophrenia \u2013 adults (2.1) ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 978,
    "fields": {
      "name": "ATENOLOL",
      "brand": "Atenolol",
      "description": "DESCRIPTION Atenolol, a synthetic, beta 1 -selective (cardioselective) adrenoreceptor blocking agent, may be chemically described as benzeneacetamide, 4-[2\u2019-hydroxy-3\u2019-[(1-methylethyl)amino]propoxy]-. It is a relatively polar hydrophilic compound with a water solubility of 26.5 mg/mL at 37\u00b0C and a log partition coefficient (octanol/water) of 0.23. Atenolol is available as 25, 50 or 100 mg tablets for oral administration.",
      "dosage": "If an optimal response is not achieved, the dosage should be increased to atenolol 100 mg given as o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 979,
    "fields": {
      "name": "ATORVASTATIN CALCIUM",
      "brand": "Atorvastatin calcium",
      "description": "11 DESCRIPTION Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Atorvastatin calcium USP is (\u03b2R, \u03b4R)-2-(p-fluorophenyl)-\u03b2,\u03b4-dihydroxy-5-isopropyl-3-phenyl-4(phenylcarbamoyl)pyrrole-l-heptanaote (1:2), trihydrate. The molecular formula of atorvastatin calcium USP is C 66 H 68 CaF 2 N 4 O 10 .3H 2 O and its molecular weight is 1209.41.",
      "dosage": "2.1 Important Dosage Information Take atorvastatin calcium tablets orally once daily at any time of ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 980,
    "fields": {
      "name": "AZITHROMYCIN",
      "brand": "Azithromycin",
      "description": "11 DESCRIPTION Azithromycin tablets USP contain the active ingredient azithromycin, a macrolide antibacterial drug, for oral administration. Azithromycin has the chemical name (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-\u03b1-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-\u03b2-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Azithromycin is derived from erythromycin; however, it differs chemically from erythromycin in that a methyl-substituted nitrogen atom is incorporated into the lactone ring.",
      "dosage": "Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 500 mg as a single dose on Da",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 981,
    "fields": {
      "name": "BACLOFEN INJECTION",
      "brand": "Gablofen",
      "description": "11 DESCRIPTION GABLOFEN (baclofen injection) is a muscle relaxant and antispastic. Baclofen's pharmacological class is a gamma-aminobutyric acid (GABA) ergic agonist. Baclofen's chemical name is 4-amino-3-(4-chlorophenyl) butanoic acid, and its structural formula is: Baclofen C 10 H 12 ClNO 2 Baclofen is a white to off-white powder, with a molecular weight of 213.66.",
      "dosage": "2.2 Screening Phase Prior to pump implantation and initiation of chronic infusion of GABLOFEN, patie",
      "stock": 100,
      "route": "INTRATHECAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 982,
    "fields": {
      "name": "BENAZEPRIL HYDROCHLORIDE",
      "brand": "Benazepril Hydrochloride",
      "description": "Its chemical name is benazepril 3-[[1-(ethoxy-carbonyl)-3-phenyl-(1S)-propyl]amino]-2,3,4,5-tetrahydro-2-oxo-1 H -1-(3S)-benzazepine-1-acetic acid monohydrochloride; its structural formula is Its empirical formula is C 24 H 28 N 2 O 5 \u2022HCl and its molecular weight is 460.96. Benazepril hydrochloride is supplied as film-coated tablets containing 5 mg, 10 mg, 20 mg, and 40 mg of benazepril hydrochloride for oral administration. Benazepril hydrochloride tablets USP, 5 mg, 10 mg, 20 mg and 40 mg meet USP Dissolution Test 2.",
      "dosage": "\u2022 Renal Impairment: Initiate with 5 mg once daily in patients with GFR <30 mL/min/1.73 m 2 (serum cr",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 983,
    "fields": {
      "name": "BISOPROLOL FUMARATE",
      "brand": "Bisoprolol fumarate",
      "description": "It possesses an asymmetric carbon atom in its structure and is provided as a racemic mixture. Bisoprolol fumarate tablets are available as 5 and 10 mg tablets for oral administration. The 5 mg tablets also contain Red Iron Oxide.",
      "dosage": "DOSAGE AND ADMINISTRATION The dose of bisoprolol fumarate tablets must be individualized to the need",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 984,
    "fields": {
      "name": "BUPROPION HYDROCHLORIDE",
      "brand": "Bupropion Hydrochloride XL",
      "description": "11 DESCRIPTION Bupropion Hydrochloride USP, an antidepressant of the aminoketone class, is chemically unrelated to tricyclic, tetracyclic, selective serotonin reuptake inhibitor, or other known antidepressant agents. Its structure closely resembles that of diethylpropion; it is related to phenylethylamines. The structural formula is: Bupropion Hydrochloride Extended-Release Tablets USP (XL) are supplied for oral administration as 150 mg and 300 mg white to pale yellow extended-release tablets.",
      "dosage": "2.2 Dosage for Major Depressive Disorder (MDD) The recommended starting dose for MDD is 150 mg once ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 985,
    "fields": {
      "name": "BUSPIRONE HYDROCHLORIDE",
      "brand": "Buspirone Hydrochloride",
      "description": "421.96 Each tablet, for oral administration, contains 5 mg, 7.5 mg, 10 mg, 15 mg or 30 mg of buspirone hydrochloride, USP (equivalent to 4.6 mg, 6.9 mg, 9.1 mg, 13.7 mg and 27.4 mg of buspirone free base, respectively). Thus, a single 15 mg tablet can provide the following doses: 15 mg (entire tablet), 10 mg (two-thirds of a tablet), 7.5 mg (one-half of a tablet), or 5 mg (one-third of a tablet). A single 30 mg tablet can provide the following doses: 30 mg (entire tablet), 20 mg (two-thirds of a tablet), 15 mg (one-half of a tablet), or 10 mg (one-third of a tablet).",
      "dosage": "To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 986,
    "fields": {
      "name": "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE",
      "brand": "Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",
      "description": "11 DESCRIPTION Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are supplied in capsule form for oral administration. Each capsule contains: Butalbital, USP 50 mg Acetaminophen, USP 325 mg Caffeine, USP 40 mg Codeine phosphate, USP 30 mg Butalbital (5-allyl-5-isobutylbarbituric acid), is a short-to intermediate-acting barbiturate. It has the following structural formula: C 11 H 16 N 2 O 3 MW 224.26 Acetaminophen (4'hydroxyacetanilide), is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "2.2 Patient Access to Naloxone for the Emergency Treatment of Opioid Overdose Discuss the availabili",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 987,
    "fields": {
      "name": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "brand": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "description": "DESCRIPTION Captopril and hydrochlorothiazide tablets, USP for oral administration combines two antihypertensive agents: captopril and hydrochlorothiazide. Captopril, USP is a white to off-white crystalline powder with characteristic sulfide-like odor; it is freely soluble in water, ethanol, methanol, chloroform, isopropyl alcohol and methylene chloride and soluble in ethyl acetate. Freely soluble in N,N-Dimethylformamide, in n-Butylamine and in diluted solutions of alkali hydroxides.",
      "dosage": "For patients insufficiently responsive to the initial dose, additional captopril or hydrochlorothiaz",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 988,
    "fields": {
      "name": "CARVEDILOL",
      "brand": "Carvedilol",
      "description": "11 DESCRIPTION Carvedilol is a nonselective \u03b2-adrenergic blocking agent with \u03b1 1 -blocking activity. It is (\u00b1)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol. Carvedilol is a racemic mixture with the following structure: Carvedilol, USP is a white to almost white crystalline powder with a molecular weight of 406.5 and a molecular formula of C 24 H 26 N 2 O 4 .",
      "dosage": "Fluid retention (with or without transient worsening heart failure symptoms) should be treated by an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 989,
    "fields": {
      "name": "CEFDINIR",
      "brand": "Cefdinir",
      "description": "DESCRIPTION Cefdinir capsules, USP contain the active ingredient cefdinir, an extended-spectrum, semisynthetic cephalosporin, for oral administration. Chemically, cefdinir is [6R-[6\u03b1,7\u03b2 (Z)]]-7-[[(2-amino-4 thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid. Cefdinir is a white to slightly brownish-yellow solid.",
      "dosage": "DOSAGE & ADMINISTRATION (see INDICATIONS AND USAGE for Indicated Pathogens) The recommended dosage a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 990,
    "fields": {
      "name": "CEFUROXIME AXETIL",
      "brand": "Cefuroxime axetil",
      "description": "Cefuroxime axetil is a semisynthetic, cephalosporin antibacterial drug for oral administration. The chemical name of cefuroxime axetil (1-(acetyloxy) ethyl ester of cefuroxime) is ( RS )-1 hydroxyethyl (6 R ,7 R )-7-[2-(2-furyl)glyoxyl-amido]-3-(hydroxymethyl)-8-oxo-5-thia-1 azabicyclo[4.2.0]-oct-2-ene-2-carboxylate, 72-( Z )-( O -methyl-oxime), 1-acetate 3-carbamate. Cefuroxime axetil is in the amorphous form and has the following structural formula: Cefuroxime axetil tablets, USP are film-coated and contain the equivalent of 250 or 500 mg of cefuroxime as cefuroxime axetil.",
      "dosage": "Pediatric patients (aged 13 years and older) who cannot swallow the cefuroxime axetil tablets whole ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 991,
    "fields": {
      "name": "CELECOXIB",
      "brand": "CELECOXIB",
      "description": "DESCRIPTION Celecoxib capsule is a nonsteroidal anti-inflammatory drug, available as capsules containing 50 mg, 100 mg, 200 mg and 400 mg celecoxib for oral administration. Its molecular formula is C 17 H 14 F 3 N 3 O 2 S, and it has the following chemical structure: Celecoxib USP is a white or almost white crystalline powder with a pKa of 11.1 (sulfonamide moiety). Celecoxib USP is hydrophobic (log P is 3.5) and is soluble in ethanol and in methylene chloride, practically insoluble in water.",
      "dosage": "For patients >25 kg the recommended dose is 100 mg twice daily. For patients who have difficulty swa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 992,
    "fields": {
      "name": "CETIRIZINE HYDROCHLORIDE TABLETS",
      "brand": "cetirizine hydrochloride",
      "description": "",
      "dosage": "Directions adults and children 6 years and over one 10 mg tablet once daily; do not take more than o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 993,
    "fields": {
      "name": "CIPROFLOXACIN",
      "brand": "ciprofloxacin",
      "description": "DESCRIPTION Ciprofloxacin ophthalmic solution is a synthetic, sterile, multiple dose, antimicrobial for topical ophthalmic use. Ciprofloxacin is a fluoroquinolone antibacterial active against a broad spectrum of gram-positive and gram-negative ocular pathogens. It is available as the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid.",
      "dosage": "DOSAGE AND ADMINISTRATION Corneal Ulcers: The recommended dosage regimen for the treatment of cornea",
      "stock": 100,
      "route": "OPHTHALMIC",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 994,
    "fields": {
      "name": "CITALOPRAM",
      "brand": "Citalopram",
      "description": "11 DESCRIPTION Citalopram tablets, USP contain citalopram, a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide is a racemic bicyclic phthalane structure and is designated (\u00b1)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3\u00addihydroisobenzofuran-5-carbonitrile hydrobromide with the following structural formula: The molecular formula is C 20 H 22 BrFN 2 O and its molecular weight is 405.35. Citalopram hydrobromide, USP occurs as a fine, white to off-white powder.",
      "dosage": "2.1 Recommended Dosage Administer citalopram tablets once daily, with or without food, at an initial",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 995,
    "fields": {
      "name": "CLINDAMYCIN PHOSPHATE",
      "brand": "Clindamycin Phosphate",
      "description": "DESCRIPTION Clindamycin phosphate topical lotion, 1% contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. Clindamycin phosphate is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The lotion contains cetostearyl alcohol (2.5%); glycerin; glyceryl stearate SE (with potassium monostearate); isostearyl alcohol (2.5%); methylparaben (0.3%); sodium lauroyl sarcosinate; stearic acid; and purified water.",
      "dosage": "DOSAGE AND ADMINISTRATION Apply a thin film of clindamycin phosphate topical lotion twice daily to a",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 996,
    "fields": {
      "name": "CLONAZEPAM",
      "brand": "Clonazepam",
      "description": "DESCRIPTION Clonazepam Tablets, USP, a benzodiazepine, is available as scored tablet with debossing \u039b containing 0.5 mg of clonazepam and unscored tablets with debossing \u039b and \u039b containing 1 mg or 2 mg of clonazepam respectively. Each 66 67 69 tablet also contains lactose monohydrate, polyethylene glycol, microcrystalline cellulose, croscarmellose sodium and magnesium stearate with the following colourants: 0.5 mg-FD & C Yellow 6 Al Lake, D & C Yellow 10 Al Lake; 1 mg-FD & C Blue 1 Al lake and FD & C Blue 2 Al lake Chemically, clonazepam is 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder.",
      "dosage": "Geriatric Patients: There is no clinical trial experience with clonazepam tablets in seizure disorde",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 997,
    "fields": {
      "name": "CLOPIDOGREL BISULFATE",
      "brand": "Clopidogrel",
      "description": "11 DESCRIPTION Clopidogrel bisulfate is a thienopyridine class inhibitor of P2Y 12 ADP platelet receptors. Chemically it is methyl (+)-( S )-\u03b1-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4 H )-\u00adacetate sulfate (1:1). The structural formula is as follows: Clopidogrel bisulfate USP is a white to off-white powder.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Acute coronary syndrome ( 2.1 ) \u2013 Initiate clopidogrel tablets with a si",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 998,
    "fields": {
      "name": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "brand": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "description": "DESCRIPTION Cyclobenzaprine hydrochloride, USP is a tricyclic amine salt which is white to off white, odourless, crystalline powder with the molecular formula C 20 H 21 N \u2022 HCl and a molecular weight of 311.9. Cyclobenzaprine hydrochloride is designated chemically as 3-(5H -dibenzo[a,d] cyclohepten-5-ylidene)- N,N -dimethyl-1-propanamine hydrochloride, and has the following structural formula: Cyclobenzaprine hydrochloride tablets, USP are available as 5 mg, 7.5 mg and 10 mg tablets for oral administration. In addition, the 5 mg tablets contain FD&C Blue #2/INDIGO Carmine Aluminum Lake.",
      "dosage": "DOSAGE AND ADMINISTRATION For most patients, the recommended dose of cyclobenzaprine hydrochloride t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 999,
    "fields": {
      "name": "DAPAGLIFLOZIN",
      "brand": "FARXIGA",
      "description": "11 DESCRIPTION Dapagliflozin, an inhibitor of SGLT2, is described chemically as D-glucitol, 1,5-anhydro-1- C -[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1 S )-, compounded with (2 S )-1,2-propanediol, hydrate (1:1:1). The empirical formula is C 21 H 25 ClO 6 \u2022C 3 H 8 O 2 \u2022H 2 O and the molecular weight is 502.98. The structural formula is: FARXIGA is available as a film-coated tablet for oral administration containing the equivalent of 5 mg dapagliflozin as dapagliflozin propanediol or the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol, and the following inactive ingredients: microcrystalline cellulose, anhydrous lactose, crospovidone, silicon dioxide, and magnesium stearate.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022 Assess volume status and correct volume depletion before initiating. I",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1000,
    "fields": {
      "name": "DESVENLAFAXINE SUCCINATE",
      "brand": "Pristiq Extended-Release",
      "description": "11 DESCRIPTION PRISTIQ is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. Desvenlafaxine is designated RS -4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol and has the empirical formula of C 16 H 25 NO 2 (free base) and C 16 H 25 NO 2 \u2219C 4 H 6 O 4 \u2219H 2 O (succinate monohydrate). Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C yellow #6.",
      "dosage": "In clinical studies, doses of 50 mg to 400 mg per day were shown to be effective, although no additi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1001,
    "fields": {
      "name": "DIAZEPAM",
      "brand": "Diazepam",
      "description": "The molecular formula is C 16 H 13 ClN 2 O and the molecular weight is 284.7. The structural formula is as follows: Diazepam is available for oral administration as tablets containing 2 mg, 5 mg or 10 mg diazepam, USP. 10 Aluminum Lake and FD&C Blue No.",
      "dosage": "2 mg to 10 mg, 3 or 4 times daily Adjunctively in Convulsive Disorders. 2 mg to 2.5 mg, 1 or 2 times",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1002,
    "fields": {
      "name": "DICLOFENAC SODIUM",
      "brand": "Diclofenac Sodium",
      "description": "",
      "dosage": "Directions Use up to 21 days unless directed by your doctor Not for strains, sprains, bruises or spo",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1003,
    "fields": {
      "name": "DICYCLOMINE HYDROCHLORIDE",
      "brand": "Dicyclomine hydrochloride",
      "description": "11 DESCRIPTION Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent available as: Dicyclomine hydrochloride capsules, USP for oral use containing 10 mg dicyclomine hydrochloride, USP. Dicyclomine hydrochloride 10 mg capsules contain the following inactive ingredients: corn starch, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. Capsule shells contain FD&C Blue No.1, FD&C Red No.40, gelatin, purified water, and sodium lauryl sulfate.",
      "dosage": "Dosage for dicyclomine hydrochloride capsules must be adjusted to individual patient needs (2) . Aft",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1004,
    "fields": {
      "name": "DIGOXIN",
      "brand": "Digoxin",
      "description": "11 DESCRIPTION Digoxin is one of the cardiac (or digitalis) glycosides, a closely related group of drugs having in common specific effects on the myocardium. These drugs are found in a number of plants. The term \u201cdigitalis\u201d is used to designate the whole group of glycosides.",
      "dosage": "2.2 Loading Dosing Regimen in Adults and Pediatric Patients For adults and pediatric patients if a l",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1005,
    "fields": {
      "name": "DILTIAZEM HYDROCHLORIDE",
      "brand": "diltiazem hydrochloride",
      "description": "DESCRIPTION Diltiazem hydrochloride is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1, 5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2, 3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride,(+)-cis-. The chemical structure is: USP Dissolution pending.",
      "dosage": "Individual patients may respond to higher doses of up to 480 mg once daily. Antihypertensives : Dilt",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1006,
    "fields": {
      "name": "DIPHENHYDRAMINE HCL",
      "brand": "Childrens Allergy Relief",
      "description": "",
      "dosage": "Directions \u25a0 if needed, take every 4-6 hours \u25a0 do not take more than 6 doses in 24-hours children un",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1007,
    "fields": {
      "name": "DIVALPROEX SODIUM",
      "brand": "Divalproex Sodium",
      "description": "Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium extended-release tablets, USP contain divalproex sodium in a once-a-day extended-release formulation equivalent to 250 or 500 mg of valproic acid. Inactive Ingredients: ammonium hydroxide, colloidal anhydrous silica, colloidal silicon dioxide, dibutyl sebacate, ethylcellulose, hydroxyethyl cellulose, hypromellose, oleic acid, polydextrose, polyethylene glycol, silicified microcrystalline cellulose, titanium dioxide and triacetin.",
      "dosage": "Although doses other than 1,000 mg once daily of divalproex sodium extended-release tablets have not",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1008,
    "fields": {
      "name": "DOXYCYCLINE",
      "brand": "doxycycline",
      "description": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Doxycycline is an antibacterial drug synthetically derived from oxytetracycline, and is available as capsules of doxycycline hyclate for oral administration. The structural formula of doxycycline monohydrate is with a molecular formula of C 22 H 24 N 2 O 8 \u2219H 2 O and a molecular weight of 462.46.",
      "dosage": "Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1009,
    "fields": {
      "name": "DULAGLUTIDE",
      "brand": "TRULICITY",
      "description": "11 DESCRIPTION Dulaglutide is a human glucagon-like peptide-1 (GLP-1) receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1 analog sequence covalently linked to the Fc portion of a modified human immunoglobulin G4 (IgG4) heavy chain by a small peptide linker and is produced using mammalian cell (Chinese hamster ovary) culture. The GLP-1 analog portion of dulaglutide is 90% homologous to native human GLP-1 (7-37).",
      "dosage": "2 DOSAGE AND ADMINISTRATION Adult Dosage ( 2.1 ) Recommended starting dosage is 0.75 mg injected sub",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1010,
    "fields": {
      "name": "ENALAPRIL MALEATE",
      "brand": "Enalapril Maleate",
      "description": "DESCRIPTION Enalapril maleate is the maleate salt of enalapril, the ethyl ester of a long-acting angiotensin-converting enzyme inhibitor, enalaprilat. Its molecular formula is C 20 H 28 N 2 O 5 \u2219C 4 H 4 O 4, and its structural formula is: Enalapril maleate is a white to off-white, crystalline powder with a molecular weight of 492.53. Enalapril is a pro-drug; following oral administration, it is bioactivated by hydrolysis of the ethyl ester to enalaprilat, which is the active angiotensin-converting enzyme inhibitor.",
      "dosage": "DOSAGE AND ADMINISTRATION Hypertension In patients who are currently being treated with a diuretic, ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1011,
    "fields": {
      "name": "ESCITALOPRAM ORAL",
      "brand": "Escitalopram Oral Solution",
      "description": "11 DESCRIPTION Escitalopram Oral Solution, USP contains escitalopram oxalate, an orally administered selective serotonin reuptake inhibitor (SSRI), present as escitalopram oxalate salt. Escitalopram is the pure S-enantiomer (single isomer) of the racemic bicyclic phthalane derivative citalopram. Escitalopram oxalate is designated S-(+)-1-[3-(dimethyl-amino)propyl]-1-( p -fluorophenyl)-5-phthalancarbonitrile oxalate with the following structural formula: The molecular formula is C 20 H 21 FN 2O \u2022 C 2 H 2 O 4 and the molecular weight is 414.40.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication and Population Recommended Dosage MDD in Adults ( 2.1 ) Initi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1012,
    "fields": {
      "name": "ESOMEPRAZOLE MAGNESIUM",
      "brand": "Acid Reducer",
      "description": "",
      "dosage": "Directions adults 18 years of age and older this product is to be used once a day (every 24 hours), ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1013,
    "fields": {
      "name": "ESZOPICLONE",
      "brand": "Eszopiclone",
      "description": "11 DESCRIPTION Eszopiclone is a hypnotic agent/nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class. The chemical name of eszopiclone is (+)-4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5 H pyrrolo[3,4- b ]pyrazin-5-(S)-yl ester. In addition, both the 1 mg and 3 mg tablets contain FD&C Blue #2/indigo carmine aluminium lake.",
      "dosage": "May increase dose if clinically indicated, to a maximum of 3 mg ( 2.1 ) \u2022 Geriatric or debilitated p",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1014,
    "fields": {
      "name": "FENTANYL CITRATE",
      "brand": "Fentanyl Citrate",
      "description": "Fentanyl citrate is chemically identified as N -(1-Phenethyl-4-piperidyl)propionanilide citrate (1:1) with the following structural formula: C 22 H 28 N 2 O \u2022 C 6 H 8 O 7 Molecular Weight is 528.59 Each mL contains fentanyl citrate equivalent to 50 mcg (0.05 mg) fentanyl base in Water for Injection. Sodium hydroxide and/or hydrochloric acid added, if needed, for pH adjustment. The pH range is 4.0 to 7.5.",
      "dosage": "For use in more major surgical procedures, in addition to adequate analgesia, may abolish some of th",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1015,
    "fields": {
      "name": "FEXOFENADINE HCL",
      "brand": "Fexofenadine HCL",
      "description": "",
      "dosage": "Directions adults and children 12 years of age and over: take one 180 mg tablet with water every onc",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1016,
    "fields": {
      "name": "FINASTERIDE",
      "brand": "Finasteride",
      "description": "11 DESCRIPTION Finasteride tablets USP, 1 mg contains finasteride as the active ingredient. Finasteride is 4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5\u03b1, 17\u03b2)-. Its structural formula is: Finasteride is a white crystalline powder with a melting point near 250\u00b0 C. It is freely soluble in chloroform and in lower alcohol solvents but is practically insoluble in water.",
      "dosage": "The recommended dose of finasteride tablets USP is one tablet (1 mg) taken once daily. In general, d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1017,
    "fields": {
      "name": "FLUCONAZOLE",
      "brand": "Fluconazole",
      "description": "DESCRIPTION Fluconazole, the first of a new subclass of synthetic triazole antifungal agents, is available as tablets for oral administration. Fluconazole is designated chemically as 2,4-difluoro-\u03b1,\u03b1 1 -bis(1H-1,2,4-triazol-1-ylmethyl) benzyl alcohol with a molecular formula of C 13 H 12 F 2 N 6 O and molecular weight of 306.3. The structural formula is: Fluconazole USP is a white crystalline solid which is slightly soluble in water and saline.",
      "dosage": "DOSAGE AND ADMINISTRATION Dosage and Administration in Adults: Single Dose Vaginal candidiasis: The ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1018,
    "fields": {
      "name": "FLUOXETINE HYDROCHLORIDE",
      "brand": "Fluoxetine",
      "description": "11 DESCRIPTION Fluoxetine capsules, USP are a selective serotonin reuptake inhibitor for oral administration. It is also marketed for the treatment of premenstrual dysphoric disorder (Sarafem \u00ae , fluoxetine hydrochloride). In addition, 20 mg capsules also contains D&C Yellow #10 and 10 mg capsules also contains FD&C Yellow #6.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication Adult Pediatric MDD ( 2.1 ) 20 mg/day in am (initial dose) 10",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1019,
    "fields": {
      "name": "FLUTICASONE PROPIONATE",
      "brand": "FLOVENT DISKUS",
      "description": "11 DESCRIPTION FLOVENT DISKUS inhalation powder is a dry powder inhaler for oral inhalation. The active component of FLOVENT DISKUS 50 mcg, FLOVENT DISKUS 100 mcg, and FLOVENT DISKUS 250 mcg is fluticasone propionate, a corticosteroid having the chemical name S- (fluoromethyl) 6\u03b1,9-difluoro-11\u03b2,17-dihydroxy-16\u03b1-methyl-3-oxoandrosta-1,4-diene-17\u03b2-carbothioate, 17-propionate and the following chemical structure: Fluticasone propionate is a white powder with a molecular weight of 500.6, and the empirical formula is C 25 H 31 F 3 O 5 S. It is practically insoluble in water, freely soluble in dimethyl sulfoxide and dimethylformamide, and slightly soluble in methanol and 95% ethanol. Each blister on the strip contains a white powder mix of micronized fluticasone propionate (50, 100, or 250 mcg) in 12.5 mg of formulation containing lactose monohydrate (which contains milk proteins).",
      "dosage": "2.2 Recommended Dosage Adult and Adolescent Patients Aged 12 Years and Older The starting dosage is ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1020,
    "fields": {
      "name": "GABAPENTIN",
      "brand": "Gabapentin",
      "description": "11 DESCRIPTION The active ingredient in Gabapentin Capsules USP is gabapentin, which has the chemical name 1-(aminomethyl)cyclohexaneacetic acid. The molecular formula of gabapentin is C 9 H 17 NO 2 and the molecular weight is 171.24. The structural formula of gabapentin is: Gabapentin is a white to off-white crystalline solid with a pK a1 of 3.7 and a pK a2 of 10.7.",
      "dosage": "2 DOSAGE AND ADMlNlSTRATION Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1021,
    "fields": {
      "name": "GEMFIBROZIL",
      "brand": "Gemfibrozil",
      "description": "DESCRIPTION Gemfibrozil, USP is a lipid regulating agent. It is available as tablets for oral administration. Each tablet contains 600 mg gemfibrozil.",
      "dosage": "DOSAGE AND ADMINISTRATION The recommended dose for adults is 1,200 mg administered in two divided do",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1022,
    "fields": {
      "name": "GLIMEPIRIDE",
      "brand": "Glimepiride",
      "description": "11 DESCRIPTION Glimepiride tablets USP, are an oral sulfonylurea that contains the active ingredient glimepiride USP. Chemically, glimepiride USP is identified as 1-[[p-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea (C 24 H 34 N 4 O 5 S) with a molecular weight of 490.62. Glimepiride USP is a white to almost white powder, soluble in dimethyl formamide, sparingly soluble in methylene chloride, practically insoluble in water.",
      "dosage": "The recommended starting dose of glimepiride tablets are 1 mg or 2 mg once daily. Patients at increa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1023,
    "fields": {
      "name": "GLIPIZIDE",
      "brand": "Glipizide",
      "description": "The Chemical Abstracts name of glipizide is 1-cyclohexyl-3-[[ p -[2-(5-methylpyrazine-carboxamido)ethyl]phenyl]sulfonyl]urea. The molecular formula is C 21 H 27 N 5 O 4 S; the molecular weight is 445.55; the structural formula is shown below: Glipizide is a whitish, odorless powder with a pKa of 5.9. Glipizide Tablets USP for oral use are available in 5 and 10 mg strengths.",
      "dosage": "In addition to the usual monitoring of urinary glucose, the patient\u2019s blood glucose must also be mon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1024,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1025,
    "fields": {
      "name": "HYDROXYCHLOROQUINE SULFATE",
      "brand": "Hydroxychloroquine Sulfate",
      "description": "DESCRIPTION Hydroxychloroquine sulfate is a white or practically white, crystalline powder, freely soluble in water; practically insoluble in alcohol, chloroform, and in ether. The chemical name for hydroxychloroquine sulfate is 2-[[4-[(7-Chloro-4-quinolyl) amino]pentyl] ethylamino]ethanol sulfate (1:1). Its structural formula is: The molecular weight of hydroxychloroquine sulfate is 433.95, and molecular formula is C 18 H 26 ClN 3 O.H 2 SO 4 .",
      "dosage": "Treatment of Uncomplicated Malaria Adults: 800 mg (620 mg base) followed by 400 mg (310 mg base) at ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1026,
    "fields": {
      "name": "IBUPROFEN",
      "brand": "Ibuprofen Dye Free",
      "description": "",
      "dosage": "Directions do not take more than directed the smallest effective dose should be used adults and chil",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1027,
    "fields": {
      "name": "INSULIN ASPART",
      "brand": "NOVOLOG",
      "description": "11 DESCRIPTION Insulin aspart is a rapid-acting human insulin analog homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Saccharomyces cerevisiae (baker's yeast). Insulin aspart has the empirical formula C 256 H 381 N 65 0 79 S 6 and a molecular weight of 5825.8 Da. NOVOLOG has a pH of 7.2-7.6.",
      "dosage": "\u2022 Continuous Subcutaneous Infusion (Insulin Pump) ( 2.2 ): o Refer to the insulin infusion pump user",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1028,
    "fields": {
      "name": "INSULIN DETEMIR",
      "brand": "LEVEMIR",
      "description": "Insulin detemir has a molecular formula of C 267 H 402 O 76 N 64 S 6 and a molecular weight of 5.917 kDa. Hydrochloric acid and/or sodium hydroxide may be added to adjust pH. Levemir Chemical Structure.jpg",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1029,
    "fields": {
      "name": "INSULIN GLARGINE",
      "brand": "BASAGLAR Tempo Pen",
      "description": "Insulin glargine has the following structural formula: BASAGLAR (insulin glargine) injection is a sterile clear and colorless aqueous solution for subcutaneous use. The 3 mL BASAGLAR prefilled pen presentations contain the following inactive ingredients per mL: glycerin (17 mg), metacresol (2.7 mg), zinc oxide (content adjusted to provide 30 mcg zinc ion), and Water for Injection, USP. BASAGLAR has a pH of approximately 4.",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1030,
    "fields": {
      "name": "INSULIN LISPRO",
      "brand": "ADMELOG",
      "description": "11 DESCRIPTION Insulin lispro is a rapid-acting human insulin analog produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli . Insulin lispro has a pH of 7.0 to 7.8. The pH is adjusted by addition of aqueous solutions of hydrochloric acid and/or sodium hydroxide.",
      "dosage": "Use in accordance with the insulin pump instructions for use. Administer ADMELOG by continuous subcu",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1031,
    "fields": {
      "name": "ISOSORBIDE MONONITRATE",
      "brand": "ISOSORBIDE MONONITRATE",
      "description": "Each tablet, for oral administration, contains either 30 mg, 60 mg or 120 mg of isosorbide mononitrate in an extended-release formulation. In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, diethyl phthalate, hydrogenated castor oil, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc and titanium dioxide. The chemical name for ISMN is 1,4:3,6-dianhydro-,D-glucitol 5-nitrate; the compound has the following structural formula: ISMN is a white, crystalline, odorless compound which is stable in air and in solution, has a melting point of about 90\u00b0C, and an optical rotation of +144\u00b0 (2% in water, 20\u00b0C).",
      "dosage": "After several days, the dosage may be increased to 120 mg (given as a single 120 mg tablet or as two",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1032,
    "fields": {
      "name": "LAMOTRIGINE",
      "brand": "Lamotrigine",
      "description": "11 DESCRIPTION Lamotrigine, USP an AED of the phenyltriazine class, is chemically unrelated to existing AEDs. Lamotrigine\u2019s chemical name is 3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine, its molecular formula is C 9 H 7 N 5 Cl 2 , and its molecular weight is 256.09. Lamotrigine orally disintegrating tablets are formulated using in-house technologies designed to mask the bitter taste of lamotrigine and achieve a rapid dissolution profile.",
      "dosage": "Adjustments to the Maintenance Dose of Lamotrigine in Women Taking Estrogen-Containing Oral Contrace",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1033,
    "fields": {
      "name": "LANSOPRAZOLE",
      "brand": "Lansoprazole",
      "description": "Lansoprazole has the following structure: Lansoprazole is a white to brownish-white odorless crystalline powder which melts with decomposition at approximately 166\u00b0C. The degradation half-life of the drug substance in aqueous solution at 25\u00b0C is approximately 0.5 hour at pH 5.0 and approximately 18 hours at pH 7.0. Lansoprazole Delayed-Release Capsules, USP are supplied in delayed-release capsules for oral administration.The delayed-release capsules are available in two dosage strengths: 15 mg and 30 mg of lansoprazole per capsule.",
      "dosage": "For patients who have difficulty swallowing capsules, Lansoprazole delayed-release capsules can be o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1034,
    "fields": {
      "name": "LEVETIRACETAM",
      "brand": "Levetiracetam Extended-release",
      "description": "11 DESCRIPTION Levetiracetam Extended-release Tablets USP is an antiepileptic drug available as 500 mg and 750 mg (white) extended-release tablets for oral administration. It has the following structural formula: Levetiracetam is a white to off-white crystalline powder with a faint odor and a bitter taste. It is freely soluble in chloroform (65.3 g/100 mL) and in methanol (53.6 g/100 mL), soluble in ethanol (16.5 g/100 mL), sparingly soluble in acetonitrile (5.7 g/100 mL) and practically insoluble in n-hexane.",
      "dosage": "2 DOSAGE & ADMINISTRATION Initiate treatment with a dose of 1,000 mg once daily; increase by 1,000 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1035,
    "fields": {
      "name": "LEVOTHYROXINE, LIOTHYRONINE",
      "brand": "NP Thyroid 120",
      "description": "NP Thyroid \u00ae (thyroid tablets, USP) for oral use is a natural preparation derived from porcine thyroid glands. They contain both tetraiodothyronine sodium (T 4 levothyroxine) and triiodothyronine sodium (T 3 liothyronine) providing 38 mcg levothyroxine (T 4 ) and 9 mcg liothyronine (T 3 ) per grain of thyroid. The inactive ingredients are calcium stearate, dextrose (agglomerated) and mineral oil.",
      "dosage": "DOSAGE AND ADMINISTRATION The dosage of thyroid hormones is determined by the indication and must in",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1036,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1037,
    "fields": {
      "name": "LORAZEPAM",
      "brand": "Lorazepam",
      "description": "DESCRIPTION Lorazepam USP, an antianxiety agent, has the chemical formula, 7-chloro-5-( o -chlorophenyl)-1,3\u2011-dihydro-3-hydroxy-2 H -1,4-benzodiazepin-2-one: It is a nearly white powder almost insoluble in water. Each lorazepam tablet, USP to be taken orally, contains 0.5 mg, 1 mg, or 2 mg of lorazepam, USP. The inactive ingredients present are anhydrous lactose, magnesium stearate, microcrystalline cellulose, and polacrilin potassium.",
      "dosage": "DOSAGE AND ADMINISTRATION Lorazepam tablets are administered orally. For insomnia due to anxiety or ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1038,
    "fields": {
      "name": "LOSARTAN POTASSIUM",
      "brand": "Losartan Potassium",
      "description": "11 DESCRIPTION Losartan potassium is an angiotensin II receptor blocker acting on the AT 1 receptor subtype. Its molecular formula is C 22 H 22 ClKN 6 O, and its structural formula is: Losartan potassium, USP is white to off-white powder with a molecular weight of 461.01. It is freely soluble in water; soluble in isopropyl alcohol; slightly soluble in acetonitrile.",
      "dosage": "Pediatric Hypertension The usual recommended starting dose is 0.7 mg per kg once daily (up to 50 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1039,
    "fields": {
      "name": "LOVASTATIN",
      "brand": "Lovastatin",
      "description": "This enzyme catalyzes the conversion of HMG-CoA to mevalonate, which is an early and rate limiting step in the biosynthesis of cholesterol. 404.55 C 24 H 36 O 5 M.W. Lovastatin Tablets USP, 40 mg also contain D&C Yellow #10 Aluminum Lake, FD&C Blue #1 Aluminum Lake, and FD&C Yellow #6 Aluminum Lake.",
      "dosage": "Patients requiring reductions in LDL-C of 20% or more to achieve their goal (see INDICATIONS AND USA",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1040,
    "fields": {
      "name": "LURASIDONE HYDROCHLORIDE",
      "brand": "Lurasidone Hydrochloride",
      "description": "11 DESCRIPTION Lurasidone hydrochloride is an atypical antipsychotic belonging to the chemical class of benzisothiazol derivatives. Its chemical name is (3a R ,4 S ,7 R ,7a S )-2-{(1 R ,2 R )-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-\u00adylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2 H -isoindole-1,3-dione hydrochloride. Its molecular formula is C 28 H 36 N 4 O 2 S\u00b7HCl and its molecular weight is 529.14.",
      "dosage": "Lurasidone hydrochloride tablets have been shown to be effective in a dose range of 40 mg per day to",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1041,
    "fields": {
      "name": "MELOXICAM",
      "brand": "Meloxicam",
      "description": "11 DESCRIPTION Meloxicam, is a nonsteroidal anti-inflammatory drug (NSAID). Its empirical formula is C 14 H 13 N 3 O 4 S 2 and it has the following structural formula: Meloxicam is a pastel yellow solid, practically insoluble in water, with higher solubility observed in strong acids and bases. Meloxicam tablets USP are available as tablets for oral administration containing 7.5 mg or 15 mg meloxicam.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest effective dosage for the shortest duration consistent wit",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1042,
    "fields": {
      "name": "MEMANTINE",
      "brand": "Memantine hydrochloride",
      "description": "11 DESCRIPTION Memantine hydrochloride, USP is an orally active NMDA receptor antagonist. The tablets also contain the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose and talc. In addition the following inactive ingredients are also present as components of the film coat: D&C Yellow #10, FD&C Blue #2, FD&C Yellow #6, macrogol, polyvinyl alcohol, talc, and titanium dioxide (5 mg tablets), and iron oxide black, iron oxide yellow, macrogol, polyvinyl alcohol, talc and titanium dioxide (10 mg tablets).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dose of memantine hydrochloride tablets is 5 mg",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1043,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1044,
    "fields": {
      "name": "METHADONE HYDROCHLORIDE",
      "brand": "Methadone Hydrochloride",
      "description": "DESCRIPTION Methadone Hydrochloride Oral Concentrate, USP, contains methadone, an opiate agonist, and is available as a cherry flavored liquid concentrate for oral administration. It is present in methadone hydrochloride oral concentrate as the racemic mixture. Other ingredients of Methadone Hydrochloride Oral Concentrate, USP (Dye-Free, Sugar-Free, Unflavored): citric acid anhydrous, purified water, and sodium benzoate.",
      "dosage": "Titration and Maintenance Treatment of Opioid Dependence Patients in maintenance treatment should be",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1045,
    "fields": {
      "name": "METHOCARBAMOL",
      "brand": "Methocarbamol",
      "description": "The chemical name of methocarbamol is 3-(2-meth-oxyphenoxy)-1,2-propanediol 1-carbamate and has the empirical formula C 11 H 15 NO 5 . Its molecular weight is 241.24. Methocarbamol tablets, USP are available as 500 mg and 750 mg tablets for oral administration.",
      "dosage": "Maintenance dosage: 2 tablets q.i.d. Methocarbamol tablets, USP: 750 mg \u2013 Adults: Initial dosage: 2 ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1046,
    "fields": {
      "name": "METHYLPHENIDATE HYDROCHLORIDE",
      "brand": "Methylphenidate Hydrochloride (LA)",
      "description": "Each Methylphenidate Hydrochloride Extended-Release Capsule contains pellets, with half the dose as immediate-release and half as delayed-release, thus providing an immediate release of methylphenidate and a second delayed release of methylphenidate. The active substance in Methylphenidate Hydrochloride Extended-Release Capsules is methyl \u03b1-phenyl-2-piperidineacetate hydrochloride. Its structural formula is as follows: M.W.",
      "dosage": "The drug and applesauce mixture should not be stored for future use. 2.3 Patients Currently Using Me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1047,
    "fields": {
      "name": "METOPROLOL TARTRATE",
      "brand": "Metoprolol Tartrate",
      "description": "11 DESCRIPTION Metoprolol tartrate tablets, USP contain metoprolol tartrate, a selective beta 1 -adrenoreceptor blocking agent. It is very soluble in water; freely soluble in methylene chloride, in chloroform, and in alcohol; slightly soluble in acetone; and insoluble in ether. Metoprolol tartrate tablets, USP are available as 25 mg, 50 mg and 100 mg tablets for oral administration containing 25 mg, 50 mg and 100 mg metoprolol tartrate, respectively.",
      "dosage": "The effective dosage range of metoprolol tartrate tablets is 100 mg to 450 mg per day. The effective",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1048,
    "fields": {
      "name": "METRONIDAZOLE",
      "brand": "Metronidazole",
      "description": "DESCRIPTION Metronidazole tablets, USP 250 mg or 500 mg is an oral formulation of the synthetic nitroimidazole antimicrobial, 2-methyl-5-nitro-1H-imidazole-1-ethanol, which has the following structural formula: Metronidazole tablets USP contain 250 mg or 500 mg of metronidazole. Inactive ingredients include powdered cellulose, hydroxypropyl cellulose, low substituted hydroxypropyl cellulose, hypromellose, polyethylene glycol, stearic acid, and titanium dioxide. Molecular Structure",
      "dosage": "There is some indication from controlled comparative studies that cure rates as determined by vagina",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1049,
    "fields": {
      "name": "MIRTAZAPINE",
      "brand": "Mirtazapine",
      "description": "Mirtazapine has a tetracyclic chemical structure and belongs to the piperazino-azepine group of compounds. It is designated 1,2,3,4,10,14b-hexahydro-2-methylpyrazino [2,1-a] pyrido [2,3-c][2] benzazepine and has the molecular formula of C 17 H 19 N 3 . The structural formula is the following and it is the racemic mixture: Mirtazapine is a white to creamy white crystalline powder which is practically insoluble in water.",
      "dosage": "If patients do not have an adequate response to the initial 15 mg dose, increase the dose up to a ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1050,
    "fields": {
      "name": "MONTELUKAST SODIUM",
      "brand": "Montelukast Sodium",
      "description": "DESCRIPTION Montelukast sodium, the active ingredient in montelukast sodium tablets, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT 1 receptor. Montelukast sodium is described chemically as [ R-(E) ]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl] cyclopropaneacetic acid, monosodium salt. Each 10-mg film-coated montelukast sodium tablet contains 10.4 mg montelukast sodium, which is equivalent to 10 mg of montelukast, and the following inactive ingredients: croscarmellose sodium, ferric oxide red, ferric oxide yellow, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose and titanium dioxide.",
      "dosage": "Patients with both asthma and allergic rhinitis should take only one dose daily in the evening (2.4)",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1051,
    "fields": {
      "name": "NAPROXEN",
      "brand": "Naproxen",
      "description": "11 DESCRIPTION Naproxen Tablets, USP and Naproxen Sodium Tablets, USP are nonsteroidal anti-inflammatory drugs available as follows: Naproxen Tablets, USP are available as follows for oral administration: 250 mg: circular, light orange colored, flat, uncoated tablets, engraved with \u2018G\u2019 and \u201832\u2019 on either side of a break line on one side and \u2018250\u2019 on the other side. The inactive ingredients are croscarmellose sodium, iron oxide red, iron oxide yellow, magnesium stearate, microcrystalline cellulose and povidone. Naproxen, USP and naproxen sodium, USP have the following structures, respectively: Naproxen Naproxen Sodium Naproxen, USP is a white to off-white crystalline powder.",
      "dosage": "Management of Pain, Primary Dysmenorrhea, and Acute Tendonitis and Bursitis Recommended starting dos",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1052,
    "fields": {
      "name": "NITROGLYCERIN",
      "brand": "NITROGLYCERIN",
      "description": "11 DESCRIPTION Nitroglycerin sublingual tablets are stabilized sublingual compressed tablets that contain 0.3 mg, 0.4 mg, or 0.6 mg nitroglycerin; as well as lactose monohydrate, NF; glyceryl monostearate, NF; pregelatinized starch, NF; calcium stearate, NF powder; and silicon dioxide, colloidal, NF. Nitroglycerin, an organic nitrate, is a vasodilating agent. The chemical name for nitroglycerin is 1, 2, 3 propanetriol trinitrate and the chemical structure is: Molecular weight: 227.09 Nitroglycerin Structural Formula",
      "dosage": "2 DOSAGE AND ADMINISTRATION Administer one tablet under the tongue or in the buccal pouch at the fir",
      "stock": 100,
      "route": "SUBLINGUAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1053,
    "fields": {
      "name": "NORTRIPTYLINE HYDROCHLORIDE",
      "brand": "Nortriptyline Hydrochloride",
      "description": "DESCRIPTION Nortriptyline Hydrochloride, USP is 1-propanamine, 3-(10,11-dihydro-5 H -dibenzo[ a,d ]cyclohepten-5-ylidene)- N -methyl, hydrochloride. The structural formula is as follows: C19H21N\u2219HCl MW = 299.84 Each capsule, for oral administration, contains nortriptyline hydrochloride equivalent to 10 mg, 25 mg, 50 mg, and 75 mg of nortriptyline hydrochloride USP. In addition, each capsule contains the following inactive ingredients: black iron oxide, colloidal silicon dioxide, D&C Yellow #10 (aluminum lake), D&C Yellow #10, FD&C Blue #1 (aluminum lake), FD&C Blue #2 (aluminum lake), FD&C Green #3 (10, 50 and 75 mg only), FD&C Red #40 (aluminum lake), gelatin, I.M.S. 74 OP, magnesium stearate, pregelatinized corn starch, shellac, sodium lauryl sulfate and titanium dioxide.",
      "dosage": "Usual Adult Dose 25 mg three or four times daily; dosage should begin at a low level and be increase",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1054,
    "fields": {
      "name": "OMEPRAZOLE",
      "brand": "Omeprazole",
      "description": "",
      "dosage": "Directions for adults 18 years of age and older this product is to be used once a day (every 24 hour",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1055,
    "fields": {
      "name": "ONDANSETRON HYDROCHLORIDE",
      "brand": "ondansetron hydrochloride",
      "description": "11 DESCRIPTION The active ingredient in ondansetron tablets is ondansetron hydrochloride as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT 3 receptor type. Chemically it is (\u00b1) 1, 2, 3, 9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, monohydrochloride, dihydrate. Each tablet also contains the inactive ingredients colloidal silicon dioxide, hypromellose 2910(5cP) (for the 4 mg and 16 mg tablets only) and hypromellose 2910 (6cP) (for the 8 mg and 24 mg tablets only), iron oxide red and iron oxide black (for the 24 mg tablet only), iron oxide yellow (for the 8 mg and 24 mg tablets only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium starch glycolate, and titanium dioxide.",
      "dosage": "2 DOSAGE AND ADMINISTRATION See full prescribing information for the recommended dosage in adults an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1056,
    "fields": {
      "name": "OXYCODONE HYDROCHLORIDE",
      "brand": "Oxycodone Hydrochloride",
      "description": "Each tablet for oral administration contains 15 mg, or 30 mg, of oxycodone hydrochloride USP. Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. The 15 mg and 30 mg tablets contain the equivalent of 13.5 mg and 27.0 mg, respectively, of oxycodone free base.",
      "dosage": "If a decision is made to discontinue the use of non-opioid analgesic, it may be necessary to titrate",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1057,
    "fields": {
      "name": "PANTOPRAZOLE SODIUM INJECTION",
      "brand": "PANTOPRAZOLE SODIUM",
      "description": "11 DESCRIPTION The active ingredient in pantoprazole sodium for injection (pantoprazole sodium), a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S, with a molecular weight of 405.4. The reconstituted solution of pantoprazole sodium for injection is in the pH range of 9.0 to 10.5.",
      "dosage": "( 2.3 , 2.4 ) 2.1 Recommended Dosage for GERD Associated with a History of EE Adult Patients The rec",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1058,
    "fields": {
      "name": "PAROXETINE HYDROCHLORIDE HEMIHYDRATE",
      "brand": "Paroxetine",
      "description": "11 DESCRIPTION Paroxetine tablets contain paroxetine hydrochloride, an SSRI. It is the hydrochloride salt of a phenylpiperidine compound identified chemically as (-)- trans -4 R -(4'-fluorophenyl)-3 S -[(3',4'- methylenedioxyphenoxy) methyl] piperidine hydrochloride hemihydrate and has the empirical formula of C 19 H 20 FNO 3 \u2022HCl\u20221/2H 2 O. The structural formula of paroxetine hydrochloride is: Paroxetine hydrochloride, USP is an odorless, off-white powder, having a melting point range of 120 o to 138 o C and a solubility of 5.4 mg/mL in water.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting and maximum daily dosage for MDD, OCD, PD, and PTSD",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1059,
    "fields": {
      "name": "PENICILLIN G BENZATHINE",
      "brand": "BICILLIN L-A",
      "description": "Description Bicillin L-A (penicillin G benzathine injectable suspension) is available for deep intramuscular injection. Its chemical structure is as follows: Bicillin L-A contains penicillin G benzathine in aqueous suspension with sodium citrate buffer and, as w/v, approximately 0.65% sodium citrate, 0.59% povidone, 0.54% carboxymethylcellulose sodium, 0.53% lecithin, 0.12% methylparaben, and 0.013% propylparaben. Bicillin L-A contains approximately 0.11 mEq of sodium per 600,000 units of penicillin G (approximately 2.59 mg of sodium per 600,000 units of penicillin G).",
      "dosage": "DOSAGE AND ADMINISTRATION Streptococcal (Group A) Upper Respiratory Infections (for example, pharyng",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1060,
    "fields": {
      "name": "PHENYTOIN SODIUM",
      "brand": "Phenytoin Sodium",
      "description": "11 DESCRIPTION Phenytoin Sodium Injection, USP is a sterile solution containing in each mL phenytoin sodium 50 mg, propylene glycol 0.4 mL and alcohol 0.1 mL in Water for Injection. pH 10.0-12.3; sodium hydroxide added, if needed, for pH adjustment. Phenytoin sodium is related to the barbiturates in chemical structure, but has a five-membered ring.",
      "dosage": "( 2.2 , 2.3 ) 2.1 General Dosing Information Because of the increased risk of adverse cardiovascular",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1061,
    "fields": {
      "name": "PIOGLITAZONE HYDROCHLORIDE",
      "brand": "PIOGLITAZONE HYDROCHLORIDE",
      "description": "11 DESCRIPTION Pioglitazone tablets are a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (PPAR) gamma that contains an oral antidiabetic medication: pioglitazone. Pioglitazone [(\u00b1)-5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2,4-] thiazolidinedione monohydrochloride contains one asymmetric carbon, and the compound is synthesized and used as the racemic mixture. The two enantiomers of pioglitazone interconvert in vivo .",
      "dosage": "(2.1) If there is inadequate glycemic control, the dose can be increased in 15 mg increments up to a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1062,
    "fields": {
      "name": "PREDNISONE",
      "brand": "PredniSONE",
      "description": "DESCRIPTION Prednisone is a glucocorticoid. Glucocorticoids are adrenocortical steroids, both naturally occurring and synthetic, which are readily absorbed from the gastrointestinal tract. Prednisone, USP is a white to partially white, crystalline powder.",
      "dosage": "Included in the situations which may make dosage adjustments necessary are changes in clinical statu",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1063,
    "fields": {
      "name": "PREGABALIN",
      "brand": "PREGABALIN",
      "description": "The molecular formula is C 8 H 17 NO 2 and the molecular weight is 159.23. Pregabalin capsules are administered orally and are supplied as imprinted hard-shell capsules containing 25, 50, 75, 100, 150, 200, 225, and 300 mg of pregabalin, along with pregelatinized starch and talc as inactive ingredients. In addition, the orange & red capsule shells contain red iron oxide.",
      "dosage": "( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) Dosing recommendations: INDICATION Dosing Regimen Maximum Dose DPN P",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1064,
    "fields": {
      "name": "PROMETHAZINE HYDROCHLORIDE",
      "brand": "PROMETHAZINE HYDROCHLORIDE",
      "description": "DESCRIPTION Each 12.5 mg promethazine hydrochloride tablet for oral administration contains 12.5 mg promethazine hydrochloride. In addition, 50 mg tablet contains FD&C Red #40 and 12.5 mg tablet contains FD&C Yellow #6. Promethazine hydrochloride is a racemic compound; the empirical formula is C 17 H 20 N 2 S\u2022HCl and its molecular weight is 320.88.",
      "dosage": "The average effective dose of promethazine hydrochloride tablets, USP for the active therapy of naus",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1065,
    "fields": {
      "name": "PROPRANOLOL HYDROCHLORIDE",
      "brand": "Propranolol Hydrochloride",
      "description": "Propranolol Hydrochloride Tablets, USP are available as tablets for oral administration containing either 10 mg, 20 mg, 40 mg, 60 mg, or 80 mg of propranolol hydrochloride, USP. 6 aluminum lake (10 mg and 80 mg), D&C Yellow no. 10 aluminum lake (10 mg, 40 mg, and 80 mg), FD&C Blue no.",
      "dosage": "Hypertension The usual initial dosage is 40 mg propranolol hydrochloride twice daily, whether used a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1066,
    "fields": {
      "name": "QUETIAPINE FUMARATE",
      "brand": "Quetiapine Fumarate",
      "description": "It is present in tablets as the fumarate salt. Quetiapine tablets, USP is supplied for oral administration as 25 mg (round peach), 50 mg (round, white), 100 mg (round yellow), 150 mg (round, off white to light yellow), 200 mg (round, white), 300 mg (capsule-shaped, white), and 400 mg (capsule-shaped, yellow) tablets. The 25 mg tablets contain red iron oxide and yellow iron oxide and the 100 mg, 150 mg and 400 mg tablets contain only yellow iron oxide.",
      "dosage": "Further adjustments can be made in increments of 25 to 50 mg twice a day, in intervals of not less t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1067,
    "fields": {
      "name": "RABEPRAZOLE SODIUM",
      "brand": "Rabeprazole sodium",
      "description": "11 DESCRIPTION The active ingredient in rabeprazole sodium delayed-release tablets is rabeprazole sodium hydrate, USP, which is a proton pump inhibitor. The stability of rabeprazole sodium hydrate, USP is a function of pH; it is rapidly degraded in acid media, and is more stable under alkaline conditions. The structural figure is: Rabeprazole sodium hydrate, USP is available for oral administration as delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium hydrate, USP.",
      "dosage": "The use of rabeprazole sodium delayed-release tablets is not recommended for use in pediatric patien",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1068,
    "fields": {
      "name": "RANITIDINE",
      "brand": "Ranitidine",
      "description": "",
      "dosage": "Directions adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1069,
    "fields": {
      "name": "RISPERIDONE",
      "brand": "RISPERIDONE",
      "description": "11 DESCRIPTION Risperidone tablets, USP contain risperidone USP, an atypical antipsychotic belonging to the chemical class of benzisoxazole derivatives. The structural formula is: Risperidone USP is a white to slightly beige powder. Tablets of 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg also contain talc and titanium dioxide.",
      "dosage": "Maintenance Therapy While it is unknown how long a patient with schizophrenia should remain on rispe",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1070,
    "fields": {
      "name": "ROSUVASTATIN CALCIUM",
      "brand": "Rosuvastatin Calcium",
      "description": "11 DESCRIPTION Rosuvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA)-reductase inhibitor. The chemical name for rosuvastatin calcium is bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt with the following structural formula: The empirical formula for rosuvastatin calcium is (C 22 H 27 FN 3 O 6 S) 2 Ca and the molecular weight is 1001.14. Rosuvastatin calcium is a white or almost white, hygroscopic powder that is slightly soluble in water, freely soluble in methylene chloride, practically insoluble in ethanol.",
      "dosage": "( 2.1 ) Pediatric Patients with HeFH : Recommended dosage range is 5 to 10 mg once daily for patient",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1071,
    "fields": {
      "name": "SERTRALINE HYDROCHLORIDE",
      "brand": "Sertraline Hydrochloride",
      "description": "DESCRIPTION Sertraline hydrochloride is a selective serotonin reuptake inhibitor (SSRI) for oral administration. It has a molecular weight of 342.7. Sertraline hydrochloride, USP has the following chemical name: (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride.",
      "dosage": "While a relationship between dose and effect has not been established for OCD, patients were dosed i",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1072,
    "fields": {
      "name": "SILDENAFIL CITRATE",
      "brand": "SILDENAFIL CITRATE",
      "description": "11 DESCRIPTION Sildenafil tablets, USP, an oral therapy for erectile dysfunction, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Sildenafil citrate, is designated chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1 H -pyrazolo[4,3- d ]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate and has the following structural formula: Sildenafil citrate, USP is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Sildenafil tablets USP are formulated as pale blue to blue film-coated tablets equivalent to 25 mg, 50 mg and 100 mg of sildenafil for oral administration.",
      "dosage": "However, sildenafil tablets may be taken anywhere from 30 minutes to 4 hours before sexual activity ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1073,
    "fields": {
      "name": "EZETIMIBE AND SIMVASTATIN",
      "brand": "Ezetimibe and Simvastatin",
      "description": "11 DESCRIPTION Ezetimibe and simvastatin tablets contain ezetimibe USP, a selective inhibitor of intestinal cholesterol and related phytosterol absorption, and simvastatin USP, an HMG-CoA reductase inhibitor. The chemical name of ezetimibe, USP is 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone. formula 1 formula 2",
      "dosage": "The maximum recommended dosage is ezetimibe and simvastatin tablets 10 mg/40 mg once daily. The ezet",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1074,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1075,
    "fields": {
      "name": "SPIRONOLACTONE",
      "brand": "Spironolactone",
      "description": "11 DESCRIPTION Spironolactone oral tablets contain 25 mg, 50 mg, or 100 mg of the aldosterone antagonist spironolactone, USP 17hydroxy-7\u03b1-mercapto-3-oxo-17\u03b1-pregn-4-ene-21-carboxylic acid \u03b3-lactone acetate, which has the following structural formula: Spironolactone, USP is practically insoluble in water, soluble in alcohol, and freely soluble in benzene and in chloroform. Inactive ingredients include calcium sulfate, corn starch, croscarmellose sodium, peppermint flavor, hypromellose, iron oxide, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, polyvinyl alcohol, povidone, talc, titanium dioxide, and triacetin. The 50 mg tablet also contains D&C yellow # 10 and FD&C yellow #6.",
      "dosage": "2.2 Treatment of Heart Failure In patients with serum potassium \u2264 5.0 mEq/L and eGFR > 50 mL/min/1.7",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1076,
    "fields": {
      "name": "TAMSULOSIN HYDROCHLORIDE",
      "brand": "Tamsulosin Hydrochloride",
      "description": "11 DESCRIPTION Tamsulosin hydrochloride is an antagonist of alpha 1A adrenoceptors in the prostate. It is sparingly soluble in water and methanol, slightly soluble in glacial acetic acid and ethanol, and practically insoluble in ether. The molecular formula of tamsulosin hydrochloride is C 20 H 28 N 2 O 5 S \u2022 HCl.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as th",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1077,
    "fields": {
      "name": "TEMAZEPAM",
      "brand": "Temazepam",
      "description": "DESCRIPTION Temazepam, USP is a benzodiazepine hypnotic agent. The chemical name is 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, and the structural formula is: C 16 H 13 ClN 2 O 2 MW = 300.74 Temazepam, USP is a white, crystalline substance, very slightly soluble in water and sparingly soluble in alcohol USP. Temazepam capsules USP, 7.5 mg, 15 mg, 22.5 mg, and 30 mg, are for oral administration.",
      "dosage": "DOSAGE AND ADMINISTRATION While the recommended usual adult dose is 15 mg before retiring, 7.5 mg ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1078,
    "fields": {
      "name": "TERAZOSIN HYDROCHLORIDE",
      "brand": "Terazosin",
      "description": "DESCRIPTION Terazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name,molecular formula and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride.C 19 H 26 ClN 5 O 4 Terazosin hydrochloride is a white, crystalline substance, freely soluble in water and isotonic saline and has a molecular weight of 423.93. Each capsule, for oral administration, contains 1 mg, 2 mg, 5 mg or 10 mg of terazosin as terazosin hydrochlolde. In addition, each capsule contains the following inactive ingredients: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, and pregelatinized starch.",
      "dosage": "DOSAGE AND ADMINISTRATION If terazosin capsules administration is discontinued for several days, the",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1079,
    "fields": {
      "name": "TIZANIDINE",
      "brand": "tizanidine",
      "description": "11 DESCRIPTION Tizanidine Tablets, USP contains tizanidine hydrochloride as the active ingredient, which is a central alpha 2 -adrenergic agonist. Its chemical name is 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiodiazole monohydrochloride. It has a molecular formula of C 9 H 8 CIN 5 S\u00b7HCl and a molecular weight of 290.17.",
      "dosage": "( 2.1 ) Recommended starting dose: 2 mg by mouth every 6 to 8 hours, as needed, up to a maximum of 3",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1080,
    "fields": {
      "name": "TOPIRAMATE",
      "brand": "topiramate",
      "description": "11 DESCRIPTION Topiramate, USP is a sulfamate-substituted monosaccharide. Topiramate tablets, USP are available as 25 mg, 50 mg, 100 mg, and 200 mg round shaped tablets for oral administration. Its saturated solution has a pH of 6.3.",
      "dosage": "Table 2: Monotherapy Target Total Daily Maintenance Dosing for Patients 2 to 9 Years of Age Weight (",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1081,
    "fields": {
      "name": "TRAMADOL HYDROCHLORIDE",
      "brand": "TRAMADOL HYDROCHLORIDE",
      "description": "The chemical name is (\u00b1) cis -2-[(dimethylamino) methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochloride. It is a white, crystalline powder that is freely soluble in water and methanol, very slightly soluble in acetone and has a pKa of 9.41. Tramadol hydrochloride extended-release tablets, USP contain 100 mg, 200 mg or 300 mg of tramadol hydrochloride, USP in an extended-release formulation.",
      "dosage": "2.5 Safe Reduction or Discontinuation of Tramadol Hydrochloride Extended-Release Tablets Do not abru",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1082,
    "fields": {
      "name": "TRAZODONE HYDROCHLORIDE",
      "brand": "Trazodone Hydrochloride",
      "description": "11 DESCRIPTION Trazodone hydrochloride is a selective serotonin reuptake inhibitor and 5HT2 receptor antagonist. Trazodone hydrochloride, USP is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]- 1,2,4-triazolo[4, 3-a]pyridin-3(2H)-one hydrochloride. It is a white to off-white, crystalline powder which is sparingly soluble in chloroform and in water.",
      "dosage": "The dosage should be initiated at a low-dose and increased gradually, noting the clinical response a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1083,
    "fields": {
      "name": "SACUBITRIL AND VALSARTAN",
      "brand": "ENTRESTO",
      "description": "Its molecular mass is 957.99 g/mol and its schematic structural formula is: ENTRESTO is available as film-coated tablets for oral administration, containing 24 mg of sacubitril and 26 mg of valsartan; 49 mg of sacubitril and 51 mg of valsartan; and 97 mg of sacubitril and 103 mg of valsartan. The film-coat inactive ingredients are hypromellose, iron oxide red (E172), polyethylene glycol 4000, talc, and titanium dioxide (E171). The film-coat for the 49 mg of sacubitril and 51 mg of valsartan tablet contains iron oxide yellow (E172).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dosage for adults is 49 mg/51 mg orally twice d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1084,
    "fields": {
      "name": "VENLAFAXINE",
      "brand": "Venlafaxine",
      "description": "DESCRIPTION Venlafaxine hydrochloride is a structurally novel antidepressant for oral administration. Each venlafaxine tablet, USP intended for oral administration contains venlafaxine hydrochloride equivalent to 25 mg or 37.5 mg or 50 mg or 75 mg or 100 mg of venlafaxine. Structured formula for venlafaxine",
      "dosage": "When treating pregnant women with venlafaxine tablets during the third trimester, the physician shou",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1085,
    "fields": {
      "name": "VERAPAMIL HYDROCHLORIDE",
      "brand": "Verapamil Hydrochloride",
      "description": "DESCRIPTION Verapamil hydrochloride is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets containing 40 mg, 80 mg, or 120 mg of verapamil hydrochloride. The structural formula of verapamil hydrochloride is: Benzeneacetonitrile, \u03b1-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-\u03b1-(1-methylethyl) hydrochloride. Verapamil hydrochloride is an almost white, crystalline powder, practically free of odor, with a bitter taste.",
      "dosage": "Angina: Clinical trials show that the usual dose is 80 mg to 120 mg three times a day. However, 40 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1086,
    "fields": {
      "name": "WARFARIN SODIUM",
      "brand": "Warfarin Sodium",
      "description": "11 DESCRIPTION Warfarin sodium tablets, USP contain warfarin sodium, an anticoagulant that acts by inhibiting vitamin K-dependent coagulation factors. 40 aluminum lake, and D&C yellow no. 10 aluminum lake and FD&C yellow no.",
      "dosage": "The duration of treatment is based on the indication as follows: For patients with a DVT or PE secon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1087,
    "fields": {
      "name": "ZALEPLON",
      "brand": "zaleplon",
      "description": "Its molecular formula is C 17 H 15 N 5 O, and its molecular weight is 305.34. Zaleplon capsules USP contain zaleplon as the active ingredient. The 5 mg capsules also contain FD&C yellow #5.",
      "dosage": "Although the risk of certain adverse events associated with the use of zaleplon capsules appears to ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1088,
    "fields": {
      "name": "ZOLPIDEM TARTRATE",
      "brand": "Zolpidem",
      "description": "11 DESCRIPTION Zolpidem Tartrate Tablets, USP contains Zolpidem tartrate, a gamma-aminobutyric acid (GABA) A receptor positive modulator of the imidazopyridine class. It has the following structure: Zolpidem Tartrate is a white to off-white crystalline powder that is sparingly soluble in water, alcohol, and propylene glycol. Opadry II (pink) contains hypromellose, FD&C Red no.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest dose effective for the patient and must not exceed a tota",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1089,
    "fields": {
      "name": "ZOLMITRIPTAN",
      "brand": "Zolmitriptan",
      "description": "11 DESCRIPTION ZOLMITRIPTAN NASAL SPRAY contains zolmitriptan, which is a selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist. Zolmitriptan is chemically designated as (S)-4-[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone and has the following chemical structure: The empirical formula is C 16 H 21 N 3 O 2 , representing a molecular weight of 287.36. The osmolarity of ZOLMITRIPTAN NASAL SPRAY for 2.5 mg is 360 to 420 mOsmol, and for 5 mg is 420 to 470 mOsmol.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting dose: 2.5 mg (2.1) Maximum single dose: 5 mg (2.1) ",
      "stock": 100,
      "route": "NASAL",
      "resupply_pending": 0,
      "pharmacy_id": 5,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1090,
    "fields": {
      "name": "ACETAMINOPHEN",
      "brand": "Pain Reliever Extra Strength",
      "description": "",
      "dosage": "Directions do not take more than directed adults and children 12 years and over take 2 gelcaps every",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1091,
    "fields": {
      "name": "HYDROCODONE BITARTRATE AND ACETAMINOPHEN",
      "brand": "Hydrocodone Bitartrate and Acetaminophen",
      "description": "DESCRIPTION Hydrocodone bitartrate and acetaminophen, USP is available in tablet form for oral administration. It is affected by light. It has the following structural formula: Acetaminophen, 4' -hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "Initial Dosage Initiating Treatment with Hydrocodone Bitartrate and Acetaminophen Tablets 2.5 mg/325",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1092,
    "fields": {
      "name": "ALBUTEROL SULFATE",
      "brand": "Albuterol Sulfate HFA",
      "description": "Albuterol sulfate has the chemical name \u03b1 1 -[( tert -butylamino)methyl]-4-hydroxy- m -xylene-\u03b1, \u03b1\u2032-diol sulfate (2:1)(salt) and the following chemical structure: Albuterol sulfate is a white crystalline powder with a molecular weight of 576.7, and the empirical formula is (C 13 H 21 NO 3 ) 2 \u2022H 2 SO 4 . Each canister contains a microcrystalline suspension of albuterol sulfate in propellant HFA\u2011134a (1,1,1,2\u2011tetrafluoroethane). Prime Albuterol Sulfate HFA before using for the first time, when the inhaler has not been used for more than 2 weeks, or when the inhaler has been dropped.",
      "dosage": "2 DOSAGE AND ADMINISTRATION For oral inhalation only. ( 2 ) Treatment or prevention of bronchospasm ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1093,
    "fields": {
      "name": "ALENDRONATE SODIUM",
      "brand": "Binosto",
      "description": "11 DESCRIPTION BINOSTO (alendronate sodium) is a bisphosphonate that acts as a specific inhibitor of osteoclast-mediated bone resorption. Alendronate sodium is chemically described as (4 amino-1-hydroxybutylidene) bisphosphonic acid, monosodium salt, trihydrate. Once the effervescent tablet is dissolved in water, the alendronate sodium is present in a citrate-buffered solution of pH 4.8 to 5.4.",
      "dosage": "Take BINOSTO upon arising for the day and at least 30 minutes before the first food, beverage, or me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1094,
    "fields": {
      "name": "ALLOPURINOL",
      "brand": "Allopurinol",
      "description": "11 DESCRIPTION Allopurinol, USP is a xanthine oxidase inhibitor. It has the following structural formula: Allopurinol, USP is known chemically as 1, 5-dihydro-4 H -pyrazolo [3, 4- d ]pyrimidin-4-one and it has a molecular weight of 136.1 g/mol. Each scored white round-shaped tablet contains 100 mg allopurinol and the inactive ingredients colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate.",
      "dosage": "2.3 Recommended Dosage for Gout The initial recommended dosage for the management of gout is 100 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1095,
    "fields": {
      "name": "ALPRAZOLAM",
      "brand": "Alprazolam",
      "description": "11 DESCRIPTION Alprazolam tablets, USP contain alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds. The chemical name of alprazolam is 8-Chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-\u03b1] [1,4] benzodiazepine. In addition, the 0.5 mg tablet contains FD&C Yellow # 6 aluminum lake and the 1 mg tablet contains FD&C Blue No.",
      "dosage": "Dosage may be increased, at intervals of every 3 to 4 days, to a maximum recommended daily dose of 4",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1096,
    "fields": {
      "name": "AMOXICILLIN",
      "brand": "Amoxicillin",
      "description": "Amoxicillin Tablets, USP: Each film coated tablet contains 500 mg or 875 mg amoxicillin as the trihydrate. Amoxicillin for Oral Suspension, USP: Each 5 mL of reconstituted suspension contains 125 mg, 200 mg, 250 mg or 400 mg amoxicillin as the trihydrate. Each 5 mL of the 125 mg, 200 mg, 250 mg, and 400 mg reconstituted suspension contains 0.30 mEq (6.95 mg) of sodium.",
      "dosage": "Dosing Recommendations for Adult and Pediatric Patients > 3 Months of Age Infection Severity Dosing ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1097,
    "fields": {
      "name": "AMLODIPINE BESYLATE",
      "brand": "Amlodipine Besylate",
      "description": "11 DESCRIPTION Amlodipine besylate is the besylate salt of amlodipine, a long-acting calcium channel blocker. Amlodipine besylate is chemically described as 3-Ethyl-5-methyl (\u00b1)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, monobenzenesulphonate. Amlodipine besylate tablets USP are formulated as tablets equivalent to 2.5 mg, 5 mg and 10 mg of amlodipine for oral administration.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022Adult recommended starting dose: 5 mg once daily with maximum dose 10 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1098,
    "fields": {
      "name": "ARIPIPRAZOLE",
      "brand": "Aripiprazole",
      "description": "11 DESCRIPTION Aripiprazole is an atypical antipsychotic drug that is available as Aripiprazole Tablets, USP. Aripiprazole is 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril. The empirical formula is C 23 H 27 Cl 2 N 3 O 2 and its molecular weight is 448.38.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Initial Dose Recommended Dose Maximum Dose Schizophrenia \u2013 adults (2.1) ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1099,
    "fields": {
      "name": "ATENOLOL",
      "brand": "Atenolol",
      "description": "DESCRIPTION Atenolol, a synthetic, beta 1 -selective (cardioselective) adrenoreceptor blocking agent, may be chemically described as benzeneacetamide, 4-[2\u2019-hydroxy-3\u2019-[(1-methylethyl)amino]propoxy]-. It is a relatively polar hydrophilic compound with a water solubility of 26.5 mg/mL at 37\u00b0C and a log partition coefficient (octanol/water) of 0.23. Atenolol is available as 25, 50 or 100 mg tablets for oral administration.",
      "dosage": "If an optimal response is not achieved, the dosage should be increased to atenolol 100 mg given as o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1100,
    "fields": {
      "name": "ATORVASTATIN CALCIUM",
      "brand": "Atorvastatin calcium",
      "description": "11 DESCRIPTION Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. Atorvastatin calcium USP is (\u03b2R, \u03b4R)-2-(p-fluorophenyl)-\u03b2,\u03b4-dihydroxy-5-isopropyl-3-phenyl-4(phenylcarbamoyl)pyrrole-l-heptanaote (1:2), trihydrate. The molecular formula of atorvastatin calcium USP is C 66 H 68 CaF 2 N 4 O 10 .3H 2 O and its molecular weight is 1209.41.",
      "dosage": "2.1 Important Dosage Information Take atorvastatin calcium tablets orally once daily at any time of ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1101,
    "fields": {
      "name": "AZITHROMYCIN",
      "brand": "Azithromycin",
      "description": "11 DESCRIPTION Azithromycin tablets USP contain the active ingredient azithromycin, a macrolide antibacterial drug, for oral administration. Azithromycin has the chemical name (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-\u03b1-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-\u03b2-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one. Azithromycin is derived from erythromycin; however, it differs chemically from erythromycin in that a methyl-substituted nitrogen atom is incorporated into the lactone ring.",
      "dosage": "Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 500 mg as a single dose on Da",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1102,
    "fields": {
      "name": "BACLOFEN INJECTION",
      "brand": "Gablofen",
      "description": "11 DESCRIPTION GABLOFEN (baclofen injection) is a muscle relaxant and antispastic. Baclofen's pharmacological class is a gamma-aminobutyric acid (GABA) ergic agonist. Baclofen's chemical name is 4-amino-3-(4-chlorophenyl) butanoic acid, and its structural formula is: Baclofen C 10 H 12 ClNO 2 Baclofen is a white to off-white powder, with a molecular weight of 213.66.",
      "dosage": "2.2 Screening Phase Prior to pump implantation and initiation of chronic infusion of GABLOFEN, patie",
      "stock": 100,
      "route": "INTRATHECAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1103,
    "fields": {
      "name": "BENAZEPRIL HYDROCHLORIDE",
      "brand": "Benazepril Hydrochloride",
      "description": "Its chemical name is benazepril 3-[[1-(ethoxy-carbonyl)-3-phenyl-(1S)-propyl]amino]-2,3,4,5-tetrahydro-2-oxo-1 H -1-(3S)-benzazepine-1-acetic acid monohydrochloride; its structural formula is Its empirical formula is C 24 H 28 N 2 O 5 \u2022HCl and its molecular weight is 460.96. Benazepril hydrochloride is supplied as film-coated tablets containing 5 mg, 10 mg, 20 mg, and 40 mg of benazepril hydrochloride for oral administration. Benazepril hydrochloride tablets USP, 5 mg, 10 mg, 20 mg and 40 mg meet USP Dissolution Test 2.",
      "dosage": "\u2022 Renal Impairment: Initiate with 5 mg once daily in patients with GFR <30 mL/min/1.73 m 2 (serum cr",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1104,
    "fields": {
      "name": "BISOPROLOL FUMARATE",
      "brand": "Bisoprolol fumarate",
      "description": "It possesses an asymmetric carbon atom in its structure and is provided as a racemic mixture. Bisoprolol fumarate tablets are available as 5 and 10 mg tablets for oral administration. The 5 mg tablets also contain Red Iron Oxide.",
      "dosage": "DOSAGE AND ADMINISTRATION The dose of bisoprolol fumarate tablets must be individualized to the need",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1105,
    "fields": {
      "name": "BUPROPION HYDROCHLORIDE",
      "brand": "Bupropion Hydrochloride XL",
      "description": "11 DESCRIPTION Bupropion Hydrochloride USP, an antidepressant of the aminoketone class, is chemically unrelated to tricyclic, tetracyclic, selective serotonin reuptake inhibitor, or other known antidepressant agents. Its structure closely resembles that of diethylpropion; it is related to phenylethylamines. The structural formula is: Bupropion Hydrochloride Extended-Release Tablets USP (XL) are supplied for oral administration as 150 mg and 300 mg white to pale yellow extended-release tablets.",
      "dosage": "2.2 Dosage for Major Depressive Disorder (MDD) The recommended starting dose for MDD is 150 mg once ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1106,
    "fields": {
      "name": "BUSPIRONE HYDROCHLORIDE",
      "brand": "Buspirone Hydrochloride",
      "description": "421.96 Each tablet, for oral administration, contains 5 mg, 7.5 mg, 10 mg, 15 mg or 30 mg of buspirone hydrochloride, USP (equivalent to 4.6 mg, 6.9 mg, 9.1 mg, 13.7 mg and 27.4 mg of buspirone free base, respectively). Thus, a single 15 mg tablet can provide the following doses: 15 mg (entire tablet), 10 mg (two-thirds of a tablet), 7.5 mg (one-half of a tablet), or 5 mg (one-third of a tablet). A single 30 mg tablet can provide the following doses: 30 mg (entire tablet), 20 mg (two-thirds of a tablet), 15 mg (one-half of a tablet), or 10 mg (one-third of a tablet).",
      "dosage": "To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1107,
    "fields": {
      "name": "BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE",
      "brand": "Butalbital, Acetaminophen, Caffeine and Codeine Phosphate",
      "description": "11 DESCRIPTION Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are supplied in capsule form for oral administration. Each capsule contains: Butalbital, USP 50 mg Acetaminophen, USP 325 mg Caffeine, USP 40 mg Codeine phosphate, USP 30 mg Butalbital (5-allyl-5-isobutylbarbituric acid), is a short-to intermediate-acting barbiturate. It has the following structural formula: C 11 H 16 N 2 O 3 MW 224.26 Acetaminophen (4'hydroxyacetanilide), is a non-opiate, non-salicylate analgesic and antipyretic.",
      "dosage": "2.2 Patient Access to Naloxone for the Emergency Treatment of Opioid Overdose Discuss the availabili",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1108,
    "fields": {
      "name": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "brand": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE",
      "description": "DESCRIPTION Captopril and hydrochlorothiazide tablets, USP for oral administration combines two antihypertensive agents: captopril and hydrochlorothiazide. Captopril, USP is a white to off-white crystalline powder with characteristic sulfide-like odor; it is freely soluble in water, ethanol, methanol, chloroform, isopropyl alcohol and methylene chloride and soluble in ethyl acetate. Freely soluble in N,N-Dimethylformamide, in n-Butylamine and in diluted solutions of alkali hydroxides.",
      "dosage": "For patients insufficiently responsive to the initial dose, additional captopril or hydrochlorothiaz",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1109,
    "fields": {
      "name": "CARVEDILOL",
      "brand": "Carvedilol",
      "description": "11 DESCRIPTION Carvedilol is a nonselective \u03b2-adrenergic blocking agent with \u03b1 1 -blocking activity. It is (\u00b1)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol. Carvedilol is a racemic mixture with the following structure: Carvedilol, USP is a white to almost white crystalline powder with a molecular weight of 406.5 and a molecular formula of C 24 H 26 N 2 O 4 .",
      "dosage": "Fluid retention (with or without transient worsening heart failure symptoms) should be treated by an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1110,
    "fields": {
      "name": "CEFDINIR",
      "brand": "Cefdinir",
      "description": "DESCRIPTION Cefdinir capsules, USP contain the active ingredient cefdinir, an extended-spectrum, semisynthetic cephalosporin, for oral administration. Chemically, cefdinir is [6R-[6\u03b1,7\u03b2 (Z)]]-7-[[(2-amino-4 thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid. Cefdinir is a white to slightly brownish-yellow solid.",
      "dosage": "DOSAGE & ADMINISTRATION (see INDICATIONS AND USAGE for Indicated Pathogens) The recommended dosage a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1111,
    "fields": {
      "name": "CEFUROXIME AXETIL",
      "brand": "Cefuroxime axetil",
      "description": "Cefuroxime axetil is a semisynthetic, cephalosporin antibacterial drug for oral administration. The chemical name of cefuroxime axetil (1-(acetyloxy) ethyl ester of cefuroxime) is ( RS )-1 hydroxyethyl (6 R ,7 R )-7-[2-(2-furyl)glyoxyl-amido]-3-(hydroxymethyl)-8-oxo-5-thia-1 azabicyclo[4.2.0]-oct-2-ene-2-carboxylate, 72-( Z )-( O -methyl-oxime), 1-acetate 3-carbamate. Cefuroxime axetil is in the amorphous form and has the following structural formula: Cefuroxime axetil tablets, USP are film-coated and contain the equivalent of 250 or 500 mg of cefuroxime as cefuroxime axetil.",
      "dosage": "Pediatric patients (aged 13 years and older) who cannot swallow the cefuroxime axetil tablets whole ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1112,
    "fields": {
      "name": "CELECOXIB",
      "brand": "CELECOXIB",
      "description": "DESCRIPTION Celecoxib capsule is a nonsteroidal anti-inflammatory drug, available as capsules containing 50 mg, 100 mg, 200 mg and 400 mg celecoxib for oral administration. Its molecular formula is C 17 H 14 F 3 N 3 O 2 S, and it has the following chemical structure: Celecoxib USP is a white or almost white crystalline powder with a pKa of 11.1 (sulfonamide moiety). Celecoxib USP is hydrophobic (log P is 3.5) and is soluble in ethanol and in methylene chloride, practically insoluble in water.",
      "dosage": "For patients >25 kg the recommended dose is 100 mg twice daily. For patients who have difficulty swa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1113,
    "fields": {
      "name": "CETIRIZINE HYDROCHLORIDE TABLETS",
      "brand": "cetirizine hydrochloride",
      "description": "",
      "dosage": "Directions adults and children 6 years and over one 10 mg tablet once daily; do not take more than o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1114,
    "fields": {
      "name": "CIPROFLOXACIN",
      "brand": "ciprofloxacin",
      "description": "DESCRIPTION Ciprofloxacin ophthalmic solution is a synthetic, sterile, multiple dose, antimicrobial for topical ophthalmic use. Ciprofloxacin is a fluoroquinolone antibacterial active against a broad spectrum of gram-positive and gram-negative ocular pathogens. It is available as the monohydrochloride monohydrate salt of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid.",
      "dosage": "DOSAGE AND ADMINISTRATION Corneal Ulcers: The recommended dosage regimen for the treatment of cornea",
      "stock": 100,
      "route": "OPHTHALMIC",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1115,
    "fields": {
      "name": "CITALOPRAM",
      "brand": "Citalopram",
      "description": "11 DESCRIPTION Citalopram tablets, USP contain citalopram, a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide is a racemic bicyclic phthalane structure and is designated (\u00b1)-1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3\u00addihydroisobenzofuran-5-carbonitrile hydrobromide with the following structural formula: The molecular formula is C 20 H 22 BrFN 2 O and its molecular weight is 405.35. Citalopram hydrobromide, USP occurs as a fine, white to off-white powder.",
      "dosage": "2.1 Recommended Dosage Administer citalopram tablets once daily, with or without food, at an initial",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1116,
    "fields": {
      "name": "CLINDAMYCIN PHOSPHATE",
      "brand": "Clindamycin Phosphate",
      "description": "DESCRIPTION Clindamycin phosphate topical lotion, 1% contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. Clindamycin phosphate is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The lotion contains cetostearyl alcohol (2.5%); glycerin; glyceryl stearate SE (with potassium monostearate); isostearyl alcohol (2.5%); methylparaben (0.3%); sodium lauroyl sarcosinate; stearic acid; and purified water.",
      "dosage": "DOSAGE AND ADMINISTRATION Apply a thin film of clindamycin phosphate topical lotion twice daily to a",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1117,
    "fields": {
      "name": "CLONAZEPAM",
      "brand": "Clonazepam",
      "description": "DESCRIPTION Clonazepam Tablets, USP, a benzodiazepine, is available as scored tablet with debossing \u039b containing 0.5 mg of clonazepam and unscored tablets with debossing \u039b and \u039b containing 1 mg or 2 mg of clonazepam respectively. Each 66 67 69 tablet also contains lactose monohydrate, polyethylene glycol, microcrystalline cellulose, croscarmellose sodium and magnesium stearate with the following colourants: 0.5 mg-FD & C Yellow 6 Al Lake, D & C Yellow 10 Al Lake; 1 mg-FD & C Blue 1 Al lake and FD & C Blue 2 Al lake Chemically, clonazepam is 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder.",
      "dosage": "Geriatric Patients: There is no clinical trial experience with clonazepam tablets in seizure disorde",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1118,
    "fields": {
      "name": "CLOPIDOGREL BISULFATE",
      "brand": "Clopidogrel",
      "description": "11 DESCRIPTION Clopidogrel bisulfate is a thienopyridine class inhibitor of P2Y 12 ADP platelet receptors. Chemically it is methyl (+)-( S )-\u03b1-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4 H )-\u00adacetate sulfate (1:1). The structural formula is as follows: Clopidogrel bisulfate USP is a white to off-white powder.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Acute coronary syndrome ( 2.1 ) \u2013 Initiate clopidogrel tablets with a si",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1119,
    "fields": {
      "name": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "brand": "CYCLOBENZAPRINE HYDROCHLORIDE",
      "description": "DESCRIPTION Cyclobenzaprine hydrochloride, USP is a tricyclic amine salt which is white to off white, odourless, crystalline powder with the molecular formula C 20 H 21 N \u2022 HCl and a molecular weight of 311.9. Cyclobenzaprine hydrochloride is designated chemically as 3-(5H -dibenzo[a,d] cyclohepten-5-ylidene)- N,N -dimethyl-1-propanamine hydrochloride, and has the following structural formula: Cyclobenzaprine hydrochloride tablets, USP are available as 5 mg, 7.5 mg and 10 mg tablets for oral administration. In addition, the 5 mg tablets contain FD&C Blue #2/INDIGO Carmine Aluminum Lake.",
      "dosage": "DOSAGE AND ADMINISTRATION For most patients, the recommended dose of cyclobenzaprine hydrochloride t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1120,
    "fields": {
      "name": "DAPAGLIFLOZIN",
      "brand": "FARXIGA",
      "description": "11 DESCRIPTION Dapagliflozin, an inhibitor of SGLT2, is described chemically as D-glucitol, 1,5-anhydro-1- C -[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1 S )-, compounded with (2 S )-1,2-propanediol, hydrate (1:1:1). The empirical formula is C 21 H 25 ClO 6 \u2022C 3 H 8 O 2 \u2022H 2 O and the molecular weight is 502.98. The structural formula is: FARXIGA is available as a film-coated tablet for oral administration containing the equivalent of 5 mg dapagliflozin as dapagliflozin propanediol or the equivalent of 10 mg dapagliflozin as dapagliflozin propanediol, and the following inactive ingredients: microcrystalline cellulose, anhydrous lactose, crospovidone, silicon dioxide, and magnesium stearate.",
      "dosage": "2 DOSAGE AND ADMINISTRATION \u2022 Assess volume status and correct volume depletion before initiating. I",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1121,
    "fields": {
      "name": "DESVENLAFAXINE SUCCINATE",
      "brand": "Pristiq Extended-Release",
      "description": "11 DESCRIPTION PRISTIQ is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. Desvenlafaxine is designated RS -4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol and has the empirical formula of C 16 H 25 NO 2 (free base) and C 16 H 25 NO 2 \u2219C 4 H 6 O 4 \u2219H 2 O (succinate monohydrate). Inactive ingredients for the 100 mg tablet consist of hypromellose, microcrystalline cellulose, talc, magnesium stearate and film coating, which consists of polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, iron oxide and FD&C yellow #6.",
      "dosage": "In clinical studies, doses of 50 mg to 400 mg per day were shown to be effective, although no additi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1122,
    "fields": {
      "name": "DIAZEPAM",
      "brand": "Diazepam",
      "description": "The molecular formula is C 16 H 13 ClN 2 O and the molecular weight is 284.7. The structural formula is as follows: Diazepam is available for oral administration as tablets containing 2 mg, 5 mg or 10 mg diazepam, USP. 10 Aluminum Lake and FD&C Blue No.",
      "dosage": "2 mg to 10 mg, 3 or 4 times daily Adjunctively in Convulsive Disorders. 2 mg to 2.5 mg, 1 or 2 times",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1123,
    "fields": {
      "name": "DICLOFENAC SODIUM",
      "brand": "Diclofenac Sodium",
      "description": "",
      "dosage": "Directions Use up to 21 days unless directed by your doctor Not for strains, sprains, bruises or spo",
      "stock": 100,
      "route": "TOPICAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1124,
    "fields": {
      "name": "DICYCLOMINE HYDROCHLORIDE",
      "brand": "Dicyclomine hydrochloride",
      "description": "11 DESCRIPTION Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent available as: Dicyclomine hydrochloride capsules, USP for oral use containing 10 mg dicyclomine hydrochloride, USP. Dicyclomine hydrochloride 10 mg capsules contain the following inactive ingredients: corn starch, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. Capsule shells contain FD&C Blue No.1, FD&C Red No.40, gelatin, purified water, and sodium lauryl sulfate.",
      "dosage": "Dosage for dicyclomine hydrochloride capsules must be adjusted to individual patient needs (2) . Aft",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1125,
    "fields": {
      "name": "DIGOXIN",
      "brand": "Digoxin",
      "description": "11 DESCRIPTION Digoxin is one of the cardiac (or digitalis) glycosides, a closely related group of drugs having in common specific effects on the myocardium. These drugs are found in a number of plants. The term \u201cdigitalis\u201d is used to designate the whole group of glycosides.",
      "dosage": "2.2 Loading Dosing Regimen in Adults and Pediatric Patients For adults and pediatric patients if a l",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1126,
    "fields": {
      "name": "DILTIAZEM HYDROCHLORIDE",
      "brand": "diltiazem hydrochloride",
      "description": "DESCRIPTION Diltiazem hydrochloride is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1, 5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2, 3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride,(+)-cis-. The chemical structure is: USP Dissolution pending.",
      "dosage": "Individual patients may respond to higher doses of up to 480 mg once daily. Antihypertensives : Dilt",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1127,
    "fields": {
      "name": "DIPHENHYDRAMINE HCL",
      "brand": "Childrens Allergy Relief",
      "description": "",
      "dosage": "Directions \u25a0 if needed, take every 4-6 hours \u25a0 do not take more than 6 doses in 24-hours children un",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1128,
    "fields": {
      "name": "DIVALPROEX SODIUM",
      "brand": "Divalproex Sodium",
      "description": "Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium extended-release tablets, USP contain divalproex sodium in a once-a-day extended-release formulation equivalent to 250 or 500 mg of valproic acid. Inactive Ingredients: ammonium hydroxide, colloidal anhydrous silica, colloidal silicon dioxide, dibutyl sebacate, ethylcellulose, hydroxyethyl cellulose, hypromellose, oleic acid, polydextrose, polyethylene glycol, silicified microcrystalline cellulose, titanium dioxide and triacetin.",
      "dosage": "Although doses other than 1,000 mg once daily of divalproex sodium extended-release tablets have not",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1129,
    "fields": {
      "name": "DOXYCYCLINE",
      "brand": "doxycycline",
      "description": "To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Doxycycline is an antibacterial drug synthetically derived from oxytetracycline, and is available as capsules of doxycycline hyclate for oral administration. The structural formula of doxycycline monohydrate is with a molecular formula of C 22 H 24 N 2 O 8 \u2219H 2 O and a molecular weight of 462.46.",
      "dosage": "Adults: The usual dose of oral doxycycline is 200 mg on the first day of treatment (administered 100",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1130,
    "fields": {
      "name": "DULAGLUTIDE",
      "brand": "TRULICITY",
      "description": "11 DESCRIPTION Dulaglutide is a human glucagon-like peptide-1 (GLP-1) receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1 analog sequence covalently linked to the Fc portion of a modified human immunoglobulin G4 (IgG4) heavy chain by a small peptide linker and is produced using mammalian cell (Chinese hamster ovary) culture. The GLP-1 analog portion of dulaglutide is 90% homologous to native human GLP-1 (7-37).",
      "dosage": "2 DOSAGE AND ADMINISTRATION Adult Dosage ( 2.1 ) Recommended starting dosage is 0.75 mg injected sub",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1131,
    "fields": {
      "name": "ENALAPRIL MALEATE",
      "brand": "Enalapril Maleate",
      "description": "DESCRIPTION Enalapril maleate is the maleate salt of enalapril, the ethyl ester of a long-acting angiotensin-converting enzyme inhibitor, enalaprilat. Its molecular formula is C 20 H 28 N 2 O 5 \u2219C 4 H 4 O 4, and its structural formula is: Enalapril maleate is a white to off-white, crystalline powder with a molecular weight of 492.53. Enalapril is a pro-drug; following oral administration, it is bioactivated by hydrolysis of the ethyl ester to enalaprilat, which is the active angiotensin-converting enzyme inhibitor.",
      "dosage": "DOSAGE AND ADMINISTRATION Hypertension In patients who are currently being treated with a diuretic, ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1132,
    "fields": {
      "name": "ESCITALOPRAM ORAL",
      "brand": "Escitalopram Oral Solution",
      "description": "11 DESCRIPTION Escitalopram Oral Solution, USP contains escitalopram oxalate, an orally administered selective serotonin reuptake inhibitor (SSRI), present as escitalopram oxalate salt. Escitalopram is the pure S-enantiomer (single isomer) of the racemic bicyclic phthalane derivative citalopram. Escitalopram oxalate is designated S-(+)-1-[3-(dimethyl-amino)propyl]-1-( p -fluorophenyl)-5-phthalancarbonitrile oxalate with the following structural formula: The molecular formula is C 20 H 21 FN 2O \u2022 C 2 H 2 O 4 and the molecular weight is 414.40.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication and Population Recommended Dosage MDD in Adults ( 2.1 ) Initi",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1133,
    "fields": {
      "name": "ESOMEPRAZOLE MAGNESIUM",
      "brand": "Acid Reducer",
      "description": "",
      "dosage": "Directions adults 18 years of age and older this product is to be used once a day (every 24 hours), ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1134,
    "fields": {
      "name": "ESZOPICLONE",
      "brand": "Eszopiclone",
      "description": "11 DESCRIPTION Eszopiclone is a hypnotic agent/nonbenzodiazepine hypnotic agent that is a pyrrolopyrazine derivative of the cyclopyrrolone class. The chemical name of eszopiclone is (+)-4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5 H pyrrolo[3,4- b ]pyrazin-5-(S)-yl ester. In addition, both the 1 mg and 3 mg tablets contain FD&C Blue #2/indigo carmine aluminium lake.",
      "dosage": "May increase dose if clinically indicated, to a maximum of 3 mg ( 2.1 ) \u2022 Geriatric or debilitated p",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1135,
    "fields": {
      "name": "FENTANYL CITRATE",
      "brand": "Fentanyl Citrate",
      "description": "Fentanyl citrate is chemically identified as N -(1-Phenethyl-4-piperidyl)propionanilide citrate (1:1) with the following structural formula: C 22 H 28 N 2 O \u2022 C 6 H 8 O 7 Molecular Weight is 528.59 Each mL contains fentanyl citrate equivalent to 50 mcg (0.05 mg) fentanyl base in Water for Injection. Sodium hydroxide and/or hydrochloric acid added, if needed, for pH adjustment. The pH range is 4.0 to 7.5.",
      "dosage": "For use in more major surgical procedures, in addition to adequate analgesia, may abolish some of th",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1136,
    "fields": {
      "name": "FEXOFENADINE HCL",
      "brand": "Fexofenadine HCL",
      "description": "",
      "dosage": "Directions adults and children 12 years of age and over: take one 180 mg tablet with water every onc",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1137,
    "fields": {
      "name": "FINASTERIDE",
      "brand": "Finasteride",
      "description": "11 DESCRIPTION Finasteride tablets USP, 1 mg contains finasteride as the active ingredient. Finasteride is 4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5\u03b1, 17\u03b2)-. Its structural formula is: Finasteride is a white crystalline powder with a melting point near 250\u00b0 C. It is freely soluble in chloroform and in lower alcohol solvents but is practically insoluble in water.",
      "dosage": "The recommended dose of finasteride tablets USP is one tablet (1 mg) taken once daily. In general, d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1138,
    "fields": {
      "name": "FLUCONAZOLE",
      "brand": "Fluconazole",
      "description": "DESCRIPTION Fluconazole, the first of a new subclass of synthetic triazole antifungal agents, is available as tablets for oral administration. Fluconazole is designated chemically as 2,4-difluoro-\u03b1,\u03b1 1 -bis(1H-1,2,4-triazol-1-ylmethyl) benzyl alcohol with a molecular formula of C 13 H 12 F 2 N 6 O and molecular weight of 306.3. The structural formula is: Fluconazole USP is a white crystalline solid which is slightly soluble in water and saline.",
      "dosage": "DOSAGE AND ADMINISTRATION Dosage and Administration in Adults: Single Dose Vaginal candidiasis: The ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1139,
    "fields": {
      "name": "FLUOXETINE HYDROCHLORIDE",
      "brand": "Fluoxetine",
      "description": "11 DESCRIPTION Fluoxetine capsules, USP are a selective serotonin reuptake inhibitor for oral administration. It is also marketed for the treatment of premenstrual dysphoric disorder (Sarafem \u00ae , fluoxetine hydrochloride). In addition, 20 mg capsules also contains D&C Yellow #10 and 10 mg capsules also contains FD&C Yellow #6.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Indication Adult Pediatric MDD ( 2.1 ) 20 mg/day in am (initial dose) 10",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1140,
    "fields": {
      "name": "FLUTICASONE PROPIONATE",
      "brand": "FLOVENT DISKUS",
      "description": "11 DESCRIPTION FLOVENT DISKUS inhalation powder is a dry powder inhaler for oral inhalation. The active component of FLOVENT DISKUS 50 mcg, FLOVENT DISKUS 100 mcg, and FLOVENT DISKUS 250 mcg is fluticasone propionate, a corticosteroid having the chemical name S- (fluoromethyl) 6\u03b1,9-difluoro-11\u03b2,17-dihydroxy-16\u03b1-methyl-3-oxoandrosta-1,4-diene-17\u03b2-carbothioate, 17-propionate and the following chemical structure: Fluticasone propionate is a white powder with a molecular weight of 500.6, and the empirical formula is C 25 H 31 F 3 O 5 S. It is practically insoluble in water, freely soluble in dimethyl sulfoxide and dimethylformamide, and slightly soluble in methanol and 95% ethanol. Each blister on the strip contains a white powder mix of micronized fluticasone propionate (50, 100, or 250 mcg) in 12.5 mg of formulation containing lactose monohydrate (which contains milk proteins).",
      "dosage": "2.2 Recommended Dosage Adult and Adolescent Patients Aged 12 Years and Older The starting dosage is ",
      "stock": 100,
      "route": "RESPIRATORY (INHALATION)",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1141,
    "fields": {
      "name": "GABAPENTIN",
      "brand": "Gabapentin",
      "description": "11 DESCRIPTION The active ingredient in Gabapentin Capsules USP is gabapentin, which has the chemical name 1-(aminomethyl)cyclohexaneacetic acid. The molecular formula of gabapentin is C 9 H 17 NO 2 and the molecular weight is 171.24. The structural formula of gabapentin is: Gabapentin is a white to off-white crystalline solid with a pK a1 of 3.7 and a pK a2 of 10.7.",
      "dosage": "2 DOSAGE AND ADMlNlSTRATION Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1142,
    "fields": {
      "name": "GEMFIBROZIL",
      "brand": "Gemfibrozil",
      "description": "DESCRIPTION Gemfibrozil, USP is a lipid regulating agent. It is available as tablets for oral administration. Each tablet contains 600 mg gemfibrozil.",
      "dosage": "DOSAGE AND ADMINISTRATION The recommended dose for adults is 1,200 mg administered in two divided do",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1143,
    "fields": {
      "name": "GLIMEPIRIDE",
      "brand": "Glimepiride",
      "description": "11 DESCRIPTION Glimepiride tablets USP, are an oral sulfonylurea that contains the active ingredient glimepiride USP. Chemically, glimepiride USP is identified as 1-[[p-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido) ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea (C 24 H 34 N 4 O 5 S) with a molecular weight of 490.62. Glimepiride USP is a white to almost white powder, soluble in dimethyl formamide, sparingly soluble in methylene chloride, practically insoluble in water.",
      "dosage": "The recommended starting dose of glimepiride tablets are 1 mg or 2 mg once daily. Patients at increa",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1144,
    "fields": {
      "name": "GLIPIZIDE",
      "brand": "Glipizide",
      "description": "The Chemical Abstracts name of glipizide is 1-cyclohexyl-3-[[ p -[2-(5-methylpyrazine-carboxamido)ethyl]phenyl]sulfonyl]urea. The molecular formula is C 21 H 27 N 5 O 4 S; the molecular weight is 445.55; the structural formula is shown below: Glipizide is a whitish, odorless powder with a pKa of 5.9. Glipizide Tablets USP for oral use are available in 5 and 10 mg strengths.",
      "dosage": "In addition to the usual monitoring of urinary glucose, the patient\u2019s blood glucose must also be mon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1145,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1146,
    "fields": {
      "name": "HYDROXYCHLOROQUINE SULFATE",
      "brand": "Hydroxychloroquine Sulfate",
      "description": "DESCRIPTION Hydroxychloroquine sulfate is a white or practically white, crystalline powder, freely soluble in water; practically insoluble in alcohol, chloroform, and in ether. The chemical name for hydroxychloroquine sulfate is 2-[[4-[(7-Chloro-4-quinolyl) amino]pentyl] ethylamino]ethanol sulfate (1:1). Its structural formula is: The molecular weight of hydroxychloroquine sulfate is 433.95, and molecular formula is C 18 H 26 ClN 3 O.H 2 SO 4 .",
      "dosage": "Treatment of Uncomplicated Malaria Adults: 800 mg (620 mg base) followed by 400 mg (310 mg base) at ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1147,
    "fields": {
      "name": "IBUPROFEN",
      "brand": "Ibuprofen Dye Free",
      "description": "",
      "dosage": "Directions do not take more than directed the smallest effective dose should be used adults and chil",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1148,
    "fields": {
      "name": "INSULIN ASPART",
      "brand": "NOVOLOG",
      "description": "11 DESCRIPTION Insulin aspart is a rapid-acting human insulin analog homologous with regular human insulin with the exception of a single substitution of the amino acid proline by aspartic acid in position B28, and is produced by recombinant DNA technology utilizing Saccharomyces cerevisiae (baker's yeast). Insulin aspart has the empirical formula C 256 H 381 N 65 0 79 S 6 and a molecular weight of 5825.8 Da. NOVOLOG has a pH of 7.2-7.6.",
      "dosage": "\u2022 Continuous Subcutaneous Infusion (Insulin Pump) ( 2.2 ): o Refer to the insulin infusion pump user",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1149,
    "fields": {
      "name": "INSULIN DETEMIR",
      "brand": "LEVEMIR",
      "description": "Insulin detemir has a molecular formula of C 267 H 402 O 76 N 64 S 6 and a molecular weight of 5.917 kDa. Hydrochloric acid and/or sodium hydroxide may be added to adjust pH. Levemir Chemical Structure.jpg",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1150,
    "fields": {
      "name": "INSULIN GLARGINE",
      "brand": "BASAGLAR Tempo Pen",
      "description": "Insulin glargine has the following structural formula: BASAGLAR (insulin glargine) injection is a sterile clear and colorless aqueous solution for subcutaneous use. The 3 mL BASAGLAR prefilled pen presentations contain the following inactive ingredients per mL: glycerin (17 mg), metacresol (2.7 mg), zinc oxide (content adjusted to provide 30 mcg zinc ion), and Water for Injection, USP. BASAGLAR has a pH of approximately 4.",
      "dosage": "Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see Warnings and Preca",
      "stock": 100,
      "route": "SUBCUTANEOUS",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1151,
    "fields": {
      "name": "INSULIN LISPRO",
      "brand": "ADMELOG",
      "description": "11 DESCRIPTION Insulin lispro is a rapid-acting human insulin analog produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli . Insulin lispro has a pH of 7.0 to 7.8. The pH is adjusted by addition of aqueous solutions of hydrochloric acid and/or sodium hydroxide.",
      "dosage": "Use in accordance with the insulin pump instructions for use. Administer ADMELOG by continuous subcu",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1152,
    "fields": {
      "name": "ISOSORBIDE MONONITRATE",
      "brand": "ISOSORBIDE MONONITRATE",
      "description": "Each tablet, for oral administration, contains either 30 mg, 60 mg or 120 mg of isosorbide mononitrate in an extended-release formulation. In addition, each tablet contains the following inactive ingredients: colloidal silicon dioxide, diethyl phthalate, hydrogenated castor oil, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc and titanium dioxide. The chemical name for ISMN is 1,4:3,6-dianhydro-,D-glucitol 5-nitrate; the compound has the following structural formula: ISMN is a white, crystalline, odorless compound which is stable in air and in solution, has a melting point of about 90\u00b0C, and an optical rotation of +144\u00b0 (2% in water, 20\u00b0C).",
      "dosage": "After several days, the dosage may be increased to 120 mg (given as a single 120 mg tablet or as two",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1153,
    "fields": {
      "name": "LAMOTRIGINE",
      "brand": "Lamotrigine",
      "description": "11 DESCRIPTION Lamotrigine, USP an AED of the phenyltriazine class, is chemically unrelated to existing AEDs. Lamotrigine\u2019s chemical name is 3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine, its molecular formula is C 9 H 7 N 5 Cl 2 , and its molecular weight is 256.09. Lamotrigine orally disintegrating tablets are formulated using in-house technologies designed to mask the bitter taste of lamotrigine and achieve a rapid dissolution profile.",
      "dosage": "Adjustments to the Maintenance Dose of Lamotrigine in Women Taking Estrogen-Containing Oral Contrace",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1154,
    "fields": {
      "name": "LANSOPRAZOLE",
      "brand": "Lansoprazole",
      "description": "Lansoprazole has the following structure: Lansoprazole is a white to brownish-white odorless crystalline powder which melts with decomposition at approximately 166\u00b0C. The degradation half-life of the drug substance in aqueous solution at 25\u00b0C is approximately 0.5 hour at pH 5.0 and approximately 18 hours at pH 7.0. Lansoprazole Delayed-Release Capsules, USP are supplied in delayed-release capsules for oral administration.The delayed-release capsules are available in two dosage strengths: 15 mg and 30 mg of lansoprazole per capsule.",
      "dosage": "For patients who have difficulty swallowing capsules, Lansoprazole delayed-release capsules can be o",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1155,
    "fields": {
      "name": "LEVETIRACETAM",
      "brand": "Levetiracetam Extended-release",
      "description": "11 DESCRIPTION Levetiracetam Extended-release Tablets USP is an antiepileptic drug available as 500 mg and 750 mg (white) extended-release tablets for oral administration. It has the following structural formula: Levetiracetam is a white to off-white crystalline powder with a faint odor and a bitter taste. It is freely soluble in chloroform (65.3 g/100 mL) and in methanol (53.6 g/100 mL), soluble in ethanol (16.5 g/100 mL), sparingly soluble in acetonitrile (5.7 g/100 mL) and practically insoluble in n-hexane.",
      "dosage": "2 DOSAGE & ADMINISTRATION Initiate treatment with a dose of 1,000 mg once daily; increase by 1,000 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1156,
    "fields": {
      "name": "LEVOTHYROXINE, LIOTHYRONINE",
      "brand": "NP Thyroid 120",
      "description": "NP Thyroid \u00ae (thyroid tablets, USP) for oral use is a natural preparation derived from porcine thyroid glands. They contain both tetraiodothyronine sodium (T 4 levothyroxine) and triiodothyronine sodium (T 3 liothyronine) providing 38 mcg levothyroxine (T 4 ) and 9 mcg liothyronine (T 3 ) per grain of thyroid. The inactive ingredients are calcium stearate, dextrose (agglomerated) and mineral oil.",
      "dosage": "DOSAGE AND ADMINISTRATION The dosage of thyroid hormones is determined by the indication and must in",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1157,
    "fields": {
      "name": "LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS",
      "brand": "Lisinopril and Hydrochlorothiazide",
      "description": "DESCRIPTION Lisinopril and hydrochlorothiazide tablets combine an angiotensin converting enzyme inhibitor, lisinopril, and a diuretic, hydrochlorothiazide. 2H 2 O and its structural formula is: Lisinopril is a white to off-white, crystalline powder, with a molecular weight of 441.52. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is: Hydrochlorothiazide is a white, or practically white, crystalline powder with a molecular weight of 297.73, which is slightly soluble in water, but freely soluble in sodium hydroxide solution.",
      "dosage": "In clinical trials of lisinopril/hydrochlorothiazide combination therapy using lisinopril doses of 1",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1158,
    "fields": {
      "name": "LORAZEPAM",
      "brand": "Lorazepam",
      "description": "DESCRIPTION Lorazepam USP, an antianxiety agent, has the chemical formula, 7-chloro-5-( o -chlorophenyl)-1,3\u2011-dihydro-3-hydroxy-2 H -1,4-benzodiazepin-2-one: It is a nearly white powder almost insoluble in water. Each lorazepam tablet, USP to be taken orally, contains 0.5 mg, 1 mg, or 2 mg of lorazepam, USP. The inactive ingredients present are anhydrous lactose, magnesium stearate, microcrystalline cellulose, and polacrilin potassium.",
      "dosage": "DOSAGE AND ADMINISTRATION Lorazepam tablets are administered orally. For insomnia due to anxiety or ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1159,
    "fields": {
      "name": "LOSARTAN POTASSIUM",
      "brand": "Losartan Potassium",
      "description": "11 DESCRIPTION Losartan potassium is an angiotensin II receptor blocker acting on the AT 1 receptor subtype. Its molecular formula is C 22 H 22 ClKN 6 O, and its structural formula is: Losartan potassium, USP is white to off-white powder with a molecular weight of 461.01. It is freely soluble in water; soluble in isopropyl alcohol; slightly soluble in acetonitrile.",
      "dosage": "Pediatric Hypertension The usual recommended starting dose is 0.7 mg per kg once daily (up to 50 mg ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1160,
    "fields": {
      "name": "LOVASTATIN",
      "brand": "Lovastatin",
      "description": "This enzyme catalyzes the conversion of HMG-CoA to mevalonate, which is an early and rate limiting step in the biosynthesis of cholesterol. 404.55 C 24 H 36 O 5 M.W. Lovastatin Tablets USP, 40 mg also contain D&C Yellow #10 Aluminum Lake, FD&C Blue #1 Aluminum Lake, and FD&C Yellow #6 Aluminum Lake.",
      "dosage": "Patients requiring reductions in LDL-C of 20% or more to achieve their goal (see INDICATIONS AND USA",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1161,
    "fields": {
      "name": "LURASIDONE HYDROCHLORIDE",
      "brand": "Lurasidone Hydrochloride",
      "description": "11 DESCRIPTION Lurasidone hydrochloride is an atypical antipsychotic belonging to the chemical class of benzisothiazol derivatives. Its chemical name is (3a R ,4 S ,7 R ,7a S )-2-{(1 R ,2 R )-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-\u00adylmethyl] cyclohexylmethyl}hexahydro-4,7-methano-2 H -isoindole-1,3-dione hydrochloride. Its molecular formula is C 28 H 36 N 4 O 2 S\u00b7HCl and its molecular weight is 529.14.",
      "dosage": "Lurasidone hydrochloride tablets have been shown to be effective in a dose range of 40 mg per day to",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1162,
    "fields": {
      "name": "MELOXICAM",
      "brand": "Meloxicam",
      "description": "11 DESCRIPTION Meloxicam, is a nonsteroidal anti-inflammatory drug (NSAID). Its empirical formula is C 14 H 13 N 3 O 4 S 2 and it has the following structural formula: Meloxicam is a pastel yellow solid, practically insoluble in water, with higher solubility observed in strong acids and bases. Meloxicam tablets USP are available as tablets for oral administration containing 7.5 mg or 15 mg meloxicam.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest effective dosage for the shortest duration consistent wit",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1163,
    "fields": {
      "name": "MEMANTINE",
      "brand": "Memantine hydrochloride",
      "description": "11 DESCRIPTION Memantine hydrochloride, USP is an orally active NMDA receptor antagonist. The tablets also contain the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose and talc. In addition the following inactive ingredients are also present as components of the film coat: D&C Yellow #10, FD&C Blue #2, FD&C Yellow #6, macrogol, polyvinyl alcohol, talc, and titanium dioxide (5 mg tablets), and iron oxide black, iron oxide yellow, macrogol, polyvinyl alcohol, talc and titanium dioxide (10 mg tablets).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dose of memantine hydrochloride tablets is 5 mg",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1164,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1165,
    "fields": {
      "name": "METHADONE HYDROCHLORIDE",
      "brand": "Methadone Hydrochloride",
      "description": "DESCRIPTION Methadone Hydrochloride Oral Concentrate, USP, contains methadone, an opiate agonist, and is available as a cherry flavored liquid concentrate for oral administration. It is present in methadone hydrochloride oral concentrate as the racemic mixture. Other ingredients of Methadone Hydrochloride Oral Concentrate, USP (Dye-Free, Sugar-Free, Unflavored): citric acid anhydrous, purified water, and sodium benzoate.",
      "dosage": "Titration and Maintenance Treatment of Opioid Dependence Patients in maintenance treatment should be",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1166,
    "fields": {
      "name": "METHOCARBAMOL",
      "brand": "Methocarbamol",
      "description": "The chemical name of methocarbamol is 3-(2-meth-oxyphenoxy)-1,2-propanediol 1-carbamate and has the empirical formula C 11 H 15 NO 5 . Its molecular weight is 241.24. Methocarbamol tablets, USP are available as 500 mg and 750 mg tablets for oral administration.",
      "dosage": "Maintenance dosage: 2 tablets q.i.d. Methocarbamol tablets, USP: 750 mg \u2013 Adults: Initial dosage: 2 ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1167,
    "fields": {
      "name": "METHYLPHENIDATE HYDROCHLORIDE",
      "brand": "Methylphenidate Hydrochloride (LA)",
      "description": "Each Methylphenidate Hydrochloride Extended-Release Capsule contains pellets, with half the dose as immediate-release and half as delayed-release, thus providing an immediate release of methylphenidate and a second delayed release of methylphenidate. The active substance in Methylphenidate Hydrochloride Extended-Release Capsules is methyl \u03b1-phenyl-2-piperidineacetate hydrochloride. Its structural formula is as follows: M.W.",
      "dosage": "The drug and applesauce mixture should not be stored for future use. 2.3 Patients Currently Using Me",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1168,
    "fields": {
      "name": "METOPROLOL TARTRATE",
      "brand": "Metoprolol Tartrate",
      "description": "11 DESCRIPTION Metoprolol tartrate tablets, USP contain metoprolol tartrate, a selective beta 1 -adrenoreceptor blocking agent. It is very soluble in water; freely soluble in methylene chloride, in chloroform, and in alcohol; slightly soluble in acetone; and insoluble in ether. Metoprolol tartrate tablets, USP are available as 25 mg, 50 mg and 100 mg tablets for oral administration containing 25 mg, 50 mg and 100 mg metoprolol tartrate, respectively.",
      "dosage": "The effective dosage range of metoprolol tartrate tablets is 100 mg to 450 mg per day. The effective",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1169,
    "fields": {
      "name": "METRONIDAZOLE",
      "brand": "Metronidazole",
      "description": "DESCRIPTION Metronidazole tablets, USP 250 mg or 500 mg is an oral formulation of the synthetic nitroimidazole antimicrobial, 2-methyl-5-nitro-1H-imidazole-1-ethanol, which has the following structural formula: Metronidazole tablets USP contain 250 mg or 500 mg of metronidazole. Inactive ingredients include powdered cellulose, hydroxypropyl cellulose, low substituted hydroxypropyl cellulose, hypromellose, polyethylene glycol, stearic acid, and titanium dioxide. Molecular Structure",
      "dosage": "There is some indication from controlled comparative studies that cure rates as determined by vagina",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1170,
    "fields": {
      "name": "MIRTAZAPINE",
      "brand": "Mirtazapine",
      "description": "Mirtazapine has a tetracyclic chemical structure and belongs to the piperazino-azepine group of compounds. It is designated 1,2,3,4,10,14b-hexahydro-2-methylpyrazino [2,1-a] pyrido [2,3-c][2] benzazepine and has the molecular formula of C 17 H 19 N 3 . The structural formula is the following and it is the racemic mixture: Mirtazapine is a white to creamy white crystalline powder which is practically insoluble in water.",
      "dosage": "If patients do not have an adequate response to the initial 15 mg dose, increase the dose up to a ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1171,
    "fields": {
      "name": "MONTELUKAST SODIUM",
      "brand": "Montelukast Sodium",
      "description": "DESCRIPTION Montelukast sodium, the active ingredient in montelukast sodium tablets, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT 1 receptor. Montelukast sodium is described chemically as [ R-(E) ]-1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl] cyclopropaneacetic acid, monosodium salt. Each 10-mg film-coated montelukast sodium tablet contains 10.4 mg montelukast sodium, which is equivalent to 10 mg of montelukast, and the following inactive ingredients: croscarmellose sodium, ferric oxide red, ferric oxide yellow, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose and titanium dioxide.",
      "dosage": "Patients with both asthma and allergic rhinitis should take only one dose daily in the evening (2.4)",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1172,
    "fields": {
      "name": "NAPROXEN",
      "brand": "Naproxen",
      "description": "11 DESCRIPTION Naproxen Tablets, USP and Naproxen Sodium Tablets, USP are nonsteroidal anti-inflammatory drugs available as follows: Naproxen Tablets, USP are available as follows for oral administration: 250 mg: circular, light orange colored, flat, uncoated tablets, engraved with \u2018G\u2019 and \u201832\u2019 on either side of a break line on one side and \u2018250\u2019 on the other side. The inactive ingredients are croscarmellose sodium, iron oxide red, iron oxide yellow, magnesium stearate, microcrystalline cellulose and povidone. Naproxen, USP and naproxen sodium, USP have the following structures, respectively: Naproxen Naproxen Sodium Naproxen, USP is a white to off-white crystalline powder.",
      "dosage": "Management of Pain, Primary Dysmenorrhea, and Acute Tendonitis and Bursitis Recommended starting dos",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1173,
    "fields": {
      "name": "NITROGLYCERIN",
      "brand": "NITROGLYCERIN",
      "description": "11 DESCRIPTION Nitroglycerin sublingual tablets are stabilized sublingual compressed tablets that contain 0.3 mg, 0.4 mg, or 0.6 mg nitroglycerin; as well as lactose monohydrate, NF; glyceryl monostearate, NF; pregelatinized starch, NF; calcium stearate, NF powder; and silicon dioxide, colloidal, NF. Nitroglycerin, an organic nitrate, is a vasodilating agent. The chemical name for nitroglycerin is 1, 2, 3 propanetriol trinitrate and the chemical structure is: Molecular weight: 227.09 Nitroglycerin Structural Formula",
      "dosage": "2 DOSAGE AND ADMINISTRATION Administer one tablet under the tongue or in the buccal pouch at the fir",
      "stock": 100,
      "route": "SUBLINGUAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1174,
    "fields": {
      "name": "NORTRIPTYLINE HYDROCHLORIDE",
      "brand": "Nortriptyline Hydrochloride",
      "description": "DESCRIPTION Nortriptyline Hydrochloride, USP is 1-propanamine, 3-(10,11-dihydro-5 H -dibenzo[ a,d ]cyclohepten-5-ylidene)- N -methyl, hydrochloride. The structural formula is as follows: C19H21N\u2219HCl MW = 299.84 Each capsule, for oral administration, contains nortriptyline hydrochloride equivalent to 10 mg, 25 mg, 50 mg, and 75 mg of nortriptyline hydrochloride USP. In addition, each capsule contains the following inactive ingredients: black iron oxide, colloidal silicon dioxide, D&C Yellow #10 (aluminum lake), D&C Yellow #10, FD&C Blue #1 (aluminum lake), FD&C Blue #2 (aluminum lake), FD&C Green #3 (10, 50 and 75 mg only), FD&C Red #40 (aluminum lake), gelatin, I.M.S. 74 OP, magnesium stearate, pregelatinized corn starch, shellac, sodium lauryl sulfate and titanium dioxide.",
      "dosage": "Usual Adult Dose 25 mg three or four times daily; dosage should begin at a low level and be increase",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1175,
    "fields": {
      "name": "OMEPRAZOLE",
      "brand": "Omeprazole",
      "description": "",
      "dosage": "Directions for adults 18 years of age and older this product is to be used once a day (every 24 hour",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1176,
    "fields": {
      "name": "ONDANSETRON HYDROCHLORIDE",
      "brand": "ondansetron hydrochloride",
      "description": "11 DESCRIPTION The active ingredient in ondansetron tablets is ondansetron hydrochloride as the dihydrate, the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT 3 receptor type. Chemically it is (\u00b1) 1, 2, 3, 9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, monohydrochloride, dihydrate. Each tablet also contains the inactive ingredients colloidal silicon dioxide, hypromellose 2910(5cP) (for the 4 mg and 16 mg tablets only) and hypromellose 2910 (6cP) (for the 8 mg and 24 mg tablets only), iron oxide red and iron oxide black (for the 24 mg tablet only), iron oxide yellow (for the 8 mg and 24 mg tablets only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, sodium starch glycolate, and titanium dioxide.",
      "dosage": "2 DOSAGE AND ADMINISTRATION See full prescribing information for the recommended dosage in adults an",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1177,
    "fields": {
      "name": "OXYCODONE HYDROCHLORIDE",
      "brand": "Oxycodone Hydrochloride",
      "description": "Each tablet for oral administration contains 15 mg, or 30 mg, of oxycodone hydrochloride USP. Oxycodone hydrochloride is a white, odorless crystalline powder derived from the opium alkaloid, thebaine. The 15 mg and 30 mg tablets contain the equivalent of 13.5 mg and 27.0 mg, respectively, of oxycodone free base.",
      "dosage": "If a decision is made to discontinue the use of non-opioid analgesic, it may be necessary to titrate",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1178,
    "fields": {
      "name": "PANTOPRAZOLE SODIUM INJECTION",
      "brand": "PANTOPRAZOLE SODIUM",
      "description": "11 DESCRIPTION The active ingredient in pantoprazole sodium for injection (pantoprazole sodium), a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S, with a molecular weight of 405.4. The reconstituted solution of pantoprazole sodium for injection is in the pH range of 9.0 to 10.5.",
      "dosage": "( 2.3 , 2.4 ) 2.1 Recommended Dosage for GERD Associated with a History of EE Adult Patients The rec",
      "stock": 100,
      "route": "INTRAVENOUS",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1179,
    "fields": {
      "name": "PAROXETINE HYDROCHLORIDE HEMIHYDRATE",
      "brand": "Paroxetine",
      "description": "11 DESCRIPTION Paroxetine tablets contain paroxetine hydrochloride, an SSRI. It is the hydrochloride salt of a phenylpiperidine compound identified chemically as (-)- trans -4 R -(4'-fluorophenyl)-3 S -[(3',4'- methylenedioxyphenoxy) methyl] piperidine hydrochloride hemihydrate and has the empirical formula of C 19 H 20 FNO 3 \u2022HCl\u20221/2H 2 O. The structural formula of paroxetine hydrochloride is: Paroxetine hydrochloride, USP is an odorless, off-white powder, having a melting point range of 120 o to 138 o C and a solubility of 5.4 mg/mL in water.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting and maximum daily dosage for MDD, OCD, PD, and PTSD",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1180,
    "fields": {
      "name": "PENICILLIN G BENZATHINE",
      "brand": "BICILLIN L-A",
      "description": "Description Bicillin L-A (penicillin G benzathine injectable suspension) is available for deep intramuscular injection. Its chemical structure is as follows: Bicillin L-A contains penicillin G benzathine in aqueous suspension with sodium citrate buffer and, as w/v, approximately 0.65% sodium citrate, 0.59% povidone, 0.54% carboxymethylcellulose sodium, 0.53% lecithin, 0.12% methylparaben, and 0.013% propylparaben. Bicillin L-A contains approximately 0.11 mEq of sodium per 600,000 units of penicillin G (approximately 2.59 mg of sodium per 600,000 units of penicillin G).",
      "dosage": "DOSAGE AND ADMINISTRATION Streptococcal (Group A) Upper Respiratory Infections (for example, pharyng",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1181,
    "fields": {
      "name": "PHENYTOIN SODIUM",
      "brand": "Phenytoin Sodium",
      "description": "11 DESCRIPTION Phenytoin Sodium Injection, USP is a sterile solution containing in each mL phenytoin sodium 50 mg, propylene glycol 0.4 mL and alcohol 0.1 mL in Water for Injection. pH 10.0-12.3; sodium hydroxide added, if needed, for pH adjustment. Phenytoin sodium is related to the barbiturates in chemical structure, but has a five-membered ring.",
      "dosage": "( 2.2 , 2.3 ) 2.1 General Dosing Information Because of the increased risk of adverse cardiovascular",
      "stock": 100,
      "route": "INTRAMUSCULAR",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1182,
    "fields": {
      "name": "PIOGLITAZONE HYDROCHLORIDE",
      "brand": "PIOGLITAZONE HYDROCHLORIDE",
      "description": "11 DESCRIPTION Pioglitazone tablets are a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (PPAR) gamma that contains an oral antidiabetic medication: pioglitazone. Pioglitazone [(\u00b1)-5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2,4-] thiazolidinedione monohydrochloride contains one asymmetric carbon, and the compound is synthesized and used as the racemic mixture. The two enantiomers of pioglitazone interconvert in vivo .",
      "dosage": "(2.1) If there is inadequate glycemic control, the dose can be increased in 15 mg increments up to a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1183,
    "fields": {
      "name": "PREDNISONE",
      "brand": "PredniSONE",
      "description": "DESCRIPTION Prednisone is a glucocorticoid. Glucocorticoids are adrenocortical steroids, both naturally occurring and synthetic, which are readily absorbed from the gastrointestinal tract. Prednisone, USP is a white to partially white, crystalline powder.",
      "dosage": "Included in the situations which may make dosage adjustments necessary are changes in clinical statu",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1184,
    "fields": {
      "name": "PREGABALIN",
      "brand": "PREGABALIN",
      "description": "The molecular formula is C 8 H 17 NO 2 and the molecular weight is 159.23. Pregabalin capsules are administered orally and are supplied as imprinted hard-shell capsules containing 25, 50, 75, 100, 150, 200, 225, and 300 mg of pregabalin, along with pregelatinized starch and talc as inactive ingredients. In addition, the orange & red capsule shells contain red iron oxide.",
      "dosage": "( 2.2 , 2.3 , 2.4 , 2.5 , 2.6 ) Dosing recommendations: INDICATION Dosing Regimen Maximum Dose DPN P",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1185,
    "fields": {
      "name": "PROMETHAZINE HYDROCHLORIDE",
      "brand": "PROMETHAZINE HYDROCHLORIDE",
      "description": "DESCRIPTION Each 12.5 mg promethazine hydrochloride tablet for oral administration contains 12.5 mg promethazine hydrochloride. In addition, 50 mg tablet contains FD&C Red #40 and 12.5 mg tablet contains FD&C Yellow #6. Promethazine hydrochloride is a racemic compound; the empirical formula is C 17 H 20 N 2 S\u2022HCl and its molecular weight is 320.88.",
      "dosage": "The average effective dose of promethazine hydrochloride tablets, USP for the active therapy of naus",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1186,
    "fields": {
      "name": "PROPRANOLOL HYDROCHLORIDE",
      "brand": "Propranolol Hydrochloride",
      "description": "Propranolol Hydrochloride Tablets, USP are available as tablets for oral administration containing either 10 mg, 20 mg, 40 mg, 60 mg, or 80 mg of propranolol hydrochloride, USP. 6 aluminum lake (10 mg and 80 mg), D&C Yellow no. 10 aluminum lake (10 mg, 40 mg, and 80 mg), FD&C Blue no.",
      "dosage": "Hypertension The usual initial dosage is 40 mg propranolol hydrochloride twice daily, whether used a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1187,
    "fields": {
      "name": "QUETIAPINE FUMARATE",
      "brand": "Quetiapine Fumarate",
      "description": "It is present in tablets as the fumarate salt. Quetiapine tablets, USP is supplied for oral administration as 25 mg (round peach), 50 mg (round, white), 100 mg (round yellow), 150 mg (round, off white to light yellow), 200 mg (round, white), 300 mg (capsule-shaped, white), and 400 mg (capsule-shaped, yellow) tablets. The 25 mg tablets contain red iron oxide and yellow iron oxide and the 100 mg, 150 mg and 400 mg tablets contain only yellow iron oxide.",
      "dosage": "Further adjustments can be made in increments of 25 to 50 mg twice a day, in intervals of not less t",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1188,
    "fields": {
      "name": "RABEPRAZOLE SODIUM",
      "brand": "Rabeprazole sodium",
      "description": "11 DESCRIPTION The active ingredient in rabeprazole sodium delayed-release tablets is rabeprazole sodium hydrate, USP, which is a proton pump inhibitor. The stability of rabeprazole sodium hydrate, USP is a function of pH; it is rapidly degraded in acid media, and is more stable under alkaline conditions. The structural figure is: Rabeprazole sodium hydrate, USP is available for oral administration as delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium hydrate, USP.",
      "dosage": "The use of rabeprazole sodium delayed-release tablets is not recommended for use in pediatric patien",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1189,
    "fields": {
      "name": "RANITIDINE",
      "brand": "Ranitidine",
      "description": "",
      "dosage": "Directions adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1190,
    "fields": {
      "name": "RISPERIDONE",
      "brand": "RISPERIDONE",
      "description": "11 DESCRIPTION Risperidone tablets, USP contain risperidone USP, an atypical antipsychotic belonging to the chemical class of benzisoxazole derivatives. The structural formula is: Risperidone USP is a white to slightly beige powder. Tablets of 0.25 mg, 0.5 mg, 2 mg, 3 mg, and 4 mg also contain talc and titanium dioxide.",
      "dosage": "Maintenance Therapy While it is unknown how long a patient with schizophrenia should remain on rispe",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1191,
    "fields": {
      "name": "ROSUVASTATIN CALCIUM",
      "brand": "Rosuvastatin Calcium",
      "description": "11 DESCRIPTION Rosuvastatin is a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA)-reductase inhibitor. The chemical name for rosuvastatin calcium is bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt with the following structural formula: The empirical formula for rosuvastatin calcium is (C 22 H 27 FN 3 O 6 S) 2 Ca and the molecular weight is 1001.14. Rosuvastatin calcium is a white or almost white, hygroscopic powder that is slightly soluble in water, freely soluble in methylene chloride, practically insoluble in ethanol.",
      "dosage": "( 2.1 ) Pediatric Patients with HeFH : Recommended dosage range is 5 to 10 mg once daily for patient",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1192,
    "fields": {
      "name": "SERTRALINE HYDROCHLORIDE",
      "brand": "Sertraline Hydrochloride",
      "description": "DESCRIPTION Sertraline hydrochloride is a selective serotonin reuptake inhibitor (SSRI) for oral administration. It has a molecular weight of 342.7. Sertraline hydrochloride, USP has the following chemical name: (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride.",
      "dosage": "While a relationship between dose and effect has not been established for OCD, patients were dosed i",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1193,
    "fields": {
      "name": "SILDENAFIL CITRATE",
      "brand": "SILDENAFIL CITRATE",
      "description": "11 DESCRIPTION Sildenafil tablets, USP, an oral therapy for erectile dysfunction, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Sildenafil citrate, is designated chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1 H -pyrazolo[4,3- d ]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate and has the following structural formula: Sildenafil citrate, USP is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Sildenafil tablets USP are formulated as pale blue to blue film-coated tablets equivalent to 25 mg, 50 mg and 100 mg of sildenafil for oral administration.",
      "dosage": "However, sildenafil tablets may be taken anywhere from 30 minutes to 4 hours before sexual activity ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1194,
    "fields": {
      "name": "EZETIMIBE AND SIMVASTATIN",
      "brand": "Ezetimibe and Simvastatin",
      "description": "11 DESCRIPTION Ezetimibe and simvastatin tablets contain ezetimibe USP, a selective inhibitor of intestinal cholesterol and related phytosterol absorption, and simvastatin USP, an HMG-CoA reductase inhibitor. The chemical name of ezetimibe, USP is 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone. formula 1 formula 2",
      "dosage": "The maximum recommended dosage is ezetimibe and simvastatin tablets 10 mg/40 mg once daily. The ezet",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1195,
    "fields": {
      "name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
      "brand": "ZITUVIMET",
      "description": "Sitagliptin is present in ZITUVIMET tablets in the form of sitagliptin free base. Sitagliptin free base is described chemically as 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3 (trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine with an empirical formula of C 16 H 15 F 6 N 5 O and a molecular weight of 407.31. In addition, the film coating contains the following inactive ingredients: polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.",
      "dosage": "( 2.1 ) The recommended starting dose in patients not currently treated with metformin is 50 mg sita",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1196,
    "fields": {
      "name": "SPIRONOLACTONE",
      "brand": "Spironolactone",
      "description": "11 DESCRIPTION Spironolactone oral tablets contain 25 mg, 50 mg, or 100 mg of the aldosterone antagonist spironolactone, USP 17hydroxy-7\u03b1-mercapto-3-oxo-17\u03b1-pregn-4-ene-21-carboxylic acid \u03b3-lactone acetate, which has the following structural formula: Spironolactone, USP is practically insoluble in water, soluble in alcohol, and freely soluble in benzene and in chloroform. Inactive ingredients include calcium sulfate, corn starch, croscarmellose sodium, peppermint flavor, hypromellose, iron oxide, magnesium stearate, microcrystalline cellulose, polydextrose, polyethylene glycol, polyvinyl alcohol, povidone, talc, titanium dioxide, and triacetin. The 50 mg tablet also contains D&C yellow # 10 and FD&C yellow #6.",
      "dosage": "2.2 Treatment of Heart Failure In patients with serum potassium \u2264 5.0 mEq/L and eGFR > 50 mL/min/1.7",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1197,
    "fields": {
      "name": "TAMSULOSIN HYDROCHLORIDE",
      "brand": "Tamsulosin Hydrochloride",
      "description": "11 DESCRIPTION Tamsulosin hydrochloride is an antagonist of alpha 1A adrenoceptors in the prostate. It is sparingly soluble in water and methanol, slightly soluble in glacial acetic acid and ethanol, and practically insoluble in ether. The molecular formula of tamsulosin hydrochloride is C 20 H 28 N 2 O 5 S \u2022 HCl.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Tamsulosin hydrochloride capsules 0.4 mg once daily is recommended as th",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1198,
    "fields": {
      "name": "TEMAZEPAM",
      "brand": "Temazepam",
      "description": "DESCRIPTION Temazepam, USP is a benzodiazepine hypnotic agent. The chemical name is 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, and the structural formula is: C 16 H 13 ClN 2 O 2 MW = 300.74 Temazepam, USP is a white, crystalline substance, very slightly soluble in water and sparingly soluble in alcohol USP. Temazepam capsules USP, 7.5 mg, 15 mg, 22.5 mg, and 30 mg, are for oral administration.",
      "dosage": "DOSAGE AND ADMINISTRATION While the recommended usual adult dose is 15 mg before retiring, 7.5 mg ma",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1199,
    "fields": {
      "name": "TERAZOSIN HYDROCHLORIDE",
      "brand": "Terazosin",
      "description": "DESCRIPTION Terazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name,molecular formula and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, monohydrochloride.C 19 H 26 ClN 5 O 4 Terazosin hydrochloride is a white, crystalline substance, freely soluble in water and isotonic saline and has a molecular weight of 423.93. Each capsule, for oral administration, contains 1 mg, 2 mg, 5 mg or 10 mg of terazosin as terazosin hydrochlolde. In addition, each capsule contains the following inactive ingredients: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, and pregelatinized starch.",
      "dosage": "DOSAGE AND ADMINISTRATION If terazosin capsules administration is discontinued for several days, the",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1200,
    "fields": {
      "name": "TIZANIDINE",
      "brand": "tizanidine",
      "description": "11 DESCRIPTION Tizanidine Tablets, USP contains tizanidine hydrochloride as the active ingredient, which is a central alpha 2 -adrenergic agonist. Its chemical name is 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiodiazole monohydrochloride. It has a molecular formula of C 9 H 8 CIN 5 S\u00b7HCl and a molecular weight of 290.17.",
      "dosage": "( 2.1 ) Recommended starting dose: 2 mg by mouth every 6 to 8 hours, as needed, up to a maximum of 3",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1201,
    "fields": {
      "name": "TOPIRAMATE",
      "brand": "topiramate",
      "description": "11 DESCRIPTION Topiramate, USP is a sulfamate-substituted monosaccharide. Topiramate tablets, USP are available as 25 mg, 50 mg, 100 mg, and 200 mg round shaped tablets for oral administration. Its saturated solution has a pH of 6.3.",
      "dosage": "Table 2: Monotherapy Target Total Daily Maintenance Dosing for Patients 2 to 9 Years of Age Weight (",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1202,
    "fields": {
      "name": "TRAMADOL HYDROCHLORIDE",
      "brand": "TRAMADOL HYDROCHLORIDE",
      "description": "The chemical name is (\u00b1) cis -2-[(dimethylamino) methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochloride. It is a white, crystalline powder that is freely soluble in water and methanol, very slightly soluble in acetone and has a pKa of 9.41. Tramadol hydrochloride extended-release tablets, USP contain 100 mg, 200 mg or 300 mg of tramadol hydrochloride, USP in an extended-release formulation.",
      "dosage": "2.5 Safe Reduction or Discontinuation of Tramadol Hydrochloride Extended-Release Tablets Do not abru",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1203,
    "fields": {
      "name": "TRAZODONE HYDROCHLORIDE",
      "brand": "Trazodone Hydrochloride",
      "description": "11 DESCRIPTION Trazodone hydrochloride is a selective serotonin reuptake inhibitor and 5HT2 receptor antagonist. Trazodone hydrochloride, USP is a triazolopyridine derivative designated as 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]- 1,2,4-triazolo[4, 3-a]pyridin-3(2H)-one hydrochloride. It is a white to off-white, crystalline powder which is sparingly soluble in chloroform and in water.",
      "dosage": "The dosage should be initiated at a low-dose and increased gradually, noting the clinical response a",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1204,
    "fields": {
      "name": "SACUBITRIL AND VALSARTAN",
      "brand": "ENTRESTO",
      "description": "Its molecular mass is 957.99 g/mol and its schematic structural formula is: ENTRESTO is available as film-coated tablets for oral administration, containing 24 mg of sacubitril and 26 mg of valsartan; 49 mg of sacubitril and 51 mg of valsartan; and 97 mg of sacubitril and 103 mg of valsartan. The film-coat inactive ingredients are hypromellose, iron oxide red (E172), polyethylene glycol 4000, talc, and titanium dioxide (E171). The film-coat for the 49 mg of sacubitril and 51 mg of valsartan tablet contains iron oxide yellow (E172).",
      "dosage": "2 DOSAGE AND ADMINISTRATION The recommended starting dosage for adults is 49 mg/51 mg orally twice d",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1205,
    "fields": {
      "name": "VENLAFAXINE",
      "brand": "Venlafaxine",
      "description": "DESCRIPTION Venlafaxine hydrochloride is a structurally novel antidepressant for oral administration. Each venlafaxine tablet, USP intended for oral administration contains venlafaxine hydrochloride equivalent to 25 mg or 37.5 mg or 50 mg or 75 mg or 100 mg of venlafaxine. Structured formula for venlafaxine",
      "dosage": "When treating pregnant women with venlafaxine tablets during the third trimester, the physician shou",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1206,
    "fields": {
      "name": "VERAPAMIL HYDROCHLORIDE",
      "brand": "Verapamil Hydrochloride",
      "description": "DESCRIPTION Verapamil hydrochloride is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets containing 40 mg, 80 mg, or 120 mg of verapamil hydrochloride. The structural formula of verapamil hydrochloride is: Benzeneacetonitrile, \u03b1-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-\u03b1-(1-methylethyl) hydrochloride. Verapamil hydrochloride is an almost white, crystalline powder, practically free of odor, with a bitter taste.",
      "dosage": "Angina: Clinical trials show that the usual dose is 80 mg to 120 mg three times a day. However, 40 m",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1207,
    "fields": {
      "name": "WARFARIN SODIUM",
      "brand": "Warfarin Sodium",
      "description": "11 DESCRIPTION Warfarin sodium tablets, USP contain warfarin sodium, an anticoagulant that acts by inhibiting vitamin K-dependent coagulation factors. 40 aluminum lake, and D&C yellow no. 10 aluminum lake and FD&C yellow no.",
      "dosage": "The duration of treatment is based on the indication as follows: For patients with a DVT or PE secon",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1208,
    "fields": {
      "name": "ZALEPLON",
      "brand": "zaleplon",
      "description": "Its molecular formula is C 17 H 15 N 5 O, and its molecular weight is 305.34. Zaleplon capsules USP contain zaleplon as the active ingredient. The 5 mg capsules also contain FD&C yellow #5.",
      "dosage": "Although the risk of certain adverse events associated with the use of zaleplon capsules appears to ",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1209,
    "fields": {
      "name": "ZOLPIDEM TARTRATE",
      "brand": "Zolpidem",
      "description": "11 DESCRIPTION Zolpidem Tartrate Tablets, USP contains Zolpidem tartrate, a gamma-aminobutyric acid (GABA) A receptor positive modulator of the imidazopyridine class. It has the following structure: Zolpidem Tartrate is a white to off-white crystalline powder that is sparingly soluble in water, alcohol, and propylene glycol. Opadry II (pink) contains hypromellose, FD&C Red no.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Use the lowest dose effective for the patient and must not exceed a tota",
      "stock": 100,
      "route": "ORAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.drug",
    "pk": 1210,
    "fields": {
      "name": "ZOLMITRIPTAN",
      "brand": "Zolmitriptan",
      "description": "11 DESCRIPTION ZOLMITRIPTAN NASAL SPRAY contains zolmitriptan, which is a selective 5-hydroxytryptamine 1B/1D (5-HT 1B/1D ) receptor agonist. Zolmitriptan is chemically designated as (S)-4-[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone and has the following chemical structure: The empirical formula is C 16 H 21 N 3 O 2 , representing a molecular weight of 287.36. The osmolarity of ZOLMITRIPTAN NASAL SPRAY for 2.5 mg is 360 to 420 mOsmol, and for 5 mg is 420 to 470 mOsmol.",
      "dosage": "2 DOSAGE AND ADMINISTRATION Recommended starting dose: 2.5 mg (2.1) Maximum single dose: 5 mg (2.1) ",
      "stock": 100,
      "route": "NASAL",
      "resupply_pending": 0,
      "pharmacy_id": 6,
      "status": "in_stock"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 10,
    "fields": {
      "quantity": 20,
      "prescribed_on": "2025-10-16 18:04:10.597485",
      "expiration_date": "2026-08-06",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 0,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 11,
    "fields": {
      "quantity": 70,
      "prescribed_on": "2025-10-16 19:43:03.319963",
      "expiration_date": "2025-10-31",
      "medicine_id": 727,
      "patient_id": 298,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 12,
    "fields": {
      "quantity": 70,
      "prescribed_on": "2025-10-16 19:46:33.913082",
      "expiration_date": "2025-10-31",
      "medicine_id": 727,
      "patient_id": 297,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 13,
    "fields": {
      "quantity": 70,
      "prescribed_on": "2025-10-16 19:49:25.722859",
      "expiration_date": "2025-10-31",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 14,
    "fields": {
      "quantity": 15,
      "prescribed_on": "2025-10-20 09:52:18.287396",
      "expiration_date": "2026-08-06",
      "medicine_id": 729,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 0,
      "refill_pending": 0,
      "refilled_on": "2025-10-22 11:41:26.498404"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 15,
    "fields": {
      "quantity": 15,
      "prescribed_on": "2025-10-21 11:08:32.929118",
      "expiration_date": "2026-08-06",
      "medicine_id": 730,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 0,
      "refill_pending": 0,
      "refilled_on": "2025-10-22 12:12:30.446231"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 16,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-10-21 11:21:11.741154",
      "expiration_date": "2026-08-05",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 1,
      "refill_pending": 1,
      "refilled_on": "2025-10-22 11:01:39.144974"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 17,
    "fields": {
      "quantity": 10,
      "prescribed_on": "2025-10-23 17:43:48.656027",
      "expiration_date": "2026-08-06",
      "medicine_id": 737,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 0,
      "refill_pending": 0,
      "refilled_on": "2025-10-23 18:17:39.686834"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 18,
    "fields": {
      "quantity": 10,
      "prescribed_on": "2025-10-23 18:59:36.078800",
      "expiration_date": "2026-08-05",
      "medicine_id": 777,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 0,
      "refilled_on": "2025-10-23 19:00:18.669327"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 19,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-10-23 19:04:25.457683",
      "expiration_date": "2025-10-23",
      "medicine_id": 733,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 20,
    "fields": {
      "quantity": 20,
      "prescribed_on": "2025-10-23 19:47:00.426195",
      "expiration_date": "2025-10-31",
      "medicine_id": 731,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 21,
    "fields": {
      "quantity": 60,
      "prescribed_on": "2025-10-23 19:47:22.725637",
      "expiration_date": "2025-10-31",
      "medicine_id": 731,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 22,
    "fields": {
      "quantity": 0,
      "prescribed_on": "2025-10-23 20:18:12.303088",
      "expiration_date": "2025-10-31",
      "medicine_id": 844,
      "patient_id": 300,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 23,
    "fields": {
      "quantity": 1,
      "prescribed_on": "2025-10-25 17:18:27.760163",
      "expiration_date": "2025-10-31",
      "medicine_id": 744,
      "patient_id": 300,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 24,
    "fields": {
      "quantity": 1,
      "prescribed_on": "2025-10-25 17:18:48.866290",
      "expiration_date": "2025-10-31",
      "medicine_id": 729,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 1,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 25,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-03 11:38:11.577604",
      "expiration_date": "2025-11-26",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 26,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-03 11:40:43.123029",
      "expiration_date": "2025-11-27",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 27,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-03 12:01:04.584141",
      "expiration_date": "2025-11-25",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 1,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 28,
    "fields": {
      "quantity": 70,
      "prescribed_on": "2025-11-03 12:09:08.929943",
      "expiration_date": "2025-11-27",
      "medicine_id": 729,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 29,
    "fields": {
      "quantity": 30,
      "prescribed_on": "2025-11-03 12:09:34.309335",
      "expiration_date": "2025-11-27",
      "medicine_id": 729,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 30,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-11-03 12:42:03.851423",
      "expiration_date": "2025-11-30",
      "medicine_id": 730,
      "patient_id": 295,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 31,
    "fields": {
      "quantity": 10,
      "prescribed_on": "2025-11-03 20:33:49.760032",
      "expiration_date": "2025-11-17",
      "medicine_id": 728,
      "patient_id": 282,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 32,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-11-03 20:34:24.805814",
      "expiration_date": "2025-11-27",
      "medicine_id": 728,
      "patient_id": 286,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 33,
    "fields": {
      "quantity": 50,
      "prescribed_on": "2025-11-03 21:02:37.683552",
      "expiration_date": "2025-11-27",
      "medicine_id": 737,
      "patient_id": 298,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 34,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-11-03 21:16:19.754423",
      "expiration_date": "2025-11-30",
      "medicine_id": 740,
      "patient_id": 289,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 35,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-04 11:27:01.397286",
      "expiration_date": "2025-11-27",
      "medicine_id": 815,
      "patient_id": 297,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 36,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-04 11:35:51.592463",
      "expiration_date": "2025-11-26",
      "medicine_id": 733,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 1,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 37,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-11-04 11:57:43.149056",
      "expiration_date": "2025-11-19",
      "medicine_id": 736,
      "patient_id": 289,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 38,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-11-04 12:33:42.197295",
      "expiration_date": "2025-11-28",
      "medicine_id": 734,
      "patient_id": 286,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 39,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-04 20:19:36.643545",
      "expiration_date": "2025-11-25",
      "medicine_id": 844,
      "patient_id": 291,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 40,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-05 10:57:41.497505",
      "expiration_date": "2025-11-13",
      "medicine_id": 808,
      "patient_id": 290,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 41,
    "fields": {
      "quantity": 10,
      "prescribed_on": "2025-11-05 17:00:34.618397",
      "expiration_date": "2026-08-05",
      "medicine_id": 732,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 0,
      "refilled_on": "2025-11-05 17:01:38.021035"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 42,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-11-05 21:47:44.575050",
      "expiration_date": "2025-11-29",
      "medicine_id": 757,
      "patient_id": 300,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 43,
    "fields": {
      "quantity": 20,
      "prescribed_on": "2025-11-05 22:05:54.606958",
      "expiration_date": "2025-11-29",
      "medicine_id": 757,
      "patient_id": 295,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 44,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-05 22:07:21.977227",
      "expiration_date": "2025-11-28",
      "medicine_id": 757,
      "patient_id": 295,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 45,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-05 22:53:40.848469",
      "expiration_date": "2025-11-25",
      "medicine_id": 744,
      "patient_id": 297,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 46,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-05 23:00:26.919030",
      "expiration_date": "2025-11-28",
      "medicine_id": 742,
      "patient_id": 297,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 47,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-06 11:01:07.147202",
      "expiration_date": "2025-11-27",
      "medicine_id": 750,
      "patient_id": 285,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 48,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-06 11:10:08.292779",
      "expiration_date": "2025-11-18",
      "medicine_id": 741,
      "patient_id": 285,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 49,
    "fields": {
      "quantity": 10,
      "prescribed_on": "2025-11-06 11:13:40.704892",
      "expiration_date": "2025-11-20",
      "medicine_id": 741,
      "patient_id": 298,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 50,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-06 11:42:46.130722",
      "expiration_date": "2025-11-27",
      "medicine_id": 814,
      "patient_id": 282,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 51,
    "fields": {
      "quantity": 10,
      "prescribed_on": "2025-11-06 11:48:02.187554",
      "expiration_date": "2025-11-26",
      "medicine_id": 814,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 52,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-06 12:07:31.568636",
      "expiration_date": "2025-11-26",
      "medicine_id": 758,
      "patient_id": 287,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 53,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-06 12:32:48.393523",
      "expiration_date": "2026-08-05",
      "medicine_id": 734,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 0,
      "refilled_on": "2025-11-06 12:34:48.288828"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 54,
    "fields": {
      "quantity": 10,
      "prescribed_on": "2025-11-06 12:33:16.883822",
      "expiration_date": "2025-11-27",
      "medicine_id": 734,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 55,
    "fields": {
      "quantity": 90,
      "prescribed_on": "2025-11-06 17:47:15.073729",
      "expiration_date": "2026-08-05",
      "medicine_id": 753,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 1,
      "refill_pending": 1,
      "refilled_on": "2025-11-06 17:50:57.317286"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 56,
    "fields": {
      "quantity": 10,
      "prescribed_on": "2025-11-06 17:48:21.479590",
      "expiration_date": "2026-08-05",
      "medicine_id": 753,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 1,
      "refill_pending": 1,
      "refilled_on": "2025-11-06 17:52:40.746651"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 57,
    "fields": {
      "quantity": 20,
      "prescribed_on": "2025-11-06 18:06:41.923921",
      "expiration_date": "2026-08-05",
      "medicine_id": 744,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 0,
      "refilled_on": "2025-11-26 21:26:39.345958"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 58,
    "fields": {
      "quantity": 10,
      "prescribed_on": "2025-11-26 19:25:24.054518",
      "expiration_date": "2025-12-03",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 1,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 59,
    "fields": {
      "quantity": 10,
      "prescribed_on": "2025-11-26 20:45:43.058453",
      "expiration_date": "2025-11-28",
      "medicine_id": 844,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 1,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 60,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-12-01 11:21:12.449436",
      "expiration_date": "2025-12-26",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 61,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-12-01 11:30:37.881703",
      "expiration_date": "2025-12-31",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 62,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-12-01 11:36:42.827486",
      "expiration_date": "2025-12-10",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 63,
    "fields": {
      "quantity": 20,
      "prescribed_on": "2025-12-01 11:37:41.548331",
      "expiration_date": "2026-08-20",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 0,
      "refilled_on": "2025-12-01 12:39:12.322399"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 64,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-12-01 11:50:34.773682",
      "expiration_date": "2025-12-24",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 65,
    "fields": {
      "quantity": 100,
      "prescribed_on": "2025-12-01 11:56:09.132822",
      "expiration_date": "2025-12-25",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 1,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 66,
    "fields": {
      "quantity": 80,
      "prescribed_on": "2025-12-01 12:12:52.865324",
      "expiration_date": "2026-01-01",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 67,
    "fields": {
      "quantity": 20,
      "prescribed_on": "2025-12-01 12:13:22.805939",
      "expiration_date": "2026-08-06",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 0,
      "refill_pending": 0,
      "refilled_on": "2025-12-01 12:39:39.598209"
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 68,
    "fields": {
      "quantity": 1,
      "prescribed_on": "2025-12-24 13:41:33.100090",
      "expiration_date": "2025-12-23",
      "medicine_id": 740,
      "patient_id": 286,
      "prescribed_by_id": 46,
      "refills_left": 2,
      "refill_pending": 1,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 69,
    "fields": {
      "quantity": 25,
      "prescribed_on": "2026-01-03 11:38:19.753949",
      "expiration_date": "2026-01-20",
      "medicine_id": 727,
      "patient_id": 1,
      "prescribed_by_id": 46,
      "refills_left": 3,
      "refill_pending": 0,
      "refilled_on": null
    }
  },
  {
    "model": "pharmacy.prescription",
    "pk": 70,
    "fields": {
      "quantity": 25,
      "prescribed_on": "2026-01-03 11:43:14.132899",
      "expiration_date": "2026-01-29",
      "medicine_id": 606,
      "patient_id": 345,
      "prescribed_by_id": 43,
      "refills_left": 2,
      "refill_pending": 0,
      "refilled_on": "2026-01-03 11:44:00.510771"
    }
  },
  {
    "model": "patients.medicationreminder",
    "pk": 11,
    "fields": {
      "frequency": 2,
      "prescription_id": 16,
      "user_id": 1,
      "is_active": 0,
      "start_date": "2025-12-15",
      "day_amount": 1,
      "remaining_days": 1,
      "is_archived": 1,
      "restoration_time": "2025-12-15 20:07:20.990550"
    }
  },
  {
    "model": "patients.medicationreminder",
    "pk": 12,
    "fields": {
      "frequency": 2,
      "prescription_id": 51,
      "user_id": 1,
      "is_active": 0,
      "start_date": "2025-12-15",
      "day_amount": 2,
      "remaining_days": 2,
      "is_archived": 1,
      "restoration_time": "2025-12-15 20:23:28.250634"
    }
  },
  {
    "model": "patients.medicationreminder",
    "pk": 13,
    "fields": {
      "frequency": 1,
      "prescription_id": 56,
      "user_id": 1,
      "is_active": 0,
      "start_date": "2025-12-15",
      "day_amount": 2,
      "remaining_days": 2,
      "is_archived": 1,
      "restoration_time": "2025-12-15 20:02:48.864839"
    }
  },
  {
    "model": "patients.medicationreminder",
    "pk": 14,
    "fields": {
      "frequency": 1,
      "prescription_id": 20,
      "user_id": 1,
      "is_active": 0,
      "start_date": "2025-12-13",
      "day_amount": 1,
      "remaining_days": 1,
      "is_archived": 1,
      "restoration_time": "2025-12-13 15:58:02.550150"
    }
  },
  {
    "model": "patients.medicationreminder",
    "pk": 15,
    "fields": {
      "frequency": 2,
      "prescription_id": 70,
      "user_id": 345,
      "is_active": 1,
      "start_date": "2026-01-05",
      "day_amount": 2,
      "remaining_days": 2,
      "is_archived": 0,
      "restoration_time": "2026-01-05 20:07:43.676673"
    }
  },
  {
    "model": "patients.remindertime",
    "pk": 41,
    "fields": {
      "time": "15:50:00",
      "reminder_id": 11,
      "is_active": 1,
      "task_id": "a8d658e7-88c1-4567-8d63-6aae3ffd381e"
    }
  },
  {
    "model": "patients.remindertime",
    "pk": 42,
    "fields": {
      "time": "07:41:00",
      "reminder_id": 11,
      "is_active": 1,
      "task_id": "0fb79fd4-db77-4cbc-948c-ee40299e779f"
    }
  },
  {
    "model": "patients.remindertime",
    "pk": 43,
    "fields": {
      "time": "15:49:00",
      "reminder_id": 12,
      "is_active": 1,
      "task_id": "8daddfc8-be65-4d75-b568-6afd4ff1e95d"
    }
  },
  {
    "model": "patients.remindertime",
    "pk": 44,
    "fields": {
      "time": "16:36:00",
      "reminder_id": 12,
      "is_active": 1,
      "task_id": "4861fffc-7fa2-4071-b0b1-06ebc80e69e9"
    }
  },
  {
    "model": "patients.remindertime",
    "pk": 45,
    "fields": {
      "time": "16:12:00",
      "reminder_id": 13,
      "is_active": 1,
      "task_id": "a6bd8bb1-a3d6-4ad2-99a5-328c225d307f"
    }
  },
  {
    "model": "patients.remindertime",
    "pk": 46,
    "fields": {
      "time": "16:20:00",
      "reminder_id": 14,
      "is_active": 1,
      "task_id": "00bfcd12-4bd1-4d22-a597-26e0d94d3c6b"
    }
  },
  {
    "model": "patients.remindertime",
    "pk": 47,
    "fields": {
      "time": "15:31:00",
      "reminder_id": 15,
      "is_active": 1,
      "task_id": "7458f41e-ac50-443b-961a-7e8a5411bb67"
    }
  },
  {
    "model": "patients.remindertime",
    "pk": 48,
    "fields": {
      "time": "15:32:00",
      "reminder_id": 15,
      "is_active": 1,
      "task_id": "42194a67-1e42-481a-8536-e6dee5038818"
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 376,
    "fields": {
      "content": "hello can i get a prescripption for acetaminophen?",
      "timestamp": "2025-12-01 22:12:12.977746",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 377,
    "fields": {
      "content": "qR",
      "timestamp": "2025-12-01 22:15:41.508363",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 378,
    "fields": {
      "content": "WaR",
      "timestamp": "2025-12-01 22:15:52.559358",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 379,
    "fields": {
      "content": "supp",
      "timestamp": "2025-12-01 22:15:56.035310",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 380,
    "fields": {
      "content": "hello",
      "timestamp": "2025-12-01 22:15:59.286423",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 381,
    "fields": {
      "content": "no way",
      "timestamp": "2025-12-01 22:16:07.601304",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 382,
    "fields": {
      "content": "yo",
      "timestamp": "2025-12-22 19:21:17.860158",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 383,
    "fields": {
      "content": "what",
      "timestamp": "2025-12-22 19:35:37.246733",
      "recipient_id": null,
      "sender_id": 348,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 384,
    "fields": {
      "content": "wow",
      "timestamp": "2025-12-22 19:41:52.492813",
      "recipient_id": null,
      "sender_id": 348,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 385,
    "fields": {
      "content": "yes",
      "timestamp": "2025-12-22 19:45:47.937623",
      "recipient_id": null,
      "sender_id": 348,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 386,
    "fields": {
      "content": "huh",
      "timestamp": "2025-12-22 19:46:13.823163",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 387,
    "fields": {
      "content": "whioa",
      "timestamp": "2025-12-22 19:52:45.952649",
      "recipient_id": null,
      "sender_id": 348,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 388,
    "fields": {
      "content": "what",
      "timestamp": "2025-12-22 19:59:53.639611",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 389,
    "fields": {
      "content": "i do get the message appended and notification but its only after i refresh",
      "timestamp": "2025-12-22 20:00:46.856264",
      "recipient_id": null,
      "sender_id": 348,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 390,
    "fields": {
      "content": "hello",
      "timestamp": "2025-12-22 20:03:29.437989",
      "recipient_id": null,
      "sender_id": 348,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 391,
    "fields": {
      "content": "hello",
      "timestamp": "2025-12-22 20:09:34.920261",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 392,
    "fields": {
      "content": "hello",
      "timestamp": "2025-12-22 20:27:14.227637",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 393,
    "fields": {
      "content": "hello",
      "timestamp": "2025-12-22 20:31:35.938702",
      "recipient_id": null,
      "sender_id": 348,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 394,
    "fields": {
      "content": "hey",
      "timestamp": "2025-12-22 20:35:21.725003",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 395,
    "fields": {
      "content": "yi",
      "timestamp": "2025-12-22 20:36:51.979219",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 396,
    "fields": {
      "content": "what",
      "timestamp": "2025-12-22 20:37:39.582443",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 397,
    "fields": {
      "content": "hello",
      "timestamp": "2025-12-22 20:57:31.034169",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 398,
    "fields": {
      "content": "what",
      "timestamp": "2025-12-22 21:02:18.961302",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 399,
    "fields": {
      "content": "yo",
      "timestamp": "2025-12-22 21:02:23.545047",
      "recipient_id": null,
      "sender_id": 348,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 400,
    "fields": {
      "content": "sup",
      "timestamp": "2025-12-22 21:02:31.250897",
      "recipient_id": null,
      "sender_id": 348,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 401,
    "fields": {
      "content": "hey",
      "timestamp": "2025-12-22 21:02:36.197593",
      "recipient_id": null,
      "sender_id": 17,
      "thread_id": 122,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 402,
    "fields": {
      "content": "You have a new prescription.",
      "timestamp": "2025-12-24 13:41:33.125996",
      "recipient_id": null,
      "sender_id": 417,
      "thread_id": 123,
      "link": "/pharmacy/patient_profile/286#prescription-68",
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 403,
    "fields": {
      "content": "hello",
      "timestamp": "2026-01-02 22:17:04.549674",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 404,
    "fields": {
      "content": "wassup",
      "timestamp": "2026-01-02 22:19:42.376419",
      "recipient_id": null,
      "sender_id": 47,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 405,
    "fields": {
      "content": "nothing much",
      "timestamp": "2026-01-02 22:20:12.742370",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 406,
    "fields": {
      "content": "wassup",
      "timestamp": "2026-01-02 22:20:40.985816",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 407,
    "fields": {
      "content": "hello",
      "timestamp": "2026-01-02 22:24:10.386641",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 408,
    "fields": {
      "content": "what",
      "timestamp": "2026-01-02 22:24:38.317523",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 409,
    "fields": {
      "content": "hey",
      "timestamp": "2026-01-02 22:25:09.448475",
      "recipient_id": null,
      "sender_id": 47,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 410,
    "fields": {
      "content": "whoa",
      "timestamp": "2026-01-02 22:28:33.659839",
      "recipient_id": null,
      "sender_id": 47,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 411,
    "fields": {
      "content": "wow",
      "timestamp": "2026-01-02 22:28:50.839590",
      "recipient_id": null,
      "sender_id": 47,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 412,
    "fields": {
      "content": "hello",
      "timestamp": "2026-01-02 22:36:29.502039",
      "recipient_id": null,
      "sender_id": 47,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 413,
    "fields": {
      "content": "You have a new prescription.",
      "timestamp": "2026-01-03 11:38:19.772777",
      "recipient_id": null,
      "sender_id": 417,
      "thread_id": 128,
      "link": "/pharmacy/patient_profile/1#prescription-69",
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 414,
    "fields": {
      "content": "You have a new prescription.",
      "timestamp": "2026-01-03 11:43:14.147573",
      "recipient_id": null,
      "sender_id": 417,
      "thread_id": 129,
      "link": "/pharmacy/patient_profile/345#prescription-70",
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 415,
    "fields": {
      "content": "yo teresa",
      "timestamp": "2026-01-03 11:45:11.376825",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 127,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 416,
    "fields": {
      "content": "yo teresa",
      "timestamp": "2026-01-03 11:57:27.354599",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 417,
    "fields": {
      "content": "yo",
      "timestamp": "2026-01-03 11:57:36.380274",
      "recipient_id": null,
      "sender_id": 325,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 418,
    "fields": {
      "content": "wassup",
      "timestamp": "2026-01-03 11:57:40.968117",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 419,
    "fields": {
      "content": "chillin",
      "timestamp": "2026-01-03 11:58:00.723893",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 420,
    "fields": {
      "content": "yo",
      "timestamp": "2026-01-03 11:58:06.383499",
      "recipient_id": null,
      "sender_id": 325,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 421,
    "fields": {
      "content": "what the helly",
      "timestamp": "2026-01-03 11:58:20.876057",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 422,
    "fields": {
      "content": "yo",
      "timestamp": "2026-01-03 12:02:16.711595",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 423,
    "fields": {
      "content": "what",
      "timestamp": "2026-01-03 12:02:26.289431",
      "recipient_id": null,
      "sender_id": 325,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 424,
    "fields": {
      "content": "sup",
      "timestamp": "2026-01-03 12:02:39.098093",
      "recipient_id": null,
      "sender_id": 325,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 425,
    "fields": {
      "content": "yo",
      "timestamp": "2026-01-03 12:02:53.157532",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 426,
    "fields": {
      "content": "no way",
      "timestamp": "2026-01-03 12:03:02.968136",
      "recipient_id": null,
      "sender_id": 325,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "pharmacy.message",
    "pk": 427,
    "fields": {
      "content": "sup",
      "timestamp": "2026-01-03 12:03:07.854069",
      "recipient_id": null,
      "sender_id": 428,
      "thread_id": 131,
      "link": null,
      "refill_fulfilled": null,
      "prescription_id": null,
      "drug_id": null,
      "resupply_fulfilled": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1591,
    "fields": {
      "message_id": null,
      "time": "2025-12-01 12:38:09.387352",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": "A refill request from Justin Jackson has been sent.",
      "drug_id": null,
      "link": "/pharmacy/refill_prescriptions/65",
      "prescription_id": 65
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1592,
    "fields": {
      "message_id": null,
      "time": "2025-12-01 12:38:09.433594",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": "A refill request from Justin Jackson has been sent.",
      "drug_id": null,
      "link": "/pharmacy/refill_prescriptions/65",
      "prescription_id": 65
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1611,
    "fields": {
      "message_id": 376,
      "time": "2025-12-01 22:12:12.998044",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1612,
    "fields": {
      "message_id": 376,
      "time": "2025-12-01 22:12:13.002870",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1614,
    "fields": {
      "message_id": 377,
      "time": "2025-12-01 22:15:41.527582",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1615,
    "fields": {
      "message_id": 377,
      "time": "2025-12-01 22:15:41.533288",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1618,
    "fields": {
      "message_id": 378,
      "time": "2025-12-01 22:15:52.580347",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1619,
    "fields": {
      "message_id": 378,
      "time": "2025-12-01 22:15:52.586543",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1622,
    "fields": {
      "message_id": 379,
      "time": "2025-12-01 22:15:56.053374",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1623,
    "fields": {
      "message_id": 379,
      "time": "2025-12-01 22:15:56.058712",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1626,
    "fields": {
      "message_id": 380,
      "time": "2025-12-01 22:15:59.309406",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1627,
    "fields": {
      "message_id": 380,
      "time": "2025-12-01 22:15:59.316164",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1630,
    "fields": {
      "message_id": 381,
      "time": "2025-12-01 22:16:07.620146",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1631,
    "fields": {
      "message_id": 381,
      "time": "2025-12-01 22:16:07.625031",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1685,
    "fields": {
      "message_id": 382,
      "time": "2025-12-22 19:21:17.895076",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1686,
    "fields": {
      "message_id": 382,
      "time": "2025-12-22 19:21:17.903307",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1689,
    "fields": {
      "message_id": 383,
      "time": "2025-12-22 19:35:37.269555",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1690,
    "fields": {
      "message_id": 383,
      "time": "2025-12-22 19:35:37.276411",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1692,
    "fields": {
      "message_id": 384,
      "time": "2025-12-22 19:41:52.524905",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1693,
    "fields": {
      "message_id": 384,
      "time": "2025-12-22 19:41:52.531382",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1695,
    "fields": {
      "message_id": 385,
      "time": "2025-12-22 19:45:47.971036",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1696,
    "fields": {
      "message_id": 385,
      "time": "2025-12-22 19:45:47.978665",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1698,
    "fields": {
      "message_id": 386,
      "time": "2025-12-22 19:46:13.856671",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1699,
    "fields": {
      "message_id": 386,
      "time": "2025-12-22 19:46:13.868225",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1701,
    "fields": {
      "message_id": 387,
      "time": "2025-12-22 19:52:45.982089",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1702,
    "fields": {
      "message_id": 387,
      "time": "2025-12-22 19:52:45.995197",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1705,
    "fields": {
      "message_id": 388,
      "time": "2025-12-22 19:59:53.671995",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1706,
    "fields": {
      "message_id": 388,
      "time": "2025-12-22 19:59:53.681128",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1709,
    "fields": {
      "message_id": 389,
      "time": "2025-12-22 20:00:46.884470",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1710,
    "fields": {
      "message_id": 389,
      "time": "2025-12-22 20:00:46.890115",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1712,
    "fields": {
      "message_id": 390,
      "time": "2025-12-22 20:03:29.471447",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1713,
    "fields": {
      "message_id": 390,
      "time": "2025-12-22 20:03:29.478510",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1715,
    "fields": {
      "message_id": 391,
      "time": "2025-12-22 20:09:34.956614",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1716,
    "fields": {
      "message_id": 391,
      "time": "2025-12-22 20:09:34.965626",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1718,
    "fields": {
      "message_id": 392,
      "time": "2025-12-22 20:27:14.260455",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1719,
    "fields": {
      "message_id": 392,
      "time": "2025-12-22 20:27:14.273596",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1721,
    "fields": {
      "message_id": 393,
      "time": "2025-12-22 20:31:35.965751",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1722,
    "fields": {
      "message_id": 393,
      "time": "2025-12-22 20:31:35.979205",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1724,
    "fields": {
      "message_id": 394,
      "time": "2025-12-22 20:35:21.762342",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1725,
    "fields": {
      "message_id": 394,
      "time": "2025-12-22 20:35:21.767459",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1728,
    "fields": {
      "message_id": 395,
      "time": "2025-12-22 20:36:52.014950",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1729,
    "fields": {
      "message_id": 395,
      "time": "2025-12-22 20:36:52.020920",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1731,
    "fields": {
      "message_id": 396,
      "time": "2025-12-22 20:37:39.614608",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1732,
    "fields": {
      "message_id": 396,
      "time": "2025-12-22 20:37:39.620208",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1734,
    "fields": {
      "message_id": 397,
      "time": "2025-12-22 20:57:31.071079",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1735,
    "fields": {
      "message_id": 397,
      "time": "2025-12-22 20:57:31.078130",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1737,
    "fields": {
      "message_id": 398,
      "time": "2025-12-22 21:02:19.001110",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1738,
    "fields": {
      "message_id": 398,
      "time": "2025-12-22 21:02:19.006687",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1740,
    "fields": {
      "message_id": 399,
      "time": "2025-12-22 21:02:23.573603",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1741,
    "fields": {
      "message_id": 399,
      "time": "2025-12-22 21:02:23.582465",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1743,
    "fields": {
      "message_id": 400,
      "time": "2025-12-22 21:02:31.276474",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1744,
    "fields": {
      "message_id": 400,
      "time": "2025-12-22 21:02:31.286769",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1746,
    "fields": {
      "message_id": 401,
      "time": "2025-12-22 21:02:36.221154",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1747,
    "fields": {
      "message_id": 401,
      "time": "2025-12-22 21:02:36.227940",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1748,
    "fields": {
      "message_id": 402,
      "time": "2025-12-24 13:41:33.133835",
      "user_id": 356,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1750,
    "fields": {
      "message_id": null,
      "time": "2025-12-29 19:28:58.481954",
      "user_id": 23,
      "reminder_id": null,
      "is_read": 1,
      "content": "A resupply of CETIRIZINE HYDROCHLORIDE TABLETS (cetirizine hydrochloride) has been requested due to low inventory.",
      "drug_id": 750,
      "link": "/pharmacy/drug_detail/750",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1751,
    "fields": {
      "message_id": null,
      "time": "2025-12-30 21:58:57.776100",
      "user_id": 23,
      "reminder_id": null,
      "is_read": 1,
      "content": "A resupply of ALLOPURINOL (Allopurinol) has been requested due to low inventory.",
      "drug_id": 731,
      "link": "/pharmacy/drug_detail/731",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1752,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:07.093374",
      "user_id": 348,
      "reminder_id": null,
      "is_read": 1,
      "content": "ALLOPURINOL (Allopurinol) has been resupplied.",
      "drug_id": 731,
      "link": "/pharmacy/drug_detail/731",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1753,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:07.100540",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": "ALLOPURINOL (Allopurinol) has been resupplied.",
      "drug_id": 731,
      "link": "/pharmacy/drug_detail/731",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1754,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:07.104806",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": "ALLOPURINOL (Allopurinol) has been resupplied.",
      "drug_id": 731,
      "link": "/pharmacy/drug_detail/731",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1755,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:07.108823",
      "user_id": 420,
      "reminder_id": null,
      "is_read": 0,
      "content": "ALLOPURINOL (Allopurinol) has been resupplied.",
      "drug_id": 731,
      "link": "/pharmacy/drug_detail/731",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1756,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:38.932047",
      "user_id": 348,
      "reminder_id": null,
      "is_read": 1,
      "content": "CETIRIZINE HYDROCHLORIDE TABLETS (cetirizine hydrochloride) has been resupplied.",
      "drug_id": 750,
      "link": "/pharmacy/drug_detail/750",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1757,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:38.939725",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": "CETIRIZINE HYDROCHLORIDE TABLETS (cetirizine hydrochloride) has been resupplied.",
      "drug_id": 750,
      "link": "/pharmacy/drug_detail/750",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1758,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:38.944071",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": "CETIRIZINE HYDROCHLORIDE TABLETS (cetirizine hydrochloride) has been resupplied.",
      "drug_id": 750,
      "link": "/pharmacy/drug_detail/750",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1759,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:38.947485",
      "user_id": 420,
      "reminder_id": null,
      "is_read": 0,
      "content": "CETIRIZINE HYDROCHLORIDE TABLETS (cetirizine hydrochloride) has been resupplied.",
      "drug_id": 750,
      "link": "/pharmacy/drug_detail/750",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1760,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:58.432886",
      "user_id": 348,
      "reminder_id": null,
      "is_read": 1,
      "content": "PANTOPRAZOLE SODIUM INJECTION (PANTOPRAZOLE SODIUM) has been resupplied.",
      "drug_id": 815,
      "link": "/pharmacy/drug_detail/815",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1761,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:58.437499",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": "PANTOPRAZOLE SODIUM INJECTION (PANTOPRAZOLE SODIUM) has been resupplied.",
      "drug_id": 815,
      "link": "/pharmacy/drug_detail/815",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1762,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:58.443394",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": "PANTOPRAZOLE SODIUM INJECTION (PANTOPRAZOLE SODIUM) has been resupplied.",
      "drug_id": 815,
      "link": "/pharmacy/drug_detail/815",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1763,
    "fields": {
      "message_id": null,
      "time": "2025-12-31 21:02:58.447209",
      "user_id": 420,
      "reminder_id": null,
      "is_read": 0,
      "content": "PANTOPRAZOLE SODIUM INJECTION (PANTOPRAZOLE SODIUM) has been resupplied.",
      "drug_id": 815,
      "link": "/pharmacy/drug_detail/815",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1765,
    "fields": {
      "message_id": 403,
      "time": "2026-01-02 22:17:04.582780",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1766,
    "fields": {
      "message_id": 403,
      "time": "2026-01-02 22:17:04.591679",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1767,
    "fields": {
      "message_id": 403,
      "time": "2026-01-02 22:17:04.596729",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1768,
    "fields": {
      "message_id": 404,
      "time": "2026-01-02 22:19:42.384648",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1769,
    "fields": {
      "message_id": 404,
      "time": "2026-01-02 22:19:42.391893",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1770,
    "fields": {
      "message_id": 404,
      "time": "2026-01-02 22:19:42.397609",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1772,
    "fields": {
      "message_id": 405,
      "time": "2026-01-02 22:20:12.769013",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1773,
    "fields": {
      "message_id": 405,
      "time": "2026-01-02 22:20:12.775991",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1774,
    "fields": {
      "message_id": 405,
      "time": "2026-01-02 22:20:12.786131",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1776,
    "fields": {
      "message_id": 406,
      "time": "2026-01-02 22:20:41.003723",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1777,
    "fields": {
      "message_id": 406,
      "time": "2026-01-02 22:20:41.012966",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1778,
    "fields": {
      "message_id": 406,
      "time": "2026-01-02 22:20:41.020040",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1780,
    "fields": {
      "message_id": 407,
      "time": "2026-01-02 22:24:10.401994",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1781,
    "fields": {
      "message_id": 407,
      "time": "2026-01-02 22:24:10.410974",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1782,
    "fields": {
      "message_id": 407,
      "time": "2026-01-02 22:24:10.417518",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1784,
    "fields": {
      "message_id": 408,
      "time": "2026-01-02 22:24:38.333937",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1785,
    "fields": {
      "message_id": 408,
      "time": "2026-01-02 22:24:38.342341",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1786,
    "fields": {
      "message_id": 408,
      "time": "2026-01-02 22:24:38.348880",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1787,
    "fields": {
      "message_id": 409,
      "time": "2026-01-02 22:25:09.457722",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1788,
    "fields": {
      "message_id": 409,
      "time": "2026-01-02 22:25:09.466880",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1789,
    "fields": {
      "message_id": 409,
      "time": "2026-01-02 22:25:09.471929",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1791,
    "fields": {
      "message_id": 410,
      "time": "2026-01-02 22:28:33.672986",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1792,
    "fields": {
      "message_id": 410,
      "time": "2026-01-02 22:28:33.681801",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1793,
    "fields": {
      "message_id": 410,
      "time": "2026-01-02 22:28:33.689578",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1795,
    "fields": {
      "message_id": 411,
      "time": "2026-01-02 22:28:50.851466",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1796,
    "fields": {
      "message_id": 411,
      "time": "2026-01-02 22:28:50.858256",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1797,
    "fields": {
      "message_id": 411,
      "time": "2026-01-02 22:28:50.865822",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1799,
    "fields": {
      "message_id": 412,
      "time": "2026-01-02 22:36:29.519213",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1800,
    "fields": {
      "message_id": 412,
      "time": "2026-01-02 22:36:29.527506",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1801,
    "fields": {
      "message_id": 412,
      "time": "2026-01-02 22:36:29.542823",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1803,
    "fields": {
      "message_id": 413,
      "time": "2026-01-03 11:38:19.777053",
      "user_id": 17,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1804,
    "fields": {
      "message_id": 414,
      "time": "2026-01-03 11:43:14.152519",
      "user_id": 428,
      "reminder_id": null,
      "is_read": 1,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1809,
    "fields": {
      "message_id": null,
      "time": "2026-01-03 11:44:00.536933",
      "user_id": 428,
      "reminder_id": null,
      "is_read": 1,
      "content": "A refill request has been fulfilled and is ready for pick up.",
      "drug_id": null,
      "link": "/pharmacy/patient_profile/345#prescription-70",
      "prescription_id": 70
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1810,
    "fields": {
      "message_id": 415,
      "time": "2026-01-03 11:45:11.391960",
      "user_id": 47,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1811,
    "fields": {
      "message_id": 415,
      "time": "2026-01-03 11:45:11.407489",
      "user_id": 371,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1812,
    "fields": {
      "message_id": 415,
      "time": "2026-01-03 11:45:11.415777",
      "user_id": 372,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1813,
    "fields": {
      "message_id": 415,
      "time": "2026-01-03 11:45:11.423330",
      "user_id": 373,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1814,
    "fields": {
      "message_id": 416,
      "time": "2026-01-03 11:57:27.364665",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1815,
    "fields": {
      "message_id": 416,
      "time": "2026-01-03 11:57:27.373939",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1817,
    "fields": {
      "message_id": 416,
      "time": "2026-01-03 11:57:27.390166",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1818,
    "fields": {
      "message_id": 416,
      "time": "2026-01-03 11:57:27.397156",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1819,
    "fields": {
      "message_id": 417,
      "time": "2026-01-03 11:57:36.391103",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1820,
    "fields": {
      "message_id": 417,
      "time": "2026-01-03 11:57:36.399034",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1821,
    "fields": {
      "message_id": 417,
      "time": "2026-01-03 11:57:36.407746",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1822,
    "fields": {
      "message_id": 417,
      "time": "2026-01-03 11:57:36.414003",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1823,
    "fields": {
      "message_id": 418,
      "time": "2026-01-03 11:57:40.980820",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1824,
    "fields": {
      "message_id": 418,
      "time": "2026-01-03 11:57:40.986626",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1826,
    "fields": {
      "message_id": 418,
      "time": "2026-01-03 11:57:41.008935",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1827,
    "fields": {
      "message_id": 418,
      "time": "2026-01-03 11:57:41.017010",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1828,
    "fields": {
      "message_id": 419,
      "time": "2026-01-03 11:58:00.734294",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1829,
    "fields": {
      "message_id": 419,
      "time": "2026-01-03 11:58:00.744107",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1831,
    "fields": {
      "message_id": 419,
      "time": "2026-01-03 11:58:00.759586",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1832,
    "fields": {
      "message_id": 419,
      "time": "2026-01-03 11:58:00.766262",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1833,
    "fields": {
      "message_id": 420,
      "time": "2026-01-03 11:58:06.395024",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1834,
    "fields": {
      "message_id": 420,
      "time": "2026-01-03 11:58:06.403163",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1835,
    "fields": {
      "message_id": 420,
      "time": "2026-01-03 11:58:06.410407",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1836,
    "fields": {
      "message_id": 420,
      "time": "2026-01-03 11:58:06.416895",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1837,
    "fields": {
      "message_id": 421,
      "time": "2026-01-03 11:58:20.888622",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1838,
    "fields": {
      "message_id": 421,
      "time": "2026-01-03 11:58:20.900663",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1840,
    "fields": {
      "message_id": 421,
      "time": "2026-01-03 11:58:20.916582",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1841,
    "fields": {
      "message_id": 421,
      "time": "2026-01-03 11:58:20.922474",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1842,
    "fields": {
      "message_id": 422,
      "time": "2026-01-03 12:02:16.725533",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1843,
    "fields": {
      "message_id": 422,
      "time": "2026-01-03 12:02:16.746135",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1844,
    "fields": {
      "message_id": 422,
      "time": "2026-01-03 12:02:16.781874",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1845,
    "fields": {
      "message_id": 422,
      "time": "2026-01-03 12:02:16.797895",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1846,
    "fields": {
      "message_id": 423,
      "time": "2026-01-03 12:02:26.300321",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1847,
    "fields": {
      "message_id": 423,
      "time": "2026-01-03 12:02:26.328325",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1848,
    "fields": {
      "message_id": 423,
      "time": "2026-01-03 12:02:26.358714",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1849,
    "fields": {
      "message_id": 423,
      "time": "2026-01-03 12:02:26.391887",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1850,
    "fields": {
      "message_id": 424,
      "time": "2026-01-03 12:02:39.110396",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1851,
    "fields": {
      "message_id": 424,
      "time": "2026-01-03 12:02:39.133204",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1852,
    "fields": {
      "message_id": 424,
      "time": "2026-01-03 12:02:39.154994",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1853,
    "fields": {
      "message_id": 424,
      "time": "2026-01-03 12:02:39.177182",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1855,
    "fields": {
      "message_id": 425,
      "time": "2026-01-03 12:02:53.173586",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1856,
    "fields": {
      "message_id": 425,
      "time": "2026-01-03 12:02:53.195809",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1858,
    "fields": {
      "message_id": 425,
      "time": "2026-01-03 12:02:53.336404",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1859,
    "fields": {
      "message_id": 425,
      "time": "2026-01-03 12:02:53.399368",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1860,
    "fields": {
      "message_id": 426,
      "time": "2026-01-03 12:03:02.982617",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1861,
    "fields": {
      "message_id": 426,
      "time": "2026-01-03 12:03:03.001778",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1862,
    "fields": {
      "message_id": 426,
      "time": "2026-01-03 12:03:03.014481",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1863,
    "fields": {
      "message_id": 426,
      "time": "2026-01-03 12:03:03.044436",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1864,
    "fields": {
      "message_id": 427,
      "time": "2026-01-03 12:03:07.862997",
      "user_id": 14,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1865,
    "fields": {
      "message_id": 427,
      "time": "2026-01-03 12:03:07.888822",
      "user_id": 16,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1866,
    "fields": {
      "message_id": 427,
      "time": "2026-01-03 12:03:07.935073",
      "user_id": 326,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1867,
    "fields": {
      "message_id": 427,
      "time": "2026-01-03 12:03:07.946534",
      "user_id": 327,
      "reminder_id": null,
      "is_read": 0,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1868,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:28:15.283841",
      "user_id": 428,
      "reminder_id": 15,
      "is_read": 1,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1871,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:32:00.031798",
      "user_id": 428,
      "reminder_id": 15,
      "is_read": 1,
      "content": null,
      "drug_id": null,
      "link": null,
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1872,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:53:41.362133",
      "user_id": 348,
      "reminder_id": null,
      "is_read": 1,
      "content": "AMOXICILLIN (Amoxicillin) has been resupplied.",
      "drug_id": 733,
      "link": "/pharmacy/drug_detail/733",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1873,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:53:41.367216",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": "AMOXICILLIN (Amoxicillin) has been resupplied.",
      "drug_id": 733,
      "link": "/pharmacy/drug_detail/733",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1874,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:53:41.370904",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": "AMOXICILLIN (Amoxicillin) has been resupplied.",
      "drug_id": 733,
      "link": "/pharmacy/drug_detail/733",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1875,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:53:41.377106",
      "user_id": 420,
      "reminder_id": null,
      "is_read": 0,
      "content": "AMOXICILLIN (Amoxicillin) has been resupplied.",
      "drug_id": 733,
      "link": "/pharmacy/drug_detail/733",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1876,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:54:36.541113",
      "user_id": 23,
      "reminder_id": null,
      "is_read": 1,
      "content": "A resupply of BUPROPION HYDROCHLORIDE (Bupropion Hydrochloride XL) has been requested due to low inventory.",
      "drug_id": 742,
      "link": "/pharmacy/drug_detail/742",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1877,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:54:45.585305",
      "user_id": 348,
      "reminder_id": null,
      "is_read": 1,
      "content": "BUPROPION HYDROCHLORIDE (Bupropion Hydrochloride XL) has been resupplied.",
      "drug_id": 742,
      "link": "/pharmacy/drug_detail/742",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1878,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:54:45.588552",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": "BUPROPION HYDROCHLORIDE (Bupropion Hydrochloride XL) has been resupplied.",
      "drug_id": 742,
      "link": "/pharmacy/drug_detail/742",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1879,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:54:45.597310",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": "BUPROPION HYDROCHLORIDE (Bupropion Hydrochloride XL) has been resupplied.",
      "drug_id": 742,
      "link": "/pharmacy/drug_detail/742",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1880,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 20:54:45.601571",
      "user_id": 420,
      "reminder_id": null,
      "is_read": 0,
      "content": "BUPROPION HYDROCHLORIDE (Bupropion Hydrochloride XL) has been resupplied.",
      "drug_id": 742,
      "link": "/pharmacy/drug_detail/742",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1881,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 21:10:30.245684",
      "user_id": 23,
      "reminder_id": null,
      "is_read": 1,
      "content": "A resupply of AMLODIPINE BESYLATE (Amlodipine Besylate) has been requested due to low inventory.",
      "drug_id": 734,
      "link": "/pharmacy/drug_detail/734",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1882,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 21:10:44.943905",
      "user_id": 348,
      "reminder_id": null,
      "is_read": 1,
      "content": "AMLODIPINE BESYLATE (Amlodipine Besylate) has been resupplied.",
      "drug_id": 734,
      "link": "/pharmacy/drug_detail/734",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1883,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 21:10:45.034426",
      "user_id": 349,
      "reminder_id": null,
      "is_read": 0,
      "content": "AMLODIPINE BESYLATE (Amlodipine Besylate) has been resupplied.",
      "drug_id": 734,
      "link": "/pharmacy/drug_detail/734",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1884,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 21:10:45.051360",
      "user_id": 350,
      "reminder_id": null,
      "is_read": 0,
      "content": "AMLODIPINE BESYLATE (Amlodipine Besylate) has been resupplied.",
      "drug_id": 734,
      "link": "/pharmacy/drug_detail/734",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.notifications",
    "pk": 1885,
    "fields": {
      "message_id": null,
      "time": "2026-01-05 21:10:45.091443",
      "user_id": 420,
      "reminder_id": null,
      "is_read": 0,
      "content": "AMLODIPINE BESYLATE (Amlodipine Besylate) has been resupplied.",
      "drug_id": 734,
      "link": "/pharmacy/drug_detail/734",
      "prescription_id": null
    }
  },
  {
    "model": "accounts.thread",
    "pk": 122,
    "fields": {
      "created_at": "2025-12-01 22:12:00.077091",
      "last_updated": "2025-12-01 22:12:00.077158"
    }
  },
  {
    "model": "accounts.thread",
    "pk": 123,
    "fields": {
      "created_at": "2025-12-24 13:41:33.113900",
      "last_updated": "2025-12-24 13:41:33.113951"
    }
  },
  {
    "model": "accounts.thread",
    "pk": 124,
    "fields": {
      "created_at": "2025-12-26 00:58:53.149582",
      "last_updated": "2025-12-26 00:58:53.149679"
    }
  },
  {
    "model": "accounts.thread",
    "pk": 125,
    "fields": {
      "created_at": "2025-12-26 20:46:56.954859",
      "last_updated": "2025-12-26 20:46:56.954922"
    }
  },
  {
    "model": "accounts.thread",
    "pk": 126,
    "fields": {
      "created_at": "2025-12-26 20:47:29.756282",
      "last_updated": "2025-12-26 20:47:29.756360"
    }
  },
  {
    "model": "accounts.thread",
    "pk": 127,
    "fields": {
      "created_at": "2025-12-31 22:58:48.982818",
      "last_updated": "2025-12-31 22:58:48.982871"
    }
  },
  {
    "model": "accounts.thread",
    "pk": 128,
    "fields": {
      "created_at": "2026-01-03 11:38:19.764971",
      "last_updated": "2026-01-03 11:38:19.765035"
    }
  },
  {
    "model": "accounts.thread",
    "pk": 129,
    "fields": {
      "created_at": "2026-01-03 11:43:14.141527",
      "last_updated": "2026-01-03 11:43:14.141567"
    }
  },
  {
    "model": "accounts.thread",
    "pk": 130,
    "fields": {
      "created_at": "2026-01-03 11:44:00.525227",
      "last_updated": "2026-01-03 11:44:00.525299"
    }
  },
  {
    "model": "accounts.thread",
    "pk": 131,
    "fields": {
      "created_at": "2026-01-03 11:57:18.831294",
      "last_updated": "2026-01-03 11:57:18.831343"
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 451,
    "fields": {
      "thread_id": 122,
      "customaccount_id": 17
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 452,
    "fields": {
      "thread_id": 122,
      "customaccount_id": 23
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 453,
    "fields": {
      "thread_id": 122,
      "customaccount_id": 348
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 454,
    "fields": {
      "thread_id": 122,
      "customaccount_id": 349
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 455,
    "fields": {
      "thread_id": 122,
      "customaccount_id": 350
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 456,
    "fields": {
      "thread_id": 123,
      "customaccount_id": 417
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 457,
    "fields": {
      "thread_id": 123,
      "customaccount_id": 420
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 458,
    "fields": {
      "thread_id": 123,
      "customaccount_id": 23
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 459,
    "fields": {
      "thread_id": 123,
      "customaccount_id": 348
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 460,
    "fields": {
      "thread_id": 123,
      "customaccount_id": 349
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 461,
    "fields": {
      "thread_id": 123,
      "customaccount_id": 350
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 462,
    "fields": {
      "thread_id": 124,
      "customaccount_id": 365
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 463,
    "fields": {
      "thread_id": 124,
      "customaccount_id": 23
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 464,
    "fields": {
      "thread_id": 124,
      "customaccount_id": 420
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 465,
    "fields": {
      "thread_id": 124,
      "customaccount_id": 348
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 466,
    "fields": {
      "thread_id": 124,
      "customaccount_id": 349
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 467,
    "fields": {
      "thread_id": 124,
      "customaccount_id": 350
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 468,
    "fields": {
      "thread_id": 125,
      "customaccount_id": 367
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 469,
    "fields": {
      "thread_id": 125,
      "customaccount_id": 23
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 470,
    "fields": {
      "thread_id": 125,
      "customaccount_id": 420
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 471,
    "fields": {
      "thread_id": 125,
      "customaccount_id": 348
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 472,
    "fields": {
      "thread_id": 125,
      "customaccount_id": 349
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 473,
    "fields": {
      "thread_id": 125,
      "customaccount_id": 350
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 474,
    "fields": {
      "thread_id": 126,
      "customaccount_id": 364
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 475,
    "fields": {
      "thread_id": 126,
      "customaccount_id": 23
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 476,
    "fields": {
      "thread_id": 126,
      "customaccount_id": 420
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 477,
    "fields": {
      "thread_id": 126,
      "customaccount_id": 348
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 478,
    "fields": {
      "thread_id": 126,
      "customaccount_id": 349
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 479,
    "fields": {
      "thread_id": 126,
      "customaccount_id": 350
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 480,
    "fields": {
      "thread_id": 127,
      "customaccount_id": 428
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 481,
    "fields": {
      "thread_id": 127,
      "customaccount_id": 47
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 482,
    "fields": {
      "thread_id": 127,
      "customaccount_id": 371
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 483,
    "fields": {
      "thread_id": 127,
      "customaccount_id": 372
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 484,
    "fields": {
      "thread_id": 127,
      "customaccount_id": 373
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 485,
    "fields": {
      "thread_id": 128,
      "customaccount_id": 417
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 486,
    "fields": {
      "thread_id": 128,
      "customaccount_id": 420
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 487,
    "fields": {
      "thread_id": 128,
      "customaccount_id": 23
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 488,
    "fields": {
      "thread_id": 128,
      "customaccount_id": 348
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 489,
    "fields": {
      "thread_id": 128,
      "customaccount_id": 349
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 490,
    "fields": {
      "thread_id": 128,
      "customaccount_id": 350
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 491,
    "fields": {
      "thread_id": 129,
      "customaccount_id": 417
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 492,
    "fields": {
      "thread_id": 129,
      "customaccount_id": 325
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 493,
    "fields": {
      "thread_id": 129,
      "customaccount_id": 326
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 494,
    "fields": {
      "thread_id": 129,
      "customaccount_id": 327
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 495,
    "fields": {
      "thread_id": 129,
      "customaccount_id": 14
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 496,
    "fields": {
      "thread_id": 129,
      "customaccount_id": 16
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 497,
    "fields": {
      "thread_id": 130,
      "customaccount_id": 417
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 498,
    "fields": {
      "thread_id": 130,
      "customaccount_id": 428
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 499,
    "fields": {
      "thread_id": 131,
      "customaccount_id": 428
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 500,
    "fields": {
      "thread_id": 131,
      "customaccount_id": 14
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 501,
    "fields": {
      "thread_id": 131,
      "customaccount_id": 16
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 502,
    "fields": {
      "thread_id": 131,
      "customaccount_id": 325
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 503,
    "fields": {
      "thread_id": 131,
      "customaccount_id": 326
    }
  },
  {
    "model": "accounts.thread_participant",
    "pk": 504,
    "fields": {
      "thread_id": 131,
      "customaccount_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 565,
    "fields": {
      "read": 1,
      "message_id": 376,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 566,
    "fields": {
      "read": 1,
      "message_id": 376,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 567,
    "fields": {
      "read": 0,
      "message_id": 376,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 568,
    "fields": {
      "read": 0,
      "message_id": 376,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 569,
    "fields": {
      "read": 1,
      "message_id": 377,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 570,
    "fields": {
      "read": 1,
      "message_id": 377,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 571,
    "fields": {
      "read": 0,
      "message_id": 377,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 572,
    "fields": {
      "read": 0,
      "message_id": 377,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 573,
    "fields": {
      "read": 1,
      "message_id": 378,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 574,
    "fields": {
      "read": 1,
      "message_id": 378,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 575,
    "fields": {
      "read": 0,
      "message_id": 378,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 576,
    "fields": {
      "read": 0,
      "message_id": 378,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 577,
    "fields": {
      "read": 1,
      "message_id": 379,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 578,
    "fields": {
      "read": 1,
      "message_id": 379,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 579,
    "fields": {
      "read": 0,
      "message_id": 379,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 580,
    "fields": {
      "read": 0,
      "message_id": 379,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 581,
    "fields": {
      "read": 1,
      "message_id": 380,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 582,
    "fields": {
      "read": 1,
      "message_id": 380,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 583,
    "fields": {
      "read": 0,
      "message_id": 380,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 584,
    "fields": {
      "read": 0,
      "message_id": 380,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 585,
    "fields": {
      "read": 1,
      "message_id": 381,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 586,
    "fields": {
      "read": 1,
      "message_id": 381,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 587,
    "fields": {
      "read": 0,
      "message_id": 381,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 588,
    "fields": {
      "read": 0,
      "message_id": 381,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 589,
    "fields": {
      "read": 1,
      "message_id": 382,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 590,
    "fields": {
      "read": 1,
      "message_id": 382,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 591,
    "fields": {
      "read": 0,
      "message_id": 382,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 592,
    "fields": {
      "read": 0,
      "message_id": 382,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 593,
    "fields": {
      "read": 1,
      "message_id": 383,
      "user_id": 17
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 594,
    "fields": {
      "read": 1,
      "message_id": 383,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 595,
    "fields": {
      "read": 0,
      "message_id": 383,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 596,
    "fields": {
      "read": 0,
      "message_id": 383,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 597,
    "fields": {
      "read": 1,
      "message_id": 384,
      "user_id": 17
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 598,
    "fields": {
      "read": 1,
      "message_id": 384,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 599,
    "fields": {
      "read": 0,
      "message_id": 384,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 600,
    "fields": {
      "read": 0,
      "message_id": 384,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 601,
    "fields": {
      "read": 1,
      "message_id": 385,
      "user_id": 17
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 602,
    "fields": {
      "read": 1,
      "message_id": 385,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 603,
    "fields": {
      "read": 0,
      "message_id": 385,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 604,
    "fields": {
      "read": 0,
      "message_id": 385,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 605,
    "fields": {
      "read": 1,
      "message_id": 386,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 606,
    "fields": {
      "read": 1,
      "message_id": 386,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 607,
    "fields": {
      "read": 0,
      "message_id": 386,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 608,
    "fields": {
      "read": 0,
      "message_id": 386,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 609,
    "fields": {
      "read": 1,
      "message_id": 387,
      "user_id": 17
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 610,
    "fields": {
      "read": 1,
      "message_id": 387,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 611,
    "fields": {
      "read": 0,
      "message_id": 387,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 612,
    "fields": {
      "read": 0,
      "message_id": 387,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 613,
    "fields": {
      "read": 1,
      "message_id": 388,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 614,
    "fields": {
      "read": 1,
      "message_id": 388,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 615,
    "fields": {
      "read": 0,
      "message_id": 388,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 616,
    "fields": {
      "read": 0,
      "message_id": 388,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 617,
    "fields": {
      "read": 1,
      "message_id": 389,
      "user_id": 17
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 618,
    "fields": {
      "read": 1,
      "message_id": 389,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 619,
    "fields": {
      "read": 0,
      "message_id": 389,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 620,
    "fields": {
      "read": 0,
      "message_id": 389,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 621,
    "fields": {
      "read": 1,
      "message_id": 390,
      "user_id": 17
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 622,
    "fields": {
      "read": 1,
      "message_id": 390,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 623,
    "fields": {
      "read": 0,
      "message_id": 390,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 624,
    "fields": {
      "read": 0,
      "message_id": 390,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 625,
    "fields": {
      "read": 1,
      "message_id": 391,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 626,
    "fields": {
      "read": 1,
      "message_id": 391,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 627,
    "fields": {
      "read": 0,
      "message_id": 391,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 628,
    "fields": {
      "read": 0,
      "message_id": 391,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 629,
    "fields": {
      "read": 1,
      "message_id": 392,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 630,
    "fields": {
      "read": 1,
      "message_id": 392,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 631,
    "fields": {
      "read": 0,
      "message_id": 392,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 632,
    "fields": {
      "read": 0,
      "message_id": 392,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 633,
    "fields": {
      "read": 1,
      "message_id": 393,
      "user_id": 17
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 634,
    "fields": {
      "read": 1,
      "message_id": 393,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 635,
    "fields": {
      "read": 0,
      "message_id": 393,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 636,
    "fields": {
      "read": 0,
      "message_id": 393,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 637,
    "fields": {
      "read": 1,
      "message_id": 394,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 638,
    "fields": {
      "read": 1,
      "message_id": 394,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 639,
    "fields": {
      "read": 0,
      "message_id": 394,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 640,
    "fields": {
      "read": 0,
      "message_id": 394,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 641,
    "fields": {
      "read": 1,
      "message_id": 395,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 642,
    "fields": {
      "read": 1,
      "message_id": 395,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 643,
    "fields": {
      "read": 0,
      "message_id": 395,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 644,
    "fields": {
      "read": 0,
      "message_id": 395,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 645,
    "fields": {
      "read": 1,
      "message_id": 396,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 646,
    "fields": {
      "read": 1,
      "message_id": 396,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 647,
    "fields": {
      "read": 0,
      "message_id": 396,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 648,
    "fields": {
      "read": 0,
      "message_id": 396,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 649,
    "fields": {
      "read": 1,
      "message_id": 397,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 650,
    "fields": {
      "read": 1,
      "message_id": 397,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 651,
    "fields": {
      "read": 0,
      "message_id": 397,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 652,
    "fields": {
      "read": 0,
      "message_id": 397,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 653,
    "fields": {
      "read": 1,
      "message_id": 398,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 654,
    "fields": {
      "read": 1,
      "message_id": 398,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 655,
    "fields": {
      "read": 0,
      "message_id": 398,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 656,
    "fields": {
      "read": 0,
      "message_id": 398,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 657,
    "fields": {
      "read": 1,
      "message_id": 399,
      "user_id": 17
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 658,
    "fields": {
      "read": 1,
      "message_id": 399,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 659,
    "fields": {
      "read": 0,
      "message_id": 399,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 660,
    "fields": {
      "read": 0,
      "message_id": 399,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 661,
    "fields": {
      "read": 1,
      "message_id": 400,
      "user_id": 17
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 662,
    "fields": {
      "read": 1,
      "message_id": 400,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 663,
    "fields": {
      "read": 0,
      "message_id": 400,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 664,
    "fields": {
      "read": 0,
      "message_id": 400,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 665,
    "fields": {
      "read": 1,
      "message_id": 401,
      "user_id": 23
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 666,
    "fields": {
      "read": 1,
      "message_id": 401,
      "user_id": 348
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 667,
    "fields": {
      "read": 0,
      "message_id": 401,
      "user_id": 349
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 668,
    "fields": {
      "read": 0,
      "message_id": 401,
      "user_id": 350
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 669,
    "fields": {
      "read": 1,
      "message_id": 403,
      "user_id": 47
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 670,
    "fields": {
      "read": 0,
      "message_id": 403,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 671,
    "fields": {
      "read": 0,
      "message_id": 403,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 672,
    "fields": {
      "read": 0,
      "message_id": 403,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 673,
    "fields": {
      "read": 0,
      "message_id": 404,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 674,
    "fields": {
      "read": 0,
      "message_id": 404,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 675,
    "fields": {
      "read": 0,
      "message_id": 404,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 676,
    "fields": {
      "read": 1,
      "message_id": 404,
      "user_id": 428
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 677,
    "fields": {
      "read": 1,
      "message_id": 405,
      "user_id": 47
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 678,
    "fields": {
      "read": 0,
      "message_id": 405,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 679,
    "fields": {
      "read": 0,
      "message_id": 405,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 680,
    "fields": {
      "read": 0,
      "message_id": 405,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 681,
    "fields": {
      "read": 1,
      "message_id": 406,
      "user_id": 47
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 682,
    "fields": {
      "read": 0,
      "message_id": 406,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 683,
    "fields": {
      "read": 0,
      "message_id": 406,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 684,
    "fields": {
      "read": 0,
      "message_id": 406,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 685,
    "fields": {
      "read": 1,
      "message_id": 407,
      "user_id": 47
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 686,
    "fields": {
      "read": 0,
      "message_id": 407,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 687,
    "fields": {
      "read": 0,
      "message_id": 407,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 688,
    "fields": {
      "read": 0,
      "message_id": 407,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 689,
    "fields": {
      "read": 1,
      "message_id": 408,
      "user_id": 47
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 690,
    "fields": {
      "read": 0,
      "message_id": 408,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 691,
    "fields": {
      "read": 0,
      "message_id": 408,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 692,
    "fields": {
      "read": 0,
      "message_id": 408,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 693,
    "fields": {
      "read": 0,
      "message_id": 409,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 694,
    "fields": {
      "read": 0,
      "message_id": 409,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 695,
    "fields": {
      "read": 0,
      "message_id": 409,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 696,
    "fields": {
      "read": 1,
      "message_id": 409,
      "user_id": 428
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 697,
    "fields": {
      "read": 0,
      "message_id": 410,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 698,
    "fields": {
      "read": 0,
      "message_id": 410,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 699,
    "fields": {
      "read": 0,
      "message_id": 410,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 700,
    "fields": {
      "read": 1,
      "message_id": 410,
      "user_id": 428
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 701,
    "fields": {
      "read": 0,
      "message_id": 411,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 702,
    "fields": {
      "read": 0,
      "message_id": 411,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 703,
    "fields": {
      "read": 0,
      "message_id": 411,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 704,
    "fields": {
      "read": 1,
      "message_id": 411,
      "user_id": 428
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 705,
    "fields": {
      "read": 0,
      "message_id": 412,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 706,
    "fields": {
      "read": 0,
      "message_id": 412,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 707,
    "fields": {
      "read": 0,
      "message_id": 412,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 708,
    "fields": {
      "read": 1,
      "message_id": 412,
      "user_id": 428
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 709,
    "fields": {
      "read": 0,
      "message_id": 415,
      "user_id": 47
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 710,
    "fields": {
      "read": 0,
      "message_id": 415,
      "user_id": 371
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 711,
    "fields": {
      "read": 0,
      "message_id": 415,
      "user_id": 372
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 712,
    "fields": {
      "read": 0,
      "message_id": 415,
      "user_id": 373
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 713,
    "fields": {
      "read": 0,
      "message_id": 416,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 714,
    "fields": {
      "read": 0,
      "message_id": 416,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 715,
    "fields": {
      "read": 1,
      "message_id": 416,
      "user_id": 325
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 716,
    "fields": {
      "read": 0,
      "message_id": 416,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 717,
    "fields": {
      "read": 0,
      "message_id": 416,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 718,
    "fields": {
      "read": 0,
      "message_id": 417,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 719,
    "fields": {
      "read": 0,
      "message_id": 417,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 720,
    "fields": {
      "read": 0,
      "message_id": 417,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 721,
    "fields": {
      "read": 0,
      "message_id": 417,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 722,
    "fields": {
      "read": 1,
      "message_id": 417,
      "user_id": 428
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 723,
    "fields": {
      "read": 0,
      "message_id": 418,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 724,
    "fields": {
      "read": 0,
      "message_id": 418,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 725,
    "fields": {
      "read": 1,
      "message_id": 418,
      "user_id": 325
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 726,
    "fields": {
      "read": 0,
      "message_id": 418,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 727,
    "fields": {
      "read": 0,
      "message_id": 418,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 728,
    "fields": {
      "read": 0,
      "message_id": 419,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 729,
    "fields": {
      "read": 0,
      "message_id": 419,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 730,
    "fields": {
      "read": 1,
      "message_id": 419,
      "user_id": 325
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 731,
    "fields": {
      "read": 0,
      "message_id": 419,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 732,
    "fields": {
      "read": 0,
      "message_id": 419,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 733,
    "fields": {
      "read": 0,
      "message_id": 420,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 734,
    "fields": {
      "read": 0,
      "message_id": 420,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 735,
    "fields": {
      "read": 0,
      "message_id": 420,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 736,
    "fields": {
      "read": 0,
      "message_id": 420,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 737,
    "fields": {
      "read": 1,
      "message_id": 420,
      "user_id": 428
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 738,
    "fields": {
      "read": 0,
      "message_id": 421,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 739,
    "fields": {
      "read": 0,
      "message_id": 421,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 740,
    "fields": {
      "read": 1,
      "message_id": 421,
      "user_id": 325
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 741,
    "fields": {
      "read": 0,
      "message_id": 421,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 742,
    "fields": {
      "read": 0,
      "message_id": 421,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 743,
    "fields": {
      "read": 0,
      "message_id": 422,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 744,
    "fields": {
      "read": 0,
      "message_id": 422,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 745,
    "fields": {
      "read": 1,
      "message_id": 422,
      "user_id": 325
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 746,
    "fields": {
      "read": 0,
      "message_id": 422,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 747,
    "fields": {
      "read": 0,
      "message_id": 422,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 748,
    "fields": {
      "read": 0,
      "message_id": 423,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 749,
    "fields": {
      "read": 0,
      "message_id": 423,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 750,
    "fields": {
      "read": 0,
      "message_id": 423,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 751,
    "fields": {
      "read": 0,
      "message_id": 423,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 752,
    "fields": {
      "read": 1,
      "message_id": 423,
      "user_id": 428
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 753,
    "fields": {
      "read": 0,
      "message_id": 424,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 754,
    "fields": {
      "read": 0,
      "message_id": 424,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 755,
    "fields": {
      "read": 0,
      "message_id": 424,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 756,
    "fields": {
      "read": 0,
      "message_id": 424,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 757,
    "fields": {
      "read": 1,
      "message_id": 424,
      "user_id": 428
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 758,
    "fields": {
      "read": 0,
      "message_id": 425,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 759,
    "fields": {
      "read": 0,
      "message_id": 425,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 760,
    "fields": {
      "read": 1,
      "message_id": 425,
      "user_id": 325
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 761,
    "fields": {
      "read": 0,
      "message_id": 425,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 762,
    "fields": {
      "read": 0,
      "message_id": 425,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 763,
    "fields": {
      "read": 0,
      "message_id": 426,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 764,
    "fields": {
      "read": 0,
      "message_id": 426,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 765,
    "fields": {
      "read": 0,
      "message_id": 426,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 766,
    "fields": {
      "read": 0,
      "message_id": 426,
      "user_id": 327
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 767,
    "fields": {
      "read": 1,
      "message_id": 426,
      "user_id": 428
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 768,
    "fields": {
      "read": 0,
      "message_id": 427,
      "user_id": 14
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 769,
    "fields": {
      "read": 0,
      "message_id": 427,
      "user_id": 16
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 770,
    "fields": {
      "read": 1,
      "message_id": 427,
      "user_id": 325
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 771,
    "fields": {
      "read": 0,
      "message_id": 427,
      "user_id": 326
    }
  },
  {
    "model": "accounts.readstatus",
    "pk": 772,
    "fields": {
      "read": 0,
      "message_id": 427,
      "user_id": 327
    }
  }
]